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RESUMEN 
El sistema respiratorio es imprescindible para la obtención del oxígeno necesario para 
los procesos metabólicos. El intercambio gaseoso tiene lugar a través de la barrera 
alveolo-capilar, donde el oxígeno y el dióxido de carbono difunden entre el espacio aéreo 
en los alveolos y los eritrocitos en el torrente sanguíneo. El epitelio respiratorio representa 
la superficie más extensa del organismo expuesta a la atmósfera y se compone de dos 
tipos celulares, las células alveolares tipo I (ATI) y las células alveolares tipo II (ATII). 
Las células ATI constituyen la mayor superficie epitelial destinada a intercambio gaseoso 
en los alveolos, mientras que la principal función de las células ATII es la síntesis y el 
ensamblaje de los componentes del surfactante pulmonar en forma de ensamblados de 
membranas altamente empaquetadas en el interior de organelas ácidas, denominadas 
cuerpos lamelares. El principal estímulo fisiológico para la secreción de surfactante es el 
estiramiento del epitelio alveolar durante la inspiración, el cual provoca un incremento en 
la concentración de calcio citoplasmático que, a su vez, desencadena la fusión de los 
cuerpos lamelares con la membrana plasmática de las células ATII y finalmente, la 
liberación de surfactante al espacio alveolar. Una vez secretado, el surfactante pulmonar 
se adsorbe y se extiende a lo largo de la interfase aire-líquido alveolar, donde el 
surfactante estabiliza la superficie respiratoria durante los sucesivos ciclos de inspiración-
espiración al reducir la tensión superficial. Además de esta función principal, el 
surfactante pulmonar también participa en la defensa pulmonar contra infecciones 
provocadas por virus, bacterias y hongos, ejerciendo actividades microbicidas directas u 
opsonizando patógenos y modulando las respuestas celulares inflamatorias. 
El surfactante pulmonar se compone de aproximadamente un 90% de lípidos y un 10% 
de proteínas específicas, en masa. La dipalmitoilfosfatidilcolina (DPPC) es el fosfolípido 
más abundante, constituyendo alrededor de un 41% de la masa total de surfactante. Entre 
otros fosfolípidos, las especies de fosfatidilglicerol (PG), cargadas negativamente, 
comprenden aproximadamente un 9% de la masa de surfactante. En lo que respecta a la 
fracción proteica del surfactante, las proteínas hidrofílicas SP-A y SP-D participan en la 
defensa inmune del pulmón, mientras que las proteínas hidrofóbicas SP-B y SP-C están 
involucradas en la función biofísica del surfactante pulmonar. 
La función tensioactiva del surfactante pulmonar comprende tres propiedades 
fundamentales: 1) rápida adsorción de los complejos de surfactante, 2) máxima 
compresión de la película interfacial, logrando muy bajas tensiones superficiales al final 
de la espiración y 3) eficiente re-extensión a lo largo de la nueva superficie expuesta 
durante la inspiración. DPPC, SP-B y SP-C poseen papeles esenciales en el surfactante 
que aseguran una actividad interfacial óptima del surfactante pulmonar. En el caso de la 
DPPC, sus cadenas acilo saturadas permiten un alto grado de empaquetamiento de estas 
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moléculas fosfolipídicas en monocapas interfaciales sometidas a compresión lateral. Por 
su parte, las proteínas SP-B y SP-C ejercen una amplia variedad de efectos sobre bicapas 
y monocapas lipídicas que promueven profundas reorganizaciones en los lípidos 
estrechamente relacionadas con la función tensioactiva del surfactante pulmonar en la 
interfase alveolar. 
SP-B es la proteína más importante para el mantenimiento de la función respiratoria, 
ya que la ausencia de su expresión conlleva fallo respiratorio en el momento del 
nacimiento. Además de su participación en la función tensioactiva del surfactante, la SP-
B está involucrada en otros procesos de la homeostasis del surfactante, incluyendo su 
participación en el procesamiento post-traduccional de la SP-C y en la biogénesis de los 
cuerpos lamelares, así como en la formación de formas extracelulares del surfactante, 
como la mielina tubular, una estructura en forma de red compuesta por lípidos del 
surfactante y las proteínas SP-A y SP-B. Aunque la estructura terciaria de la proteína SP-
B no se conoce en su totalidad, su purificación a partir de surfactante pulmonar porcino 
solubilizado en detergente reveló la existencia de complejos nativos de SP-B que adoptan 
una estructura en forma de anillos de 10 nm de diámetro. De acuerdo con un modelo de 
la estructura tridimensional de la SP-B basada en la estructura de la Saposina B, la 
organización supramolecular nativa de la SP-B consistiría en 5 o 6 dímeros covalentes 
ensamblados en forma de anillo, que se dispondrían de manera paralela a la superficie de 
bicapas lipídicas a través la interacción de los segmentos helicoidales amino- y carboxilo-
terminales con las cabezas polares de los fosfolípidos. 
OBJETIVOS 
El principal objetivo de esta Tesis es contribuir al conocimiento de las estructuras y 
funciones de los complejos proteicos nativos presentes en el surfactante pulmonar, con 
un foco especial en aquellos constituidos por SP-B. Así, se han abordado cinco objetivos 
específicos en este trabajo: 
1. La realización de análisis composicionales y estructurales de complejos proteicos 
procedentes de surfactante solubilizado en detergente o de nanodiscos de surfactante. 
Además, se utilizó la técnica del entrecruzamiento de proteínas para intentar clarificar las 
interacciones entre SP-B y SP-C en ambientes lipídicos cuasi-nativos. 
 
2. El estudio del efecto de los complejos proteicos del surfactante en la 
permeabilidad y la dinámica interfacial de las membranas del surfactante pulmonar, para 
proponer un potencial mecanismo para la acción dual de la SP-B en ambas actividades 
del surfactante. 
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3. El abordaje de una caracterización más profunda de los oligómeros nativos de SP-
B, principalmente en ambientes lipídicos, tratando de generar muestras con una calidad 
apropiada para una posterior caracterización estructural de los complejos a alta 
resolución. 
 
4. El estudio de características estructurales de la SP-B aplicando metodologías de 
espectroscopía de fluorescencia, incluyendo la determinación de la estequiometria de los 
oligómeros nativos de SP-B en membranas y un estudio cuantitativo de los cambios 
topológicos inducidos por SP-B en estructuras multilamelares. 
5. El estudio del efecto de la SP-B en la secreción del surfactante en células ATII. 
Esclarecimiento de los mecanismos de señalización que conectan la SP-B con la 
exocitosis de cuerpos lamelares en células ATII. 
 
RESULTADOS PRINCIPALES Y CONCLUSIONES 
El presente trabajo revela características estructurales y funcionales de la SP-B a través 
de tres procesos inducidos por la proteína: la agregación de membranas que conduce a la 
reorganización de estructuras del surfactante, la permeabilidad de membranas a través de 
la formación de poros, que permiten el flujo de lípidos y moléculas polares, y la 
estimulación de la secreción de surfactante en células ATII. 
A lo largo de esta Tesis, ha quedado probado de manera reiterada la existencia de una 
organización supramolecular de la SP-B en el surfactante pulmonar. Además de los 
complejos nativos de SP-B purificados a partir de membranas de surfactante solubilizadas 
en detergente, los dímeros de SP-B procedentes del extracto orgánico completo del 
surfactante pulmonar o de la proteína aislada en solvente orgánico son capaces de auto-
ensamblarse en presencia de lípidos, dando lugar a la estructura en forma de anillo del 
oligómero de SP-B, que se dispone sobre las cabezas polares de los fosfolípidos en 
bicapas y monocapas. 
Se sabe que la SP-B induce la formación de estructuras multicapa altamente cohesivas 
asociadas a la monocapa interfacial, que parece constituir un reservorio de surfactante 
que asegura la estabilidad de la película tensioactiva contra el estrés mecánico producido 
por los continuos ciclos alveolares de compresión-expansión durante la respiración. Los 
experimentos de transferencia de energía por resonancia Förster resuelta en el tiempo 
(Time-resolved FRET) realizados en este trabajo aportan información cuantitativa sobre 
la topología de los agregados SP-B/membrana, demostrando que la conexión entre dos 
membranas está mediada por la interacción de dos oligómeros de SP-B en forma de 
anillos. Estas interacciones SP-B/SP-B serán responsables del papel de la SP-B en la 
función biofísica del surfactante pulmonar en la interfase alveolar, pero también podrían 
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estar participando en el empaquetamiento de membranas durante la biogénesis de los 
cuerpos lamelares en las células ATII. 
Sobre el estudio de la permeabilidad de membranas del surfactante, el bloqueo 
selectivo de la SP-B con anticuerpos demuestra que los oligómeros de SP-B en forma de 
anillo son responsables de la generación de poros en membranas del surfactante, que 
permiten el flujo de moléculas polares y la transferencia de lípidos a través de membranas 
interconectadas del reservorio de surfactante y entre estas y la monocapa interfacial. De 
acuerdo con los resultados obtenidos del estudio de FRET, dos oligómeros de SP-B 
constituirían la maquinaria de transferencia de lípidos que aseguraría la función 
tensioactiva óptima del surfactante pulmonar. Además, la presencia de estas estructuras 
formadoras de poros en las membranas del surfactante facilitaría la difusión de iones, 
gases, como el oxígeno, y pequeñas moléculas polares, como péptidos implicados en la 
defensa innata del pulmón, asegurando un equilibrio iónico adecuado en la fina capa de 
fluido que recubre el epitelio alveolar y una rápida difusión de oxígenos desde el espacio 
aéreo a través de las membranas del surfactante. 
El presente trabajo revela que la SP-B extracelular asociada a membranas induce de 
manera eficiente la secreción de surfactante pulmonar en células ATII. La SP-B activa la 
ruta de señalización purinérgica P2Y2 que produce un incremento en Ca
2+ citoplasmático, 
el cual en última instancia desencadena la exocitosis de cuerpos lamelares. Nuestros datos 
sugieren que la SP-B promueve la secreción de surfactante via liberación de ATP mediada 
por canales desde las células ATII. La SP-B induciría la exocitosis de surfactante en 
células ATII. SP-B induciría la exocitosis de surfactante en células ATII para reponer el 
espacio alveolar con surfactante recién secretado, asegurando el establecimiento de una 
red con una densidad apropiada de membranas de surfactante en la interfase alveolar. 
Finalmente, esta Tesis muestra recurrentes evidencias de la relevancia de las 
interacciones nativas para la función óptima del surfactante pulmonar. Las interacciones 
de la proteína SP-B con otros componentes del surfactante ha demostrado ser importante 
para la actividad de la proteína. Nuestros resultados muestran que la presencia de PG es 
necesaria para asegurar la función adecuada de la SP-B con respecto a dos procesos: la 
permeabilidad de membranas y la estimulación de la secreción de surfactante en células 
ATII. Respecto a las interacciones de SP-B con otras proteínas del surfactante, nuestros 
resultados sugieren la presencia de complejos nativos constituidos por SP-B junto con 
SP-A o SP-C en surfactante solubilizado en detergentes. También se han sugerido 
posibles interacciones entre SP-B y SP-C por el bloqueo selectivo de estas proteínas con 
anticuerpos que acarrea una disfunción de la secreción de surfactante inducida por SP-B 
y altera la permeabilidad de las membranas del surfactante. Además, la SP-C parece 
modular la estructura de los poros formados por la SP-B en las membranas, manteniendo 
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una adecuada permeabilidad del surfactante nativo. La interacción entre SP-B y SP-C 
sería crucial para la modulación espacial y temporal de sus actividades, necesarias para 
la función óptima del surfactante pulmonar. 
Para concluir, la presente Tesis confirma que la SP-B es una pieza clave del surfactante 
pulmonar, al ejercer papeles fundamentales en cada etapa del ciclo del surfactante. En 
primer lugar, la SP-B es necesaria para lograr la función tensioactiva óptima del 
surfactante pulmonar en la interfase alveolar. En segundo lugar, la SP-B participa en la 
biogénesis de los cuerpos lamelares en células ATII. Y, por último, el presente trabajo 
demuestra por primera vez que la SP-B estimula la secreción de surfactante en células 
ATII, asegurando la disponibilidad de complejos de surfactante recién secretados en la 
interfase alveolar. 
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ABSTRACT 
The respiratory system is necessary to obtain the oxygen required for metabolic 
processes. Gas exchange takes place through the alveolar-capillary barrier, where oxygen 
and carbon dioxide diffuse between air space in alveoli and erythrocytes in the 
bloodstream. The respiratory epithelium represents the largest surface in the organism 
exposed to the atmosphere and comprises two cell types, alveolar type I (ATI) and 
alveolar type II (ATII) cells. ATI cells constitute the major gas exchange surface in the 
alveoli, whereas the main function of ATII cells is the synthesis and assembly of the 
components of pulmonary surfactant in the form of tightly packed membrane arrays 
inside acidic organelles, called lamellar bodies. The primary physiological stimulus for 
surfactant secretion is the mechanical stretching of alveolar epithelium during inspiration, 
which leads to a rise in the cytoplasmic calcium concentration that triggers the fusion of 
lamellar bodies with the plasma membrane of ATII cells and finally, surfactant release. 
Once secreted, pulmonary surfactant is adsorbed and spread along the alveolar air-liquid 
interface, where surfactant stabilizes the respiratory surface during successive inspiration-
exhalation cycles by reducing the surface tension. Besides this main role, pulmonary 
surfactant also participates in lung defense against infection caused by virus, bacteria and 
fungi, exerting direct microbicidal activities or opsonization of pathogens and modulating 
the inflammatory cellular responses. 
Pulmonary surfactant is composed of approximately 90% of lipids and 10% of specific 
surfactant proteins, by mass. Dipalmitoylphosphatidylcholine (DPPC) is the most 
abundant phospholipid, constituting about 41% of total mass of surfactant. Among other 
phospholipids, negatively charged phospatidylglycerol (PG) species comprise of 
approximately 9% of surfactant mass. Regarding the protein fraction of pulmonary 
surfactant, hydrophilic proteins SP-A and SP-D play roles in the lung immune defense, 
whereas hydrophobic proteins SP-B and SP-C are involved in the biophysical function of 
pulmonary surfactant. 
Surface function of pulmonary surfactant involves three relevant properties: 1) fast 
interfacial adsorption of surfactant assemblies, 2) maximal compression of the interfacial 
film, achieving very low surface tension at the end of exhalation and 3) efficient film re-
spreading along the new exposed surface area during inhalation. DPPC, SP-B and SP-C 
plays essential roles in surfactant that ensure an optimal surface activity of the pulmonary 
surfactant. In the case of DPPC, its saturated acyl chains allow a highly packing state of 
these phospholipid species in interfacial monolayers upon lateral compression. 
Concerning the proteins SP-B and SP-C, they exert a wide variety of effects on lipid 
bilayers and monolayers that lead to deep lipid rearrangements closely related to the 
surface active function of pulmonary surfactant at the alveolar interface. 
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SP-B is the most important protein for maintenance the respiratory function, since its 
lack of expression leads to respiratory failure at birth. Besides its participation in the 
interfacial function of surfactant, SP-B is involved in other processes of the surfactant 
homeostasis, including its participation in the post-translational processing of SP-C and 
in biogenesis of lamellar bodies, as well as the formation of extracellular surfactant forms, 
such as tubular myelin, a net-like structure formed by surfactant lipids and the proteins 
SP-A and SP-B. Although the tertiary structure of the protein SP-B is not yet well-known, 
its purification from detergent-solubilized porcine pulmonary surfactant revealed the 
existence of native SP-B complexes that adopt a ring-shaped structure of 10 nm of 
diameter. According to a proposed model of tridimensional structure of SP-B based on 
the structure Saposin B, the native supramolecular organization of SP-B would consist of 
5 or 6 covalent dimers assembled in a ring-shaped structure, which would locate parallel 
to the surface of lipid bilayers through the interaction of N-terminal and C-terminal helical 
segments of the protein with the polar head groups of phospholipids.   
OBJECTIVES 
The main objective of this Thesis is to contribute to the understanding of the structures 
and functions of the native protein complexes present in pulmonary surfactant, with a 
particular focus on those constituted by SP-B. In this way, five specific objectives have 
been addressed in the present work: 
1. To perform a compositional and structural analysis of protein complexes derived 
from detergent-solubilized surfactant or surfactant nanodiscs. Besides, protein 
crosslinking is applied to attempt the clarification of the interactions between proteins 
SP-B and SP-C in quasi-native lipid environments. 
 
2. To study the effect of surfactant protein complexes on the permeability and 
interfacial dynamics of pulmonary surfactant membranes, in order to propose a potential 
mechanism for the dual action of SP-B on both surfactant activities. 
 
3. To address a deeper structural characterization of native SP-B oligomers, mainly 
in lipid environments, attempting the generation of samples with a proper quality, in order 
to approach further high-resolution structural characterization of the complexes. 
 
4. To study the structural features of SP-B applying fluorescence spectroscopy 
methodologies, including the determination of the stoichiometry of native SP-B 
oligomers in membranes and a quantitative study of the topological changes induced by 
SP-B in multilamellar structures. 
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5. To study the effect of SP-B on surfactant secretion by ATII cells. Elucidation of 
the signaling mechanisms connecting SP-B with lamellar body exocytosis in ATII cells. 
MAIN RESULTS AND CONCLUSIONS 
The present work reveals structural and functional features of SP-B through the study 
of three processes induced by the protein: membrane aggregation that lead to 
rearrangement of surfactant structures, membrane permeability trough the formation of 
pores, which allow the flow of lipids and polar molecules, and stimulation of surfactant 
secretion by ATII cells.  
The existence of a supramolecular organization of SP-B in pulmonary surfactant has 
been repeatedly proven throughout this Thesis. In addition to native SP-B complexes 
purified from detergent-solubilized surfactant membranes, SP-B dimers from both the 
whole organic extract of pulmonary surfactant or the protein isolated in organic solvent 
are able to self-assemble in the presence of lipids, yielding the ring-shaped structure of 
the SP-B oligomer that locates over the polar head groups of phospholipids in bilayers 
and monolayers.  
It is known that SP-B induces the formation of highly cohesive multilayered structures 
associated to the interfacial monolayer, which seems to constitute a surfactant reservoir 
that ensures the stability of the surface active film against mechanical stress induced by 
continuous alveolar compression-expansion cycles during breathing. Time-resolved 
Förster Resonance Energy Transfer (FRET) experiments performed in the present work 
provide quantitative information about the topology of SP-B/membrane aggregates, 
demonstrating that the connection between two membranes is mediated by the interaction 
of two SP-B ring-shaped oligomers. These SP-B/SP-B interactions would be responsible 
for the role of SP-B on the biophysical function of pulmonary surfactant at the alveolar 
interface, but also might be involved in the membrane packing during lamellar body 
biogenesis in ATII cells. 
Regarding the study of surfactant membranes permeability, the selective blockage of 
SP-B with antibodies demonstrates that SP-B ring shaped oligomers are responsible for 
the generation of pores in surfactant membranes, that allow the flow of polar molecules 
and the lipid transfer across the interconnected membranes of the surfactant reservoir and 
between these and the interfacial monolayer. According to the results obtained from 
FRET study, two SP-B oligomers would constitute the lipid transfer machinery that 
would ensure the optimal interfacial function of pulmonary surfactant. Moreover, the 
presence of such pore-forming structures in surfactant membranes would facilitate the 
diffusion of ions, gases, such as oxygen, and small polar molecules, such as peptides 
involved in lung innate defense, ensuring a proper ion equilibrium in the alveolar fluid 
and a rapid oxygen diffusion from air space through surfactant membranes. 
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The present work reveals that extracellular membrane-associated SP-B efficiently 
induces secretion of pulmonary surfactant by ATII cells. SP-B activates the P2Y2 
purinergic signaling pathway that leads to an increase in cytoplasmic Ca2+, which 
ultimately triggers exocytosis of lamellar bodies. Our data suggest that SP-B prompts 
surfactant secretion via channel-mediated ATP release from ATII cells. SP-B would 
induce surfactant exocytosis by ATII cells to replenish the alveolar space with newly 
secreted surfactant, ensuring the establishment of a network with a proper density of 
surfactant membranes at the alveolar interface.  
Finally, this Thesis showed recurring evidences of the relevance of native interactions 
for the optimal function of pulmonary surfactant. SP-B interactions with other surfactant 
components have been shown to be important for the protein activity. Our results show 
that the presence of PG is required to ensure the proper function of SP-B with respect two 
features: membrane permeability and stimulation of surfactant secretion by ATII cells. 
Regarding SP-B interactions with other surfactant proteins, our results suggest the 
presence of native complexes constituted by SP-B together with SP-A or SP-C in 
surfactant solubilized by detergents. Possible interactions between SP-B and SP-C have 
been also suggested by the selective blockage of these proteins with antibodies that lead 
to an impairment of SP-B-induced surfactant secretion and alters the surfactant membrane 
permeability. Furthermore, SP-C seems to modulate the structure of SP-B-generated 
pores, maintaining the proper native surfactant permeability. The interaction between SP-
B and SP-C would be crucial for the spatial and temporal modulation of their activities, 
required for the optimal function of the pulmonary surfactant. 
To conclude, the present Thesis confirms that SP-B is a key element of pulmonary 
surfactant, playing essential roles at every stage of the surfactant cycle. Firstly, SP-B is 
required to achieve the optimal surface function of pulmonary surfactant at the alveolar 
interface. Secondly, SP-B is involved in the biogenesis of lamellar bodies in the alveolar 
type II cells. And lastly, the present work demonstrates for the first time that SP-B 
stimulates the surfactant secretion by alveolar type II cells, ensuring the availability of 
newly secreted surfactant complexes at the alveolar interface.
  
 
 
 
 
 
 
 
 
 
  
  
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
  
  
 
 
 
  
Introduction 
27 
 
1. INTRODUCTION 
1.1. THE LUNG: RESPIRATORY PHYSIOLOGY 
Respiration is the essential physiological process for life where organisms obtain 
oxygen, required for multiple metabolic processes. Throughout the evolution and due to 
habitat expansion, different respiratory systems have been developed to facilitate the 
exchange of gas with the environment, as skin, tracheae, gills, and lungs, as well as their 
intermediate stages, which coexist within the same species either temporally separated 
(like gills in larvae and lungs in adult stage) or simultaneously (such as skin, gills and 
lungs in some salamanders). Lungs have evolved as specialized organs for handling gas 
exchange between bloodstream and the atmosphere, where the air is ventilated through 
internal sack-like structures that regularly inflate and deflate. In mammals, the 
bronchoalveolar lung is a branching organ composed of a set of tubes that progressively 
subdivide up to reach alveoli, the functional units of the lung. This architecture maximizes 
the surface area engaged in the gas exchange with the atmosphere. Human lungs present 
around 480 million alveoli with an average diameter of 200 µm (Ochs et al., 2004), which 
yields a respiratory surface area of about 70 m2 (Daniels and Orgeig, 2003).  
Gas exchange is ultimately a passive diffusion process that takes place through the 
alveolar-capillary barrier. From alveoli to hemoglobin in the erythrocytes, the oxygen 
would pass through the alveolar lining fluid (or hypophase), alveolar epithelium, 
interstitial layer, capillary endothelial cells and membranes of erythrocytes. 
 
Figure 1.1. Schematic representation of the alveolar-capillary barrier. 
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The alveolar epithelium is composed by two cellular types: alveolar type I (ATI) cells 
and alveolar type II (ATII) cells. Thin and flattened ATI cells comprise the major gas 
exchange surface of the alveolus (about 93% surface area) (Crapo et al., 1983), and also 
participate in the maintenance of the alveolar fluid. ATII cells are cuboidal and polarized 
cells that only represent about 7% of the alveolar surface (Crapo et al., 1983). ATII cells 
perform multiple essential functions, including production of pulmonary surfactant, 
maintenance of the alveolar fluid and production of molecules involved in inflammation 
and repair processes of the lung tissue (Mason, 2006). Besides, a third cellular type can 
be also found in a healthy alveolus, the alveolar macrophages, which constitute the first 
line defense against pathogens, but also participate in the alveolar homeostasis 
(Divangahi, King and Pernet, 2015). 
ATII cells are the only cells able to synthesize all the components of pulmonary 
surfactant to assemble them in acidic organelles, called lamellar bodies (Weaver, Na and 
Stahlman, 2002). Upon secretion, pulmonary surfactant adsorbs and spreads along the 
air-liquid interface to form a surface-active film, accomplishing its main function: the 
stabilization of the respiratory surface by minimizing surface tension during inhalation-
exhalation cycles (Parra and Perez-Gil, 2015).  
 
1.2. THE PULMONARY SURFACTANT AT THE ALVEOLAR INTERFACE 
The alveolar epithelium is covered by a lining fluid, establishing the air-liquid 
interface. Molecules in the bulk of a liquid and molecules at the interface are subjected to 
different interaction forces. Molecules deep into the liquid phase establish polar 
interactions with other surrounding molecules that are spatially balanced. However, 
molecules at the interface scarcely establish interactions with the molecules of the gas 
phase (air), resulting in a net attractive force towards the liquid phase and a high state of 
energy. To minimize this energy, the system decreases the area exposed to the interfacial 
film by reducing the number of molecules at the interface, generating the surface tension. 
In the mammalian alveolar interface, as an interface subjected to compression-expansion 
cycles, the continuous changes in the interfacial area would require extra input of energy 
to increase the respiratory surface against surface tension during inhalation (Hills, 1999).  
Alveoli are quasi-spherical sacks of a variety of sizes, from 3.3 to 4.8·106 µm3 in 
human lung (Ochs et al., 2004). According to Young-Laplace’s law, the pressure inside 
a spheric chamber (like a bubble) is directly proportional to surface tension and inversely 
proportional to radius (∆𝑃 = 2 𝛾/𝑟). Pulmonary alveoli can be considered as 
interconnected bubbles of different sizes, at constant surface tension the smaller ones 
would be subjected to higher pressures and would tend to collapse toward those of larger 
size during inhalation, resulting in the progressive collapse of the lung.  
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Figure 1.2. Surface tension at the alveolar interface and the function of pulmonary surfactant. 
A) Molecules at the air-liquid interface experience a net force toward the bulk of the fluid, which leads 
to minimize the exposed area to the air. When pulmonary surfactant is present, water molecules are 
excluded from the interface and surface tension is reduced. Once surfactant phospholipids saturate the 
interface, the equilibrium surface tension is reached. Upon lateral compression of surfactant film, the 
highly packing of phospholipids restricts the exposure of water molecules to the interface almost 
entirely, reaching minimal surface tension ˂ 1 mN/m. B) Schematic representation of the Young-
Laplace’s law for two ideal spherical alveoli of different radii. In the absent of surfactant, a gradient 
of pressures is established between the two interconnected alveoli, which leads to the collapse of the 
alveolus with shorter radius. When surfactant is present, the system is stabilized. 
 
Pulmonary surfactant has evolved to stabilize the alveolar interface by reducing 
surface tension. This main function is primarily accomplished by surfactant 
phospholipids, which are intercalated between water molecules at the alveolar surface, 
reducing the surface tension at the alveolar air-liquid interface. Once the phospholipid 
molecules are stably packed at the interface, the surface tension at equilibrium is reached. 
For an air-water interface the surface tension at 37 °C is about 70 mN/m, whereas in the 
presence of surfactant the surface tension decreases down to 20 mN/m at equilibrium. 
However, the mammalian alveolar interface is a dynamic surface since it is subjected to 
continuous compression-expansion processes during breathing. Thus, to prevent the 
alveolar collapse at the end of exhalation, pulmonary surfactant is able to reach very low 
surface tensions, ˂ 1 mN/m (Hills, 1999). 
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1.3. PULMONARY SURFACTANT: COMPONENTS AND FUNCTION 
As explained, the major function of pulmonary surfactant is the stabilization of the 
respiratory surface, minimizing the surface tension at the alveolar air-liquid interface. The 
composition of this system has been optimized along the evolution to accomplish this role 
efficiently.  
In most mammals, pulmonary surfactant is constituted by approximately 90% lipids 
(by mass), from which phosphatidylcholine (PC, around 60-70%) and 
phosphatidylglycerol (PG, about 9%) are predominant. Besides, surfactant also contains 
neutral lipids, such as cholesterol (up to 8%) and other minor species (monoacylglycerol, 
diacylglycerol, triacylglycerol and free fatty acids) (Goerke, 1998). In contrast, the 
protein fraction constitutes about 10% by mass of the pulmonary surfactant. They include 
four specific proteins associated to surfactant SP-A, SP-B, SP-C and SP-D, which are 
essential for both the biophysical function of surfactant and the innate immune defense at 
the alveolar surface (Perez-Gil and Weaver, 2010). 
 
Figure 1.3. Composition of pulmonary surfactant. Pulmonary surfactant obtained from 
bronchoalveolar lavages of mammalian lungs comprises around 90% of lipids and 10% of proteins. 
DPPC: dipalmitoylphosphatidylcholine, PC: phosphatidylcholine, PG: phosphatidylglycerol, PL: 
phospholipids, NL: neutral lipids and SPs: surfactant proteins (SP-A, -B, -C and -D). 
 
LIPID FRACTION 
Phospholipids represent the most abundant component in pulmonary surfactant. Their 
structure consists in a polar headgroup and a hydrophobic region comprised by two 
hydrocarbon chains. Surfactant mainly contains glycerophospholipids, constituted by a 
glycerol molecule sterified by two hydrocarbon chains and a negatively-charged 
phosphate group bound to a polar variable group. Phospholipids can be classified by the 
charge of the polar group, which includes zwitterionic (null net charge at physiologic pH), 
such as phosphatidylcholine (PC) and phosphatidylethanolamine (PE), and anionic 
phospholipids (negatively charged), as phosphatidylglycerol (PG), phosphatidylinositol 
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(PI) and phosphatidylserine (PS). The two hydrocarbon chains also define relevant 
properties of the phospholipids depending on their chain length, unsaturation degree and 
the position of these unsaturations. 
 
Figure 1.4. Structure of glycerophospholipids. Representation of the molecular structure of 
dipalmitoylphosphatidylcholine, including the hydrophobic region and the polar region. Most 
common polar groups of phospholipids present in pulmonary surfactant, choline (PC), glycerol (PG), 
inositol (PI), serine (PS) and ethanolamine (PE). Adapted from (Campbell, Reece and Mitchell, 1999; 
Kelly and Jacobs, 2011). 
 
The phospholipid fraction, and especially the most abundant species, 
dipalmitoylphosphatidylcholine (DPPC), are the main responsible for the surface active 
function of pulmonary surfactant. Due to its amphipathic structure, phospholipid adopts 
an energetic favorable orientation at the air-liquid interface, with the polar heads 
interacting with the liquid phase and the hydrophobic chains oriented towards the air, 
displacing water molecules from the surface and decreasing surface tension. The lack of 
unsaturations in the acyl chains of DPPC makes this phospholipid particularly favorable 
to form a tightly and stable film at the interface, yielding very low surface tensions upon 
film compression (near 0 mN/m). PCs with unsaturated fatty acids show larger average 
molecular sizes and cannot be packed as tight as DPPC molecules, displaying higher 
surface tension values (Possmayer et al., 2001). 
Lipids dispersed in water have the ability to self-assemble into different 
supramolecular organizations due to the hydrophobic effect. They adopt preferential 
geometrical shapes depending on the lipid structure, leading to the so-called lipid 
polymorphism. Most phospholipids, as PC, are considered to have a cylindrical shape, 
since the cross-sectional areas of the headgroup and the acyl chains are similar. This 
molecular structure favors the generation by self-assembly of flat bilayer structures, also 
termed lamellar phases, whose curvature is virtually 0. In contrast, those lipid species 
with a cross-sectional area of polar headgroup smaller than the acyl chains, such as 
phosphatidylethanolamine (PE), generates negatively-curved structures, termed 
hexagonal type II phase and cubic phase. In the case of amphipathic molecules with a 
larger cross-sectional area of the headgroup, as lysophospholipids or detergents, they give 
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rise to positively-curved structures such as micelles or type I phases. Apart from the lipid 
chemical structure, many other factors, like temperature, pH, lateral pressure and 
hydration, influence the overall organization of lipid structures. Furthermore, the 
incorporation of membrane proteins can modulate the curvature of these lipid assemblies 
(Goñi, 2014).  
 
Figure 1.5. Structures of lipid phases according to their molecular structure. Cylindrical-shaped 
lipids, as phosphatidylcholines (PC), preferentially assemble into lamellar phases. Conical lipids like 
phosphatidylethanolamine (PE) or dyacilglycerol (DAG) tend to form negatively-curved structures 
(hexagonal phase HII or cubic phase). Inverted conical lipids, such as detergents or lysophospholipids, 
arrange as positively-curved structures (hexagonal phase HI). Adapted from (Jouhet, 2013). 
 
In membranes, phospholipids adopt different levels of molecular ordering and mobility 
as a function of the temperature. An increase in temperature would take the membrane 
from an ordered state, the gel (Lβ) phase, with a high packing degree and little rotational 
mobility of the phospholipids, to a more disordered state, the liquid crystalline (Lα) phase. 
This phase transition occurs at the melting temperature (Tm), where both phases ordered 
and disordered coexist in equilibrium. The Tm of a given phospholipid depends on the 
number of unsaturations and the length of its acyl chains, where long, saturated 
phospholipids undergo the phase transition at higher temperatures than short, unsaturated 
ones. The melting temperature of DPPC is 41 °C. Thus, a pure DPPC film would be in a 
gel phase at 37 °C, the physiological temperature of most homeothermic mammals. 
Pulmonary surfactant exhibits a fine balance between the proportion of saturated and 
unsaturated phospholipids, which allows the coexistence of ordered and disordered 
phases at a wide range of temperatures, including the physiological values (De La Serna 
et al., 2004). In interfacial monolayers, phospholipids also organize into ordered and 
disordered phases depending on its lipid composition, temperature and compression state. 
Lipids with a high lateral mobility constitute the liquid-expanded (Le) phase, which would 
correspond to a Lα phase in bilayers. However, upon lateral compression of the interfacial 
film, the area is reduced and the interactions between molecules increase, causing the 
shift to a more ordered phase, the liquid-condensed (Lc) state, whose high packing state 
is comparable to Lβ phase in bilayers (Parra and Perez-Gil, 2015).   
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With respect to lipid phase segregation, cholesterol also displays an important role 
modulating the thermodynamic properties and lipid packing of membranes. The 
incorporation of this small amphipathic molecule into phospholipid monolayers and 
bilayers gives rise to two distinct liquid phases: liquid-ordered (Lo) and liquid-disordered 
(Ld) (Veatch and Keller, 2002). When cholesterol partitions into Ld phases, the 
translational mobility and diffusion of phospholipids is restricted. However, in Lo phases, 
the interactions of cholesterol with phospholipids lead to phase fluidization. Cholesterol 
present in pulmonary surfactant has been shown to influence the lateral organization of 
its membranes (De La Serna et al., 2004). 
In pulmonary surfactant, the coexistence of ordered and disordered phases at different 
temperatures and lateral pressures manifests in a high stability of surfactant layers at high 
compression sustained by saturated molecules, mainly DPPC, and enough fluidity and 
dynamics, favored by unsaturated species. Moreover, proteins SP-B and SP-C show a 
preferential partition into disordered domains (Nag et al., 1997; De La Serna et al., 2004). 
Thus, the lipid composition together with surfactant proteins provides surfactant 
membranes with the optimal structure and dynamics to respond to physiological demands.  
 
PROTEIN FRACTION 
Besides lipids, pulmonary surfactant is composed by four specific proteins: SP-A, SP-
B, SP-C and SP-D, which are essential for surfactant activity at alveoli. They can be 
classified in two groups depending on both nature and function: hydrophilic proteins, SP-
A and SP-D, participate in innate immune defense at the alveolar surface, while 
hydrophobic proteins, SP-B and SP-C, are involved in the biophysical function of 
surfactant. 
Figure 1.6. Surfactant proteins 
in the context of the alveolar 
hypophase. SP-B and SP-C are 
proteins permanently integrated 
into surfactant membranes, from 
which they modulate the surface 
activity of the pulmonary 
surfactant, while SP-A and SP-D 
are soluble proteins mainly 
involved in host defense. In the 
case of SP-A, it can also 
participate in the biophysical 
function of pulmonary surfactant 
by mediating contacts between 
bilayers and between these and 
the monolayer at the near-
interface environment. 
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Hydrophylic proteins SP-A and SP-D 
SP-A and SP-D are components of the innate immune defense system in the alveolar 
epithelium. SP-A is the most abundant protein in pulmonary surfactant, constituting 5-6 
% in mass of surfactant as obtained from the bronchoalveolar fluid, in contrast to only 
0.5% of SP-D (Serrano and Perez-Gil, 2006). Oligomerization of SP-A and SP-D is 
required to constitute biologically active proteins. Monomers of SP-A (28-37 KDa) are 
assembled into a structure constituted by 6 trimers (630 KDa) (Crouch and Wright, 2001), 
whereas SP-D (monomers of 43 KDa) associates in trimers that can further oligomerize 
forming dodecamers (520 KDa) and even higher order oligomers (Arroyo et al., 2018). 
These hydrophilic proteins belong to a family of mammalian C-type lectins containing 
collagen regions, termed collectins. They share structural features particularly optimized 
for their function in the host innate defense, including a N-terminal containing cysteines 
responsible of the oligomerization via disulfide bonds, a triple helical collagen region, an 
α-helical coiled coil neck segment (involved in the trimerization of the protein) and a C-
terminal globular lectin domain (Kishore et al., 2006). SP-A and SP-D recognize 
carbohydrate epitopes in the outer surface of virus, bacteria and fungi through their lectin 
domains or CRD (carbohydrate recognition domains). Upon binding, they opsonize and 
aggregate pathogens, enhancing their phagocytosis by macrophages, monocytes, 
neutrophils and dendritic cells (Wright, 2005). Lung collectins also display a direct 
microbicidal activity by increasing the permeability of bacterial membranes and inducing 
leakage (Wu et al., 2003). Additionally, SP-A and SP-D modulate the inflammatory 
cellular response by binding to membrane receptors of various immune cells (Wright, 
2005). 
 
Figure 1.7. Schematic representation of SP-A and SP-D structures. As members of the collectin 
family, SP-A and SP-D show structural common features as C-type lectin domain, also termed 
carbohydrate recognition domain (CRD). SP-A quaternary structure consists of a hexamer of trimers, 
while SP-D assembles into tetramers of trimers. Adapted from (Thursz and Khamri, 2010). 
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Regarding their membrane-interacting properties, SP-A binds preferentially to DPPC 
via the CRD domain in a Ca2+ dependent manner (Kuroki and Akino, 1991; Casals, 
Miguel and Perez-Gil, 1993; Palaniyar et al., 1998; Yu and Possmayer, 1998) and can 
promote lipid vesicle aggregation. SP-A is essential for the formation of tubular myelin 
(Palaniyar et al., 1999) and contributes to the surface activity of surfactant, enhancing the 
interfacial adsorption of phospholipids and generating a highly cohesive multilayer film 
with optimal biophysical properties (Lopez-Rodriguez et al., 2016). On the contrary, SP-
D is not usually associated to surfactant membranes, being 75% of total amount of SP-D 
in the aqueous fraction of the bronchoalveolar lavage (Kishore et al., 2006). However, 
SP-D is able to interact with PI and glucosylceramide, both minor lipids in pulmonary 
surfactant that contain sugar groups (Kuroki et al., 1992; Ogasawara, Kuroki and Akino, 
1992). Both proteins are involved in the homeostasis and recycling of surfactant 
(Hawgood and Poulain, 2001). SP-A inhibits surfactant secretion and enhances the lipid 
uptake by alveolar type II cells (Dobbs et al., 1987; Rice et al., 1987; Wright et al., 1987). 
In the case of SP-D, in vivo experiments demonstrate the relevance of SP-D in the 
modulation of the surfactant lipid pool by yielding structural conversion of surfactant 
membranes  (Korfhagen et al., 1998; Ikegami et al., 2009). 
 
Hydrophobic proteins SP-B and SP-C 
SP-B and SP-C account each for about 1% in mass of the total content of pulmonary 
surfactant. However, with a molecular weight of 3.7 KDa, SP-C is more abundant than 
SP-B in molar terms. 
SP-B 
SP-B is a 79-residue polypeptide with a molecular weight of 8.7 KDa. It presents a 
highly hydrophobic content (approximately 40%) and mainly adopts an α-helical 
secondary structure (Johansson and Curstedt, 1997). SP-B contains 6 cysteines in a highly 
conserved position that establish 3 intramolecular disulfide bridges (Cys8-Cys77, Cys 11-
Cys71, Cys 35-Cys46) and an additional cysteine (Cys 48) responsible for the formation 
of the intermolecular disulfide bridge of the covalent homodimer of 18 KDa. Besides, SP-
B exhibits positive net charge of +7, which yields a preferential interaction with anionic 
phospholipids (Perez-Gil, Casals and Marsh, 1995; Cabré et al., 2012). 
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Figure 1.8. Protein sequence alignment of SP-B from different species. Cysteines involved in 
intramolecular disulfide bonds (represented by connecting lines) are colored blue, while cysteine 
responsible for the interdimer disulfide bond is colored purple. The unique and highly conserved 
tryptophan residue is in yellow. Positive and negatively charged residues are marked with plus and 
minus symbols. Adapted from (Mingarro et al., 2008). 
 
The amphipathic character of SP-B and the presence of charged residues suggest that 
the protein establishes a superficial interaction with bilayers and monolayers. 
Hydrophobic regions of its amphipathical segments would interact with the acyl chains 
of phospholipids, while basic amino acid residues establish electrostatic interactions with 
polar head groups of anionic phospholipids. This superficial interaction of SP-B with 
membranes has been supported by fluorescence anisotropy (Baatz, Elledge and Whitsett, 
1990), nuclear magnetic resonance (Morrow et al., 1993) and time-resolved Förster 
resonance energy transfer (Cabré et al., 2012). However, a deeper insertion of the protein 
with the membrane has been suggested by differential scanning calorimetry (Shiffer et 
al., 1993) and electron spin resonance (Perez-Gil, Casals and Marsh, 1995). 
SP-B belongs to the saposin-like protein (SAPLIP) family. SAPLIP are small proteins 
that contain 4 or 5 amphipathic α-helices and 6 highly conserved cysteines involved in 
the formation of 3 disulfide bonds, responsible for the so called saposin fold. This family 
includes membrane-interacting proteins with diverse functions, such as saposins, 
involved in the degradation of sphingolipids as co-lipases, and several antimicrobial 
proteins, like NK-lysin and granulysin. However, SP-B is the only member of the family 
which is permanently associated to lipids due to its high hydrophobicity. Since the three 
dimensional structure of SP-B is still unkown, several structural models of the protein has 
been developed based on other SAPLIPs. 
Sequence alignment of the sequence of SP-B and NK-lysin, a monomeric 
antimicrobial and antitumor protein, predicted the existence of 4 amphipathic α-helices 
which are associated by pairs, 1-4 and 2-3, through disulfide bonds, with Cys 48 being 
located at the hydrophilic face of helix 3 (Andersson et al., 1995). Based on this model, 
the interaction of SP-B dimer with membranes could imply the connection between two 
bilayers, where each SP-B monomer would locate in one of them (Johansson and 
Curstedt, 1997) (Figure 1.9 A). 
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Figure 1.9. Structural models of SP-B based on NK-lysin. A) Model of SP-B based on the sequence 
of NK-lysin developed by (Andersson et al., 1995). Up: schematic representation of a SP-B monomer 
where the amphipathic helices (shown as rectangles) are aligned and intramolecular disulfide bonds 
are highlighted. Down: possible structure of a SP-B dimer in membranes, where the two monomers 
are located in different phospholipid bilayers. Taken from (Johansson and Curstedt, 1997). B) SP-B 
model based on the quaternary structure of NK-Lysin, according to (Zaltash et al., 2000). 
Representation of the globular SP-B dimer where charged residues are colored blue, hydrophobic 
residues in yellow and other residues in white. 
 
On the other hand, a model for the three-dimensional structure of SP-B dimer was 
generated from the structure of NK-lysin obtained by nuclear magnetic resonance (NMR) 
(Zaltash et al., 2000). According to this model, SP-B monomer would be constituted by 
5 amphipathic α-helices, where the hydrophobic regions are buried towards the inner of 
the protein. SP-B dimer is a globular fold stabilized by the interdisulfide bond between 
Cys 48, which aligned the highly conserved and charged residues Glu 51 and Arg 52 of 
both monomers allowing the establishment of two saline bonds (Figure 1.9 B). It has been 
proposed that the existence of these non-covalent bonds could still sustain the 
dimerization of the mutated form of SP-B Cys48Ser (Zaltash et al., 2001), which supports 
the evidence that the interdisulfide bond C48-C48 is not crucial for SP-B activity 
(Ikegami, Takabatake and Weaver, 2002). This proposed globular structure may unfold 
at the air-liquid interface upon surface tension increases, extending its structure and 
exposing the hydrophobic region towards the air, and folding again upon monolayer 
compression (Fullagar et al., 2003). 
Recently, an oligomeric structural model of SP-B was generated from the three-
dimensional structure of saposin B. In this model, SP-B monomers with 5 amphipathic 
α-helixes (6-18, 25-35, 43-53, 56-62, 69-74) show two structural variants that differ on 
the presence of a kink between helices 3 and 4, as in saposin B monomers (Figure 1.10 
A). From these modelled SP-B monomers, open and closed conformations of SP-B 
dimers were generated (Figure 1.10 B). These non-covalent dimers would be formed by 
the interactions between helices 1 and N-terminal segments through an antiparallel coiled 
coil. Cys 48, involved in the covalent dimerization of SP-B, and residues involved in the 
salt bond, Glu 51 and Arg 52, would locate into the external face of the dimer. Modeled 
structures satisfying disulfide bond and salt bridges predict the existence of a high-order 
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oligomer formed by 5 or 6 dimers (Figure 1.10 C-D). This model implies a superficial 
SP-B-membrane interaction defined by the contact of helices 1 and 5 with polar 
headgroups of phospholipids, while Trp 9 residues and the N-terminal segment might 
insert deep into the bilayer. The hydrophobic residues of each non-covalent dimer are 
shielded in the inner of the dimer, forming a hydrophobic cavity that could accomodate a 
phospholipid molecule, like saposin B dimer. The concerted opening of all dimers in the 
oligomer would induce the pivoting of the whole structure toward the inner of the 
membrane, eventually exposing the SP-B hydrophobic cavities to the phospholipid acyl 
chains and the eventual loading of the complex. This feature of the oligomeric model is 
in agreement with experimental evidences suggesting that SP-B mediates lipid transfer 
between membranes (Poulain et al., 1992; Poulain, Nir and Hawgood, 1996). 
 
Figure 1.10. Oligomeric model of SP-B structure based on saposin B. A) SP-B monomers 
generated using the two structural variants of saposin B. B) SP-B dimers modeled from the open (up) 
and closed (down) dimers of saposin B. C and D) Models of hexamers and pentamers of open (up) 
and closed (down) SP-B dimers. Model developed by (Olmeda et al., 2015). 
 
The oligomerization model of SP-B has been confirmed by the presence of native SP-
B complexes in detergent-solubilized pulmonary surfactant (Olmeda et al., 2015). As 
determined by transmission electron microscopy, these fully-functional SP-B complexes 
purified in detergent are ring-shaped particles with a diameter of  ̴ 10 nm, which could be 
formed by the vertical apposition of two rings. Each SP-B ring would be constituted by 5 
or 6 SP-B dimers. It has been proposed that the docking of SP-B oligomers between 
different membranes could be required for the optimal activity of pulmonary surfactant 
at the air-liquid interface at two stages: 1) enhancement of interfacial adsorption through 
lipid transfer between surfactant structures and 2) maximizing the mechanical stability of 
the interfacial monolayer by formation of multilayered structures. 
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Figure 1.11. Supramolecular structure of SP-B complexes obtained from surfactant membranes 
solubilized with CHAPS. A) Representative trasnsmission electron micrograph of negative-stained 
SP-B complexes. Scale bar, 100 nm. B) Selection of representative single particles. C) Selection of 
representative 2-dimensional averages obtained from the oligomeric SP-B complexes. Scale bar, 30 
nm. D) Front and side views of the 3-dimensional model built from oligomeric SP-B complexes, 
obtained by angular refinement. E) Front and side views of the 3-dimensional model of oligomeric 
SP-B complex (transparent gray density), showing the atomic structure theoretical model of a hexamer 
(blue) and pentamer (pink) of SP-B dimers fitting into the electron microscopy density. Taken from 
(Olmeda et al., 2015). 
 
Regarding SP-B functions, it has been described that SP-B induces membrane 
rearrangements leading to aggregation, fusion and lysis of vesicles (Ryan et al., 2005). 
These membrane perturbing activities seem to lie underneath the ability of SP-B to form 
multilayered aggregates attached to a monolayer film (Krol et al., 2000; Diemel et al., 
2002; Cruz et al., 2004; Cabre et al., 2009), as well as promoting lipid transfer from 
vesicles to a preformed interfacial monolayer (Oosterlaken-Dijksterhuis et al., 1991a, 
1991b) or directly to the clean air-liquid interface (Cruz et al., 2000; Schurch et al., 2010), 
which entails the reduction of surface tension at the alveolar surface. An extensive study 
for the identification of the functional determinants of the SP-B described that helices 1 
and 2 are responsible for aggregation, lipid mixing and fusion of membranes, while N-
terminal domain (residues 1-9) is critical for the surface tension reducing property of SP-
B (Ryan et al., 2005). In addition, SP-B, together with SP-C, induces membrane 
permeabilization  (Parra et al., 2011, 2013). 
SP-B is the most relevant protein for the maintenance of the respiratory surface, since 
the absence of its expression leads to lethal respiratory failure at birth (Nogee et al., 1993; 
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Clark et al., 1995). Besides its participation in the biophysical function of surfactant, SP-
B is involved in many functions throughout the metabolic cycle of surfactant.  SP-B 
participates in the post-translational processing of SP-C (Vorbroker et al., 1995) and 
promotes the lipid packing to generate lamellar bodies (Stahlman et al., 2000). Moreover, 
it is required, together with SP-A, to convert tightly associated membrane arrays inside 
lamellar bodies into net-like structures, termed tubular myelin, once surfactant is secreted 
towards the alveolar hypophase (Williams, 1977). These functions of SP-B are explained 
in detail in the context of surfactant homeostasis in section 1.4. 
Finally, given the presence of the common structural framework of saposins, SP-B 
exhibits a limited antimicrobial activity by inducing membrane permeabilization in Gram 
positive and Gram negative bacteria, as well as a likely function of bacterial opsonization, 
which is related to its ability to aggregate membranes (Ryan et al., 2006). 
 
SP-C 
SP-C is the only surfactant protein exclusively present in the lungs. It is a 35 amino 
acid transmembrane protein (4.3 KDa), which adopts an α-helical structure between 
residues 9 and 34, rich in aliphatic residues, mostly valine (Guy Vandenbussche et al., 
1992; Johansson et al., 1994). The N-terminal segment of SP-C (residues 1-8) exhibits an 
amphipathic character with a positive net charge, yielding a preferential interaction with 
anionic phospholipids (Perez-Gil, Casals and Marsh, 1995). Furthermore, the N-terminal 
segment is double palmitoylated at cysteines 5 and 6.  
 
Figure 1.12. Surfactant protein SP-C. A) Molecular model of the SP-C monomer based on the 
structure obtained by NMR of the protein in organic solvent (Johansson et al., 1994). B) Amino acid 
sequences of human and porcine SP-C. The α-helical segment is colored blue and cysteines subjected 
to palmitoylation colored yellow. Positively charged residues are marked with plus and minor 
symbols. 
 
Regarding its function, SP-C alters lipid packing in membranes and monolayers, 
affecting the lateral organization of lipids (Pérez-Gil et al., 1992; Dico et al., 1997). SP-
C also promotes interfacial adsorption and lipid exchange between bilayers and between 
bilayers and monolayers (Possmayer et al., 2001; Wang et al., 2005). It has been 
suggested that the N-terminal segment would have the potential to perturb lipids of the 
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adjacent bilayer or monolayer, inducing packing defects in interfacial monolayers 
(Plasencia, Keough and Perez-Gil, 2005) and bilayers, leading to vesicle aggregation and 
leakage (Plasencia et al., 2004). The double palmitoylation contributes to reach and 
maintain the lowest surface tensions at high compression rates, in the presence of SP-B 
and cholesterol, although it is not required for interfacial lipid adsorption (Baumgart et 
al., 2010). It has been proposed that palmitoylation is important for SP-C to induce the 
generation of interdigitated phases (Plasencia et al., 2008; Roldan, Pérez-Gil, et al., 
2017), which would potentially take part of bilayer-bilayer and bilayer-monolayer 
transitions, especially at high compression pressures. Moreover, these SP-C-induced 
interdigitated phases appear to maximize the segregation of lipid phases (Roldan, Pérez-
Gil, et al., 2017). Additionally, SP-C would have a potential role in cholesterol 
mobilization and pulmonary homeostasis at the alveolar interfaces, since SP-C has the 
ability to fragment lipid bilayers into small highly curved vesicles where cholesterol 
accumulates (Roldan et al., 2016). Some evidences have been found about a likely 
dimerization of SP-C through a specific motif in its C-terminal segment (Kairys, Gilson 
and Luy, 2004). In this way, SP-C/SP-C interactions have been recently confirmed in 
membranes by time-resolved fluorescence spectroscopy (Cabre et al., 2018). 
Lack or dysfunction of SP-C expression is not as critical as SP-B, since animals can 
breathe and survive (Nogee, 2004). However, deficiencies in SP-C are related to chronic 
severe respiratory pathologies associated with emphysema and pulmonary fibrosis 
(Glasser et al., 2003). Thus, SP-C may be essential for an efficient stabilization of the 
respiratory epithelium at long term. 
 
SP-B and SP-C: role at the surfactant film 
SP-B and SP-C display essential functions for an optimal interfacial activity of 
pulmonary surfactant, which involves three relevant properties, in all of which SP-B and 
SP-C participate (Figure 1.13): 
 Fast adsorption into the interface. Surfactant proteolipid assemblies accumulated 
near the interface are transferred into and spread along the interface.  The interfacial 
adsorption of phospholipids is not energetically favorable because transfer of 
phospholipids entails transient exposure of acyl chains to polar environments, making 
this process slow. Both SP-B and SP-C enhance the insertion of phospholipids into 
the interface, increasing the rate of lipid adsorption (on the scale of seconds), although 
SP-B is specially effective in this process (Schurch et al., 2010). It has been proposed 
that upon touching the interface, SP-B and SP-C, in a concerted way, would unravel 
the newly-secreted surfactant membranes and catalyze the lipid insertion into the 
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interface (Hobi et al., 2016). The proteins would somehow form structures conducting 
surface active lipid species without allowing their exposure to water. 
 
 Maximal compression of the interfacial film. As surfactant film is subjected to 
successive compression-expansion cycles, this system has to be very dynamic with 
fast lipid reorganization processes to maintain the stability of the respiratory surface. 
During exhalation, the reduction of the alveolar surface is stabilized by a deep 
decrease in surface tension, to near 0 mN/m. To achieve this extremely low surface 
tension, the maximal compaction of the material at the surface film is required. As 
mentioned before, saturated acyl chains of DPPC achieve a high degree of packing, 
leading to very low surface tension. Thus, upon compression of the film, this becomes 
enriched in DPPC molecules, while the unsaturated phospholipids and other lipids 
result excluded from the monolayer and form multilayered structures attached to the 
interface. This process has been called “squeeze-out” and it has been proposed to be 
driven by the hydrophobic protein fraction of surfactant (Keating et al., 2012). 
Although excluded from the monolayer upon compression, SP-B promotes film 
stability, likely by facilitating the formation of highly cohesive multillamelar arrays 
(Taneva and Keough, 1994b; Diemel et al., 2002; Cruz et al., 2004; Cabre et al., 2009; 
Schurch et al., 2010; Bernardino de la Serna et al., 2013). It has been proposed that a 
continuous network of membrane multilayers are established by the apposition of SP-
B oligomers between membranes, so that a pair of connected oligomers would form 
a hydrophobic pore through which lipids could be transferred (Olmeda et al., 2015). 
This assumption is supported by experimental evidences that reveal that SP-B induces 
the formation of multilayered structures through SP-B/SP-B interactions (Cabre et al., 
2009). On the other hand, SP-C is excluded from the interface under high compression 
pressures, but the palmitoylated N-terminal segment of SP-C is entitled to maintain 
the association with the highly packed interfacial film, which would be especially 
relevant at the end of exhalation (Taneva and Keough, 1994c; Plasencia et al., 2008). 
 
 Efficient film re-spreading is essential for maintaining the equilibrium surface 
tension (around 20 mN/m) during inhalation. This re-adsorption process entails the 
lipid transfer from the interconnected multilamellar arrays into the interfacial 
monolayer. This process is also enhanced by both hydrophobic proteins, although 
SP-B appears to be more efficient promoting re-spreading of the film (Taneva and 
Keough, 1994a; Serrano and Perez-Gil, 2006), most likely because of the specialized 
structure of SP-B pores.  
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Figure 1.13. Participation of SP-B and SP-C in surfactant dynamics during compression-
expansion cycles. Up: monolayer and membrane reservoir connected by both hydrophobic proteins 
showing the exclusion of material from the interface that occurs during compression (exhalation). 
Down: re-spreading of the interfacial film and adsorption of new material during expansion 
(inhalation). 
 
1.4. PULMONARY SURFACTANT HOMEOSTASIS 
SYNTHESIS OF SURFACTANT COMPONENTS 
Although a fraction of pulmonary surfactant is recycled, de novo synthesis of 
surfactant components is continuously required to satisfy the demand of surface active 
material. These surfactant components are produced by alveolar type II cells. Synthesis 
of lipids and most of the surfactant proteins undergo different pathways that converge 
during the assembly of surfactant complexes into the lamellar bodies. 
 
LIPID SYNTHESIS 
Surfactant phospholipids are produced in ATII cells by novo synthesis in the 
endoplasmic reticulum (ER) or by remodeling from extracellular surfactant (Olmeda, 
Martinez-Calle and Perez-Gil, 2017). In the case of the major lipid component of 
surfactant, 45 % of DPPC comes from de novo synthesis (via the Kennedy pathway), 
whereas the remodeling pathway contributes with 55-75% of DPPC (Batenburg, 1992). 
Both pathways intersect at the enzyme LPCAT1, which regulates the PC synthesis to 
demand for surfactant (Butler and Mallampalli, 2010). 
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PROTEIN SYNTHESIS 
Both SP-A and SP-D are synthesized as propeptides that undergo post-translational 
modifications, such as glycosylations and hydroxilations,  and oligomerization processes 
during trafficking via endoplasmic reticulum and Golgi in alveolar type II cells (Weaver 
and Whitsett, 1991; Crouch, 1998). The secretion of SP-D to the alveolar space seems to 
be regulated by a constitutive route of secretion that is independent of lamellar body 
secretion. In contrast, whether the newly-synthesized SP-A secretion occurs either as a 
regulated process via lamellar bodies or as constitutive release by an alternative pathway 
is still a matter of controversy. Some studies proposed that SP-A is exocytosed to the 
alveolar space not associated to lamellar bodies, corresponding the fraction of SP-A 
present in lamellar bodies to the previously endocytosed protein (Osanai, Mason and 
Voelker, 1998; Ochs et al., 2002; Schmiedl et al., 2005). Alternatively, it has been 
described that the alveolar uptake is not the major source of SP-A in lamellar bodies, 
suggesting that newly-synthesized SP-A would be primarily secreted via this organelle 
(Fisher, Dodia and Chander, 1994). 
Hydrophobic proteins SP-B and SP-C are synthesized as much larger precursors that 
suffer multiple proteolytic cleavage steps before reaching their mature forms and being 
assembled into LBs (lamellar bodies). Both proteins follow parallel pathways of 
endosomal processing from ER (endoplasmic reticulum) to LBs, involving the sequential 
enzymatic activities of several proteases and a progressive decrease in the pH gradient 
down to 5.5 in LBs. 
 
Figure 1.14. Synthesis and processing of SP-B and SP-C in alveolar type II cells. Both proSP-B 
and proSP-C are sequentially cleaved along the endosomal pathway (RER: rough endoplasmic 
reticulum, Golgi, MVB: multivesicular bodies, CB: composite bodies, LB: lamellar bodies) until they 
are assembled into lamellar bodies for its exocytosis. Taken from (Lopez-Rodriguez and Perez-Gil, 
2014). 
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The gene encoding SP-B is located in the chromosome 2 and its expression is regulated 
by TTF1 (thyroid transcription factor 1) (Lopez-Rodriguez and Perez-Gil, 2014). Human 
SP-B mRNA is translated into to a preprotein consisting of 381 amino acids. This 
preprotein is translocated to the ER to initiate its post-translational processing. SP-B 
precursor (proSP-B) of 42 KDa consists of 3 saposin-like domains: the mature SP-B 
sequence and the glycosilated N-terminal and C-terminal propeptides. Both propeptides 
would protect the highly hydrophobic mature peptide from the exposure to the aqueous 
environment. In particular, the N-terminal domain act as a chaperone involved in the pH-
regulated proteolytic processing of the mature SP-B (Serrano, Cabre and Perez-Gil, 
2007). Processing of the 42 KDa precursor to the 8 KDa mature SP-B takes place in 
multivesicular bodies, intermediate composite bodies and lamellar bodies and involves at 
least the sequential participation of Cathepsin H, Napsin A and Pepsinogen C proteases 
(Brasch et al., 2003; Guttentag et al., 2003; Gerson et al., 2008), whose activities are 
largely dependent on the pH gradient along the endosomal pathway (Serrano, Cabre and 
Perez-Gil, 2007; Banares-Hidalgo, Perez-Gil and Estrada, 2014). Together with mature 
SP-B, the free N-terminal fragment is also transported to LBs and further secreted to the 
alveolar hypophase, where it exhibits a microbicidal activity related to its saposin-like 
domain (Brasch et al., 2004; Yang et al., 2010). As the mature SP-B, the C-terminal 
propeptide might somehow also participate in modulating lamellar body biogenesis, as 
transgenic mice expressing a SP-B precursor lacking the C-terminal propeptide exhibited 
an increased tissue surfactant pool size and dramatically enlarged lamellar bodies (Akinbi 
et al., 1997). Moreover, and given that the C-terminal propeptide contains another saposin 
domain, it has been proposed that this peptide might display a further antimicrobial-
protecting role (Perez-Gil and Weaver, 2010) 
SP-C is synthesized as a proprotein of 197 amino acids and a molecular weight of 21 
KDa, which consists of a N-terminal propeptide, the mature sequence of SP-C and a C-
terminal propeptide. ProSP-C is inserted in the ER through the transmembrane segment 
of the mature SP-C, with the C-terminal region facing the ER lumen and the N-terminal 
segment exposed to the cytoplasm (Beers and Mulugeta, 2005). After its insertion in the 
ER, proSP-C is palmitoylated in Cys 5 and 6 (corresponding positions in the mature SP-
C sequence). This palmitoylated precursor initiates its sequential proteolytic processing 
towards the final generation of the 4 KDa mature SP-C in the lamellar bodies.  
SP-B is required for the proper processing of proSP-C (Vorbroker et al., 1995). 
Although the mechanism by which SPB modulates the cleavage of SP-C is still unclear, 
it has been proposed that membrane fusion and lysis promoted by the mature form of SP-
B would cause the orientation of the N-terminal domain of the proSP-C towards the lumen 
of multivesicular bodies, and its exposure to the specific proteases that release the N-
terminal domain from the mature SP-C (Weaver and Conkright, 2001). Alternatively, 
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since a direct molecular interaction between SP-B and SP-C has been determined (Cabre 
et al., 2018), one could speculate about a possible interaction between SP-B and SP-C 
precursors that might facilitate the processing cleavage of SP-C, although this is 
something that needs to be further clarified. 
 
ASSEMBLY OF SURFACTANT INTO LAMELLAR BODIES 
Lamellar bodies (LBs) are the specialized acidic organelles in ATII cells where 
surfactant is stored in a highly packed stated. After synthesis, surfactant components must 
be transferred to LBs. Newly synthesized SP-B and SP-C are incorporated to the lamellar 
bodies via multivesicular bodies, as well as lipids derived from the remodeling pathways. 
In contrast, the transport of newly synthesized lipids to LBs is not completely understood, 
although it is likely that they bypass these organelles (Olmeda, Martinez-Calle and Perez-
Gil, 2017). A non-vesicular vesicular transport of PC from the ER to LBs has been 
proposed based on the experimental evidence that the disruption of Golgi by brefeldin A 
does not affect surfactant secretion (Agassandian and Mallampalli, 2013). This non-
vesicular transport of PC in ATII cells seems to be mediated by the phospholipid transport 
protein StarD10 (Lin et al., 2015). 
Lipid and protein assembly into tightly-packed structures of LBs requires the action of 
the protein ABCA3 (ATP-binding cassette transporter A3), which belongs to the family 
of membrane transporters that pump lipids across membranes coupled to ATP hydrolysis.  
ABCA3 is localized at the limiting membrane of the LBs and is responsible for the 
transfer of lipids into the lumen of these organelles (Ban et al., 2007; Cheong et al., 2007). 
The energy provided by the hydrolysis of ATP during the continuous lipid transfer 
towards the inner of LB could be used to form highly packed lipid-protein structures, with 
a highly dehydrated state and the likely generation of non-lamellar phases (Cerrada et al., 
2015; Malacrida et al., 2016). Once LBs are secreted and unpacked in contact with the 
alveolar interface, the accumulated energy would lead to a rapid and highly efficient 
interfacial adsorption. This hypothesis is supported by experimental data which 
demonstrated that lamellar body-like particles (LBPs or secreted LBs) obtained from 
ATII cell cultures showed faster interfacial adsorption kinetics than surfactant membranes 
purified from bronchoalveolar fluid, which are already unpacked by pre-exposure to air 
(Ravasio et al., 2010).  
Besides ABCA3, SP-B is also necessary for proper LB biogenesis, as SP-B deficiency 
entails the formation of immature LBs with loosely packed membranes that once secreted, 
fail to form functional films (Stahlman et al., 2000). SP-B would allow the packing and 
organization of surfactant membranes in LBs, due to its ability to promote membrane-
membrane interactions. 
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SECRETION OF LAMELLAR BODIES 
The primary physiological stimulus for surfactant secretion is the mechanical 
stretching of alveoli during inspiration, which leads to an elevation of the cytoplasmic 
calcium (Nicholas, Power and Barr, 1982). Although in vitro studies have demonstrated 
that stretching of ATII cells promotes surfactant secretion (Wirtz and Dobbs, 1990; Frick 
et al., 2004), ATI cells are the primary sensors of lung inflation that in turn modulate 
ATII cell secretion of surfactant. The mechanical stretching of ATI cells triggers 
oscillations in calcium concentration that propagate to ATII cells through gap junctions 
(Ashino et al., 2000). Additionally, the response of ATI cells to stretching promotes ATP 
release to the extracellular fluid, which induces surfactant secretion in ATII cells (Patel 
et al., 2005). Moreover, different lines of evidence have shown that exposure of ATII 
cells to air also prompts surfactant secretion (Ramsingh et al., 2011; Ravasio et al., 2011). 
During lung inflation, alveolar surface extension leads to a reduction in thickness of the 
hypophase covering the alveolar epithelium, and subsequently, the surface tension 
increases. It has been suggested that the thinning of the hypophase and the elevation in 
surface tension exert forces onto the apical side of ATII cells that, in turn, trigger 
surfactant secretion by an increase in cytoplasmic calcium concentration (Ravasio et al., 
2011). 
Surfactant secretion, as a vital process, is highly regulated by different signaling 
pathways. Several physiological agents, such as β-adrenergic and purinergic agonists 
(ATP and UTP) stimulate surfactant secretion through activation of signaling mediators, 
such as protein kinase A (PKA), protein kinase C (PKC), phospholipase C (PLC) and 
Ca2+/calmodulin-dependent protein kinase (CaMK) (Rooney 2001). On the contrary, SP-
A can inhibit surfactant exocytosis  (Dobbs, Wright et al. 1987, Rice, Ross et al. 1987), 
although the mechanism is still unclear. 
Ca2+ is the major second messenger, responsible for triggering the fusion of LB with 
the ATII plasma membrane. Mechanical stretch-induced Ca2+ signal in ATII cells is 
supplied by both Ca2+ release from intracellular stores and Ca2+ entry from extracellular 
space through TRPV2 channel, the latter being the main contributor to increase 
cytoplasmic calcium concentration ([Ca2+]c) (Frick et al., 2004; Fois et al., 2012).  Ca
2+ 
induced-LB fusion is determined not only by the amplitude of the calcium concentration 
peak but also by the integrated [Ca2+]c value over time (=dose) (Frick et al., 2001). Upon 
stimulation of ATII cells, a transient elevation of [Ca2+]c above the threshold of 320 nM 
Ca2+ activates several cytoskeletal elements that are involved in the trafficking and 
docking of the LB to the plasma membrane (Figure 1.15). The LB fusion machinery is 
integrated by annexins-2 and -7, some SNARE proteins (syntaxin-2 and SNAP23/25 in 
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the plasma membrane and VAMP-2, located in the limiting membrane of LB), as well as 
some regulatory proteins, as Rab14 and Rab3D. 
 
Figure 1.15. Secretion of lamellar bodies. Mechanical stretch of alveoli elicits oscillations in [Ca2+]c 
in alveolar type II cells, originated from extracellular Ca2+ entry, Ca2+ release from intracellular Ca2+ 
stores as well as paracrine signaling from alveolar type I cells. This [Ca2+] signal triggers LB fusion 
with the plasma membrane. Upon LB fusion, extracellular Ca2+ gets access to P2X4 channel in the 
outer limiting membrane of the fused lamellar body. ATP-mediated Ca2+ pumping prompts additional 
local rise in [Ca2+], termed “fusion activated Ca2+ entry” (FACE), which leads to the fusion pore 
dilation and facilitates surfactant release. During the post fusion stage, an actin coat together with 
actin-associated proteins surround the fused vesicle. Actin coat contraction results in the compression 
of the whole vesicle that leads to the final surfactant release. 
 
Once LB is fused with the plasma membrane, the surfactant release to the alveolar 
lining fluid is delayed minutes and even hours not only because of the high 
hydrophobicity of the tightly packed membranes, which impedes its rapid diffusion in 
aqueous solution, but also because of the mere existence of the fusion pore that constitutes 
a mechanical barrier for surfactant release (Haller et al., 2001; Singer et al., 2003). The 
final surfactant release is a step-wise regulated process, which includes the fusion pore 
dilation and the compression of the fused vesicle to favor surfactant release. The 
expansion of the fusion pore is a Ca2+ dependent process. After a single LB fusion event, 
an elevation in cytoplasmic calcium takes place at the site of vesicle fusion (Miklavc et 
al., 2009, 2010). This Ca2+ entry mechanism associated with the LB fusion process is 
called “fusion-activated Ca2+ entry” (FACE). FACE is mediated via activation of the 
purinergic cation channel P2X4, located in the limiting membrane of LBs (Miklavc et al., 
2011). Upon LB fusion, this channel becomes immediately part of the apical membrane. 
Activation of P2X4 by extracellular ATP results in a localized transient Ca
2+ entry 
surrounding the fused LB, which then accelerates the fusion pore expansion and 
subsequent surfactant release. However, the molecular mechanisms that transduce this 
Ca2+ signal into forces that facilitate the fusion pore opening are not completely 
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understood. It has been proposed that Synaptotagmin-7, expressed in LBs, might be the 
molecular linker between FACE and fusion pore dilation (Neuland, Sharma and Frick, 
2014). 
Besides regulatory mechanisms for the fusion pore opening, surfactant release requires 
the involvement of an active extrusion machinery, constituted by actin and actin-
associated proteins (Miklavc et al., 2009, 2012, 2015; Kittelberger et al., 2016). Upon LB 
fusion, actin molecules polymerize surrounding the fused vesicle. This actin coat 
compresses the whole vesicle, resulting in collapse of the vesicle into the plasma 
membrane and surfactant release. 
 
Figure 1.16. Transmission electron micrographs of extracellular and intracellular surfactant 
forms. A) Lamellar body exocytosis by alveolar type II cell in a rat lung (scale bar, 1 µm), taken from 
(Perez-Gil, 2008). B) Alveolar subphase in a section of an adult rat lung, where secreted lamellar 
bodies (LB) and tubular myelin (TM) are visualized (scale bar, 1 µm); taken from (Goerke, 1998). C 
and D) Alveolar surface film from a guinea pig lung showing multilamellar structures (ML) associated 
to the interfacial monolayer (scale bars, (C) 0.6 µm and (D) 0.1 µm); taken from (Schurch, Green and 
Bachofen, 1998). 
 
After secretion of lamellar bodies, they mostly retain their densely packed 
organization, as lamellar body-like particles (Haller et al., 2004). Upon contact with the 
air-liquid interface, these structures unravel in a cooperative and efficient way forming 
an interfacial film thanks to the coordinated action of SP-B and SP-C (Hobi et al., 2016). 
Moreover, some unpacked surfactant membranes have been found rearranged in a lattice-
like structure, termed tubular myelin. Tubular myelin was initially considered as an 
intermediate form between LBs and functional surfactant membranes attached to the 
interface (Sanderson and Vatter, 1977; Williams, 1977). However, the need of tubular 
myelin as a precursor of surface films has not been well-established and is a matter of 
controversy, as several in vitro and in vivo studies have reported that the presence of 
tubular myelin is not essential for surfactant biophysical activity (Massaro, Clerch and 
Massaro, 1981; Ikegami et al., 1998; Sato and Kishikawa, 2001) . DPPC, PG, SP-A, SP-
B and Ca2+ are the essential components to reconstitute in vitro the structure of tubular 
myelin (Suzuki, Fujita and Kogishi, 1989). Although the way these components interact 
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is scarcely understood, it has been proposed that SP-A octadecamers may interact with 
LB membranes by its CRD domains, generating corrugated membrane assemblies. 
Protein-protein interactions of SP-A established by its N-terminal segment would 
promote the apposition of corrugated membranes, leading to the formation of lattice-
structures. Furthermore, according to this model, the presence of SP-B/SP-B interactions 
would be relevant in the tubular myelin structure by favoring membrane-membrane 
interactions (Palaniyar et al., 2001; Perez-Gil, 2008). Although the specific function of 
the tubular myelin is still unclear, it has been proposed that it could work as an 
antimicrobial network, where SP-A and other molecules of the host defense would be 
located (McCormack and Whitsett, 2002). 
Finally, besides LBPs and tubular myelin, large lipid vesicles can also be formed by 
the unpacking of secreted LBs. All these extracellular complex lipid-protein assemblies 
would constitute a surfactant pool in the hypophase to satisfy its demand at the interface. 
 
DEGRADATION AND RECYCLING 
Once surfactant reaches the interface and forms the functional film that stabilizes the 
respiratory surface, it is subjected to successive compression-expansion cycles that lead 
to compositional and structural reorganizations of surfactant components coupled to a 
progressive loss of “spent” material (Gunther et al., 1999). Maintenance of a functional 
surfactant film continuously requires its refinement through clearance of its components 
and the replacement with newly-secreted surfactant. The “spent” surfactant is released 
from the interfacial film in the form of small aggregates and driven towards alveolar type 
II cells and alveolar macrophages for clearance. 
Surfactant lipids can be recycled by ATII cells through a process mediated by SP-A. 
SP-A binds to small aggregates and upon its interaction with a specific receptor in ATII 
cell, probably P63 (Bates, 2010), both SP-A and lipids are internalized by a clathrin-
dependent pathway. Lipids are transferred to lamellar bodies from early endosomes in a 
calmodulin-dependent mechanism (Wissel et al., 2001). Alternatively, lipids can also be 
uptaken by alveolar type II cells in an actin-dependent process, although this pathway 
contributes in a lesser extent to surfactant recycling (Bates et al., 2008).  
A fraction of proteins and lipids might be altered as a consequence of their exposure 
to an oxidizing environment or at the presence of external harmful agents in the 
respiratory airways. Thus, degradation of these not-fully active components is essential 
for a proper turnover of the surfactant pool and it mainly occurs in alveolar macrophages, 
although ATII cells can also participate in surfactant lipid catabolism (Olmeda, Martinez-
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Calle and Perez-Gil, 2017). Lipid degradation in both cells mainly occurs through the 
action of PLA2.  
SP-C and SP-D modulate the uptake of phospholipids and thus, accomplish essential 
roles in maintaining the homeostasis of surfactant. SP-D appears to participate in the 
conversion of  large aggregates of surfactant into small aggregates, probably through 
binding to PI, although the mechanism remains unclear (Ikegami et al., 2009). In the case 
of SP-C, this protein induces membrane fragmentation that leads to the formation of small 
lipoprotein vesicles enriched in cholesterol (Roldan et al., 2016). Recently, it has been 
described that SP-C and cholesterol increase lipid uptake by alveolar macrophages. After 
the engulfment process, lipids are accumulated intracellularly in the form of lipid 
droplets, while SP-C is located at defined regions in the plasma membrane (Roldán López 
et al., 2017). 
 
1.5. METHODS FOR MEMBRANE PROTEIN PURIFICATION 
DETERGENTS 
Over the past decades, the use of detergents has made a clear impact on the progress 
of membrane protein research. Detergents serve as tools to solubilize, isolate and 
manipulate membrane proteins for subsequent structural and functional characterization. 
They are surface-active molecules that self-associate in aqueous solutions forming 
globular structures, termed as micelles, where polar head groups form an envelope in 
contact with water while hydrophobic tails are sequestered from water in the inner of the 
micelle. Thus, detergent micelles provide an amphipathic environment that can somehow 
mimic lipid bilayers and solubilize membrane proteins by interaction with hydrophobic 
regions of the protein, preventing their exposure to water and maintaining protein stability 
(Garavito and Ferguson-Miller, 2001).  
The general properties of detergents that are pertinent as membrane protein tools are 
the critical micelle concentration (cmc) and the aggregation number. At low 
concentrations, detergent molecules exist as monomers in aqueous solution. As detergent 
concentration increases above the cmc, detergent monomers start to self-associate into 
micelles. The cmc of a given detergent varies with temperature, pH, ionic strength, as 
well as the presence of proteins, lipids and other detergents (Seddon, Curnow and Booth, 
2004). The aggregation number is the number of monomers contained in a micelle, so 
that the size of the micelle can be described by the aggregation number (Garavito and 
Ferguson-Miller, 2001).  
Detergents can be classified according to the type of polar head group (Garavito and 
Ferguson-Miller, 2001; Seddon, Curnow and Booth, 2004): 
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 Ionic detergents contain a hydrophilic head group with a net charge that 
can be either cationic or anionic. The cmc of an ionic detergent is determined by 
the combined effect of the repulsive interactions between headgroups and the 
hydrophobic interactions of the tails. Ionic detergents, such as sodium dodecyl 
sulfate (SDS), are very effective in membrane solubilization, but they usually 
cause protein denaturation.  
 Nonionic detergents contain an uncharged head group, such as n-dodecyl-
β-maltoside (DDM). They are milder than ionic detergents, as they break lipid-
lipid and protein-lipid associations, rather than protein-protein interactions. Thus, 
nonionic detergents solubilize membrane proteins maintaining their structure.  
 Zwitterionic detergents have charged hydrophilic head group with a zero 
net charge. They combine properties of the other two types of detergents. They 
are harsher than nonionic detergents. CHAPS (3-[(3-Cholamidopropyl) 
dimethylammonio]-1-propanesulfonate) is a known member of this group, which 
has a high cmc that decreases with increasing of ionic strength (Chattopadhyay 
and Harikumar, 1996). 
The optimal choice of the detergent is key to ensure the solubilization of the membrane 
protein of interest into a functional, active form comparable to that in their native 
membranes. Besides, this choice has to take into account the type of techniques that will 
be used for the study of the solubilized membrane protein. Therefore, the process of 
solubilization of a membrane protein requires a detailed previous analysis to determine 
the best detergent and its optimal concentration. 
Membrane protein solubilization by detergents strongly depends on 
detergent/lipid/protein ratios. The solubilization process of membrane proteins goes 
through several stages as the detergent to lipid ratio increases (Silvius, 1992; le Maire, 
Champeil and Møller, 2000). At low detergent concentration, detergent monomers insert 
into the bilayers with minimal membrane perturbation. As the concentration of detergent 
increases, the membrane bilayer is disrupted, giving rise to the start of membrane 
solubilization. At this stage, lipid/protein/detergent mixed micelles coexist with intact 
membranes. Further detergent addition leads to the formation of mixed lipid/detergent 
micelles and membrane proteins surrounded by micellar detergent. A steady increase of 
solubilized lipid and protein fractions occurs by addition of detergent until their complete 
solubilization.  However, such a high detergent concentration is not recommended as this 
could lead to the inactivation or aggregation of the protein (Silvius, 1992). Besides, the 
presence of remaining lipids in protein solubilized complexes would be an evidence of 
the importance of this lipid-protein interaction in the structure and function of the 
membrane protein (Catoire, Warnet and Warschawski, 2014).  
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Figure 1.17. Solubilization of membrane proteins using detergents. Taken from Jena Bioscience 
GmbH’s website. 
 
Once the membrane protein is solubilized and eventually purified, it can be 
reconstituted into alternative lipid membranes for further study in a desired lipid 
environment. Two common approaches can be used to form proteoliposomes with a 
protein purified in detergent. The first one is based on diluting the detergent/protein 
mixture into the liposome suspension. When the detergent is below its cmc, micelles 
becomes unstable, disaggregating in monomeric detergents, and the protein transfers into 
the liposomes. In a second approach, the concentration of detergent used is enough to 
destabilize the membranes of the vesicles, favoring the incorporation of the protein into 
the liposomes, after which an additional step to remove the excess of detergent becomes 
essential. Depletion of detergent from a vesicle suspension can be performed by several 
methods, including size-exclusion chromatography, dialysis and adsorption to 
hydrophobic beads (Seddon, Curnow and Booth, 2004). 
The dissociating properties of detergents have been used to extract membrane proteins 
from their native membranes. In a solution of membrane protein solubilized in detergent, 
detergent molecules are in equilibrium with molecules bound to the protein, micelles and 
monomers. To prevent its desorption from the hydrophobic regions of the protein, the 
detergent concentration must be close to its cmc. However, under these conditions, 
detergents tend to destabilize the membrane protein by two main mechanisms: 1) 
detergent micelles can solubilize hydrophobic cofactors, lipids or subunits, that 
contributes to the stability of the membrane protein; and 2) detergents can disrupt 
intramolecular protein-protein interactions, altering the 3D structure of the protein 
(Breyton, Pucci and Popot, 2010).  This problem has been overcome with the 
development of new alternatives to conventional detergents, such as amphipols, 
nanodiscs and SMA-lipid nanoparticles. 
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AMPHIPOLS 
Amphipols are amphipathic polymers, composed by numerous hydrophobic groups 
and many highly polar moieties, which are usually charged. The unique feature of 
amphipols is their ability to self-assemble into well-defined particles of several KDa. For 
instance, four molecules of amphipol A8-35 form a 9-10 KDa particle (Popot, 2010; 
Popot et al., 2011). A8-35, which is by far the most extensively used amphipol, shows a 
low charge density which seems to favor the stability of membrane proteins. A8-35 has 
been shown to form a soluble complex with a very wide range of membrane proteins, 
from ˂ 5KDa to > 1.1 MDa (Popot, 2010). 
 
Figure 1.18. Membrane protein stabilized by Amphipols. A) Representative cartoon, amphipols 
are shown in blue. Modified from (Liang and Tamm, 2018) B) Chemical structure of amphipol A8-
35. Modified from (Popot, 2010). 
 
Amphipols show a high affinity for the surface of the protein, so that the equilibrium 
dissociation constant is small, which means that little amounts of surfactant would be 
sufficient to surround the hydrophobic regions of the membrane protein. In contrast to 
detergents, the free surfactant phase vanishes in solution of amphipols-stabilized 
membrane proteins (Breyton, Pucci and Popot, 2010; Popot, 2010). Besides its stabilizing 
properties, amphipols are compatible with a wide range of biochemical and biophysical 
techniques, like size exclusion chromatography, analytical ultracentrifugation, electron 
microscopy, small-angle X-ray scattering and solution nuclear magnetic resonance. 
Generally, amphipols are unable to directly extract membrane proteins from native 
membranes, because they are poorly dissociating surfactants (Breyton, Pucci and Popot, 
2010; Popot et al., 2011). Therefore, a previous solubilization of the target protein by 
detergents is required before transferring it to the polymer. The incubation of the 
detergent-solubilized protein with amphipols gives rise to the formation of the ternary 
complex membrane protein/detergent/amphipol. These complexes can also incorporate 
lipids that had been solubilized by detergents or lipids added afterwards to enhance the 
stability and/or activity of the protein. Finally, the detergent is removed usually by 
adsorption to polystyrene beads or by detergent dilution below its cmc. In the latter case, 
the detergent remains in the solution as monomers and its concentration surrounding the 
protein surface declines. The concentration ratio amphipol to membrane protein must be 
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optimized in each case, because it varies depending on the molecular mass of the protein 
and the extent of its hydrophobic surface.  
 
NANODISCS 
Nanodiscs are soluble self-assembled phospholipid bilayers that constitute a useful 
tool to reconstitute membrane proteins in a desired lipid environment. They consist of a 
circular fragment of phospholipid bilayer encapsulated by two molecules of a membrane 
scaffolding protein (MSP) derived from Apolipoprotein A1. The interactions between 
phospholipids and MSP molecules are established by the amphipathic α-helices of the 
protein that shield the acyl chains of the phospholipid bilayer from the aqueous 
environment (Denisov et al., 2004). Nanodiscs have been extensively used over the last 
decade, mostly due to the development of new constructs of MSP proteins, including 
truncated and extended variants of MSP that generate nanodiscs that range in size from   ̴
7 to  ̴ 17 nm of diameter (Denisov and Sligar, 2017), as the length of the MSP determines 
the size of nanodisc. Thus, nanodiscs show a defined and stable size which depends on 
the MSP construct used to yield them. The advantage of nanodiscs over other self-
assembled systems, such as micelles, bicelles or liposomes, is that they are more stable 
and with a better defined structure because of the strong interaction between the scaffold 
proteins and lipids. 
In this Thesis, the membrane scaffolding protein used was MSP1D1 (its sequence is 
shown in figure 1.19), which yields nanodiscs of about 10 nm of diameter. MSP1D1 
shows a polihistidine tag at its N-terminal end, followed by a linker containing a Tobacco 
Etch Virus (TEV) protease site, to enable tag removal, and the main MSP sequence 
(Ritchie et al., 2009). The histidine tag allows purification of the generated nanodiscs by 
immobilized metal affinity chromatography.  
The general protocol for the formation of nanodiscs begins with the solubilization of 
lipids by cholate, followed by the addition of purified MSP (Ritchie et al., 2009). The 
molar ratio phospholipid to MSP is key to yield nanodiscs efficiently. The number of 
phospholipid molecules that can be incorporated into the nanodisc depends on the length 
of the MSP belt. An optimal ratio phospholipid/MSP ensures that there is a complete self-
assembly of nanodiscs with a homogeneous size. If the ratio is shifted, the excess of 
scaffold protein or phospholipid would lead to the formation of aggregates that could be 
removed by a size-exclusion chromatography or ultracentrifugation. Nanodiscs self-
assemble by progressive removal of detergent by adsorption to polystyrene beads or by 
dialysis. 
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Figure 1.19. Nanodiscs are discoidal lipid bilayers assembled by two molecules of amphipathic 
helical membrane scaffolding protein (MSP). A) Representative illustration of a nanodisc. Taken 
from (Denisov and Sligar, 2017). B) Sequence of the scaffolding protein MSP1D1 consisting of 
histidine tag (green), recognition site for TEV protease (orange) with cleavage in G/S, and the 
sequence of the MSP (blue). 
 
For the incorporation of a given membrane protein into nanodiscs the protein must be 
previously solubilized in detergent. This detergent-solubilized protein is mixed together 
with cholate-solubilized phospholipids and MSP, and finally, detergent is removed by 
one of the methods previously mentioned. To obtain nanodiscs with the membrane 
protein, temperature, time of incubation and the molar ratio of scaffold protein, lipids and 
membrane protein should be optimized. Additionally, the presence of cofactors or 
substrates that enhance the stability and/or activity of the membrane protein should be 
considered (Ritchie et al., 2009; Denisov and Sligar, 2017). 
Nanodiscs have been successfully assembled with various synthetic lipids and with 
mixtures of native lipids. Moreover, nanodiscs can be assembled directly from native 
tissue or cell membranes solubilized by detergent (Marty et al., 2013; Roy et al., 2015; 
Wilcox et al., 2015). The removal of detergent by common methods ensures the self-
assembly of nanodiscs. This experimental approach allows the generation of membrane 
protein nanodisc libraries, which reflect the protein and lipid interactome of the original 
membrane.  
The potential of the nanodisc technology as a powerful and versatile tool for the study 
of the structure and function of membrane proteins has been demonstrated by numerous 
investigations that combined the use of nanodiscs with a wide range of biochemical and 
biophysical techniques, as X-ray crystallography, electron microscopy, small-angle X-
ray scattering (SAXS) and liquid chromatography combined with tandem quadrupole 
mass spectrometry (LC/MS/MS) (reviewed in (Denisov and Sligar, 2017)). 
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SMA/lipid nanoparticles 
Recently, styrene/maleic acid (SMA) copolymers have been developed to directly 
extract membrane proteins from natural or artificial membranes without the use of 
detergents (Knowles et al., 2009; Orwick et al., 2012; Long et al., 2013; Postis et al., 
2015). SMA copolymers recruit membrane proteins and associated lipids into SMA/lipid 
particles (SMALPs) (Dörr et al., 2016). These lipid particles are discoidal nanoscale lipid 
bilayer systems, similar to MSP nanodiscs, in which acyl chains of the boundary 
phospholipids are shielded by SMA copolymer, instead of membrane scaffolding 
proteins.  
SMA is produced by the copolymerization of styrene and maleic anhydride. The 
distribution of the two types of monomers in the resulting polymer depends on their ratio, 
from a nearly regular distribution with a ratio 1:1 to less regular polymers for ratios 1:2 
to 1:4, commonly used in biochemical applications.  
 
Figure 1.20. Protein stabilization in membrane-mimetic system using SMA polymers. A) 
Representative illustration of SMA lipid nanoparticles, SMA polymers are shown as orange belts. 
Modified from (Liang and Tamm, 2018). B) Structure of SMA copolymer, repeating units of styrene 
(n) and maleic anhydride alternate within the resulting copolymer. 
 
The size range of the particles depends on the styrene/maleic anhydride ratio, as well 
as the protein and lipids used (Zhang et al., 2015, 2017; Craig et al., 2016; Dörr et al., 
2016). Thus, SMALPs emerge as a membrane mimetic tool with different nanoscale 
sizes, which can be used for the study of a wide range of membrane proteins, even 
mitochondrial complexes of around 200 KDa (Long et al., 2013). Unlike the length of a 
particular MSP construct, the polymer length is not exactly fixed, so that the range of 
particle sizes obtained can be more variable. Thus, to obtain a more homogeneous sample 
size, the experimental conditions need to be optimized, mainly lipid to protein and lipid 
to SMA ratios, and combined with a size-exclusion chromatography. 
SMALPs have been successfully used for functional and structural studies on 
membrane proteins in a near-native environment, providing a wide number of 
biochemical and biophysical applications (reviewed in (Dörr et al., 2016)). 
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2. OBJECTIVES 
Pulmonary surfactant protein SP-B is essential for life. Although its folding and three-
dimensional tertiary structure is not yet well-known, the native structure of SP-B seems 
to be assembled in the form of a ring-shaped oligomer, formed by 5 or 6 covalent SP-B 
dimers. SP-B, together with SP-C, exerts a wide variety of effects on surfactant lipid 
bilayers and monolayers that lead to profound rearrangements closely related to the 
surface active function of pulmonary surfactant at the alveolar interface. 
The main objective of the present Thesis is to contribute to the understanding of the 
structure and function of the native protein complexes present in pulmonary surfactant, 
with a particular focus on those constituted by SP-B. In this way, five specific objectives 
have been addressed in the present work: 
1. To perform a compositional and structural analysis of protein complexes derived 
from detergent-solubilized surfactant or surfactant nanodiscs. Besides, protein 
crosslinking is applied to attempt the clarification of the interactions between proteins 
SP-B and SP-C in quasi-native environments. 
2. To study the effect of surfactant protein complexes on the permeability and 
interfacial dynamics of pulmonary surfactant membranes, in order to propose a 
potential mechanism for the dual action of SP-B on both surfactant activities. 
3. To address a deeper structural characterization of native SP-B oligomers, mainly 
in lipid environments, attempting the generation of samples with a proper quality, in 
order to approach further high-resolution structural characterization of the complexes. 
4. To study the structural features of SP-B applying fluorescence spectroscopy 
methodologies, including the determination of the stoichiometry of native SP-B 
oligomers in membranes and a quantitative study of the topological changes induced 
by SP-B in multilamellar structures. 
5. To study the effect of SP-B on surfactant secretion by alveolar type II cells. 
Elucidation of the signaling mechanisms connecting SP-B with lamellar body 
exocytosis in ATII cells. 
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3. MATERIALS AND METHODS 
3.1. MATERIALS 
Pulmonary surfactant from bronchoalveolar lavages 
Pulmonary surfactant was isolated from bronchoalveolar lavage fluid (BALF) of 
porcine adult lungs, as previously described (Taeusch et al., 2005). Porcine lungs were 
obtained from industrial slaughterhouse (Matadero Madrid-Norte S.A., San Agustín de 
Guadalix, Madrid). Lavages were performed with 2.5 L of cold 5 mM Tris pH 7.4, 150 
mM NaCl solution per respiratory apparatus. The obtained BALF was filtered through a 
gauze and centrifuged at 1000 g for 5 minutes at 4 °C to eliminate cells and debris. BALF 
was stored at -20 °C. Purification of pulmonary surfactant fraction from BALF required 
a first centrifugation at 100000 g for 1 hour at 4 °C to pellet surfactant membranes and a 
subsequent density gradient centrifugation that allowed the separation of pulmonary 
surfactant complexes from other cell membranes. For this last centrifugation, pellets were 
resuspended in a 16% NaBr, 0.9 % NaCl (w/v) solution and disposed in the appropriate 
centrifuges tubes. The discontinuous gradient was formed by addition of 13% NaBr, 0.9% 
NaCl solution, followed by 0.9% NaCl solution. Tubes were centrifuged in a swinging 
angle rotor at 120000 g for 2 hours at 4 °C. Surfactant membranes were concentrated at 
a fringe between the 0.9% NaCl solution and the 13% NaBr, 0.9% NaCl solution. After 
removing the upper solution carefully, surfactant fractions were recovered and 
homogenized in 0.9% NaCl solution. Pulmonary surfactant was aliquoted, frozen in liquid 
N2 and stored at -80 °C. 
 
Organic extract from pulmonary surfactant 
Pulmonary surfactant hydrophobic components were obtained by organic extraction 
(Bligh and Dyer, 1959). One volume of pulmonary surfactant was mixed with two 
volumes of methanol and one volume of chloroform, followed by thoroughly vortexing 
of the mixture for 30 seconds. The single-phase solution was then incubated for 30 
minutes at 37 °C under continuous shaking to flocculate the water soluble-proteins in the 
mixture. Next, one volume of distilled water and one additional volume of chloroform 
were added and the mixture was thoroughly vortexed. After that, it was centrifuged at 600 
g for 5 minutes at 4 °C to obtain a biphasic solution. After careful collection of the organic 
solvent phase, two volumes of chloroform were added to the aqueous phase, followed by 
centrifugation and organic phase harvesting. This repetitive process improves the yield 
of the extraction of lipids and hydrophobic proteins. The material recovered at the several 
organic phases, defined as organic extract from pulmonary surfactant (OE), was 
preserved at -20 °C. 
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Obtaining of lipid and hydrophobic protein fractions of pulmonary surfactant 
To separate the lipid fraction and the hydrophobic protein fraction of organic extract 
of PS, a size exclusion chromatography was performed. OE was concentrated using a 
rotatory evaporator and applied into a gel filtration-packed column (Sephadex LH-20, GE 
Healthcare) equilibrated with chloroform/methanol 2:1 (v/v). Absorbances at 240 nm and 
280 nm were measured in the collected fractions to identify the lipid fraction (LF) and 
the hydrophobic protein fraction (PF). All fractions were stored at -20 °C.  
 
Purification of SP-B and SP-C from minced lungs 
To improve their yielding, surfactant proteins SP-B and SP-C were also isolated from 
porcine minced lungs (Perez-Gil, Cruz and Casals, 1993). Each respiratory apparatus was 
minced and lavaged with 1 L of cold 5 mM Tris pH 7.4, 150 mM NaCl. Minced lungs 
were filtered with a gauze and centrifuged (1000 g, 4 °C, 5 minutes) to remove cells and 
debris. A second centrifugation (3000 g, 4 °C, 2 hours) allowed the yield of membranes 
in the pellet. Pellets were harvested and stored at -20 °C. To continue the purification 
process, pellets of minced lungs were thawed and an organic extraction was performed to 
obtain SP-B and SP-C together with lipids. The obtained organic solvent solution was 
subjected to two sequential size exclusion chromatographies. For the first one, a Sephadex 
LH-20 resin packed-column (GE Healthcare) was used equilibrated with 
chloroform/methanol (2:1, v/v) as mobile phase. Absorbances at 240 nm and 280 nm were 
measured to resolve the protein fraction (SP-B and SP-C) from lipids. Protein fraction 
was carefully concentrated by rotatory evaporation and loaded onto a Sephadex LH-60 
column (GE Healthcare), with chloroform/methanol (1:1, v/v), 0.5% 0.1N HCl as eluent. 
SP-B eluted in the void volume of the chromatrogram, showing absorbance at 240 nm 
and 280 nm. Meanwhile, SP-C eluted in a second peak, which absorbs only at 240 nm 
due to the lack of aromatic amino acids. Fractions of SP-B and SP-C were harvested and 
preserved at -20 °C. Purity was determined by western blot and protein was quantified by 
amino acid analysis. 
 
Fluorescent labelling of SP-B with BODIPY FL 
SP-B was derivatized with BODIPY FL NHS-ester (Thermo Fisher Scientific) as 
described in  (Cabre et al., 2018). The apparent pH of the organic solution containing SP-
B was adjusted to 6.6 by adding an appropriate volume of 50 mM Tris in methanol, which 
allowed the deprotonation of the N-terminal amino group of SP-B. BODIPY FL dissolved 
in methanol (10 mg/ml) was added to the protein solution in a molar probe/protein 
proportion of 3:1. Conjugation reaction took place overnight at 4 °C. After that, the 
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protein/probe solution was reacidified up to an apparent pH of 2 to stop the reaction and 
the non-conjugated probe was removed by a Sephadex LH-20 chromatography (GE 
Healthcare) in chloroform/methanol (1:1, v/v), 0.5% 0.1 N HCl. BODIPY FL/SP-B 
fractions were detected by measuring absorbances at 280 nm and 504 nm. The degree of 
SP-B labelling was estimated from amino acid analysis and spectroscopic determination 
of the probe. The molar extinction coefficient used for BODIPY FL in 
chloroform/methanol (1:1, v/v) was 504nm = 82103 M-1cm-1 (Haugland, 2002). The 
molar ratio probe/protein determined for BODIPY FL/SP-B was 0.91.  
 
Lipid and protein/lipid sample preparation 
Throughout this Thesis, different liposomes or proteoliposomes were extensively 
used: porcine pulmonary surfactant membranes (PS), multilamellar vesicles (MLVs), 
which are formed by numerous concentric membranes and are highly polidisperse in size, 
small unilamellar vesicles (SUVs) with diameters between 20-50 nm, large unilamellar 
vesicles (LUVs) with diameters around 100 nm and giant unilamellar vesicles (GUVs) in 
the range of microns. These vesicles contained a variety of components; native pulmonary 
surfactant and its derivatives (organic extract, lipid fraction, hydrophobic protein fraction 
and isolated SP-B and SP-C), as well as the following synthetic lipids (purchased from 
Avanti lipids): 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-
sn-glycero-3-phospho-(1'-rac-glycerol) (DPPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC), and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-
glycerol) (POPG). 
Multilamellar vesicles 
Multilamellar vesicles were prepared by the evaporation-rehydration method. Proper 
volumes of the appropriate lipid and protein stock solutions in organic solvent were mixed 
inside glass tubes. Mixtures were dried under N2 stream. To remove solvent traces, tubes 
were kept under a vacuum centrifuge for 2 hours, obtaining dried films at the bottom of 
the tubes. Membranes were reconstituted by hydration of dried films in 5 mM Tris pH 
7.4, 150 mM NaCl. Rehydration process took place for 1 hour with intermittent shaking 
at 1400 rpm. The incubation temperature, which is key for proper membrane 
reconstitution, was in all cases higher than the phase transition temperatures of the 
corresponding phospholipid mixtures. Thus, dried films containing DPPC (Tm= 41 °C), 
which is the main component of pulmonary surfactant, were rehydrated at 45 °C. 
Liposomes or proteoliposomes containing only unsaturated lipid species, like POPC 
and/or POPG (Tm= -2 °C) were reconstituted at 37 °C. 
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Small unilamellar vesicles 
Sonication of MLV suspensions produces small unilamellar vesicles (SUVs) in the 
range of 15-50 nm. Probe tip sonicator delivers high energy input to the lipid suspension, 
disrupting membranes. When these membranes reseal, they form vesicles with a high 
curvature, which makes them very unstable.  
Small unilamellar vesicles were formed using a sonicator Hierlcher UP200 equipped 
with a titanium probe and the following parameter settings: 0.5 s/cycle and 65% of 
amplitude. MLVs were sonicated for 2 cycles of 2 minutes. SUVs suspensions were used 
immediately, taking care of keeping them always in ice. 
Large unilamellar vesicles 
Unilamellar vesicles can also be obtained by extrusion of MLVs suspensions through 
a polycarbonate filter with defined pore size. As the concentric layers of MLVs deform 
to be able to pass through the pores, rupture and resealing of membranes occurs. After 
repeatedly extruding the MLVs suspension, a population of unilamellar vesicles is formed 
with a mean diameter that reflects the filter pore size. The advantage of the extrusion 
method in comparison to sonication is that the resulting liposome suspensions show 
higher homogeneity and stability. 
In the present work, MLVs suspensions were extruded using a Mini-Extruder (Avanti 
Polar Lipids) with 10 mm diameter filter discs and polycarbonate membranes Nucleopore 
Track-Etch with 100 nm diameter pore (both from Whatman). The extrusion process was 
performed at 45 °C. MLV suspensions were forced to pass 15 times through the filters, 
until the turbidity was decreased. At the end, LUV suspensions were obtained with a mean 
diameter of 100 nm. These suspensions were immediately used or kept at 4 °C to be used 
in the same day. 
Giant unilamellar vesicles 
Giant unilamellar vesicles (GUVs) are a well-established membrane model to study 
physicochemical properties of biological membranes and the activity of associated 
membrane proteins. Due to their size in the micrometric range, these vesicles can be 
visualized or manipulated by optical microscopy. A number of methods have been 
developed in order to get giant unilamellar vesicles with diameters between 1-100 µm 
(Walde et al. 2010).  
In the present work, giant vesicles of diverse complexity in composition were obtained 
by membrane hydration in the presence of an electric field, the so-called electroformation 
method (Angelova and Dimitrov 1986). This technique is based on the application of an 
electric field on a dried lipid film deposited on a conductive glass slide or platinum wires. 
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In this work, dried films were formed on indium-tin oxide (ITO) coated glass slides, with 
70-100 Ω/sq surface resistivity (Sigma Aldrich). GUVs were prepared from two different 
sources, lipids and proteins dissolved in organic solvent or pulmonary surfactant 
membranes in aqueous buffer. 
For GUVs originated from organic solvent samples, 50 µl of lipid or lipoprotein stocks 
containing 1 mg/ml of phospholipid (typically labelled with 0.5% molar Rhodamine-
DOPE) were spread over two ITO glasses. After drying the films in a vacuum chamber 
for 2 hours to completely remove organic solvent, the electroformation chamber was 
assembled: the two film-covered glasses were disposed with the conducting sides face to 
face and separated by a 2 mm thick Teflon spacer, pre-coated with vacuum grease. The 
chamber was filled with a sucrose solution (200 mOsm), sealed at both sides with vinyl 
paste (Critoseal, Leica Biosystems) and connected to a function generator. 
Electroformation was performed at 45 °C, protected from light, in three different phases: 
phase I, sine wave with a frequency 8 Hz, peak-to-peak amplitude ramped up from 250 
to 1500 mV for 30 minutes; phase II, sine wave at constant 8 Hz frequency and an 
amplitude of 1500 mV during 2 hours; and phase III, sine wave with ramped down from 
6 to 0 Hz and a constant amplitude of 1500 mV for 30 minutes. After electroformation, 
the suspensions were carefully collected from the chamber and stored at 4 °C. 
Some modifications of this protocol were included for GUVs formed from native 
pulmonary surfactant membranes. Native surfactant at 10 mg/ml of phospholipid was 
incubated with Rhodamine-DOPE, added in an aliquot of DMSO (4.43 µl at 1 mg/ml), at 
a final concentration of 0.5% molar for one hour at 37 °C. Labeled native surfactant 
suspension was diluted at 1mg/ml of phospholipid and drops of the preparation (50 µl) 
were spread over two ITO glasses, where the film was then gradually dried under a 
nitrogen stream, and finally surfactant covered glasses were kept in a vacuum chamber 
for 30 minutes. 
 
Primary ATII cell cultures 
ATII cells were isolated from Sprague-Dawley rats according to the procedure of 
(Dobbs, Gonzalez and Williams, 1986) with minor modifications (Haller et al., 1998). 
Briefly, lungs were cleared of blood by perfusion and removed from the thorax. After 
lavage, the lungs were instilled with 0.05 % trypsin and 0.5 % elastase (w/v) solution, 
incubated at 37 °C, and minced with scissors in the presence of DNase. After stopping 
the enzymatic digestion by addition of fetal bovine serum (FBS), the cell suspension was 
sequentially filtered through cotton gauze and three nylon meshes (100-, 20-, and 10-μm 
mesh size) and centrifuged at 160 g for 8 minutes at room temperature. The cell pellet 
was resuspended in DMEM and panned on an IgG-coated plastic dish to remove 
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macrophages. The unattached cells were again centrifuged and then suspended in 
Mucilair (Epithelix) supplemented with 1% (v/v) gentamicin 10 mg/ml (Thermo Fisher 
Scientific). Yield and purity of ATII cell isolations were routinely monitored using a 
combined cell counting and lysotracker staining assay. The average purity of all the ATII 
isolations used in this Thesis was 85-95%. After isolation, cells were seeded on 8-well 
chambers (Ibidi) or 96-well plate (Sarstedt) and cultured in 95% humidified air and 5% 
CO2 at 37 °C. Experiments were performed 48 hours after isolation. 
 
Isolated plasma membrane from ATII cell cultures 
Isolation of plasma membrane of ATII cell cultures was performed based on methods 
described by (Duck-Chong, 1978; Gupta et al., 2006). Pellets from 16∙106 ATII cells were 
thawed and then incubated for 30 minutes at 4 °C with lysis buffer containing 20 mM 
Tris pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% triton X-100 (v/v) and a protease inhibitor 
cocktail (Sigma Aldrich). Following, cell suspensions were sonicated (4 cycles of 15 
seconds, 10% amplitude) and centrifuged (16000 g, 4 °C, 20 minutes) to pellet 
membranes. After that, pellets were resuspended in 5 mM Tris pH 7.4, 0.32 M sucrose. 
Isolation of ATII plasma membrane was performed through a sucrose density-gradient 
ultracentrifugation in a swinging angle rotor (100000 g, 4 °C, 1 hour). The discontinuous 
gradient was formed with 5 mM Tris pH 7.4 solutions containing 1.2, 0.9, 0.7 and 0.5 M 
sucrose. At the top of the centrifuge tube, ATII membranes solubilized in 5 mM Tris, 0.32 
M sucrose were added. Upon ultracentrifugation, plasma membranes were located at the 
bottom of the tube, forming a pellet. Finally, plasma membrane pellet was resuspended 
in 5 mM Tris pH 7.4, 150 mM NaCl, 0.1% Triton X-100 (v/v). Isolated ATII plasma 
membrane suspension was stored at 4 °C until the following day for co-
immunoprecipitation assay (detailed in section 3.2 Analytical techniques). 
 
3.2. ANALYTICAL TECNIQUES 
Phospholipid quantification 
Phospholipid concentration was determined by phosphorus quantification (Rouser, 
Siakotos and Fleischer, 1966). Samples were dried in glass tubes, and then lipid 
hydrolysis and phosphorus mineralization was performed by incubation with 0.65 ml of 
70% perchloric acid in a sand bath at 260 °C for 30 minutes. Tubes were capped with 
glass globes to prevent from acid solution evaporation. Next, 3.5 ml of milliQ water, 0.5 
ml of 2.5% ammonium molybdate (w/v) and 0.5 ml 10% ascorbic acid (w/v) were added 
and thoroughly vortexed after each solution addition. The colorimetric reaction was 
triggered by incubation at 100 °C for 7 minutes, where ascorbic acid reduced phospho-
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molybdic complexes, resulting in a blueish sample solution. A calibration curve with 
known amounts of phosphate were assessed together with samples of interest. 
Absorbance at 820 nm was measured in samples and calibration standards. 
 
Thin layer chromatography 
Lipid composition of pulmonary surfactant reconstituted into MSP nanodiscs was 
analyzed by thin layer chromatography (TLC). 60 µl of nanodisc preparations were dried 
under N2 stream and solubilized in 10 µl of chloroform/methanol 2:1 (v/v). These samples 
and a set of lipid standards (10 µg) were applied at the bottom of a 20 x 20 cm silica plate 
(TLC Silica Gel 60, Millipore). Once applied samples were dried, TLC was performed 
by incubating the silica plate with the mobile phase solution chloroform/methanol/water 
(65:25:4, v/v/v) at room temperature. Finally, plate was air-dried and stained with iodide 
vapors for analysis. 
 
Amino acid analysis 
The highly hydrophobic character of proteins SP-B and SP-C, the use of organic 
solvents for their isolation and the lack of aromatic amino acids in SP-C prevented the 
use of conventional techniques to determine protein concentration, such as 
spectrophotometry or Bradford assay. Thus, 200-300 µl of purified protein in organic 
solvent (about 10-20 µg) was dried under N2 stream and subjected to an acidic hydrolysis 
under vacuum for 24 hours at 100 ºC. The acid solution contained 6 N HCl, 0.1% phenol 
(w/v) and a known nor-leucine concentration to be used as an internal standard. After 
hydrolysis, HCl was evaporated under N2 stream followed by two washing/evaporation 
steps with milliQ water to ensure the complete removal of HCl. Finally, samples were 
resuspended in 0.2 N sodium citrate and subjected to ion exchange chromatography and 
post-column nynhidrin derivatization using a high performance amino acid analyzer 
(Biochrom 30, Biochrom). From the obtained chormatograms, the amounts of each amino 
acid species and the known sequence of each protein were used to determine the 
concentration of each protein.  
 
ATP quantification by luciferase assay 
ATP release in non- or SP-B-stimulated ATII cell cultures was quantified by the 
luciferase assay as follows. 106 rat primary ATII cells were seeded into wells of a 96-well 
plate and maintained in MucilAir medium. 48 hours after seeding, the medium was 
exchanged with fresh medium containing 100 µM ARL 67156. The cells were then 
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stimulated with POPC:POPG vesicles containing 12% SP-B (by weight) and supernatants 
were collected for ATP quantification. ATP release was quantified using ATP 
Determination kit (Thermo Fisher Scientific). In parallel, extracellular ATP was 
determined in non-treated ATII cells, following the same procedure. 
 
Electrophoretic analysis of proteins 
SDS-PAGE 
Hydrophobic surfactant proteins obtained from minced lungs, protein complexes 
obtained from solubilization of pulmonary surfactant by detergent or from reconstitution 
into nanodiscs, as well as samples from the SP-B co-immunoprecipitation of plasma 
membrane proteins from rat ATII cells, were analyzed by electrophoresis in 
polyacrylamide gels. 
Water-soluble samples were prepared in loading buffer containing 10% glycerol, 2% 
SDS and 0.03% bromophenol blue in the presence or absence of 5% ß-mercaptoethanol, 
as reducing agent. In the case of samples in organic solvent, they were first evaporated 
under a nitrogen stream before adding the loading buffer. All samples were boiled for 10 
minutes and afterwards, loaded into gels of different polyacrylamide percentages, 
together with prestained protein standards (Precision Plus Protein Dual Color Standards, 
Bio-Rad, or HiMark Pre-stained Protein Standard, Thermo Fisher Scientific). 
Electrophoresis were performed at 110 V. 
After SDS-PAGE, gels were stained by silver nitrate or Coomassie Brilliant Blue R-
250 or were transferred to the appropriate membranes for protein immunodetection. 
BN-PAGE 
Blue Native (BN)-PAGE allows to determine native molecular masses and 
oligomerization states of proteins, as well as identifying protein-protein interactions. This 
electrophoretic technique makes use of the anionic probe Coomassie Blue G-250 (Sigma) 
to produce a charge shift of proteins to negative charge, allowing their migration primarily 
depending on their mass.  
Samples were diluted into loading buffer containing 5% Coomassie Blue G-250 and 1 
M aminocaproic acid, enhancing the latter the solubilization of membrane proteins. A 
high molecular weight calibration kit for native electrophoresis (GE Healthcare) was used 
as protein standards. For BN-PAGE, gradient gels of 4-20% polyacrylamide (Bio-Rad) 
and two different electrophoresis buffers were used: dark cathode buffer (15 mM BisTris, 
15 mM tricine pH 7, 0.02% Blue G-250), light cathode buffer (which differs from the 
first buffer in the percentage of probe, 0.002% Blue G-250) and anode buffer (50 mM 
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BisTris pH 7). Electrophoresis were performed at 4 °C in two steps: first, at 100 V in dark 
cathode buffer until the dye had run one third of the gel, and secondly, dark cathode buffer 
was replaced by light cathode buffer and the voltage was increased to 220 V. 
Finally, gels were stained by silver nitrate staining or transferred to membranes for 
immunoblotting. In the latter case, membranes were unstained previously to the blocking 
step by incubation with 8% acetic acid for 15 minutes, followed by a membrane drying 
step and washing in methanol. 
Two-dimensional electrophoresis 
Native protein complexes of pulmonary surfactant were studied by BN-PAGE 
followed by SDS-PAGE. Gel strips from the BN-PAGE were cut and incubated for 2 
hours with equilibration buffer containing 50 mM Tris pH 8.8, 30% glycerol (v/v), 2% 
SDS (v/v), 0.002% bromophenol blue (w/v) and 30 mM DTT. After a quick rinse with 
running buffer, the gel strip was placed on the top of a separating gel. A one-well plastic 
comb was also placed over the gel to load the protein standards. A sealing solution 
containing 0.5% agarose (w/v) and 0.002% bromophenol blue (w/v) was added. After 
gelation of the agarose, and loading of protein standards, SDS-PAGE was performed at 
110 V.  
Silver nitrate staining 
After electrophoresis, gels were fixed for 30 minutes in a solution containing 40% 
ethanol and 10% acetic acid and incubated then for 30 minutes in sensitizing solution 
(30% ethanol, 0.5% glutaraldehyde, 0.8 M sodium acetate and 12.6 mM sodium 
thiosulphate). Afterwards, gels were washed three times with milliQ water for 5 minutes, 
and incubated in silver solution (0.6 mM silver nitrate, 0.04% formaldehyde) for 20 
minutes. After a quick rinse with milliQ water, bands were developed with a solution 
containing 0.2 M sodium carbonate and 0.02% formaldehyde. The reaction was stopped 
with 50 mM EDTA pH 8. 
Coomassie staining 
Gels were incubated in a solution containing 1 mg/ml Coomassie Brilliant Blue R-250, 
50% methanol and 10% acetic acid for 30 minutes. Destaining with 10% acetic acid, 45% 
methanol solution revealed blue stained bands. 
Western blot 
Proteins in gel were transferred to a PVDF (polyvinylidene fluoride) membrane (Bio-
Rad) using a wet transfer system at 300 mA for 1 hour at room temperature. For gradient 
polyacrylamide gels, transfer settings were 400 mA for 90 minutes at 4 °C. Membrane 
was then blocked in PBS containing 0.05% Tween-20 and 5% milk for 2 hours. The 
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primary antibody, diluted in blocking solution, was added for overnight incubation at 4 
°C. After consecutive washing with PBS-Tween, membrane was incubated with the HRP-
labeled secondary antibody in blocking solution for 1 hour at room temperature, followed 
by extensive washing with PBS-Tween to eliminate unbound antibody. Finally, 
membrane was developed in Millipore Immobilon Western Chemiluminiscent HRP 
Substrate. Images were recorded in Image Quant LAS500 (GE Healthcare). 
The primary antibody dilutions used were rabbit polyclonal anti human SP-A antibody 
1:10000 (kindly supplied by Dr. J. Floros, from Penn State University, USA), rabbit 
polyclonal anti human SP-B antibody 1:5000 and rabbit polyclonal anti human SP-C 
antibody 1:1500, both from Seven Hills Bioreagents, and, lastly, mouse monoclonal α-
His6 Peroxidase IgG1 (Sigma). As HRP-conjugated secondary antibody, polyclonal swain 
α-rabbit Ig 1:2000 (Dako) was used. 
 
Protein crosslinking 
In order to study protein-protein interactions between SP-B and SP-C, a number of 
crosslinking reactions were performed by using dithiobis(succinimidyl propionate) 
(DSP), BS3 (bis(sulfosuccinimidyl)suberate) and (PEGylated bis(sulfosuccinimidyl) 
suberate) BS(PEG)9 (purchased from Thermo Fisher Scientific). These are 
homobifunctional crosslinking reagents with NHS-ester groups at both ends, which 
specifically crosslink primary amines, although they differ in their structure, providing 
them with different water-solubility, membrane permeation abilities and range of 
crosslinking chain length. 
First, the hydrophobic protein fraction of surfactant (PF), a mixture of isolated SP-B 
and SP-C, or SP-B alone were reconstituted into vesicles made of the lipid fraction (LF) 
of pulmonary surfactant or synthetic lipid mixtures DPPC:POPC:POPG (5:2.5:1.5, 
w:w:w) or POPC:POPG (7:3, w:w). Proteoliposome suspensions were prepared at a 
phospholipid concentration of 100 g/ml in 15 mM MOPS pH 7.4, 50 mM NaCl or 20 
mM HEPES pH7, 150 mM NaCl. Protein:lipid ratio used in each case is indicated in the 
text in Chapter 1. Multilamellar preparations were sonicated to form small unilamellar 
vesicles or extruded using polycarbonate filter membranes with pore size of 100 nm to 
form large unilamellar vesicles.  
Next, 12-25 µl of vesicles (1-2.5 µg of total protein) were crosslinked with the 
appropriate reagent at the desired crosslinker:protein molar ratios. Stocks of crosslinking 
reagents were prepared as follows: 10 mM DSP in DMSO, 25 mM BS3 and 2.5 mM 
BS(PEG)9 in milliQ water. The reaction was performed for 30 minutes at 37 °C (30 
seconds vortexing every 5 minutes) or eventually for 2 hours at 4 °C (30 seconds 
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vortexing every 15 minutes). The crosslinker was quenched by addition of 5 mM Tris pH 
7. Samples were concentrated with StrataClean Resin (Agilent Technologies), diluted in 
loading buffer and loaded into a 4-20% polyacrylamide gel (Bio Rad), to be analyzed by 
SDS-PAGE and subsequent immunoblotting for SP-B and SP-C detection 
In addition to the crosslinking experiments between SP-B dimers or SP-B and SP-C 
reconstituted into vesicles, SP-B complexes purified in detergent from pulmonary 
surfactant (15 µg protein) were subjected to crosslinking by BS(PEG)9 following the same 
protocol detailed above. 
 
Co-immunoprecipitation assay 
To identify a putative receptor of SP-B in the plasma membrane (PM) of ATII cells, a 
co-immunoprecipitation assay was performed. Prior to the immunoprecipitation, rabbit 
polyclonal α-SP-B antibody (from Seven Hills Bioreagents) was crosslinked to Protein A 
beaded agarose resin (Santa Cruz Biotechnology) by the crosslinker agent dithiobis 
succinimidyl propionate (DSP) (from Thermo Fisher Scientific). For this, 100 µl of beads 
were diluted in 100 µl of blocking solution (PBS, pH7 containing 1 mg/ml BSA). After 
15 minutes of incubation at 4 °C, beads were pelleted by centrifugation at 1000 g for 5 
minutes, and then incubated with α-SP-B antibody in blocking solution (1 µl of antibody 
diluted 1/10 in solution) for 1 hour at 4 °C with gentle agitation. Beads were then washed 
with blocking solution and crosslinked to the antibody with DSP through three 
consecutive incubations with 2.5 mM DSP, followed by washing in PBS. For crosslinker 
quenching, conjugated beads were incubated for 30 minutes with 1 M Tris and washed 
with PBS. Next, free antibody was removed by incubating twice with a solution 
containing 0.2 M glycine pH 2.8 for 30 minutes, followed by three washing steps with 
PBS. 
Before immunoprecipitation, ATII plasma membrane fraction (234 nmol) was 
incubated with POPC:POPG (7:3) SUVs containing SP-B (46 nmol SP-B) for 3 hours at 
room temperature with gentle agitation. Next, sample was solubilized in CHAPS 1% (1 
hour with thoroughly agitation) and was then preclarified by incubation with 20 µl of 
naïve Protein A-agarose beads for 2 hours. 
For immunoprecipitation, solubilized and precleared suspension containing SP-B and 
ATII PM fraction was added to α-SP-B-conjugated Protein A-agarose beads and the 
mixture was then incubated overnight at 4 °C with gentle shaking. After washing 6 times 
in PBS, bead-bound proteins were eluted in three consecutive steps: 0.2 M glycine, 2% 
SDS and SDS-PAGE loading buffer containing 5% ß-mercaptoethanol (boiling the 
mixture at 99 °C). Eluted fractions were analyzed by SDS-PAGE. 
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Mass spectrometry 
Interaction between SP-B and a putative receptor in plasma membrane of ATII cells 
was studied by co-immunoprecipitation coupled to mass spectrometry analysis. After, co-
immunoprecipitation and SDS-PAGE, the gel was stained by silver nitrate with a 
modified mass spectrometry-compatible protocol lacking fixing agents. Stained bands of 
interest were cut and digested by trypsin. Next, samples were subjected to MALDI-
TOF/TOF analysis in order to allow protein identification by peptide mass fingerprint and 
fragmentation. The proteomic analysis was performed in the Proteomics Unit of 
Complutense University of Madrid.  
Furthermore, silver stained bands from the electrophoretic analysis of pulmonary 
surfactant solubilized by CHAPS were also subjected to mass spectrometry, following 
the same procedure described above. 
 
Analytical ultracentrifugation 
In velocity sedimentation analysis, macromolecules are subjected to a high centrifugal 
field where centrifugal force is higher than diffusion, promoting a net transport of sample 
towards the outside of the rotor. This hydrodynamic method splits macromolecular 
species with different sedimentation coefficient, which depends on the macromolecular 
mass, density and shape.  
SP-B complexes purified by CHAPS, as well as SP-B complexes stabilized with 
amphipols, were subjected to velocity sedimentation (48000 rpm, at 20 °C, for 4 hour) in 
a Proteome Lab XL-I ultracentrifuge (Beckman Coulter). These experiments were 
performed at the Analytical Ultracentrifugation and Light Scattering facilities in Centro 
de Investigaciones Biológicas (CSIC, Madrid).  
 
3.3. PURIFICATION AND STABILIZATION METHODS OF MEMBRANE 
PROTEIN COMPLEXES FROM PULMONARY SURFACTANT MEMBRANES 
Purification of native SP-B complexes from CHAPS-solubilized pulmonary 
surfactant 
SP-B complexes from PS were purified upon detergent solubilization as previously 
described (Olmeda et al., 2015). Surfactant was solubilized by CHAPS 
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(detergent:phospholipid molar ratio of 6:1, purchased from Sigma Aldrich) for 1 hour at 
25 °C under vigorous shaking, and loaded onto a 5 ml prepacked ion exchange 
chromatography Hitrap SP HP column (GE Healthcare). 50 mM phosphate pH 7, 9.8 mM 
CHAPS and 3 different concentrations of NaCl (0.15, 0.5, and 1 M) were subsequently 
eluted. Fractions of 1 mL were collected and the absorbance was measured at 280 nm. 
SP-B was collected at fractions eluted with 1 M NaCl. Sample purity was assessed by 
western blot and protein was quantified by bicinchoninic acid assay (Thermo Fisher 
Scientific) or by Lowry assay. 
 
Stabilization of SP-B complexes by GraFix method 
GraFix (Gradient Fixation) is a technique that allows stabilization of macromolecular 
complexes, improving the sample quality for negative-staining EM and cryo-EM 
(Kastner et al., 2008). During GraFix, macromolecules undergo a weak, intramolecular 
chemical crosslinking while being purified by density gradient ultracentrifugation. The 
GraFix procedure combines a glycerol-density gradient ultracentrifugation purification 
with a mild and progressive increasing exposure of macromolecules to glutaraldehyde, 
the crosslinking reagent. 
SP-B complexes purified from CHAPS-solubilized PS were subjected to GraFix 
method as an approach to stabilize the macromolecular oligomers. A continuous gradient 
of 50 mM PBS pH 7, 150 mM NaCl, ranging from 30 % sucrose (w/v) and 45% 
glutaraldehyde (v/v) to 5% sucrose and 15% glutaraldehyde, was formed by a gradient 
former. 100 µl of SP-B complexes purified with CHAPS were applied at the top of the 
density gradient. Glutaraldehyde stock used was a commercial solution specially purified 
for electron microscopy applications, purchased from Sigma Aldrich. To analyze the 
impact of crosslinking agent on the macromolecular association of SP-B, a continuous 
sucrose gradient ultracentrifugation in the absence of glutaraldehyde was performed by 
following the same procedure. After centrifugation in a swinging angle rotor at 50000 g, 
4 °C, for 14 hours, a pasteur pipette connected to a peristaltic pump was introduced at the 
bottom of the centrifuge tube to collect sample fractions of 180 µl. After harvesting all 
the solution from the centrifuge tube, non-visible pellet was resuspended in 50 mM PBS 
pH 7, 150 mM NaCl. Purification profile was obtained by absorbance measurements at 
280 nm. Electrophoretic mobility of SP-B in the different fractions was analyzed by SDS-
PAGE followed by western blot. For SDS-PAGE, fractions were concentrated by 
StrataClean resin (Agilent Technologies) and diluted in loading buffer. 
 
Stabilization of SP-B complexes by amphipols 
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Amphipol A8-35 (Anatrace) was used to stabilize SP-B complexes purified from 
CHAPS-solubilized pulmonary surfactant. The solution of SP-B complexes contained 50 
mM phosphate pH 7, 10 mM CHAPS, 1 M NaCl. A8-35 powder was dissolved in distilled 
water to obtain a 5 mg/ml stock. In order to optimize the experimental procedure, several 
protein:A8-35 mass ratios were tested, from 0.25% to 8% (by weight). After incubation 
for 30 minutes in ice, the detergent was removed from the mixtures by incubation with 
nonpolar polystyrene adsorbent, Bio-Beads SM-2 Resin (Bio-Rad). Efficiency of the 
different A8-35 concentrations to “trap” SP-B complexes was analyzed by BN-PAGE in 
4-20% polyacrylamide gradient gels. Next, a size exclusion chromatography was 
performed with the solution containing A8-35 and SP-B at a ratio 1:1 (w/w), after sample 
concentration using Vivaspin 500 with a molecular weight cut off of 10000 Da (GE 
Healthcare). Suspension of SP-B/A8-35 was loaded onto a Superdex 200 10/300GL (GE 
Healthcare) equilibrated in 50 mM phosphate pH 7, 1M NaCl at room temperature at a 
flow rate of 0.5 ml/minute, monitoring absorbance at 280 nm and collecting fractions of 
0.250 ml. The oligomerization state of selected fractions were analyzed by BN-PAGE 
and sedimentation velocity analytical ultracentrifugation.  
 
Purification of pulmonary surfactant proteins into MSP1D1 nanodiscs 
Expression and purification of MSP1D1 
The plasmid with the construct His6tag-MSP1D1 was generously provided by Dr. 
Germán Rivas (Centro de Investigaciones Biológicas, CSIC, Madrid). This plasmid was 
cloned into E. coli BL21 (DE3) and His6tag-MSP1D1 expression was induced in LB 
medium containing kanamicin 1:1000 and 1 mM IPTG. 
Bacterial cultures were centrifuged and pellets were collected and stored at -80 °C. 
The pellets were then lysed by 20 mM phosphate buffer pH 7, containing 1% Triton x-
100 (v/v) and PMSF. The suspension was vortexed gently for 30 minutes at 4 °C and then 
sonicated to facilitate the rupture of bacterial membranes. To obtain the soluble fraction, 
the bacterial lysate was ultracentrifuged at 30000 g during 30 minutes. Protein 
purification was performed by an immobilized metal affinity chromatography (5 ml 
prepacked column HisTrap HP, purchased from GE). The chromatography consisted of 
several elution steps which involve the use of 40 mM Tris pH 8, containing 300 mM NaCl 
and the following specific components at each step: 1. 1% Triton x-100 (v/v); 2. 50 mM 
cholate; 3. 50 mM imidazole; 4. 300 mM imidazole. Total protein content of collected 
fractions was determined by measuring absorbance at 280 nm. Yield and purity of the 
purification process was evaluated by SDS-PAGE and subsequent Coomassie staining. 
HisTag-MSP1D1 eluted with the buffer containing 500 mM imidazole and, subsequently, 
was dialyzed in 20 mM Tris pH 7.4, 100 mM NaCl, 1 mM EDTA. Protein concentration 
Materials and methods 
 
79 
 
was determined spectrophotometrically by using ε280 = 21,000 M–1 cm–1. Protein aliquots 
were stored at -80 °C. 
SP-B reconstitution into MSP nanodiscs 
First, SP-B purified in organic solvent was reconstituted into 8 mM POPC vesicles in 
20 mM Tris pH 7.4, 150 mM NaCl. Next, proteoliposome suspensions were solubilized 
with 4 mM CHAPS during 90 minutes at 25 oC under vigorous shaking. Then, MSP1D1 
was added to the suspensions and the mixture was incubated for 1 hour at 4 °C with gentle 
shaking. In order to set up the experimental conditions that yielded SP-B nanodiscs, 
various suspensions with different ratios of POPC, SP-B and MSP1D1 were assessed, as 
detailed in the table below: 
POPC:MSP1D1(mol/mol) MSP1D1:SP-B (mol/mol) POPC:SP-B (mol/mol) 
40:1 4:1 160:1 
50:1 4:1 200:1 
60:1 4:1 246:1 
Following, the detergent was removed from the mixtures by incubation with Bio-
Beads SM-2 Resin, allowing the formation of nanodiscs. Suspensions were centrifuged 
at 100000 g for 20 min at 4 °C and pellets were collected. After centrifugation, samples 
were injected onto a Superdex 200 10/300GL equilibrated in reconstitution buffer at room 
temperature at a flow rate of 0.5 ml/minute, with absorbance monitoring at 280 nm and 
collection of 0.250 ml fractions. Fractions were analyzed by SDS-PAGE on 16% 
polyacrylamide gels and Coomassie staining. 
Formation of native pulmonary surfactant nanodiscs 
Two different concentrations of pulmonary surfactant, 56 and 224 mM of 
phospholipid, were used to form the nanodiscs. Surfactant suspensions were solubilized 
by CHAPS or cholate (6:1 or 3.5:1, molar ratio detergent:phospholipid, respectively) for 
90 minutes at 37 °C under vigorous shaking. MSP1D1 was then added (molar ratio 
MSP1D1: phospholipid, 1:100, unless otherwise stated) and the mixtures were incubated 
for 1 hour at 37 °C with gentle agitation. Next, Bio-Beads SM-2 resin were added to the 
suspensions to remove detergent. Samples were centrifuged at 100000 g for 20 minutes 
at 4 °C, discarding supernatants. Nickel affinity chromatography was used to separate 
nanodiscs assembled by MSP1D1 from free surfactant membranes. Suspensions were 
loaded onto a HisTrap HP prepacked column (GE Healthcare). For nanodiscs 
purification, the column was equilibrated using 20 mM Tris pH 7.4, 150 mM NaCl and 
MSP1D1 nanodiscs were eluted by 500 mM imidazol-supplemented buffer. Fractions of 
1 ml were collected and absorbance was measured at 280 nm. Subsequently, nanodiscs 
were subjected to a size exclusion chromatography using a Superdex 200 10/300GL 
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column equilibrated in 20 mM Tris pH 7.4, 150 mM NaCl at room temperature at a flow 
rate of 0.5 ml/minute, with absorbance monitoring at 280 nm and collection of 0.5 ml 
fraction. Fractions collected from both affinity and size exclusion chromatography were 
assayed using SDS-PAGE on 16% polyacrylamide gels and immunoblotting detection for 
MSP1D1, SP-A, SP-B or SP-C. 
 
SP-B reconstitution into SMA lipid nanoparticles 
A mixture of POPC:POPG (7:3, by weight) and SP-B in organic solvent (10%, 
protein:lipid weight ratio) was reconstituted into MLVs in 5 mM pH 7.4, 150 mM NaCl 
at 37 °C for 1 hour. Styrene:maleic anhydride (SMA) copolymer powder at a ratio 3:1 
(purchased from Sigma Aldrich) was dissolved at 10% (w/v) in liposome reconstitution 
buffer, followed by 1 minute of water-bath sonication to complete solubilization. Lipid 
nanoparticles were formed with a mass ratio of lipid to polymer of 1:1.5 (w:w) and a final 
SMA concentration of 5% (w/v) by adding SMA polymers dropwise to the POPC:POPG 
+ SP-B vesicles. Samples were then mixed thoroughly by vortexing and equilibrated 
through two freeze/sonication cycles. At the same time, SMA lipoparticles containing 
POPC:POPG (7:3, w/w) were formed following the same protocol. A size exclusion 
chromatography was performed by injecting nanoparticle samples onto Superdex 200 
10/300 GL column equilibrated in liposome reconstitution buffer at room temperature at 
a flow rate of 0.5 ml/minute with monitoring absorbance at 280 nm. Collected fractions 
of 0.150 ml were analyzed by BN-PAGE and visualized by transmission electron 
microscopy and atomic force microscopy. 
 
3.4. FLUORESCENCE SPECTROSCOPY 
Luminiscence is the emission of light from any substance and occurs from 
electronically excited states to ground states. Luminiscence is formally divided into two 
categories: fluorescence and phosphorescence, which differ from each other in the nature 
of the excited state. Fluorescence occurs when the electron in the excited orbital has 
opposite spin than the second electron in the ground state level. In this scenario, the return 
to the ground state by emission of a photon is spin allowed and, thus, it occurs rapidly. 
The emission rates of fluorescence are about 108 s-1, so that fluorescence lifetimes are 
typically near 10 ns. The lifetime of a fluorophore (𝜆) is the average time a fluorophore 
population spends in the excited state before decaying to the ground state. Several 
processes occur between adsorption and emission of a photon, as Jablonski diagram 
illustrates (Figure 3.4.1). A fluorophore is usually excited to a higher vibrational level of 
the excited electronic states (S1 or S2), and then the molecule rapidly relaxes to the lowest 
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level of the excited state S1 in a radiationless process called internal conversion. It usually 
occurs within 10-12 s, so that it is prior to the photon emission.  
In the case of phosphorescence, energy undergoes an intersystem crossing from S1 
excited state to a triplet excited state, where the photon emission comes from. In T1 state, 
the excited electron shows the same spin orientation as the ground state electron. Thus, 
transition to the ground state is a spin forbidden process and the emission rates are slow, 
103- 100 s-1. Phosphorescence lifetimes are typically milliseconds to seconds. 
 
Figure 3.4.1. Jablonski diagram. Illustration from (Lakowicz, 2006). 
 
Steady-state and time-resolved fluorescence spectroscopy 
Fluorescence spectroscopy measurements can be performed by two methodologies: 
steady-state and time-resolved. In steady-state fluorescence the sample is illuminated 
with a continuous beam of light, and the intensity is recorded. Once the sample is exposed 
to light, the steady state is reached almost immediately after the sample is exposed to light 
due to the nanosecond timescale of fluorescence. For the time-resolved fluorescence 
measurements, the sample is exposed to a pulse of light, whose width is typically shorter 
than the decay time of the sample. The intensity decay is recorded with a high-speed 
detection system that allows intensity and anisotropy decay measurements in the range of 
nanoseconds. On the contrary, the steady-state measurements are the result of the 
integrstion over time of the time-resolved phenomena over the intensity of the sample. 
Thus, much of the molecular information is lost during the averaging process and can be 
only obtained by time-resolved measurements. For instance, the shape of the anisotropy 
decay contains information about the shape of the macromolecule and its flexibility. 
Moreover, different conformational states of macromolecules can be detected by different 
intensity decay times. In the presence of resonance energy transfer, the intensity decays 
reveal the spatial distribution of acceptors around the donors. 
 
Fluorescence anisotropy 
Anisotropy measurements are based on the principle of photoselective excitation of 
fluorophores by polarized light. All fluorophores show transition moments that occur 
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along a specific direction in the molecular axis. A fluorophore preferentially absorbs 
photons whose electric vectors are aligned parallel to the transition moment of the 
fluorophore. Thus, upon excitation with a polarized light, only those fluorophore 
molecules whose absorption transition dipole is parallel to the electric vector of excitation 
reach an excitation state (photoselection). The selectively excited fluorophores emit 
photons along a fixed axis of the molecule (polarized emission). The anisotropy is 
determined by the angle between absorption and emission transition moments of the 
fluorophore. 
The measurement of fluorescence anisotropy is illustrated in figure 3.4.2, where the 
excitation light is oriented parallel to the z axis and the emission intensity is measured 
through a polarizer. When the emission polarizer is oriented parallel to the direction of 
the polarized excitation light, the emission intensity measured is called 𝐼∥. While, 𝐼⊥  is 
the observable emission intensity when the polarizer is perpendicular to the direction of 
the polarized light. These intensity measurements are used to calculate the anisotropy by 
the following expression: 
 𝑟 =
𝐼∥ − 𝐼⊥
𝐼∥ + 2𝐼⊥
 
The difference between 𝐼∥  and 𝐼⊥ is normalized by the total measured intensity 𝐼∥ +
2𝐼⊥. Thus anisotropy is a dimensionless intensity ratiometric measurement. In the absence 
of artifacts, anisotropy is independent of the fluorophore concentration. 
 
Figure 3.4.2. Schematic diagram for measurement of fluorescence anisotropies. Illustration from 
(Mann and Krull, 2003). 
 
The maximum 𝑟 value of a fluorophore, termed as fundamental anisotropy (𝑟0) 
corresponds to the emission anisotropy observed in the absence of other depolarizing 
processes taking place during the excited state lifetime. The 𝑟0 values provide a 
measurement of the angle between the excitation and emission transition moments of a 
fluorophore in a dilute highly viscous solution, where rotational diffusion or resonance 
energy transfer (RET) do not occur. A number of factors can alter the experimental 
anisotropy, yielding lower values than 𝑟0. Rotational diffusion of fluorophores is a 
dominant cause of fluorescence depolarization. If a fluorophore can freely rotate between 
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excitation and emission, the anisotropy detected for that molecule will change. With time, 
the preferential orientation of excited fluorophores resulting from the action of 
photoselection with polarized light will be counteracted by random molecular rotations. 
Fluorophore excitation and its descent to the lowest vibrational energy level of the S1 
excited state occurs on a picosecond time scale. However, molecular rotation of the 
fluorophore typically is a much slower process, ranging from 10 picoseconds to 
milliseconds (Korczynski and Włodarczyk, 2009). Thus, the longer a fluorophore remains 
in the excited state (longer fluorescence lifetime), the higher the probability is that the 
molecule rotates before emitting a photon. Thus, if molecular rotation occurs, the 
anisotropy will decay from an initial value (𝑟0) to lower values. Depolarization by 
rotational diffusion of a spherical fluorophore is given by the Perrin equation (Perrin, 
1926): 
𝑟0
𝑟
= 1 + 𝜏 𝜙⁄  
where 𝜏 is the fluorescence lifetime and 𝜙 is the rotational correlation time for the 
diffusion process. 𝜙 is related to the rotational diffusion coefficient (D), which is a 
function of the temperature, the viscosity and the molar volume of the fluorophore.  
The steady-state anisotropy of a fluorophore or a macromolecule bound to a 
fluorophore is given by: 
𝑟 =
𝑟0
1 + (𝜏 𝜙)⁄
 
Steady-state anisotropy analysis has been extensively applied to the study of protein-
protein and protein-lipid interactions induced by proteins in membranes. These 
anisotropy measurements provide information about the structure and dynamics of the 
protein (size and shape), and the membrane (fluidity). 
Moreover, the rotational motions of a fluorophore can be analyzed from time-resolved 
anisotropy decay. For a spherical molecule, the anisotropy follows a single-exponential 
decay: 
𝑟(𝑡) =  𝑟0 𝑒
−𝑡/𝜙 
According to the formalism, large molecules have longer correlation times and the 
anisotropy decay will be slower. Only spherical molecules display a single exponential 
anisotropy decay. A fluorophore bound to a protein in an anisotropic environment would 
display more complex decays of anisotropy: 
𝑟(𝑡) =  ∑ 𝛽𝑖 𝑒
(− 
𝑡
𝜙𝑖
)
+ 𝑟∞
𝑛
𝑖=1
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where 𝛽𝑖 and 𝜙𝑖 are the normalized amplitude and the rotational correlation time of 
the 𝑖th decay component of anisotropy, respectively. The  residual anisotropy, 𝑟∞, is a 
constant term that describes 𝑟 value at time 𝑡 → ∞, when the rotational motion of the 
fluorophore is restricted, thus 𝑟∞> 0 (typical case of proteins inserted in membranes).  
Time-resolved parameters contains precise information about the shape, size, segmental 
flexibility of the macromolecule, as well as the rigidity of the environment (for instance, 
a lipid membrane) (Lakowicz, 2006). 
 
Resonance energy transfer 
Förster resonance energy transfer (FRET) is a photophysical phenomenon, which 
occurs between a donor fluorophore in the excited state and an acceptor molecule in the 
ground state. Energy transfer requires that the emission spectra of the donor overlaps with 
the absorption spectra of the acceptor. Upon excitation of the donor, the energy is 
transferred to the acceptor through long-range dipole-dipole interactions between both 
molecules. Due to the FRET process, the donor fluorophore results quenched and the 
acceptor turns out excited, followed by a relaxation process to the ground state. In case 
of the acceptor molecule is a fluorophore, S1→S0 transition may take place by photon 
emission. 
The rate of energy transfer depends upon the extent of spectral overlap of the emission 
spectrum of the donor with the absorption spectrum of the acceptor, the quantum yield of 
the donor, the relative orientation of the donor and acceptor transition dipoles, and the 
distance between both molecules. The rate of energy transfer from a donor to and 
acceptor, 𝑘𝑇(𝑟), is: 
𝑘𝑇(𝑟) =
1
𝜏𝐷
(
𝑅0
𝑟
)
6
 
where 𝜏𝐷 is the lifetime of the donor in the absence of acceptor, 𝑟 is the donor-acceptor 
distance and 𝑅0 is the Förster distance. 
The Förster distance, 𝑅0,is the distance at which the efficiency of FRET is 50%, which 
typically ranges from 20 to 60 Å. These distances are comparable in size to biological 
macromolecules. Thus, FRET can be used as a “spectroscopic ruler” to measure, for 
instance, the distance between a protein and its ligand, between sites of multi-subunits in 
proteins or to estimate the size of nanodomains in lipid bilayers (Lakowicz, 2006). 
The transfer efficiency can be obtained from the decrease of donor fluorescence 
lifetime in the presence or absence of acceptor: 
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𝐸 = 1 −
𝜏𝐷𝐴
𝜏𝐷
 
For unlinked donors and acceptors, the situation becomes more complex due to the 
wide range of donor-acceptor distances. In this case, it is important to consider that the 
acceptor concentration determines the proximity between donor and acceptor, and one 
donor might be surrounded for more than one acceptor molecule. 
There are two general types of FRET reactions, hetero-FRET and homo-FRET, which 
differ in the spectral overlap. The hetero-FRET occurs in the presence of a donor 
fluorophore and an acceptor with different absorption and emission spectra. In contrast, 
when the FRET reaction involves two fluorophores with identical spectra, the transfer is 
called homo-FRET. 
 
Oligomer stoichiometry of SP-B by fluorescence anisotropy-based homo-FRET 
measurements 
Steady-state and time-resolved fluorescence anisotropy-based homo-FRET 
experiments were performed to determine the degree of oligomerization of SP-B 
complexes in membranes.  
Sample preparation 
For these homo-FRET experiments, a stock of SP-B was fluorescently labeled with 
BODIPY FL at its amino terminal region, showing a high yield of labeling, with molar 
ratio probe/protein of 0.91 (the procedure is detailed in 3.1. Materials). Following, 
vesicles of different proteolipid composition were prepared with mixtures of 
BODIPY/SP-B and SP-B at different proportions to vary the fractional labeling of the 
sample. POPC:POPG (7:3, molar ratio) LUVs containing different proportions of 
BODIPY/SP-B and non-fluorescent SP-B (0.67% total protein/lipid molar ratio) were 
generated at a final lipid concentration of 0.3 mM. Additionally, mixtures of 
BODIPY/SP-B and SP-B were reconstituted into LUVs made of surfactant lipids and 
supplemented with SP-C, at a final lipid concentration of 0.357 mM of phospholipid with 
SP-B and SP-C concentrations of 0.67% and 0.088% (protein/lipid molar ratios), 
respectively. 
Proteoliposomes were prepared as follows: mixtures of BODIPY/SP-B and SP-B at 
different molar ratios were dried under a nitrogen stream together with lipids and the dried 
films were later rehydrated in 5 mM Tris pH 7, 150 mM NaCl at 45 °C. After 5 freeze-
thaw cycles, vesicle suspensions were extruded to form LUVs with a diameter of  ̴ 100 
nm. 
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Steady-state measurements 
For steady-state fluorescence anisotropy measurements, samples were excited at 335 
nm or 470 nm, and the polarized emission was detected at 515 nm. For excitation at 335 
nm, the bandwidth used was 8 nm, while bandwidths of 4 nm were applied for excitation 
at 470 nm and emission at 515 nm. Steady-state anisotropy, 〈𝑟〉 , was determined 
according to (Lakowicz, 2006): 
〈𝑟〉 =
𝐼𝑉𝑉 − 𝐺 ∙ 𝐼𝑉𝐻
𝐼𝑉𝑉 + 2𝐺 ∙ 𝐼𝑉𝐻
 
Eq. 3.4.1 
where the different intensities are the vertical and horizontal components of the 
fluorescence emission with excitation vertical (𝐼𝑉𝑉 and 𝐼𝑉𝐻, respectively) and horizontal 
(𝐼𝐻𝑉 and 𝐼𝐻𝐻, respectively) to the emission axis. The latter pair of components was used 
to calculate G factor (𝐺 = 𝐼𝐻𝑉 𝐼𝐻𝐻⁄ ). The G factor is an instrumental correction factor 
which takes into account the transmission efficiency of the monochromators to the 
polarization of the incoming light. Data are shown as average ± standard deviation of 2 
independent experiments. 
Time-resolved measurements 
The fluorescence intensity decay curves, 𝐼(𝑡), were described by a sum of discrete 
exponential terms (Lakowicz, 2006): 
𝐼(𝑡) =  ∑ 𝛼𝑖  𝑒
(−𝑡 𝜏𝑖)⁄
𝑛
𝑖=1
 
Eq. 3.4.2  
where 𝛼𝑖 and 𝜏𝑖 are, respectively, the amplitude and the lifetime of the 𝑖th decay 
component of fluorescence. Briefly, the fluorescence decay parameters (𝛼𝑖 and 𝜏𝑖) were 
obtained by iterative convolution of the fluorescence decay 𝐼(𝑡) with the instrumental 
response function, IRF(t), and fitting to the experimental data, Iexp(t). In all cases, two 
decay times gave the best fit to the fluorescence decays. 
Then, the anisotropy decay parameters were obtained by simultaneous iterative 
convolution of 𝐼𝑉𝑉(𝑡) and 𝐼𝑉𝐻(𝑡). 
𝐼𝑉𝑉(𝑡) =  
𝐼(𝑡)
3
 [1 + 2𝑟(𝑡)] 
𝐼𝑉𝐻(𝑡) =  
𝐼(𝑡)
3
 [1 − 𝑟(𝑡)] 
Eq. 3.4.3 and 3.4.4 
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with the IRF and globally fitting to the experimental parallel and perpendicular 
polarized components of the fluorescence, after fixing the fluorescence decay parameters 
to the values obtained from the first step.  
The fluorescence anisotropy decay curves, 𝑟(𝑡), were fitted to a sum of discrete 
exponential terms: 
𝑟(𝑡) = 𝛽1𝑒
(−𝑡 𝜙1)⁄ + 𝛽2𝑒
(−𝑡 𝜙2)⁄  
Eq. 3.4.5 
where 𝛽 and 𝜙 are the normalized amplitude and the rotational correlation time of the 
two decay components of the bi-exponential anisotropy decay, respectively. From the 
obtained anisotropy decay parameters ( 𝛽 and 𝜙 ), the apparent time-zero anisotropy, 
𝑟(0), was calculated [𝑟(0) = 𝛽1 + 𝛽2]. For this fitting model of bi-exponential 
anisotropy decay, the second decay component displays a very long lifetime, so that the 
residual anisotropy is defined by the anisotropy of the long-term component [𝑟∞ = 𝛽2]. 
Data analysis was carried out using a non-linear least squares iterative convolution 
method based on the Marquardt algorithm (Marquardt, 1963). A reduced 𝜒𝐺
2 value < 1.3 
and a random distribution of weighted residuals and autocorrelation plots were used to 
evaluate the goodness of the fitness (Lakowicz, 2006). To confirm the suitability of the 
fit, the expected steady-state fluorescence anisotropy, 〈𝑟〉𝑐𝑎𝑙𝑐, was calculated from the 
parameters obtained in the time-resolved analysis  
〈𝑟〉𝑐𝑎𝑙𝑐 =
∫ 𝐼(𝑡) ∙ 𝑟(𝑡)𝑑𝑡
∞
0
∫ 𝐼(𝑡)𝑑𝑡
∞
0
 
Eq. 3.4.6 
and then, compared to the experimental steady-state anisotropy for each sample. 
 
FRET study of SP-B-induced membrane aggregates 
The structure of aggregates formed by SP-B and negatively-charged membranes, 
POPC:POPG at a molar ratio 7:3, were characterized at the nanoscale using FRET 
methodologies. FRET experiments were performed between donor and acceptor 
membrane probes BODIPY(500/510)-PC and ORB, respectively, or between SP-B 
labeled with BODIPY FL as donor, and ORB as acceptor. SP-B was covalently labeled 
at its amino terminal segment with BODIPY FL, showing a molar probe/protein ratio of 
0.91 (the experimental procedure is described in 3.1 Materials). BODIPY 500/510 C12-
HPC and octadecyl rhodamine B chloride (R18), also called ORB, were purchased from 
Thermo Fisher Scientific (Figure 3.4.3). The concentrations of stock probe solutions 
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were determined spectrophotometrically using the molar absorption coefficient values 
ε(BODIPY500/510-PC, 509 nm, in EtOH)= 8.6 x 104 M-1 cm-1 (Haugland, 2002) and 
ε(ORB, 555 nm, in ethanol)= 85 x 103 M-1   cm-1 (Johansson and Niemi, 1987). 
 
Figure 3.4.3. Chemical structure of BODIPY 500/510 C12-HPC (BODIPY-PC) and octadecyl 
rhodamine B chloride (R18, ORB). Taken from Thermo Fisher Scientific’s catalog. 
 
Sample preparation 
For preparation of all liposomes or proteoliposomes, adequate amounts of synthetic 
lipids, proteins and probes were mixed in chloroform/methanol solutions, dried under 
nitrogen stream, and rehydrated in 5 mM Tris pH 7, 150 mM NaCl at 45 °C. Multilamellar 
vesicle suspensions were subjected to 5 freeze-thaw cycles and then extruded to form 
LUVs with a diameter of  ̴ 100 nm.  
For FRET experiments, two different procedures of sample preparation were followed. 
The first one consisted of the reconstitution of the protein (native SP-B or BODIPY/SP-
B) together with the lipid mixture POPC:POPG (7:3, mol/mol) labeled with the 
corresponding membrane probes. Then, vesicle suspension was extruded to form LUVs. 
By this method, two different vesicle suspensions were prepared: 
Mixture 1: POPC:POPG labeled with BODIPY-PC and ORB and containing different 
amounts of unlabeled SP-B, with final protein concentration that varied between 0 and 5 
µM SP-B. 
Mixture 2: POPC:POPG labeled with ORB and supplemented with different amounts 
of SP-B labeled with BODIPY FL (BODIPY/SP-B). The final protein concentration 
varied between 0 and 4.17 µM BODIPY/SP-B. 
The second procedure for sample preparation consisted of the generation of 
POPC:POPG (7:3, mol/mol) LUVs labeled with the corresponding membrane probes. 
Then, 5 µl of native SP-B or BODIPY/SP-B in methanolic solution at different protein 
concentration were added to the vesicle suspension. Due to the high miscibility of 
methanol in water and the hydrophobic character of these proteins, both native SP-B and 
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labeled SP-B will be instantaneously incorporated into membranes. To prepare the protein 
in methanolic solution, the original protein stock in methanol:chloroform solution was 
transferred to methanol by chloroform evaporation under nitrogen stream, keeping the 
protein solution at the desired concentration for the assay. Two different vesicle 
suspensions were prepared following this procedure: 
Mixture 3: SP-B in methanolic solution was added onto POPC:POPG LUVs labeled 
with BODIPY-PC and ORB. FRET experiments were performed at a final protein 
concentration ranging from 0 to 5 µM SP-B. 
Mixture 4: BODIPY/SP-B in methanol was added onto POPC:POPG LUVs labeled 
with ORB. Final protein concentration in the suspensions varied between 0.4 and 4.44 
µM BODIPY/SP-B. 
For water/membrane partitioning assay of ORB, POPC:POPG (7:3, mol/mol) at 
variable phospholipid concentration (0.05 µM - 1mM) were labeled with a fixed 
concentration of ORB (0.75 µM). 
FRET measurements 
Time-resolved FRET measurements were obtained by the fluorescence intensity donor 
decays in the absence and in the presence of acceptors. Thus, in addition to all the samples 
described above, it was necessary to prepare vesicle suspensions with the same 
proteolipid composition but in the absence of the acceptor molecule, ORB.  
All samples contained POPC:POPG (7:3, molar ratio) LUVs at a final lipid 
concentration of 0.5 mM. For the FRET pair BODIPY-PC/ORB, the donor/lipid ratio was 
kept 1:1000, whereas for the FRET pair formed by BODIPY/SP-B and ORB, the 
donor/lipid ratio was given by the protein content.  In all experiments, the ORB/lipid ratio 
was kept 1:400. 
After 1 hour of sample stabilization at room temperature, vesicle suspensions 
containing donor alone or donor and acceptor probes were subjected to time-resolved 
donor intensity decay measurements. Data analysis was carried out using a nonlinear 
least-squares iterative convolution based on the Marquardt algorithm (Marquardt, 1963). 
The goodness of the fit was determined by global X2 values and a random distribution of 
weighted residuals and autocorrelation plots. For each experimental condition, FRET 
efficiency was obtained. Moreover, donor intensity decays were faced to different models 
of protein-membrane interactions, using a set of formalisms (see section 7.2.2.2. FRET 
modelling in Chapter 4).  
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Liposome aggregation assay 
Protein-induced membrane aggregation was determined from variation in the 
absorption at 630 nm, which reflects the increase in turbidity of the LUVs suspension 
containing SP-B or BODIPY/SP-B. Samples containing different protein concentrations 
were incubated for 1 hour at room temperature and then, absorbances at 630 nm were 
measured in a spectrophotometer. 
 
Instrumentation  
Absorption spectroscopy was performed with a Shimadzu UV-3101PC 
spectrophotometer (Shimadzu Scientific Instruments). When required, absorption spectra 
were corrected for turbidity using the method described by (Castanho, Santos and Loura, 
1997). Steady-state fluorescence measurements were carried out on a SLM-Aminco 8100 
Series 2 spectrofluorimeter (SLM Instruments) in L-format. For anisotropy 
measurements, the equipment was operated with automated rotating Glan-Thompson 
polarizers. The light source was a 450-watt Xe arc lamp and the reference was a 
Rhodamine B quantum counter solution. Correction of emission spectra was performed 
using the apparatus correction software. 
Time-resolved fluorescence intensity decays with picosecond resolution were obtained 
by the time-correlated single-photon timing system described elsewhere (Loura, Fedorov 
and Prieto, 1996; de Almeida et al., 2005). The samples were excited at 335 nm by pulses 
from a frequency doubled, mode-locked Tsunami Ti: sapphire laser (Spectra Physics) 
pumped by Nd:YVO4 diode laser (Spectra Physics). The fluorescence was detected by a 
Hamamatsu R-2809U microchannel plate photomultiplier at the 515 nm that was selected 
using a Jobin-Yvon HR320 monochromator in combination with an adequate cut-off filter 
to avoid interference from Rayleigh-scattered light. The instrument response function 
(IRF) was recorded as excitation light scattered by a Ludox solution (silica, colloidal 
water solution from Sigma Aldrich). Data were collected using a multichannel analyzer 
with a time window of 1024 channels, at time scale of 39.1 ps/channel, and up to 50000 
and 20000 counts in the peak channel of the IRF and decay curves, respectively. In the 
case of fluorescence anisotropy decay measurements, the parallel and perpendicular 
polarized components of the fluorescence to the plane of polarization of the excitation 
beam were alternatively recorded. For this setup system, the instrumental G factor is 
expected to be 1 because the polarized fluorescence light components were depolarized 
before the entrance slit of the monochromator. Quartz cuvettes of 5 x 5 mm were used for 
all the spectroscopy measurements. In the case of time-resolved measurements, samples 
were continuously agitated with a magnetic stirring bar. 
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3.5. IMAGING TECHNIQUES 
Epifluorescence microscopy 
Fluorescence microscopy allows visualizing fluorescent probes by using a high 
intensity light source that emits light in a broad range of spectrum, from ultraviolet to 
visible. In the particular case of an epifluorescence microscope, the optical components 
are mounted in a way that the specimen is illuminated from above. 
 
Epifluorescence microscopy for the evaluation of membrane permeability 
Permeability of pulmonary surfactant membranes to polar molecules was evaluated in 
giant vesicles by their direct visualization under fluorescence microscopy. Different 
lipoprotein mixtures labelled with Rhodamine-DOPE (at 1% molar concentration) were 
used to form giant unilamellar vesicles as described in section 3.1. Materials, ‘Lipid and 
protein-lipid sample preparation’.  Giant vesicles prepared in a 200 mOsm sucrose 
solution were transferred to equiosmolar glucose solutions containing two different types 
of polar fluorescent probes (from Sigma Aldrich): calcein (at a final concentration of 100 
µM) or dextrans of different average sizes (final concentration of 50 µM) labelled with 
fluorescein isothiocyanate (FITC). The employed FITC-dextrans and their estimated 
hydrodynamic radii are detailed in table 3.1. Vesicles were incubated in these fluorescent 
solutions at room temperature in darkness for 3 hours. Then, the preparations were 
visualized by fluorescence microscope Leica DM-4000B (Leica Microsystems) with L5 
and TX2 fluorescence filters and recorded with a digital camera C10600-10B ORCA-R2 
(Hamamatsu). The images were processed with FIJI software (Schindelin et al., 2012). 
Three independent experiments were performed to evaluate the permeability of each kind 
of surfactant-based GUVs. 
 
Table 3.5.1. Approximate Stokes’ radii of FITC-dextrans. Product data taken from Sigma 
Aldrich. 
 
For the evaluation of a possible blockage effect by -SP-B or -SP-C antibodies on 
the permeability of pulmonary surfactant-based GUVs, vesicle suspensions were pre-
incubated with the specific antibodies for 2 hours at room temperature and then, incubated 
in FITC-dextrans for 3 hours to evaluate the permeability of vesicles in the presence of 
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the antibodies. For these experiments, the following polyclonal antibodies were used: anti 
human SP-B and anti-human SP-C antisera (from Seven Hills Bioreagents), anti-human 
SP-A antiserum (kindly supplied by Dr. J. Floros, from Penn State University, USA), 
anti-human tubulin antiserum (Sigma Aldrich) and anti-human SP-B Ig (Millipore). 
Antibodies concentrations used for each experiment are detailed in Chapter 2, section 
5.2.1.2. In the case of antisera, their antibody concentration was determined by the Easy-
Titer Mouse IgG Assay Kit (Thermo Fisher Scientific), while the total protein 
concentration was quantified by Lowry method. Three independent experiments were 
performed to evaluate the blockage effect of the diverse antibodies on the permeability of 
each kind of surfactant-based GUVs. 
 
Live-cell real time imaging assay for the study of lamellar body exocytosis in alveolar 
type II cell cultures 
Lamellar body (LB) exocytosis in rat primary alveolar type II cell cultures was real-
time monitored by a fluorescent-based method that combines the use of the probe Fura-2 
acetoxymethyl ester (AM) and the membrane probe N-(3-triethylammoniumpropyl)-4-
(4-(dibutylamino)styryl)pyrinidium dibromide (FM1-43). This water-soluble dye, non-
fluorescent in aqueous medium, is able to reversibly partition into membranes, exhibiting 
a bright fluorescence intensity in lipid environments. In this method, single exocytotic 
events are detected in ATII cell cultures, as a consequence of FM1-43 in the extracellular 
medium gaining access to surfactant membranes in fusing LBs through the fusion pore, 
while changes in cytoplasmic Ca2+ concentration are monitored by Fura-2 measurements 
in stimulated cells. 
To evaluate the ability of pulmonary surfactant and its derivatives to stimulate lamellar 
body exocytosis in ATII cells, a variety of protein-lipid suspensions were employed: 
POPC or POPC:POPG (7:3) containing organic solvent-isolated SP-B and/or SP-C (12% 
of either protein, by weight), POPC:POPG supplemented with SP-B purified in detergent 
(12%) or vesicles formed by organic extract from pulmonary surfactant (with equivalent 
total protein amount to vesicles containing both proteins). For the concentration-response 
assay, POPC:POPG vesicles containing different protein:lipid ratios were tested, 
maintaining lipid content constant while varying the amount of SP-B. All these 
preparations were bath sonicated for 1 hour to form LUVs before applying them to the 
ATII cell cultures. 
For combined Fura-2 AM and FM1-43 experiments, cells were loaded with 2 μM Fura-
2 AM for 30 minutes in MucilAir, washed twice in bath solution (10 mM Hepes pH 7.4, 
5 mM glucose, 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2) and kept in bath 
solution with 1 μM FM1-43. ATII cells were treated with vesicles containing different 
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components of pulmonary surfactant in order to evaluate their effects on LB fusion. As a 
control for efficient induction of LB fusion and surfactant secretion, ATII cells were 
treated with 100 μM ATP, a known potent agonist for LB fusion. ATP concentration was 
chosen to induce maximum fusion response. Different chemical agents were used to 
characterize the mechanism behind the regulatory effect of SP-B towards surfactant 
secretion. Apyrase (50 U/ml) was applied at the start of the experiment for extracellular 
ATP depletion. Cells were incubated with 200 nM thapsigargin for 20 minutes in order 
to deplete intracellular Ca2+ stores. To block P2Y2 receptor, the cells were pretreated with 
800 μM suramin for 5 minutes. In the experiments with connexin and pannexin inhibitors, 
cells were incubated with 10 μM carbenoxolone or 100 μM flufenamic acid for 15 
minutes. 
Images were acquired in an IMIC Digital Microscope (TILL Photonics) using its 
corresponding control software, Live Acquisition, and a 40x objective lens (Olympus). 
For Fura-2 AM, dye-loaded cells were illuminated for 100 ms at 50% intensity and at the 
excitation wavelengths 340 nm and 387 nm, respectively, while for FM 1-43 dye, the 
used exposure time and intensity were 100 ms and 60%, respectively, and the excitation 
wavelength was 482 nm. Image analysis was performed by FIJI.  
The extent of exocytosis during 15-minute observation time was expressed in two 
ways. First, as percentage of fusing cells, which refers to the number of cells showing at 
least one fusion event, per total number of cells. Lamellar body fusion events with plasma 
membrane were followed by the appearance of FM1-43 fluorescence spots. Alternatively, 
LB exocytosis was also evaluated as percentage of cells showing Ca2+ peak, using data 
obtained by image analysis of Fura-2 signal. 
Samples from three different primary cell isolations were tested in duplicate for each 
experimental condition. 
Citotoxicity assay of alveolar type II cells by propidium iodide uptake 
Cells were rinsed and challenged with 8 μM propidium iodide (PI) for 5 minutes to 
assess integrity of plasma membrane in cells exposed to SP-B.  PI is a small fluorescent 
molecule that can only enter the cells and produce fluorescence upon binding to DNA 
when the plasma membrane is damaged. Images were acquired in an IMIC Digital 
microscope, using a 20x objective lens (Olympus, Tokyo, Japan) and an excitation 
wavelength of 563 nm.  
Alternatively, cytotoxicity of the different treatments with secretagogues and 
inhibitors was detected and quantitatively evaluated from the maintenance of plasma 
membrane integrity to the permeation of the FM1-43 probe, which only penetrates and 
labels internal membranes in cells with damaged plasma membrane. 
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Atomic force microscopy 
Atomic force microscopy (AFM) is a technique where a cantilever with a sharp tip is 
systematically scanned across a sample surface to produce high resolution images by 
measuring different physical properties of a sample at nanometric scale. This assembly is 
translated over the sample by a computer-controlled piezo scanner with subnanometer 
accuracy. Surface topography induces cantilever deflections, which allow to determine 
the surface contour of the sample. There are two classical imaging operating modes: 
contact and tapping. In the contact mode, the tip keeps permanent contact with the sample 
due to the rise and descent of the sample by the scanner to maintain this contact. In the 
tapping mode, the cantilever oscillates at or slightly below its resonant frequency with a 
fixed amplitude. During scanning, the tip touches intermittently the sample, contacting 
the surface at the bottom of its swing. The interaction between tip and sample surface 
alters the resonance frequency of the cantilever and thus, changes in the amplitude are 
registered. A feedback loop maintains constant the amplitude of oscillations while this 
feedback response is used to generate the topographical image. Tapping mode uses lower 
forces, reducing the potential damage of soft samples, such as biological samples. This 
operating mode also allows to produce a secondary type of image, the phase image, which 
detects variations in composition, adhesion, friction and viscoelasticity of the scanned 
material. 
In this Thesis, samples of SP-B purified in detergent or SP-B (either purified in 
detergent or isolated in organic solvent) incorporated into lipids were characterized by 
AFM. Two different methods for sample preparation were employed: 
 Direct application of the sample onto mica supports. 20 µl of 50 µg/ml 
POPC:DPPG (7:3, by weight) SUVs containing or not SP-B were placed on a 
mica square. After 5 minutes of incubation, mica is washed with 3 ml of fresh 
milliQ water. Mica is placed vertical and the water is carefully added on the top 
edge of mica, letting it run over the surface. Finally, mica is dried under a N2 
stream. 
 Interfacial films transferred to mica. These samples were prepared using a 
Langmuir balance to prepare the so-called Langmuir-Blodgett films, as detailed 
in a specific section below. 
AFM images were obtained with a Nanoscope IIIa scanning probe microscope 
(Bruker), operated in tapping mode, using TESP-SS tips (Bruker), in the ICTS Centro 
Nacional de Microscopía Electrónica (Universidad Complutense de Madrid). Image 
analysis was performed by NanoScope Analysis software (Bruker). 
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Transmission electron microscopy 
Transmission electron microscopy (TEM) uses an electron beam to be transmitted 
through a specimen to visualize it with a resolution at angstrom scale. TEM operates as 
follows. The electron gun generates the electron beam, which is focused onto the object 
by a set of condenser lens. The beam strikes the specimen and some parts of it are 
scattered, depending on the sample density. The unscattered electrons hit onto a 
fluorescent screen, giving rise to an image of the object with its different parts displayed 
in varied darkness as a consequence of density variation. 
In this Thesis, transmission electron microscopy was employed to visualize protein 
complexes in pulmonary surfactant, as well as SP-B complexes in different environments. 
Carbon-coated cupper grids (EMS400-Cu, Gilder grids) were subjected to glow 
discharging. Then, 2-3 µl of sample were applied onto the grid for 2-3 minutes. The 
excess of liquid was eliminated by drying with filter paper before washing twice with 
milliQ water and drying again with filter paper. 2% uranyl acetate (w/v) was used as 
staining agent. After 1 minute of grid incubation with uranyl acetate, the stain excess was 
eliminated with a filter paper. The grids were imaged in a JEOL JEM-1230 transmission 
electron microscope operated at 100 kV and recorded at a magnification of 40000x using 
a TemCam-F416 (TVIPS). TEM images were obtained in the Electron Microscopy 
Facility at the Centro de Investigaciones Biológicas (CSIC, Madrid). 
 
3.6. INTERFACIAL TECHNIQUES 
Captive bubble surfactometry 
The captive bubble surfactometer (CBS), designed and developed by Dr. Samuel 
Schürch and coworkers at the University of Calgary (Canada) (Schurch et al., 1989), has 
become an essential tool to study the biophysical behavior of films of pulmonary 
surfactant or clinical surfactant preparations under physiologically meaningful 
conditions. 
The CBS is an experimental setup where the surface activity of pulmonary surfactant 
can be monitored once adsorbed into the air-water interface of an air bubble confined in 
a buffer-filled chamber under controlled environmental conditions (Figure 3.6.1). The 
specific software of the equipment calculates surface tension, area and volume of the 
bubble, from measuring its height and diameter, which is recorded by a video camera 
(Schoel, Schurch and Goerke, 1994).  
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Figure 3.6.1. Overview of the CBS system used in the present Thesis, with a detailed image of 
the bubble chamber (right). 
 
The chamber consists of a glass cylinder on a metallic base with a small hole (2 mm) 
through which a bubble of approximately 0.035-0.040 cm3 can be created, and through 
which a capillary is inserted for sample injection. The opposite side of the chamber is 
sealed with an agarose cap, where the created bubble is settled. The cap is adjusted to a 
piston, which is moved in a controlled way producing the compression and expansion of 
the space between the agarose cap and the sealed metallic base. The bubble volume 
changes as pressure inside the chamber varies by the piston movement. As bubble volume 
is decreased, the surface area is subsequently reduced and, in the presence of surfactant 
film, the surface tension drops, which results in a bubble flattening. The chamber is filled 
with 5 mM Tris pH 7.4, 150 mM NaCl, 10% sucrose. The presence of sucrose increases 
the density of the buffer, helping surfactant to float against the air bubble during injection, 
preventing its dilution into the subphase. The chamber is thermostatted at 37 °C. 
Temperature is controlled by enclosing the chamber in a water bath which allows a 
homogeneous distribution of the heat provided by a heater. Degasification of the subphase 
buffer is required before starting the experiment. This process is performed by expanding 
a bubble in the sealed chamber during 10 minutes, allowing the liberation of the dissolved 
air in the buffer in the form of little air bubbles that join to the main expanded bubble, 
due to the pressure inside the chamber. Pulmonary surfactant preparations are usually 
tested at 25 mg/ml phospholipid concetration, although in the experiments performed in 
this Thesis, a limiting surfactant concentration of 4.7 mg/ml was used with the aim of 
detecting the potential disfunction of surfactant film in the presence of a polyclonal anti-
SP-B IgG. 
The evaluation of surface activity of surfactant films in the CBS is performed in 4 
stages: 
 Initial adsorption kinetics: it simulates the adsorption process of surfactant 
from the aqueous subphase to the alveolar-liquid interface and allows analysing 
the ability of surfactant samples to be adsorbed into the interface and form a 
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surface active film. The sample ( ̴ 200 nl) is applied with a microcapilar, directly 
over the bubble surface. Then, changes in bubble shape, and thus in surface 
tension, are registered during 5 minutes (Figure 3.6.2 A-B). Upon native 
surfactant adsorption into the air-liquid interface, surface tension drops, in a few 
seconds, from 70 mN/m to an equilibrium surface tension of about 20 mN/m. 
 
Figure 3.6.2. Surface tension drives changes in bubble shape.  In the CBS system, a bubble is 
created (A) and, after surfactant sample injection, surface tension decreases down to reaching 
equilibrium, producing flattening of the bubble (B). Upon compression, the surface active film 
leads to a further drop of surface tension, close to 0 N/m, which causes an extreme flattening of 
the bubble (C). During expansion, surface tension increases to original values (D). 
 
 Post-expansion adsorption: after sealing the chamber, the bubble is 
expanded up to a maximum bubble volume of 0.15 cm3 by the motion of the piston 
controlled by the software. Then, the surface tension is again registered for 5 
minutes. This stage evaluates the ability of re-organization, transferring and 
spreading of surfactant structures into an expanding surface. Typically, native 
surfactant films rapidly lead to a surface tension decrease down to ≈ 20 mN/m. 
 Quasi-static cycling: it consists of 4 low speed stepwise compression-
expansion cycles, in which the bubble volume changes 20% over the volume in 
the immediately previous step. Maximal bubble volume is set during the post-
expansion adsorption stage (0.15 cm3), whereas minimal bubble volume is set 
manually at each compression cycle. Upon cycling, an active surfactant film is 
able to reach minimal surface tension with values near 0 mN/m under compression 
and, during subsequent expansion, low maximal surface tension is restored to the 
original state (Figure 3.6.2 C-D). At the end of compression, collapse of the 
bubble can occur, so that the area of the bubble is dramatically reduced without 
change in surface tension (this can be identified visually as a relaxation of the 
flattened bubble shape). Data are shown as surface tension-area isotherms, which 
give information about minimal and maximal surface tension reached by the film 
and hysteresis of each cycle. Low speed compression-expansion cycles allow 
analysis of re-organization of the surfactant films and also film stability due to the 
relaxation process of the film between compression-expansion steps. However, 
no direct physiological implications can be inferred at this stage, as the speed of 
compression-expansion cycles during breathing is much faster.  
 Dynamic compression-expansion cycling: at this final stage, fast 
compression-expansion cycles are applied to the bubble at a rate of 20 cycles/min, 
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which mimic physiological breathing rates. Maximal and minimal bubble 
volumes are set taking as a reference the limits applied in the 4th quasi-static cycle. 
Typically, the 1st, 10th and 20th cycles are analyzed as illustrative parts of the 
cycling dynamics, plotting surface tension-area isotherms.  
 
Langmuir balance 
Surface balances constitute a classical method to assess the interfacial activity of 
pulmonary surfactant preparations. They can evaluate the adsorption of surfactant to an 
air-liquid interface, its spreading along this interface and even its interfacial behavior 
under compression/expansion cycles. There are several types of surface balances, 
although all of them are equipped with a Teflon thermostatted trough that confines the 
aqueous solution, and a pressure sensor which monitors real-time changes in surface 
tension or pressure. Surface pressure is defined as the difference between the surface 
tension in the absence and in the presence of surface active material.  
Π = 𝛾𝑤𝑎𝑡𝑒𝑟 − 𝛾𝑠𝑢𝑟𝑓𝑎𝑐𝑡𝑎𝑛𝑡 
Langmuir balances allow to evaluate the dynamics of the interfacial activity of 
pulmonary surfactant, as the surface area of the trough can be modified by the computer-
controlled movement of a mobile barrier. Upon injection of surfactant on the surface of 
the aqueous solution, the amphipathic molecules form an interfacial film. Closure of the 
mobile barrier causes the compression of the interfacial film, increasing lateral pressure 
and packing density of the molecules (typically phospholipids) in the monolayer. Opening 
the barrier gives rise to the reorganization of material in an expanded area (Figure 3.6.3).  
 
Figure 3.6.3. Schematic illustration of a Langmuir balance. 
 
Compression isotherms register the increase of surface pressure (reduction in surface 
tension) as surface area diminishes. This allows determination of changes in the molecular 
organization of interfacial films during compression, which may also reflect the 
occurrence of lateral phase transitions. The compression isotherm of a DPPC film is 
commonly used to explain the phase transitions that undergoes a phospholipid interfacial 
film during compression (Figure 3.6.4). At low surface pressure, phospholipid molecules 
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are in gas-like phase, characterized by extremely high mobility and disorder, where the 
intermolecular interactions are very scarce. Upon compression, surface area is diminished 
favoring that phospholipids interact between them by van der Waals attractive forces or 
headgroup interactions, so that the surface pressure starts rising up to a phase termed as 
liquid-expanded (LE), where the phospholipids still have a high mobility because of the 
presence of trans-gauche isomerizations at the phospholipid acyl chains. Further film 
compression generates the orientation of phospholipids perpendicular to the surface plane 
and the lipid packing, which drives saturated phospholipids into the liquid-condensed 
(LC) phase. Between the LE and LC phases, a plateau indicates the coexistence of both 
phases, during which the work of compression is used to complete the lipid packing 
without increase in surface pressure. If compression still progresses, the interfacial 
monolayer turns much less compressible and the surface pressure rises up to 70 mN/m. 
At the highest compression levels, the interfacial film may collapse, generating the 
conversion of  bi-dimensional structures into three-dimensional ones (Takamoto, Aydil, 
et al., 2001; Wustneck et al., 2005), that may or may not continue associated to the 
interface. 
 
Figure 3.6.4. π/A isotherm of a DPPC monolayer at 24ºC. LE: liquid-expanded phase, LC: liquid-
condensed phase, LE–LC: liquid-condensed/liquid-expanded coexistence. Image modified from 
(Wustneck et al., 2005). 
 
In this Thesis, the interfacial activity of POPC:DPPG films was characterized as a 
previous step for further structural studies of the effect of SP-B on these mixed 
monolayers. 33 nmol of the lipid mixture in chloroform/methanol (2:1, v/v) solution was 
spread onto a buffered subphase (5 mM Tris pH 7.4, 150 mM NaCl) at 25 °C in a surface 
balance (Nima Technology). After spreading of the monolayer, the organic solvent was 
allowed to evaporate for 10 minutes. Then, the monolayer was compressed at a rate of 65 
cm2/min. 
In addition to measuring the interfacial activity of surfactant material, the Langmuir 
balance allowed the transference of the interfacial film onto a mica support for further 
structural characterization by atomic force microscopy (AFM) (Figure 3.6.5). A 
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comparative study of the morphology of POPC:DPPG films containing native SP-B 
complexes purified from detergent-solubilized PS or SP-B isolated in organic solvent was 
performed. For this purpose, dried lipid films of POPC:DPPG (7:3, w:w) were rehydrated 
in the presence of SP-B purified in detergent to form vesicles at a lipid concentration of 
5 mg/ml and different SP-B concentrations (10 and 20% w/w, protein/lipid ratio). In 
parallel, dried lipid films were rehydrated in the presence of buffer with an equivalent 
amount of detergent than lipoprotein samples. After detergent removal by incubation with 
Bio-Beads SM-2 Resin, multilamellar suspensions were sonicated to form small 
unilamellar vesicles (SUVs). On the other hand, organic mixtures of POPC:DPPG (7:3, 
w:w) containing or not SP-B isolated in organic solvent (20% w/w, protein/lipid ratio) 
were prepared. Different samples, either in the form of small unilamellar vesicle 
suspensions or chloroform/methanol solutions, were spread onto the surface of a buffered 
subphase at 25 °C in a surface balance (Nima Technology). In the case of solvent 
mixtures, 5 µl containing 33 nmol of phospholipids were applied onto the interface, 
whereas 30 µl of vesicle suspensions containing SP-B or 100 µl of vesicle suspensions 
without the protein (200 or 660 nmol of phospholipids, respectively) were directly 
deposited at the surface. After waiting 10 minutes to allow organic solvent evaporation 
(in the case of aqueous suspension this step was kept in the procedure), monolayers were 
compressed to the required pressure at a slow rate of 25 cm2/min. After 30 minutes of 
equilibration, monolayers were transferred to the mica support, which was previously 
immersed in the subphase, to form Langmuir-Blodgett films at a transfer speed of 5 
mm/min. Film transferences onto mica supports were performed at 12 °C (subphase 
temperature was gradually refrigerated during 30 minutes of equilibration), due to it has 
been suggested that a higher rigidity of the monolayer could be favored the formation of 
the oligomeric structure of SP-B in the film, as it was previously observed in solvent-
spread films of DPPG + SP-B (Olmeda et al., 2015). Lipid monolayers without the protein 
were also transferred at this low temperature with the aim to be compared with those 
containing SP-B. Alternatively, interfacial films of native SP-B complexes from 
detergent-solubilized PS in the absence of lipids were generated. 6 nmol of SP-B purified 
in detergent at different concentrations of protein (1 and 2 mg/ml of SP-B) were applied 
and spread onto the surface of the buffered subphase at 12 °C. Interfacial films of SP-B 
purified in detergent were then transferred to a mica support for AFM analysis. 
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Figure 3.6.5. Schematic illustration of the method used to obtain Langmuir-Blodgett films.  
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4. CHARACTERIZATION OF NATIVE PROTEIN COMPLEXES IN 
PULMONARY SURFACTANT 
 
4.1. INTRODUCTION 
Pulmonary surfactant is a highly dynamic system, which adopts a variety of structural 
arrangements according to the stage of its biological cycle. Surfactant is assembled by 
alveolar type II cells into tightly packed membranes stored in specialized acidic 
organelles, called lamellar bodies (LBs) (Weaver, Na and Stahlman, 2002). Upon 
secretion, surfactant undergoes structural conversion processes giving rise to different 
structures, such as lamellar body-like particles, tubular myelin, multilayer assemblies and 
the interfacial monolayer spread along the respiratory surface (Goerke, 1998). Protein-
protein and protein-lipid interactions are behind this dynamic polymorphism of 
pulmonary surfactant. In particular, SP-B and SP-C have been proposed as the major 
players for these membrane rearrangements due to their membrane-perturbing activities. 
Several functional studies have suggested the existence of interactions between SP-B and 
SP-C as both proteins, though showing partially overlapping interfacial activities, are 
required acting together in a concerted way for surfactant to achieve its optimal function 
(Taneva and Keough, 1994d; Schurch et al., 2010; Roldan et al., 2016). Additionally, 
both of them are necessary for the disassembly of secreted lamellar body-like particles to 
give rise to the formation of the interfacial monolayer film and its associated multilayer 
arrays upon touching the air-liquid interface (Hobi et al., 2016). In the case of protein SP-
A, interactions with SP-B can be also suspected, as these proteins display a cooperative 
action enhancing the adsorption of phospholipids to the air-liquid interface (Hawgood et 
al., 1987), and both of them are required for the formation of tubular myelin (Perez-Gil, 
2008). 
Direct or indirect interactions among the different proteins of surfactant seem to be 
important for the proper function of the system. Thus, the scope of this chapter is to 
elucidate the existence of supramolecular protein complexes in pulmonary surfactant 
membranes. During the first section of the chapter, pulmonary surfactant or its organic 
extract were solubilized by the zwitterionic detergent CHAPS in order to get native 
protein complexes, whose composition and structure were analyzed. Secondly, SP-B and 
SP-C reconstituted into lipid vesicles were conjugated with a variety of protein 
crosslinking reagents to attempt the determination of the stoichiometry of potential SP-B 
oligomers and SP-B/SP-C heterocomplexes. Lastly, a solubilized membrane protein 
library from pulmonary surfactant was generated using the nanodisc technology in order 
to get insights of the interactions between different components of the pulmonary 
surfactant. 
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1.2. RESULTS 
1.2.1. BIOCHEMICAL ANALYSIS OF PROTEIN COMPLEXES IN 
PULMONARY SURFACTANT 
Pulmonary surfactant purified from bronchoalveolar lavages was solubilized by the 
zwitterionic detergent CHAPS in order to characterize protein complexes by 
electrophoresis. Silver staining of non-denaturing Blue Native (BN)-PAGE reveals the 
existence of protein complexes of high molecular weight (Figure 4.1A). Several silver-
stained bands were subjected to protein identification by mass spectrometry, revealing 
that immunoglobulins were present at the well-defined band over 669 KDa marker (green 
arrowhead), while the band over 66 KDa marker contained albumin (red arrowhead). 
Western blots showed the presence of surfactant proteins in high molecular weight bands. 
SP-B and SP-C were forming part of high molecular weight complexes, which were not 
detected as well-defined bands but as smears, likely as a consequence of excessive 
amount of detergent and lipids. In contrast, SP-A was detected in the upper region of the 
lane, in agreement with the presence of highly oligomerized SP-A aggregates unable to 
penetrate through the gel under native conditions.  
Next, in order to test the stability of the native supramolecular complexes, electrophoresis 
in the presence of SDS was performed (Figure 4.1B). SP-A aggregates were able to 
dissociate during the denaturing electrophoresis, showing lower molecular weight bands 
corresponding to dimers, trimers, hexamers and other higher molecular weight oligomers. 
In the case of SP-B, complexes were partly split into entities of lower molecular weight, 
showing a smear from 37 KDa to 250 KDa. Regarding SP-C, this protein seemed to be 
completely disassembled of high molecular weight complexes in the presence of anionic 
detergent, showing a smear below 37 KDa. 
 
Figure 4.1. Surfactant protein complexes in CHAPS-solubilized pulmonary surfactant. A) Silver 
staining and western blots from non-denaturing BN-PAGE (A) and from SDS-PAGE under non-
reducing conditions (B) on 4-20% polyacrylamide gels. Arrowheads correspond to bands containing 
proteins identified by mass spectrometry: albumin (red) and immunoglobulin heavy chain (green). 
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In order to improve the biochemical characterization of pulmonary surfactant 
complexes solubilized by CHAPS, as no defined bands were mostly observed in western 
blots of non-denaturing and non-reducing gels, a second SDS-PAGE dimension under 
reducing conditions was performed from gel strips obtained from Blue Native-PAGE 
(Figure 4.2 A) and SDS-PAGE (Figure 4.2 B).  In this way, we intended to ensure that 
smeared bands were in fact made up of surfactant proteins (which would be particularly 
important due to the presence of endogenous immunoglobulins in surfactant that could 
generate unspecific binding of secondary antibodies), and determining the size range of 
the native complexes which they were initially associated to.  
Second dimension electrophoresis from BN gel strip caused the dissociation of the 
high molecular complexes in several bands (silver staining, Figure 4.2 A). The upper side 
of non-denaturing strip was resolved as several bands from 100 to 23 KDa. The band with 
mobility corresponfing to about 500 KDa in the first dimension split in several spots in 
the second dimension: 100, 75, 65, 50, 37 and 25 KDa. In the case of the defined band 
around 100 KDa in the non-denaturing strip, two main bands of about 65 and 50 KDa 
were revealed in the second dimension. The protein composition of several spots of this 
bidimensional electrophoresis were analyzed by mass spectrometry, although only few of 
them could be identified accurately. This is the case of 65 KDa bands from around 500 
KDa and 100 KDa in first non-denaturing dimension, which contained albumin (red 
arrowhead). Besides, transferrin was detected in the 75 KDa band corresponding to the 
area of around 500 kDa in the first dimension strip (purple arrowhead). 
The presence of surfactant proteins in BN gel strips was analyzed by western blots of 
the second dimension, revealing bands which corresponded to their monomeric forms, as 
expected in the presence of reducing agent (Figure 4.2 A). SP-A was detected in the 
upper side of the non-denaturing strip, pointing that SP-A under native electrophoresis 
was associated into complexes heavier than mere octadecamers ( ̴ 630 KDa), which were 
not able to penetrate the gel. SP-B was also detected along almost the entire non-
denaturing strip, including the very top segment of it, although the major proportion of 
the protein was distributed between 440 and 140 KDa. On the other hand, SP-C was 
detected between 669 and over 140 KDa. These results confirmed the existence of SP-A, 
SP-B and SP-C in native high molecular weight complexes, in agreement with the results 
obtained by direct western blots of the first dimensions. The co-existence of different 
surfactant proteins into high molecular weight bands could also suggest possible 
interactions between SP-A and -B, as well as between SP-B and -C. 
Finally, silver staining of the second dimension of the SDS-PAGE gel strip showed a 
notable lower complexity than the one obtained from BN-PAGE strip (Figure 4.2 B). 
Regarding to immunoblotting analysis for surfactant proteins, SP-A was detected from 
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the top region to 75 KDa of the denaturing first dimension gel strip. In the case of SP-B, 
most of the protein in the non-reducing gel was associated into structures of low 
molecular weights, 30-50 KDa, such as dimers or tetramers of SP-B. However, a minor 
fraction of SP-B was detected as a smear between 50-150 KDa, forming higher 
oligomeric structures. In contrast, SP-C was restricted to the region between 37-50 KDa 
of the first dimension strip. Thus, second dimension electrophoresis confirmed the 
presence of a variety of macromolecular protein complexes that were partly disrupted in 
the presence of SDS. 
 
Figure 4.2. Characterization of surfactant protein complexes by two dimensional 
electrophoresis. Second dimension was performed of a band strip from previous BN-PAGE (A) or 
SDS-PAGE under non-reducing conditions (B). All second dimension electrophoresis were SDS-
PAGE in the presence of reducing agent and gels contained 12% polyacrylamide for silver staining 
and α-SP-A western blot, and 16% polyacrylamide for α-SP-B and α-SP-C western blots. Arrowheads 
correspond to bands containing proteins that could be identified by mass spectrometry: transferrin 
(purple) and albumin (red). 
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1.2.2. BIOCHEMICAL AND STRUCTURAL ANALYSIS OF SURFACTANT 
PROTEIN COMPLEXES RECONSTITUTED INTO MEMBRANES 
Two-dimensional electrophoresis analysis of detergent-solubilized surfactant 
suggested the possible presence of SP-B/SP-C complexes. To get deeper insight of these 
protein heterocomplexes found in PS membranes, vesicles made by its extract (containing 
SP-B 1% and SP-C 1%, mass protein to lipid ratio) were used. After vesicle solubilization 
with CHAPS, suspension was subjected to a size-exclusion chromatography (SEC). This 
chromatography did not allow to resolve complexes of different defined molecular sizes 
entirely, showing overlapped peaks that contain both SP-B and SP-C (Figures 4.3 A-B). 
To compare the supramolecular organization of SP-B in the organic extract of PS with 
that of SP-B alone reconstituted into synthetic model membranes, POPC or POPC:POPG 
vesicles containing SP-B 10% (by weight, protein to lipid) were solubilized with CHAPS 
and subjected to similar analysis. Size-exclusion chromatograms of both preparations 
showed two different populations that contain SP-B (Figures 4.3 A-B); the first one was 
comprised by protein complexes from 29 KDa to ˂  66 KDa, while the other one contained 
protein entities lower than 12.4 KDa, according to the elution volumes of a set of protein 
standards of known molecular weight. The peaks eluting first from SP-B vesicles and OE 
vesicles contained protein aggregates similar in size.  
Electrophoretic analysis under native conditions (BN-PAGE) of detergent-solubilized 
OE suspension showed a major proportion of SP-B forming aggregates higher than 200 
KDa, but also SP-B was detected as a smear from 100 KDa to the end of the lane, which 
might had contained SP-B dimers and low order oligomeric forms (Figure 4.3 C).  After 
performing SEC of this sample, SP-B and SP-C were detected as smears with molecular 
weights higher than 140 KDa in fractions 1 and 2. Thus, size-exclusion chromatography 
got rid of low molecular weight SP-B oligomers detected in the original suspension of 
solubilized OE. In the case of fractions from SEC of CHAPS-solubilized POPC:POPG 
vesicles supplemented with SP-B, this protein was detected in well-defined bands with 
approximate molecular weights of 200, 232 and 500 KDa. Therefore, SP-B complexes 
solubilized from vesicles made by either organic extract or POPC:POPG + SP-B show 
high order oligomerization states. A previous study has revealed the existence of native 
SP-B oligomers by their purification from pulmonary surfactant solubilized in CHAPS 
(Olmeda et al., 2015). The native electrophoretic analysis of SP-B purified in detergent 
showed the presence of high order oligomers (SP-Bdet in figure 4.3 C), with a similar 
band profile as solubilized OE or the SP-B-supplemented vesicle suspensions analyzed 
along this section. Moreover, notice that all immunoblots from BN-PAGE showed in 
Figure 4.3 C showed very large protein aggregates with molecular weights higher than 
669 KDa in the top of the blot. So, samples from SEC of different elution volumes, with 
estimated molecular weights lower than 66 KDa (according to the column calibration), 
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showed not only higher molecular weight oligomers but also large protein aggregates in 
native electrophoresis, meaning that protein mixed micelles could undergo an aggregation 
process after SEC. SP-B might prompt this process by establishing protein-protein 
interactions between oligomers, as suggested in (Olmeda et al., 2015). 
 
Figure 4.3. Size separation of CHAPS-solubilized surfactant protein complexes. Vesicles made 
by organic extract from pulmonary surfactant or of POPC or POPC:POPG (7:3) containing SP-B 10% 
(w/w, protein/lipid) were solubilized by CHAPS (detergent/phospholipid mass ratios of 5:1 and 1.5:1, 
respectively) . (A) Profiles of size-exclusion chromatography in Superdex 200 10/300GL column of 
detergent-solubilized vesicles made of organic extract (OE vesdet; blue), POPC + SP-B (POPC SP-B 
vesdet, black) and POPC:POPG + SP-B (POPC:POPG SP-B vesdet; grey dashed line). Several fractions 
from each chromatogram were chosen for biochemical and structural characterization (numbered from 
1 to 5). (B-C) α-SPB and α-SP-C western blots from SDS-PAGE under reducing conditions or BN-
PAGE. Original OE vesdet refers to CHAPS-solubilized vesicles of organic extract before size-
exclusion chromatography. SP-B from PSdet corresponds to BN-PAGE analysis of SP-B complexes 
purified from CHAPS-solubilized pulmonary surfactant. SDS-PAGE and BN-PAGE were performed 
on 16% and 4-20% polyacrylamide gels, respectively. 
 
To structurally characterize the protein complexes observed by native electrophoresis, 
fractions obtained from SEC were analyzed by TEM (Figure 4.4). Fractions 1 and 2 from 
detergent-solubilized organic extract show surfaces covered by domains likely formed by 
detergent, lipid and protein, in which ring-shaped particles with a 10 nm of average 
diameter could be distinguished (labeled with circles). Apart from these flattened 
surfaces, several vesicle-like arrangements were visualized. In the case of solubilized 
POPC or POPC:POPG membranes containing 10% SP-B, similar domains in the surface 
were visualized, although the size of these domains abruptly decreased in late eluted 
fractions named as 2. Nevertheless, both fractions show ring-shaped structures similar to 
those observed in solubilized vesicles made by organic solvent mixtures. These particles 
of 10 nm of diameter are compatible in size and shape to SP-B complexes purified from 
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pulmonary surfactant visualized by TEM and AFM, which fitted with the tridimensional 
model of SP-B that predicted SP-B oligomers constituted by 5 or 6 SP-B covalent dimers 
(Olmeda et al., 2015).  
 
Figure 4.4. Transmission electron micrographs of fractions 1 and 2 obtained from size-exclusion 
chromatography of the different vesicle preparations solubilized by CHAPS. Samples were 
negatively stained for TEM. White circles label ring-shaped particles of 10 nm of average diameter. 
Scale bars, 100 nm. Enlarged views of some ring-shaped particles from the different vesicle 
suspensions solubilized by CHAPS are shown on the right panel (scale bars, 10 nm). 
 
1.2.3. BIOCHEMICAL ANALYSIS OF SP-B/SP-C INTERACTIONS BY PROTEIN 
CROSSLINKING 
Chemical crosslinking is a widely used method to covalently stabilize protein-protein 
interactions. In this chapter, a number of crosslinking reactions were performed to 
characterize possible macromolecular assemblies containing SP-B and SP-C in the 
pulmonary surfactant system. The results from the previous section suggested that protein 
macromolecular assemblies of pulmonary surfactant are re-established upon membrane 
reconstitution of pulmonary surfactant derivatives isolated in organic solvent. To further 
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investigate the protein interactions involved in the generation of such assemblies, the 
starting material for these experiments included vesicles made of lipid fraction (LF) of 
pulmonary surfactant or mixtures of synthetic lipids supplemented with hydrophobic 
protein fraction (PF) (containing SP-B and SP-C, in their precise native proportion), a 
mixture of isolated SP-B and SP-C (close to physiological proportion, 1:1 (w/w)) or SP-
B alone.  
The first approach to crosslink SP-B oligomers themselves and together with SP-C 
was performed by dithiobis(succinimidyl propionate) (DSP). This agent is an amine-
reactive crosslinker with N-hydroxysuccinimide (NHS) ester reactive ends and a 
cleavable disulfide bond in its 8-carbon spacer arm. Proteins generally contains several 
primary amines in the N-terminal segment of the protein and in the side chain of lysine 
reisudes which are targets for NHS-ester group at physiological pH. Particularly, SP-B 
contains two lysine residues per monomer and each SP-C monomer only have one lysine, 
as well as their respective amine terminal group. Small unilamellar vesicles (SUVs) 
containing PF, a mixture of SP-B and SP-C or SP-B at different protein concentrations, 
were subjected to crosslinking at different molar ratios DSP:protein (Figure 4.5 A). None 
of the conditions tested resulted in an efficient stabilization of SP-B complexes with the 
expected molecular weight of 87 or 104.4 KDa, depending on whether the structure is 
formed by the association of 5 or 6 covalent dimers, respectively (Olmeda et al., 2015). 
However, most of SP-B showed an electrophoretic behavior compatible with the covalent 
dimer (17.4 KDa) and assemblies of two covalent dimers (34.8 KDa).  Smears of protein 
with higher molecular weights were detected for all conditions tested, although it is 
worthy to notice that crosslinked SP-B in LF vesicles showed four defined bands of high 
molecular weights labelled from B1 to B4 in Figure 4.5 A: B1 of approximately 200KDa, 
which could correspond to a decamer of SP-B dimers; B2, with a molecular weight around 
75-100 KDa, might contain from pentamers to octamers of SP-B dimers; whereas B3 and 
B4 might be constituted by tetramers and trimers of SP-B dimers, respectively. On the 
other hand, no other protein assembly was detected for SP-C but its monomeric form 
(right panel in Figure 4.5 A), with an electrophoretic mobility of 10 KDa (as expected 
for SP-C in membranes, due to alteration of its electrophoretic behavior by the presence 
of lipids). Concerning the effect of DSP concentration, a progressive loss of material was 
detected when molar ratios above 50:1 were tested. This fact might be due to an excessive 
crosslinker concentration, which could negatively affect protein stability, promoting its 
aggregation. To increase the detection of possible protein oligomers, higher protein 
concentrations were assessed. To this end, crosslinking experiments by DSP were 
performed with POPC:POPG (7:3, w/w) SUVs containing PF 10% (protein to lipid, 
weight), a mixture of SP-B and SP-C (at its roughly physiological mass proportion 1:1, 
with a 5% of each protein) or SP-B alone at 10%. Crosslinking reactions were performed 
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with molar ratios DSP to protein varying from 10:1 to 100:1. Figure 4.5 B shows for all 
reactions that SP-B was detected as a smear with molecular weights lower than 71 KDa. 
In the case of SUVs with 10% SP-B, a band ˂ 31 KDa can also be distinguished, which 
would correspond to covalent SP-B dimers. 
 
Figure 4.5. SDS-PAGE analysis of surfactant protein complexes after crosslinking by DSP. A) 
Anti SP-B and anti SP-C western blots of small unilamellar vesicles (SUVs) made by lipid fraction 
(LF) of pulmonary surfactant containing the hydrophobic protein fraction (PF) 5% (w:w, protein:lipid) 
or SP-B 2.5% (w/w). B) SUVs made by a mixture of POPC:POPG (7:3, w:w) supplemented with PF 
10%, a mixture of isolated SP-B and SP-C (5% of each protein, according to its approximate 
physiological ratio 1:1, in mass) or SP-B 10% (w/w). Crosslinking assays were performed at different 
crosslinker:protein molar ratios, which are indicated over each line. SDS-PAGE were run into 4-20% 
polyacrylamide gels. 
 
Although DSP is a membrane permeable crosslinker, which could be in principle 
favourable for membrane proteins, crosslinking efficiency for SP-B and SP-C oligomers 
resulted very poor, as previously shown, so next approach involved the use of an 
alternative sulfonated amine-reactive crosslinker, bis(sulfosuccinimidyl)suberate (BS3). 
BS3 is a water-soluble crosslinker, widely used to crosslink proteins in the external plasma 
membrane of cells, due to its inability to permeate through membranes. It is important to 
consider that the presence of SP-B and SP-C imparts to phospholipid membranes a high 
permeability to a polar molecules (Parra et al., 2011). In this work, a range of molar ratios 
BS3:protein was used to crosslink SP-B and SP-C reconstituted in small vesicles with 
different lipid/protein composition. Again, the SDS-PAGE analysis showed a low yield 
of crosslinking reactions for all BS3 concentrations (Figure 4.6). Most of SP-B was 
forming entities of low molecular weight, although weak bands of high molecular weight 
were detected, which showed similar molecular weights to bands B1 to B4 distinguished 
in crosslinking of SP-B-supplemented LF vesicles by DSP (Figures 4.5 A and 4.6 A-B). 
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In the case of SP-C, only SP-C monomers were detected in the suspensions containing 
PF and a mixture of isolated SP-B and SP-C. Concerning the lipid composition of 
vesicles, lipid fraction (LF) of pulmonary surfactant and the synthetic mixture 
POPC:POPG (7:3) showed similar crosslinking yields.
 
Figure 4.6. SDS-PAGE analysis of surfactant protein complexes upon crosslinking by BS3. Small 
unilamellar vesicles (SUVs) were made by lipid fraction (LF) (A) or a mixture of POPC:POPG 
(7:3,w:w) (B) containing the hydrophobic protein fraction (PF) 10% (w:w, protein:lipid), a mixture of 
isolated SP-B and SP-C (5% of each protein, according to its physiological ratio 1:1, in mass) or SP-
B 10% (w:w). Vesicles were crosslinked by BS3 at different crosslinker:protein molar ratios, which 
are indicated over each line. SDS-PAGE was run into 4-20% polyacrylamide gels followed by western 
blots for SP-B and SP-C detection. 
 
The existence of a tridimensional model structure for SP-B oligomers based on the 
structure of Saposin B (Olmeda et al., 2015) resulted to be a useful tool to determine 
expected distances between amine groups of amino acid residues susceptible to 
conjugation by NHS-ester of bifunctional crosslinking reagents. Distances between 
primary amine residues of adjacent covalent SP-B dimers were measured using Pymol 
Software. Thus, the interdimer distances between amine groups of side chain of lysine 
varied from 10.8 to 31.1 Å, whereas distances varying from 9.7 to 36.5 Å were measured 
between side chains of lysine and amino group of the N-terminal end of the protein. In 
case of intradimer distances between amino groups of N-terminal region, measured values 
increased to 57.3-67.3 Å. 
As both amine-reactive crosslinkers DSP and BS3 have spacer arms of 12 and 11.4 Å, 
respectively, the length of these spacers restrict largely the number of amine group pairs 
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in SP-B complexes that can be available for the crosslinking reactions. PEGylated 
bis(sulfosuccinimidyl)suberate [BS(PEG)9] emerged as a reasonable alternative. This is 
a water-soluble amine-reactive crosslinker with a flexible polyethylene glycol spacer 
between NHS esters, which result in a spacer arm length of 35.8 Å. A number of 
crosslinking reactions were performed to target SP-B complexes, varying lipid 
composition and size of vesicles, as well as temperature and duration of crosslinking 
reaction. In this set of experiments, SP-B was reconstituted in membranes of two different 
synthetic lipid mixtures, POPC:POPG (7:3) and DPPC:POPC:DPPG (5:2.5:1.5). The 
latest one mimics the phospholipid composition of pulmonary surfactant but in the 
absence of phospholipid with primary amine groups, such as phosphatidylserine (PS) or 
phosphatidylethanolamine (PE). PS and PE only represents about 8 % in mass of the total 
phospholipid content of pulmonary surfactant (Blanco and Perez-Gil, 2007), but their 
presence could interfere to some extent in the protein conjugation with NHS esters of 
BS(PEG)9. The electrophoretic analysis of crosslinked samples showed that neither the 
use of a crosslinking agent with a long spacer arm neither the substitution of FL by a 
mixture of synthetic lipids free of PS and PE enhanced crosslinking efficiency for SP-B 
complexes (Figure 4.7 A-B). Moreover, in an attempt to improve the yield of 
crosslinking, we performed the experiments with vesicles containing those proteolipid 
mixtures diminishing the reaction temperature from 37ºC to 25ºC, for 30 min, or to 4ºC 
during 2 hours. However, decreasing the crosslinking reaction rate did not lead to favor 
the stabilization of SP-B oligomers (data not shown). Finally, SP-B complexes purified 
in CHAPS from detergent-solubilized pulmonary surfactant were subjected directly to 
crosslinking by BS(PEG)9 at different concentrations. However, the subsequent SDS-
PAGE analysis showed that SP-B was mostly found as covalent dimers or as assemblies 
of two covalent dimers (Figure 4.7 C). Therefore, BS(PEG)9 was not able to stabilize 
high molecular weight oligomers of SP-B. To sum up, none of the protein crosslinking 
experiments in this section allowed to confirm the existence of SP-B oligomers nor SP-
B/SP-C interactions.  
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Figure 4.7. SDS-PAGE analysis of SP-B complexes upon crosslinking by BS(PEG)9. Small 
unilamellar vesicles (SUVs) (A) or large unilamellar vesicles (LUVs) (B) made by a mixture of 
POPC:POPG (7:3, in mass) or DPPC:POPC:DPPG (5:2.5:1.5, in mass)  containing SP-B 10% (w:w, 
protein:lipid). (C) A sample containing SP-B complexes purified from detergent-solubilized 
pulmonary surfactant was directly subjected to crosslinking. All suspensions were crosslinked by 
BS(PEG)9 at different crosslinker:protein molar ratios, which are indicated over each line. SDS-PAGE 
were run into 4-20% polyacrylamide gels followed by western blots for SP-B detection. 
 
1.2.4. PULMONARY SURFACTANT COMPLEXES INCORPORATED INTO 
MSP NANODISCS 
Pulmonary surfactant membranes were reassembled into MSP1D1 nanodiscs to study 
surfactant protein-lipid complexes through their compositional analysis. The first step of 
the nanodiscs formation method is the solubilization of pulmonary surfactant membranes 
by detergent. Here, PS solubilization was performed by the ionic detergent cholate or by 
CHAPS, a zwitterionic detergent. Next, cholate-solubilized scaffolding protein MSP1D1 
(final molar ratio 100:1, phospholipid to MSP1D1) was added to solubilized PS and by a 
detergent removal step, nanodiscs were self-assembled containing lipoprotein 
components of PS. To purify the assembled nanodiscs, an immobilized metal ion affinity 
chromatography (IMAC) was performed (Figure 4.8). Thanks to the His6tag attached to 
the MSP1D1 N-terminal region, nanodiscs were retained in Ni2+-NTA resin until its 
elution with imidazole. The electrophoretic analysis showed that nanodiscs formed from 
cholate-solubilized PS scarcely contain SP-A and SP-B. The vast proportion of these 
proteins were found in the non-retained fraction of the IMAC. In the case of SP-C, this 
protein was not detected at any fraction. On the other hand, nanodiscs generated from 
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CHAPS-solubilized PS included SP-B, SP-C and a little proportion of SP-A. However, 
most of SP-A and also part of SP-B and SP-C were not incorporated into nanodiscs, being 
found in the non-retained fraction of the chromatography. These results suggest that 
CHAPS yields better solubilization of PS membranes than cholate, achieving nanodiscs 
enriched in surfactant proteins. Therefore, a new purification of nanodiscs was performed 
with a higher amount of CHAPS-solubilized PS (four times) in order to improve the 
detection of surfactant components confined into nanodiscs (blue dashed line in IMAC 
profile, Figure 4.8).  
 
Figure 4.8. Incorporation of pulmonary surfactant complexes into MSP1D1 nanodiscs (molar 
ratio 100:1, phospholipid to MSP1D1). Immobilized Ni2+ affinity chromatography was performed 
from suspensions containing nanodiscs assembled together with PS solubilized by different 
detergents: 56 mM of PS solubilized by cholate at a molar ratio detergent:phospholipid of 3.5:1 (dotted 
green line), PS (56 mM) solubilized by CHAPS at molar ratio 6:1 (dark blue line), CHAPS-solubilized 
PS (224 mM) at molar ratio 6:1 (light blue dashed line). Left panel shows the chromatography profiles 
of the different preparations eluted with 500 mM imidazole-supplemented Tris buffer, pH7.4. Right 
panel: SDS-PAGE analysis under reducing conditions of IMAC eluted fractions (named as nanodisc 
fraction, ND) and the flow-through (FT) non-retained fractions from nanodiscs of CHAPS-solubilized 
and cholate-solubilized PS at low phospholipid concentration. Immunoblots were performed for 
detection of SP-A, SP-B, SP-C and His-tag (MSP). 
 
To continue the study of surfactant complexes, the three different PS nanodiscs 
suspensions were subjected to size-exclusion chromatography in a Superdex 200 column. 
Nanodiscs assembled with CHAPS-solubilized PS were separated in different peaks 
according to its size (Figure 4.9 A). Peak 1 was composed by a minor proportion of MSP, 
SP-A and SP-B. Early elution of this fraction would be related to the presence of high 
molecular weight protein complexes, such as SP-A octadecamer (~ 630 KDa) and, likely, 
SP-B oligomers. Most of SP-B and SP-C were confined to nanodiscs eluted into two 
overlapped peaks, were peak 3 contained nanodiscs with SP-B and SP-C and peak 4 was 
constituted by nanodiscs that seem to contain only a low amount of SP-C. Moreover, free 
MSP and SP-B were eluted at the end of the SEC, pointing to the presence of free protein 
not incorporated into discs. On the other hand, nanodiscs formed from cholate-solubilized 
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PS seemed to consist of a more homogeneous suspension in size, where only SP-B could 
be detected in the peak containing nanodiscs (peaks 3 and 4) (Figure 4.9 C). However, 
the presence of SP-A and SP-C could not be discarded due to the low PS concentration 
used for nanodiscs formation. Besides this, it’s noteworthy to point out the huge 
proportion of MSP which is not assembled into nanodiscs, as shown by the last peak of 
the SEC profile. Comparing nanodiscs formed by CHAPS-solubized PS and by cholate-
solubilized PS, both at low concentration of phospholipid (Figure 4.9 B-C), it is clear 
that the use of CHAPS favors the insertion of protein complexes into nanodiscs.  
 
Figure 4.9. Analysis of nanodiscs formed from pulmonary surfactant. Size-exclusion 
chromatography (SEC) profiles in a Superdex 200 10/300GL column and subsequent SDS-PAGE 
analysis under reducing conditions of three different preparations of nanodiscs assembled from: (A) 
CHAPS-solubilized PS (224 mM of phospholipid) at molar ratio 6:1 (detergent: phospholipid), (B) 
CHAPS-solubilized PS (56 mM) solubilized by CHAPS at molar ratio 6:1 and (C) cholate-solubilized 
PS (56 mM) at molar ratio 3.5:1. Immunoblots were performed for detection of SP-A, SP-B, SP-C and 
His-tag (MSP). Tables show the relative amount of protein detected for each chromatography profile; 
it is also indicated when the protein was not detected (n.d.) throughout the chromatogram. 
 
Following with the characterization of the pulmonary surfactant nanodiscs, the 
suspension containing nanodiscs from CHAPS-solubilized PS and its fractions obtained 
by SEC were subjected to a lipid compositional analysis by TLC (Thin Layer 
Chromatography) (Figure 4.10). The idea was to determine whether the different proteins 
or complexes could be associated to particular lipid species. Results showed that the 
original PS nanodiscs suspension seemed to be formed mainly by phosphatidylcholine 
(PC), as well as phosphatidylinositol/phosphatidylserine (PI/PS). Regarding the lipid 
composition of fractions 1-4 of pulmonary surfactant nanodiscs subjected to SEC, 
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nanodiscs of peak 3, enriched in SP-B and SP-C, contained mainly PC and PI/PS, as well 
as phosphatidylethanolamine (PE) and PG, in minor proportion. In the case of peak 4, in 
which SP-C was previously detected, nanodiscs contained PC and PI/PS, in lower 
amount. No lipid content was detected for peak 1 and 5, probably due to low sample 
concentration. 
 
Figure 4.10. Compositional analysis of lipids contained in nanodiscs formed from CHAPS-
solubilized PS (224 mM of phospholipid). The original PS nanodiscs suspension (PS/NDs) and 
fractions obtained from SEC were subjected to a thin layer chromatography (TLC). AP indicates the 
application point of the samples. Synthetic lipids were also loaded to compare migration of the main 
surfactant lipids. PC: phosphatidylcholine, PG: phosphatidylglycerol, PI: phosphatidylinositol, PS: 
phosphatidylserine, PE: phosphatidylethanolamine, SM: sphingomyelin, Chol: cholesterol. 
 
This work analyzed for the first time the composition of lipoprotein complexes in 
pulmonary surfactant applying the MSP nanodiscs technology, although results obtained 
suggested that there was scope for improvement. For instance, SEC profiles showed that 
some SP-B remained out of nanodiscs (Figure 4.9 A-B), which could be overcome by 
increasing the MSP1D1 concentration. Therefore, new pulmonary surfactant nanodiscs 
were assembled with an increased molar ratio of phospholipid to MSP1D1 of 50:1, in 
comparison to the ratio 100:1 used in previous experiments. After purification by IMAC 
of these PS nanodiscs, which contained SP-A, SP-B and SP-C (Figure 4.11 A), the 
sample was subjected to size-exclusion chromatography (Figure 4.11 B). SEC profile 
showed poorly resolved peaks. Despite this, protein composition of different collected 
fractions was analyzed, showing the presence of a huge amount of assembled empty 
nanodiscs, which did not contain any surfactant protein (fractions 5/6). Moreover, a 
considerable amount of non-assembled MSP1D1 was found (fraction 8). All together, the 
results pointed to a wide excess of MSP1D1 over total pulmonary surfactant content. On 
the other hand, nanodiscs containing SP-B and SP-C (fractions 3/4) were detected, and a 
peak containing only SP-B (fractions 1-2) was also found. Although no other protein was 
detected in this fraction, it is likely that besides SP-B, it also contained a little amount of 
SP-A, as in peak 1 of Figure 4.9 A. In order to attempt the separation of loaded nanodiscs 
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from empty discs formed as a consequence of the excess of MSP, an ion exchange 
chromatography was subsequently performed with discrete increasing of ionic strength, 
taking advantage of the difference in charge between the anionic protein MSP1D1 and 
the cationic surfactant proteins SP-B and SP-C at pH 7. However, this chromatography 
did not allow a proper separation of both types of nanodiscs (data not shown).  
 
Figure 4.11. Assembly of CHAPS-solubilized surfactant into MSP1D1 nanodiscs, at a molar 
ratio phospholipid:MSP of 50:1. A) IMAC profile of eluted PS nanodiscs with 500 mM imidazole. 
B) SEC profiles of pulmonary surfactant nanodiscs in Superdex 200 10/300GL column and SDS-
PAGE analysis. Immunoblots were performed for detection of SP-A, SP-B, SP-C and His-tag (MSP). 
Tables show the relative amount of protein detected for each chromatographic fraction; it is also 
indicated when the protein was not detected (n.d.) throughout the chromatogram. ND: eluted fraction 
of PS nanodiscs obtained from IMAC. 
 
4.3. DISCUSSION 
Solubilization of pulmonary surfactant membranes by CHAPS was implemented in a 
previous work (Olmeda, 2011). In that work, an extensive study of solubilization of 
pulmonary surfactant membranes was performed by using different detergents, including 
CHAPS, dodecyl maltoside and digitonin. CHAPS resulted to be the most efficient 
detergent to solubilize PS membranes, extracting native complexes of diverse high 
molecular weights. Further analysis by gradient density centrifugation and size-exclusion 
chromatography showed that surfactant native complexes purified by this detergent were 
clustered around two populations, different in density, size and amount of associated 
lipid, but both containing SP-A, SP-B and SP-C. 
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In the present work, these native surfactant protein complexes purified in CHAPS were 
biochemically analyzed by 2D BN/SDS-PAGE. This method allows to identify individual 
proteins from complexes in combination with immunoblotting or mass spectrometry 
analysis. Three serum proteins have been detected forming somehow part of pulmonary 
surfactant complexes: albumin, transferrin and immunoglobulin. It is known that serum 
proteins can also participate in the progression of lung injury, as their physiological levels 
increase during lung edema and inflammation (Hallman, Sarnesto and Bry, 1994; Wattiez 
et al., 1999; Shirahama et al., 2010; Okamoto et al., 2012). However, previous proteomic 
analysis of healthy human BAL already revealed the presence of these three proteins with 
relevant physiological, antioxidant and immunological function (Chen et al., 2008; 
Nguyen et al., 2014). In the case of immunoglobulins, it has been described that collectins 
SP-A and SP-D interact with these immune molecules in order to modulate the host 
defense response (Nadesalingam, Reid and Palaniyar, 2005; Lin and Wright, 2006; 
Vieira, Kung and Bhatti, 2017). In this way, structural studies revealed the presence of 
immunoglobulins and albumin in the alveolar lining fluid of normal rat lungs, as granular 
deposits, and closely associated to tubular myelin (Bignon et al., 1975, 1976). 
Furthermore, albumin and transferrin were also detected in isolated LBs from healthy rat 
lungs (Wang et al., 2008). The presence of albumin, immunoglobulin and transferrin in 
the native surfactant complexes purified by CHAPS indicates that these proteins are 
associated with pulmonary surfactant membranes under physiological conditions and 
strengthen the hypothesis of a potential role in the alveolar fluid. 
Regarding surfactant proteins, 2D BN/SDS-PAGE revealed the existence of high order 
molecular weight structures containing SP-A, SP-B and SP-C under native conditions. 
However, protein complexes solubilized by CHAPS were partly disassembled during the 
first denaturing dimension of the electrophoresis. In this way, SP-A aggregates observed 
under native conditions underwent a dissociation process during denaturing 
electrophoresis, towards the generation of dimers, trimers and higher oligomeric 
structures, such as hexamers or octadecamers, as previously described (Sánchez-Barbero 
et al., 2005). Concerning SP-C, native complexes of this protein were also observed under 
native conditions, but were completely disassembled in the presence of SDS into entities 
below 37 KDa, which would correspond to monomers and dimers. The presence of SP-C 
oligomers under native conditions is not completely unexpected, as dimerization and 
further oligomerization have been previously suggested (Kairys, Gilson and Luy, 2004; 
Luy et al., 2004; Roldan, Pérez-Gil, et al., 2017). In the case of SP-B, unlike SP-C, a 
significant part of the protein remained associated in complexes with high molecular 
weight (150-50 KDa) after the denaturing process, pointing to a higher stability of the 
interactions involved in SP-B supramolecular assemblies. 
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In this regard, a previous study revealed the existence of an oligomeric structure of 
SP-B under native conditions (Olmeda et al., 2015). Upon surfactant solubilization by 
CHAPS, SP-B is assembled into ring-shaped complexes with 10 nm of diameter, 
visualized by electron microscopy or atomic force microscopy. These obtained particles 
fitted reasonably well with a three-dimensional structure model of SP-B based on the 
Saposin B structure, which predicted the potential formation of SP-B oligomers 
constituted by 5 or 6 SP-B covalent dimers (Olmeda et al., 2015). Considering these data, 
the expected molecular weights for decamers and dodecamers of SP-B would be 87 and 
104.4 KDa, respectively. The electrophoretic analysis of SP-B purified in detergents 
showed a diffuse pattern of bands of high molecular weight reflecting the existence of 
multiple associations of SP-B with diverse high order oligomerization states [as shown in 
Figure 4.3 C and (Olmeda et al., 2015)]. In the present work, the compositional analysis 
of native complexes in CHAPS-solubilized surfactant by 2D SDS/SDS-PAGE revealed 
that a significant part of SP-B is assembled into high order oligomers, varying from 50 to 
150 KDa. Moreover, under native conditions, SP-B oligomers seemed to be associated to 
SP-A or SP-C, yielding higher order hetero-oligomers.  
In the case of SP-B and SP-C, both proteins were found together in native complexes 
of molecular weights ranged between 214 and 644 KDa. These native surfactant 
assemblies have been not only observed in solubilized pulmonary surfactant membranes, 
but also we have found that SP-B and SP-C are able to assemble into complexes larger 
than 140 KDa after membrane reconstitution of the organic extract from surfactant. In the 
same way, SP-B isolated in organic solvent is able to re-establish a high order 
oligomerization state once reconstituted in POPC/POPG model membranes. Moreover, 
upon detergent-solubilization of these types of vesicles (containing the whole 
hydrophobic fraction of PS or isolated SP-B), ring-shaped particles with 10 nm of average 
diameter were visualized by TEM, in agreement with  SP-B oligomers purified by 
detergent (Olmeda et al., 2015). Besides, these ring-shapes particles similar in size were 
also observed in detergent-solubilized POPC vesicles containing SP-B. Therefore, 
anionic phospholipids seemed not to be required for the oligomerization of SP-B, in 
contrast to what previously suggested (Olmeda et al., 2015). 
To sum up, these results would suggest the existence of SP-B/SP-C complexes, 
although the fact that the two proteins are detected at the same spots in a native 
electrophoresis or in 2D BN/SDS-PAGE is not necessarily a definitive proof for a real 
assembly of these proteins, as different complexes might co-localize with similar 
electrophoretic mobility. Nevertheless, in a very recent FRET (Förster Resonance Energy 
Transfer) study we have described the existence of SP-B oligomers and SP-B/SP-C 
heterocomplexes in surfactant membranes (Cabre et al., 2018). That work also proposed 
that SP-B/SP-C interactions could dissociate arrays of two SP-B oligomers, favoring the 
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formation of SP-B/SP-C complex. However, the nature of these SP-B/SP-C interactions 
is not yet completely understood. Crosslinking studies performed during this chapter did 
not allow to elucidate the stoichiometry of the SP-B oligomer nor of the SP-B/SP-C 
heterocomplexes, even if these negative results do not imply that such interactions do not 
exist.  There are some factors that may affect the yield of membrane protein crosslinking, 
among others, solubility of the reagent, the length of its structure and experimental 
conditions such as pH or temperature.  Crosslinking experiments performed throughout 
the present chapter have looked after several possibilities for these variables. Besides, 
NHS-ester reagents are the most common used for protein labeling and crosslinking, as 
they react with primary amines of the side chains of lysines and the N-terminal group of 
the proteins at physiological pH. Apart from its respective amine terminal groups, SP-B 
has two lysines whereas SP-C is a 35-amino acid transmembrane polypeptide with only 
one lysine (K9) located in the junction between the transmembrane poli-valyl helix and 
the N-terminal amphipathic segment. It is worthy to consider that the scarce number of 
amine groups and their likely non-favorable location inside both proteins could have 
hindered the crosslinking reaction between them. Despite this, the existence of SP-B/SP-
C complexes have been suggested in both native PS and reconstituted membranes from 
the organic extract of PS by 2D BN/SDS PAGE and native electrophoresis, respectively. 
This outcome would support the hypothesis that SP-B/SP-C interactions are involved in 
the synergistic action of both proteins that facilitate a proper biophysical function of 
pulmonary surfactant, by enhancing the interfacial adsorption of phospholipids, 
maintaining the stability of surface active films and modulating the architecture of 
phospholipid bilayers (Taneva and Keough, 1994d; Schurch et al., 2010; Hobi et al., 
2016; Roldan et al., 2016). Moreover, SP-B and SP-C are involved in regulating 
membrane permeability towards ions, polar and nonpolar molecules in a concerted way 
(Parra et al., 2011, 2013). The role of SP-B and SP-C on the membrane permeability of 
pulmonary surfactant system will be extensively addressed in the Chapter 2. 
Regarding SP-A/SP-B interactions, two dimensional electrophoresis have revealed the 
presence of complexes containing both proteins, with a high order of oligomerization. 
These heterocomplexes could be behind the formation of tubular myelin, which requires 
SP-B, SP-A, phospholipids and Ca2+ (Suzuki, Fujita and Kogishi, 1989). Although the 
functional role of this lattice structure of surfactant membranes is not known, it might 
perform a host defense function related to SP-A role in lung immunology (Perez-Gil, 
2008). However, these SP-A/SP-B heterocomplexes could also accomplish a biophysical 
role at the respiratory alveolar surface. SP-B enhances the adsorption of phospholipids 
into the air-liquid interface. This activity is enhanced in the presence of SP-A (Schurch 
et al., 1992; Rodriguez-Capote et al., 2001). Besides this, SP-A is able to prevent the 
inhibition induced by albumin of the surface active film in the presence of SP-B and Ca2+, 
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maintaining minimal surface tensions under compression below 1 mN/m (Venkitaraman 
et al., 1990). These facts suggest that supramolecular protein complexes of SP-B and SP-
A could associate to the interfacial monolayer improving its stability during compression-
expansion mechanics. Whether both proteins could be indirectly interacting through 
lipids (Sarker et al, 2011), or whether native SP-A/SP-B complexes are stabilized by 
direct protein-protein interactions remains an open question, although this hypothesis 
might be supported by the fact that SP-A prompts the formation of protein-rich phases in 
DPPC:PG monolayers containing SP-B (Taneva and Keough, 2000), and also by data 
obtained by FRET studies among both proteins (Nag et al., 1996).  
Lastly, MSP nanodiscs technology was applied to attempt the generation of a 
solubilized membrane protein library (SMPL) from pulmonary surfactant, and to test the 
possibility that some of the native surfactant protein or protein/lipid heterocomplexes 
could be found assembled together into nanodiscs. Some studies can be found at the 
literature taking advantage of this system for obtaining such membrane proteomes 
(Civjan et al., 2003; Marty et al., 2013). Nevertheless, nanodiscs are generally used to 
confine isolated proteins or small complexes, constituting a useful platform for 
interactomics studies. The implementation of nanodiscs formed from surfactant 
membranes required a previous optimization of the solubilization method of PS. 
Eventually, the solubilization of PS membranes with the zwitterionic detergent CHAPS 
enhanced the incorporation of proteins inside nanodiscs, in comparison to solubilization 
with cholate. Three different populations of particles were established according to its 
size, from largest to smallest: 1) aggregates containing MSP, SP-A and SP-B, 2) those 
with SP-B and SP-C, and 3) the smallest nanodiscs containing SP-C. However, the 
relative amount of each population is inversely proportional to its size. MSP1D1 
generates nanodiscs with  ̴ 9.7 nm of diameter. Because of that, it is reasonable that 
confinement of a surfactant membrane patch containing a small protein of 3.7 KDa, SP-
C, could be favorable against confining larger proteins such as SP-B oligomers. 
Moreover, the lipid composition analysis showed that nanodiscs containing SP-B and SP-
C were formed essentially by PC, and also contain PI (or PS) and PG. Comparing the 
lipid composition of the original nanodisc suspension with the fraction of nanodiscs 
containing SP-B and SP-C, the latest one seemed to be enriched in anionic phospholipid. 
It is well-known that cationic proteins SP-B and SP-C establish preferential interactions 
with anionic phospholipids, such as PG and PI (Perez-Gil, Casals and Marsh, 1995). 
Results obtained in this line suggest that nanodisc technology can be an attractive tool to 
further investigate the properties of the protein complexes found. 
The direct generation of nanodiscs from native surfactant membranes sheds also some 
light on the establishment of protein-protein interactions in this system. Separation of 
different types of discs with different size and protein composition confirms the existence 
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of native protein complexes in surfactant. So, we can conclude that both the 
electrophoretic analysis of solubilized surfactant membranes or of membranes 
reconstituted from its individual components, as well as the analysis of the solubilized 
membrane protein libraries generated from surfactant, strongly suggest the existence of 
SP-A/SP-B and SP-B/SP-C interactions in surfactant membranes, resulting in the 
assembly of protein complexes whose physiological role could have essential 
implications for a proper function of pulmonary surfactant. 
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5. ROLE OF SURFACTANT PROTEIN COMPLEXES ON THE 
PERMEABILITY AND INTERFACIAL DYNAMICS OF PULMONARY 
SURFACTANT MEMBRANES 
5.1. INTRODUCTION 
The hydrophobic proteins SP-B and SP-C are determinant for the dynamics of the 
pulmonary surfactant system. The ability of these proteins to perturb membranes has been 
extensively studied. Interestingly, SP-B and SP-C are responsible for membrane 
permeability to ions and to hydrophilic and hydrophobic molecules (Parra et al., 2011, 
2013), supposedly through formation of pores into phospholipid membranes. On one 
hand, SP-B belongs to saposins, a family of membrane-associated proteins that include 
several cytolysins, which are able to induce membrane pore-forming structures (Olmeda, 
García-Álvarez and Pérez-Gil, 2013). The oligomeric structure of SP-B orientates parallel 
to the membrane surface, where would transfer lipids between membranes and interface 
(Olmeda et al., 2015). On the other hand, the existence of SP-B/SP-C interactions has 
been described in membranes, which could modulate the proper arrangement of lipid-
protein complexes in pulmonary surfactant (Cabre et al., 2018). Furthermore, in the 
previous chapter we have also found the presence of both proteins at high molecular 
weight native complexes in surfactant, which also support the hypothesis of the existence 
of SP-B/SP-C interactions. 
In the present chapter, the effects of proteins SP-B and SP-C on the permeability of 
pulmonary surfactant, as well as model membranes, have been analyzed by visualizing 
giant vesicles (GVs) made of different lipid/protein composition under fluorescence 
microscopy. The permeabilization effect of these proteins has been characterized by using 
polar fluorescent probes, such as calcein or fluorescently-labeled dextrans of different 
sizes, from 4 to 250 KDa. The latter have been used to determine the size range of 
molecules that are able to permeate through membranes containing SP-B and/or SP-C. 
Besides, this study is completed by characterizing the blockage of surfactant membrane 
permeability towards fluorescein isothiocyanate (FITC)-dextrans by incubation of the 
lipoprotein complexes with α-SP-B or α-SP-C antibodies.  
Finally, to connect the ability of SP-B to permeate membranes with the role of the 
protein in facilitating the formation and dynamics of pulmonary surfactant films during 
respiratory cycles, the behavior of SP-B-containing surfactant complexes has been 
studied by captive bubble surfactometry, in the absence or presence of α-SP-B antibodies. 
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5.2. RESULTS 
5.2.1. SURFACTANT MEMBRANE PERMEABILITY TOWARDS 
FLUORESCENT POLAR MOLECULES 
5.2.1.1. Membrane permeability to fluorescent polar probes and estimation of pore 
size  
Pulmonary surfactant membranes labelled with Rhodamine-DOPE (1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine) were reconstituted to form giant vesicles (GVs). 
Fluorescent microscopy experiments were performed in order to monitor the permeation 
of fluorescent polar molecules present in the solution through pulmonary surfactant GVs. 
The size of giant vesicles allowed us to visualize them directly by optical microscopy and 
evaluate the membrane morphology and the partition of a fluorescent probe in the sample 
simultaneously.  
Figure 5.1 illustrates how calcein, a 623 Da fluorescent polar probe, is able to 
penetrate through bilayers in GVs made of whole pulmonary surfactant, confirming that 
pulmonary surfactant membranes are permeable to polar molecules. In order to further 
characterize the permeability of these membranes, we evaluated the ability of 
fluorescently labeled dextrans of different sizes, FITC-dextrans from 4 KDa to 250 KDa, 
to permeate through surfactant GVs. The results revealed that only small dextrans (up to 
40 kDa) were able to permeate through surfactant vesicles, showing even higher 
fluorescence intensities inside the vesicles than at the external medium, whereas 
surfactant membranes turned out to be non-permeable to dextrans larger than 70 KDa 
(Figure 5.1). Membrane permeability for each dextran size was quantitatively determined 
as the percentage of permeated (filled) vesicles with respect to the total number of vesicles 
analyzed. Permeability ratios of surfactant GVs for each dextran size are included in the 
table 5.1.  
 
 
 
 
 
 
 
 
Figure 5.1. Permeability of pulmonary surfactant 
membranes. GVs made of pulmonary surfactant, labeled 
with Rhodamine-DOPE and incubated in the presence of 
calcein or FITC-dextrans with two different chain sizes 
(40 and 70 KDa). Red fluorescence signal of Rhodamine-
DOPE labeled membranes is shown in the first column, 
and green fluorescence shown in the second column 
belongs to the corresponding fluorescent polar probe, 
calcein or FITC-dextrans.  
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To get a deeper insight of the determinants of this feature of pulmonary surfactant 
membranes, permeability of vesicles containing different surfactant components was 
analyzed. Firstly, the whole hydrophobic fraction of surfactant obtained by organic 
extraction (OE) was used to form GVs, which contained the lipids and hydrophobic 
proteins SP-B and SP-C. These OE GVs were permeable to FITC-dextrans up to 40 KDa 
(Figure 5.2 and table 5.1), showing a similar permeability behavior to that of native 
surfactant membranes.  
 
 
 
 
 
Figure 5.2. Permeability of reconstituted membranes 
from the organic extract of surfactant. GVs made of 
the organic extract of surfactant, labeled with 
Rhodamine-DOPE (red fluorescence signal) were 
incubated in the presence of FITC-dextrans with two 
different chain sizes, 40 and 70 KDa (green signal). 
 
In contrast, when the protein-free lipid fraction of surfactant (LF), obtained by LH-20 
chromatography of organic extract, was used to form GVs, not even calcein (623 Da) was 
able to permeate through the membranes, as shown in Figure 5.3 A. However, GVs made 
of the lipid fraction supplemented with the hydrophobic protein fraction of surfactant (PF) 
at 1% (w/w) returned to be permeable to FITC-dextrans up to 40 KDa, mimicking the 
permeability size threshold of pulmonary surfactant vesicles (Figure 5.3 B and table 5.1). 
In alternative experiments, isolated proteins SP-B and SP-C (separated from each other 
by LH-60 chromatography) were mixed, maintaining their physiological proportion with 
the lipid fraction of surfactant, to form GVs that turned out to be permeable to dextrans 
of higher sizes than the maximal size able to cross native surfactant membranes, 
becoming non-permeable only to probes larger than 250 KDa (Figure 5.3 C and table 
5.1).  
Figure 5.3. Permeability of 
membranes containing surfactant 
hydrophobic proteins. GVs were 
formed by protein-free surfactant 
lipid fraction (A), the lipid fraction 
supplemented with 1% (w/w) of the 
hydrophobic surfactant protein 
fraction (B) or with a mixture of 
purified SP-B and SP-C (0.5% (w/w) 
of each protein) (C). Membranes are 
labeled with Rhodamine-DOPE (red 
fluorescent signal) and incubated in a 
solution containing calcein or FITC-
dextrans of two different chain sizes 
(40 and 70 KDa) (green signal). 
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Lastly, permeability of GVs made by the surfactant lipid fraction combined with 
isolated SP-B or SP-C was analyzed. Membranes containing 1% SP-B were found to be 
permeable to dextrans up to 70 KDa (Figure 5.4 A), whereas vesicles containing 1% SP-
C showed permeability, in a higher or lower proportion, to every dextran from 4 KDa to 
250 KDa (Figure 5.4 B). Regarding the morphology of these GVs, vesicles were 
substantially different depending on its composition. SP-B-supplemented LF GVs were 
mostly large oligolamellar vesicles, which tended to form vesicle aggregates. In contrast, 
SP-C GV suspension reflected a population of vesicles heterogeneous in size, with a 
relevant presence of vesicles smaller than 1 µm, which might be the result of vesicle 
fragmentation processes. 
 
Figure 5.4. Permeability of membranes supplemented with SP-B or SP-C. GVs made of surfactant 
lipid fraction containing 0.5% (w/w) SP-B (A) or 0.5% (w/w) SP-C (B) were labeled with Rhodamine-
DOPE (red) and incubated in the presence of FITC-dextrans (green) of two different chain sizes (4 
and 250 KDa). Scale bars correspond to 10 µm. 
 
For comparison of the several samples studied, table 5.1 summarizes the permeability 
ratios to the different FITC-dextrans of the different tested vesicles. Vesicles made of 
whole native pulmonary surfactant, its organic extract or the mixture of lipid and the 
hydrophobic protein fractions (LF + PF) showed a comparable permeability, up to 40 
KDa dextrans, yielding a cut off in hydrodynamic radius of the permeable dextrans of 
approximately 4.5 nm. On the other hand, GVs containing the lipid fraction with a mixture 
of purified SP-B and SP-C, or SP-B alone, yielded a higher threshold (about 6 nm), being 
permeable to dextrans up to 70 KDa.  It is worthy to notice that GVs supplemented with 
SP-C did not show a marked boundary of permeability, but a progressive decrease of 
permeability to dextrans from FD40 to FD250. All these results suggest the existence of 
SP-B/SP-C complexes, with consequences in the pores of surfactant membranes, 
accounting for the permeability of surfactant to polar molecules. 
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Table 5.1. Permeability of GVs made by different pulmonary surfactant components to 
fluorescent dextrans of different size. Tested GVs were made of PS, the native surfactant 
membranes, OE, the whole hydrophobic fraction of surfactant obtained by organic extraction, LF + 
PF, a mixture of surfactant lipid fraction and hydrophobic protein fraction 1% (w/w), LF + SP-B/SP-
C, lipid fraction with a mixture of purified SP-B and SP-C (0.5% (w/w) of each protein), LF + SP-B, 
lipid fraction with SP-B 0.5% (w/w) and LF + SP-C, lipid fraction with SP-C 0.5% (w/w). 
Hydrodynamic radius (Rh) for each FITC-dextran is also indicated. Data are shown as mean percentage 
of permeable vesicles (standard deviation). 
 
Regarding the lipid component of surfactant membranes, its influence on the 
generation of these SP-B/SP-C complexes and their effect on permeability was studied in 
two different model membrane systems. Pure POPC GVs or POPC:POPG (7:3) GVs 
containing different protein content were incubated with calcein or the set of FITC-
dextrans from 4 KDa to 250 KDa. Table 5.2 shows that the permeability to large polar 
molecules for pure POPC GVs varied depending on their protein composition, in this 
order: mixture of purified SP-B/SP-C ˂ PF ˂ SP-B. Meanwhile, POPC:POPG (7:3) GVs 
containing PF, SP-B/SP-C or SP-B shared the same cut off, being permeable to polar 
molecules up to 40 KDa. On the other hand, a clear threshold of permeability could not 
be determined for both SP-C-supplemented GVs, as described before for GVs made of 
the lipid fraction containing SP-C. Thus, in general, the presence of PG in the composition 
of GVs was necessary to allow permeability of membranes to dextrans of similar sizes to 
those permeabilizing through native surfactant.  
 
Table 5.2. Permeability of GVs of two different lipid compositions, POPC and POPC:POPG 
(7:3), in the presence of different surfactant proteins. Either GVs were supplemented with the 
hydrophobic protein fraction (PF) 1% (w/w), a mixture of purified SP-B and SP-C (0.5% (w/w) of 
each protein), SP-B 0.5% or SP-C 0.5% (w/w). Data are shown as mean percentage of permeable 
vesicles (standard deviation).  
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5.2.1.2. Blockage of membrane permeability by antibodies 
In order to further characterize the effect of these proteins on surfactant membranes, 
permeability of GVs containing different components of pulmonary surfactant towards 
FITC-dextrans was evaluated in the presence of antibodies against the hydrophobic 
surfactant proteins, SP-B and SP-C. The results are summarized in table 5.3. 
 
Table 5.3. Blockage of permeability of surfactant-based GVs to fluorescent dextrans by α-SP-B 
or α-SP-C antibodies. Different proteoliposomes were assessed:  GVs made of the lipid fraction 
containing SP-B 0.5% (w/w) (A), of the lipid fraction combined with a mixture of purified SP-B and 
SP-C (0.5% (w/w) of each protein) (B) or of the lipid fraction plus the hydrophobic protein fraction 
1% (w/w) (C), and GVs made by the whole organic extract from pulmonary surfactant (OE) (D). GVs 
pretreated or not with α-SP-B or α-SP-C antisera (1 µM IgG), were incubated with FITC-dextrans 
from 4 to 250 KDa. Data are shown as mean percentage of permeable vesicles (standard deviation).  
 
GVs made of surfactant lipid fraction supplemented with SP-B were pre-incubated 
together with -SP-B polyclonal antiserum (at a final IgG concentration of 1 µM) for 2 
hours, before testing their permeability to fluorescent dextrans. Under these conditions, 
SP-B-containing LF GVs showed a significant reduction in their permeability to polar 
molecules (Table 5.3). To discard non-specific effects of the antibody, the same GVs 
were also pretreated with -SP-C polyclonal antiserum (final IgG concentration 1 µM), 
which showed no blockage of permeability. On the other hand, GVs made of LF 
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combined with the hydrophobic protein fraction or a mixture of isolated SP-B and SP-C, 
as well as GVs made by the organic extract of surfactant, underwent a reduction of 
permeability towards polar molecules when pretreated with either α-SP-B or α-SP-C 
antisera (Table 5.3). As expected, in the case of GVs made of native pulmonary 
surfactant, pretreatment with different concentrations of α-SP-B or α-SP-C antisera led, 
in both cases, to a progressive blockage of permeability to polar molecules in a 
concentration-dependent manner, reaching the highest permeability impairment when 
pretreated with 5 µM antisera (Figure 5.5).  
 
Figure. 5.5. Blockage of permeability towards FITC-dextrans in pulmonary surfactant GVs (PS) 
by using increasing concentrations of α-SP-B or α-SP-C antisera. Surfactant GVs were pre-treated 
with α-SP-B or α-SP-C antisera at concentrations of 0.5, 1 and 5 µM IgG. After that, GVs were 
incubated in FITC-dextrans from 4 to 40 KDa. Permeability ratio (%) was plotted for FITC-dextrans 
of different sizes. 
 
To verify that the permeability of pulmonary surfactant vesicles was affected 
specifically by α-SP-B and α-SP-C immunoglobulins present in antisera, and not by any 
other antisera component, PS GVs were pretreated with 5 µM α-tubulin antiserum, 
showing no effect on permeability (table 5.4). These data confirmed that impairment of 
permeability in surfactant membranes was carried out by the specific interaction of the 
antibodies with SP-B and SP-C. 
The hydrophilic protein SP-A can be associated with surfactant membranes, 
accomplishing a role in the biophysics of pulmonary surfactant (Cockshutt, Weitz and 
Possmayer, 1990; Schurch et al., 1992; Sáenz et al., 2007; Lopez-Rodriguez et al., 2016). 
To examine whether SP-A would participate in the permeability of pulmonary surfactant 
membranes, native surfactant GVs were incubated with -SP-A antiserum, and 
permeability of vesicles towards FITC-dextrans was analyzed. Table 5.4 shows that this 
antibody did not affect the permeability of surfactant GVs to dextrans, suggesting that 
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SP-A is not involved in the modulation of permeability of surfactant membranes towards 
polar molecules. 
 
Table 5.4. Permeability blockage of surfactant membranes by α-SP-A or a non-related 
surfactant antiserum. Permeability ratios (%) to FITC-dextrans of native pulmonary surfactant GVs 
(PS) pre-incubated with α-tubulin or α-SP-A antisera at a final Ig concentration of 5 µM. Data are 
shown as mean percentage of permeable vesicles (standard deviation).  
 
 
5.2.2. FUNCTIONAL INHIBITION OF PULMONARY SURFACTANT BY α-SP-B 
ANTIBODY 
In order to study the biophysical activity of pulmonary surfactant (PS) in the presence 
of a polyclonal α-SP-B antibody at conditions comparable to those producing 
permeability blockage, we evaluated its tensioactive function by captive bubble 
surfactometry (CBS). Upon injection of control PS (without pretreatment with the 
antibody) at a concentration of 4.7 mg/mL of phospholipid, surface tension dropped to 
21.9 ± 0.8 mN/m after 5 minutes of initial adsorption and to 23.2 ± 0.6 mN/m after 
expanding the bubble for 5 minutes. Figure 5.6 shows how pulmonary surfactant was 
able to dramatically decrease the surface tension in a few seconds, revealing that, at this 
low concentration, surfactant was able to efficiently and quickly adsorb and spread along 
the interface, as previously described (Schurch, Green and Bachofen, 1998). Cycling 
isotherms of pulmonary surfactant films showed almost no compression/expansion 
hysteresis along quasi-static and dynamic cycles. Marked hysteresis was only present in 
the first quasi-static cycle, during which the energy provided by the compression is 
employed to promote a structural transition of the film at the interface resulting in a 
depuration of the less active material out of the interface, the so-called “squeeze-out” 
(Schurch et al., 1994). The subsequent cycles presented a progressive decrease in 
hysteresis as a result of the irreversible refinement of material at the interface. Pulmonary 
surfactant reached then minimal surface tensions ≤ 0.8 mN/m with ≤ 20% of area 
reduction during compression and a maximal surface tension lower than 32 mN/m during 
expansion. 
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Figure 5.6. Surface active function of pulmonary surfactant. Captive bubble surfactometry of 
pulmonary surfactant at a phospholipid concentration of 4.7 mg/ml. Top: Initial and post-expansion 
adsorption kinetics. Data are mean ± standard deviation obtained from 3 independent experiments. 
Bottom: representative examples of quasi-static and dynamic compression-expansion cycling 
isotherms (n=3). 
 
Blockage experiments of surfactant membrane permeability towards polar molecules 
were performed upon pre-incubation of PS GVs with a polyclonal α-SP-B antiserum. It 
has been previously described that some surface-active components of the serum, such as 
albumin, compete with pulmonary surfactant to reach the air-liquid interface, impeding 
the proper adsorption of surfactant and the formation of surfactant film (Lopez-Rodriguez 
et al., 2012). Thus, evaluation of the functional inhibition of pulmonary surfactant films 
by α-SP-B antiserum required to set up experimental conditions that avoided the 
interference of serum in CBS experimental conditions. Pulmonary surfactant (4.7 mg/ml 
phospholipid) was incubated for 3 hours at 37oC, together with serum at two different 
total protein concentrations, 5.1 and 3.8 mg/ml, as determined by Lowry assay. Then, the 
surface activity of these surfactant preparations was evaluated (Figure 5.7).  
Pretreatment of PS with both serum concentrations showed efficient initial and post-
expansion interfacial adsorption, reaching surface tensions at equilibrium near 20 mN/m. 
Cycling isotherms of surfactant films formed by PS pretreated with 5.1 mg/ml of serum 
showed an increased minimal surface tension, about 18 mN/m, with a marked hysteresis 
in every compression-expansion cycle. During the first dynamic cycle, minimal surface 
tension dropped to 1 mN/m, but surfactant film was no longer stable along the remaining 
cycles (Figure 5.7). On the other hand, cycling isotherms for PS pretreated with 3.8 
mg/ml of serum reached minimal surface tension ˂ 1 mN/m with only about 20% area 
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reduction during compression, with the exception of the presence of hysteresis in the first 
quasi-static cycle. Therefore, films formed by PS treated with serum 3.8 mg/ml 
maintained its interfacial activity.  
 
Figure 5.7. Interfacial behavior of surfactant in the presence of serum or α-SP-B antiserum. 
Captive bubble surfactometry of 4.7 mg/ml surfactant pre-incubated or not with serum or α-SP-B 
antiserum at different total protein concentrations. Top: Initial and post-expansion adsorption kinetics. 
Data are mean ± standard deviation obtained from 3 independent experiments. Bottom: representative 
examples of quasi-static and dynamic compression-expansion cycling isotherms for each sample, n=3. 
 
In the light of the previous results, PS was incubated for 3 hours with polyclonal α-
SP-B antiserum at 3.8 mg/ml of protein concentration (4.63 µM IgG) for the evaluation 
of its surface activity (Figure 5.7). α-SP-B-treated PS was able to reduce surface tension 
near 20 mN/m, showing interfacial adsorption kinetics similar to non-treated PS. 
Regarding the activity of surfactant film upon cycling, minimal surface tensions ˂ 1 
mN/m were reached and, though first and second quasi-static cycle exhibited hysteresis, 
it disappeared during the remaining cycles. To sum up, the chosen concentration of α-SP-
B antiserum, whose serum components do not interfere in the surface activity assay, 
seems to be not sufficient to inhibit the biophysical function of pulmonary surfactant 
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through specific SP-B/antibody interaction. Comparing these results with those that lead 
to blockage of surfactant permeability by α-SP-B antiserum, permeability of GVs resulted 
entirely blocked with even 0.5 µM of antibody, which correspond to 9.6 Ig/SP-B molar 
ratio, whereas 4.63 µM of α-SP-B did not inhibit the surface active function of surfactant, 
corresponding to a Ig/SP-B molar ratio of 0.86. It was obvious that higher concentrations 
of anti-SP-B antibody were required to achieve the inhibition of the interfacial function 
of the surfactant. 
Facing the possibility that blocking of surfactant function by -SP-B antiserum could 
be masked by inhibition mediated by serum itself at high concentration, a purified rabbit 
polyclonal α-SP-B Ig was chosen to evaluate its effect on the interfacial activity of 
pulmonary surfactant. In order to correlate α-SP-B blockage results obtained from the 
biophysical activity analysis of PS with those from the permeability study of surfactant 
membranes to polar molecules, it was imperative to test the pulmonary surfactant GVs 
permeability towards FITC-dextrans in the presence of different concentrations of the 
purified polyclonal α-SP-B Ig. Table 5.5 compares the effect of α-SP-B antiserum and α-
SP-B Ig on the permeability of pulmonary surfactant GVs towards a set of FITC-labeled 
dextrans. PS treated with any of the antibodies underwent a substantial decrease in 
permeability upon increasing antibody concentration. Both antiserum and purified Ig, 
applied in the concentration range 1-5 µM Ig, showed a similar blockage effect on 
permeability of surfactant GVs to 4 and 40 KDa FITC-dextrans. 
 
Table 5.5. Permeability blockage of surfactant membranes by α-SP-B antibodies from different 
sources. Comparative chart of blockage effect on pulmonary surfactant GVs (PS) permeability (in %) 
towards 4 and 40 KDa FITC-dextrans by α-SP-B antiserum and purified α-SP-B Ig. Data are shown 
as mean percentage of permeable vesicles (standard deviation). 
 
To study the interfacial activity of pulmonary surfactant (PS) in the presence of the 
purified polyclonal α-SP-B Ig, surfactant (at 4.7 mg/ml phospholipid) was incubated for 
3 hours at 37oC with different concentrations of the purified α-SP-B Ig (0.5, 5 and 10 µM 
Ig). Besides, some experimental controls were assessed in parallel: non-treated PS and 
PS incubated together with 10 µM of a rabbit IgG. Then, surface activity of the samples 
was evaluated by captive bubble surfactometry. PS pretreated with 0.5 µM of -SP-B Ig 
reduced surface tension to 20.9 ± 1.2 mN/m after 5 minutes of injection, and to 20.8 ± 0.2 
mN/m after expanding the bubble for 5 minutes (Figure 5.8 and table 5.6). However, for 
this sample a clearly slower interfacial adsorption kinetics was observed in comparison 
to PS, in both initial and post-expansion adsorption. Specifically, it required 180 seconds 
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to reach surface tensions close to the equilibrium, while native surfactant typically reaches 
the same tension values in less than 20 seconds. Upon cycling, PS treated with 0.5 µM α-
SP-B Ig reached very low minimal surface tensions close to 0 mN/m, except for the first 
quasi-static cycle, 4.4 mN/m. It is noticeable that, unlike untreated PS, that only exhibited 
hysteresis in the first quasi-static cycle, all quasi-static cycles of PS treated with 0.5 µM 
α-SP-B Ig showed hysteresis, although it was progressively reduced (Figure 5.8 and 
table 5.7). 
 
Figure 5.8. Interfacial behavior of surfactant in the presence of α-SP-B Ig. Interfacial adsorption 
of pulmonary surfactant (4.7mg/ml) pre-incubated with 0.5, 5 or 10 µM of α-SP-B Ig, or 10 µM of a 
control IgG. Top: Initial and post-expansion adsorption kinetics of the different tested surfactant 
samples. Data are mean ± standard deviation obtained from 3 independent experiments. Bottom: 
representative examples of quasi-static and dynamic compression-expansion cycling isotherms for 
each sample, n=3. 
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Table 5.6. Effect of α-SP-B Ig on initial (IA) and post-expansion (PEA) interfacial adsorption of 
surfactant. Pulmonary surfactant at 4.7mg/ml (PS) was pre-incubated with 0.5, 5 or 10 µM of α-SP-
B Ig, or 10 µM of a control IgG. Data are shown as mean ± standard deviation, n=3.  
 
 
Table 5.7. Effect of α-SP-B Ig on the behavior of PS films subjected to quasi-static and dynamic 
compression-expansion cycling. For each sample, the following parameters of the last quasi-static 
(Q-stat 4) and dynamic (Dyn 20) cycles are shown: minimal surface tension (min), maximal surface 
tension (max) and relative area reduction needed for the film to reach minimal tension (R.A. min).  
Pulmonary surfactant at 4.7 mg/ml (PS) was preincubated with 0.5, 5 or 10 µM of α-SP-B Ig, and 10 
µM of a control IgG. Data are shown as mean ± standard deviation, n=3. 
 
In contrast, pretreatment of PS with higher α-SP-B Ig concentrations, 5 or 10 µM, 
showed a clear impairment of surfactant activity (Figure 5.8). 5 µM α-SP-B Ig pre-treated 
PS reached equilibrium surface tensions of 42.2 ± 1.6 mN/m and 60.8 ± 0.4 mN/m after 
initial and post-expansion adsorption, respectively (Table 5.6). In this same way, for 10 
µM α-SP-B pre-treated PS, values of surface tension at equilibrium were 42.5 ± 1.2 mN/m 
for initial and 60.1 ± 2.8 mN/m for post-expansion adsorption. Thus, in the presence of 
α-SP-B concentration of 5 µM or higher, PS was not able to efficiently form a surface 
active film at the air-liquid interface, which would decrease surface tension to values near 
20 mN/m. Moreover, upon bubble expansion, surface tension only decreased to about 60 
mN/m which depicts that some material of the pre-existing monolayer film could spread 
along the enlarged interface, but the remaining material in the aqueous subphase was not 
able to adsorb and replenish the interface. In the same line, cycling of PS treated with 5 
or 10 µM α-SP-B Ig were highly defective (Figure 5.8). Minimal surface tensions only 
decreased to about 20 mN/m after 60% area reduction (table 5.7), revealing that 
surfactant was fully inhibited in the presence of concentrations of -SP-B Ig above 5 M. 
On the other hand, to discard non-specific effects of the purified polyclonal antibody 
on the biophysical function of pulmonary surfactant, the surface activity of PS treated 
with 10 µM of a rabbit IgG (named as control IgG), was assessed. Control IgG-treated 
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PS reduced surface tension to 22.1 ± 0.6 mN/m after 5 min of initial adsorption and to 
23.8 ± 0.4 after 5 min of bubble expansion (Figure 5.8 and table 5.6). Upon cycling, PS 
treated with 10 µM control IgG reached minimal surface tensions close to 0 mN/m, with 
only about 20% area reduction during compression, with the exception of the presence of 
hysteresis in the first quasi-static cycle (Figure 5.8 and table 5.7). Therefore, 10 µM 
control IgG did not affect surface activity of PS film. 
 
5.3. DISCUSSION 
Previous studies showed that SP-B and SP-C provide pulmonary surfactant with 
permeability to both membrane and polar probes, as well as ions (Parra et al., 2011, 2013). 
This chapter addresses a deeper study of the features of surfactant membrane permeability 
to polar molecules. Additionally, this work present evidences of the dual role of SP-B on 
membrane permeability and biophysical function of surfactant, which seems to be 
intrinsically related to the oligomeric protein structure, suggesting that both surfactant 
functions could be connected, with SP-B acting as the main link. 
Studies with FITC-dextrans confirm that the synergic action of SP-B and SP-C 
modulates the permeability of surfactant membranes towards polar molecules. When both 
proteins are separated, SP-B promotes aggregation of giant vesicles and their 
transformation into larger vesicles, in agreement with its ability to promote association 
and fusion between membranes, (Chang, Nir and Poulain, 1998; Cruz et al., 2000; Ryan 
et al., 2005). Our results have shown that SP-B is able to make GVs permeable to polar 
molecules with a defined size threshold. This could suggest that SP-B induces pore 
formation in membranes. On the other hand, FITC-dextrans of all sizes were able to 
permeate SP-C-containing vesicles. Moreover, the presence of SP-C was found to 
destabilize bilayers, promoting fragmentation of vesicles. A previous study proposed that 
membrane fragmentation induced by SP-C was triggered by SP-C clustering in defined 
regions of the vesicle (Roldan et al., 2016)  However, in the presence of the physiological 
mixture of both proteins SP-B and SP-C (PF), the morphology of the vesicles is 
maintained apparently intact. Therefore, SP-B and SP-C seem to modulate each other, 
providing surfactant membranes with specific properties which are clearly distinct from 
the activities of each individual protein by itself. The study by (Roldan et al., 2016) has 
already described this dual behavior of SP-B and SP-C in PS derived membranes. SP-C 
showed the ability to transform larger vesicles into smaller ones, independently of lipid 
composition, whereas SP-B promoted the fusion of small vesicles, generating larger 
vesicles. These fission/fusion activities in membranes were canceled out when both 
proteins were present, conferring stability to the membrane. 
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The present work describes the existence of pores in pulmonary surfactant membranes 
with a hydrodynamic pore radius (rp) of approximately 4.5 nm. The generation of these 
pores is induced by SP-B, presumably by assembly of dimers in a supraoligomeric ring-
shaped structure of this protein (Olmeda et al., 2015), which has been observed in 
monolayers and bilayers, as shown in Chapter 3 of the present Thesis. Blockage of 
membrane permeability by α-SP-B and α-SP-C antibodies revealed that permeability of 
pore complexes in PS membranes is not only dependent of SP-B, but also SP-C is 
involved. Blockage generated by α-SP-C antibody could imply that SP-C is directly 
taking part of pore complexes, or, at least, is modulating the pore size. In this regard, it is 
interesting to highlight that SP-B alone in surfactant lipid membranes forms pores with a 
rp about 6 nm, which are larger than pores described in PS membranes and lipid surfactant 
membranes supplemented with the hydrophobic surfactant fraction (4.5 nm). SP-C seems 
therefore to participate in the architecture of the SP-B pore in surfactant membranes by 
imposing a restraint in pore size. Hence, the present results strongly suggest that protein 
complexes formed by SP-B and SP-C would modulate the permeability of pulmonary 
surfactant. We had also previously observed the presence of high molecular weight 
complexes in native surfactant containing both proteins (chapter 1). A recent study has 
demonstrated the existence of SP-B/SP-C interactions by time-resolved Förster resonance 
energy transfer techniques (Cabre et al., 2018), although the detailed structure of the 
resulting heterocomplex remains unclear. The progressive blockage of permeability to 
larger FITC-dextrans, as α-SP-B or α-SP-C concentrations increase, suggest that SP-
B/SP-C complexes are composed of a defined number of molecules of each protein. 
However, the stoichiometry of this complex cannot be deduced from the present work 
due to the polyclonal nature of the antibodies used in this study.  
Another interesting conclusion of our results is the fact that a mixture of previously 
isolated SP-B and SP-C (re-mixed at the physiological SP-B/SP-C proportion, 1:1, by 
weight) induces a membrane permeability behavior which differs from that in the 
presence of the hydrophobic protein fraction (PF) (both in simple lipid models or in whole 
native surfactant lipids). This result is in agreement with those previously found by Parra 
and coworkers. In that work, the authors described how calcein freely diffuse through 
POPC GVs supplemented by the mixture of isolated SP-B and SP-C, showing a 
homogeneous distribution inside and outside of the vesicles, while this probe was 
gathered mostly inside PF-containing vesicles (Parra et al., 2011). This apparent 
functional impairment of samples containing the mixture of the purified proteins has been 
also shown during the comparative analysis of interfacial function of systems prepared 
by reconstituting defined fractions of native surfactant (Schurch et al., 2010). These 
evidences would suggest that original SP-B/SP-C complexes are poorly re-established 
once the proteins are mixed after isolation, maybe because the proper conformation of the 
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proteins is altered or due to the loss of some unknown component during the purification 
process. So, these data warn about the risk of inferring conclusions from structural and 
functional studies of hydrophobic surfactant proteins performed with model systems 
containing separated SP-B and SP-C. 
It is clear that pulmonary surfactant membranes are intrinsically permeable to water-
soluble molecules, and that SP-B/SP-C complexes are essential for this feature. 
Additionally, the anionic phospholipid POPG would be involved in the modulation of the 
membrane pore structure induced by SP-B/SP-C complexes. Permeability studies in 
POPC GVs supplemented with different surfactant protein components showed that these 
vesicles lose the ability to permeate to FITC-dextrans larger than 4 KDa for POPC+ PF, 
or 20 KDa for POPC+ SP-B, which means a significant reduction of pore size in these 
bilayers. In POPC:POPG (7:3) GVs, all surfactant protein mixtures led to membranes that 
were permeable up to FD40. These results suggest that PG participates in the pore 
structure induced by SP-B/SP-C complexes, probably due to electrostatic interactions 
between the anionic phospholipid and the hydrophobic cationic surfactant proteins 
(Perez-Gil, Casals and Marsh, 1995; Takamoto, Lipp, et al., 2001; Cabré et al., 2012). 
Particularly, it is noteworthy that POPC:POPG (7:3) GVs supplemented with SP-B alone 
or a mixture of isolated SP-B and SP-C showed pores with estimated rp of 4.5 nm, whereas 
LF GVs with similar protein content showed larger pores (rp≈ 6 nm). Anionic 
phospholipids, PG and PI, represents only 8-15% by mass of the pulmonary surfactant 
lipids (Parra and Perez-Gil 2015), in contrast to 30% of PG in the POPC:POPG GVs used 
for this study. This excess of POPG seems to confer to the membranes the ability to 
bypass the absence of native SP-B/SP-C complexes, diminishing the SP-B pore diameter, 
and restoring that of native surfactant. Therefore, anionic phospholipids would 
accomplish an essential role to finely tune the structural organization of SP-B and SP-C 
in pulmonary surfactant membranes. 
To understand the molecular mechanisms by which SP-B modulates the dynamical 
behavior of surfactant films, we evaluated the effect of specific SP-B inhibition in these 
membranes. The application of α-SP-B antibody seemed to affect primarily to the 
interfacial adsorption ability of surfactant. The highest antibody concentrations (5 µM 
and 10 µM α-SP-B Ig) prevented the formation of an efficient surfactant film along the 
air-liquid interface. This deleterious effect became more apparent when evaluating 
interfacial adsorption upon surface expansion, where surfactant films pre-treated with 
high α-SP-B Ig concentrations were not able to substantially decrease surface tension, 
which means that almost no new surfactant material was adsorbed and spread along the 
newly exposed interface. Moreover, the impairment of formation of a stable surface active 
film persisted during compression-expansion cycles. Lower α-SP-B Ig concentrations 
allowed us to analyze subtle changes in the dynamics of the surfactant films in the 
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presence of this inhibitory agent. Pre-treatment of pulmonary surfactant with 0.5 µM α-
SP-B Ig showed slower interfacial adsorption kinetics, although surfactant was finally 
able to reduce surface tension at similar levels than native surfactant films did in both 
initial and post-expansion adsorption experiments. However, in the presence of 0.5 µM 
α-SP-B Ig, surfactant films still became unstable upon cycling, showing difficulties to 
efficiently reach low surface tensions. Taken together, these results confirm that SP-B is 
essential to promote interfacial adsorption of lipids and film stability, sustaining very low 
surface tensions in compressed films, and that pre-treatment with a specific antibody is 
able to block such tensioactive function  
Previous in vivo studies demonstrated that intratracheal administration of monoclonal 
α-SP-B antibodies triggered respiratory distress syndrome, characterized by collapsed 
alveoli alternating with hyperaerated areas and intraalveolar edema with a moderate 
inflammatory response (Eijking et al., 1991; Robertson et al., 1991). Besides, Eijking and 
coworkers contributed with in vitro measurements of surface activity by pulsating bubble 
surfactometry (Eijking et al., 1991), in which 3.1 nM of a monoclonal rat -SP-B 
antibody inhibited the function of 5 mg/ml bovine surfactant, showing high minimal 
surface tension upon compression. Although similar inhibitory levels of pulmonary 
surfactant have been reported in the present results, the surfactant inactivation was yielded 
with molar ratio antibody to antigen of 0.093, whereas the previous work used a much 
lower molar ratio, 0.00046, to achieve the same goal. This discrepancy might be primarily 
a consequence of different affinities of antibody-antigen interaction, but also due to the 
presence of serum 10% (v/v) in the monoclonal rat antibody stock used in the study of 
Eijking, which could partly interfere in surfactant function, as demonstrated in the present 
chapter. 
A three-dimensional structural model of SP-B based on Saposin B structure considered 
the co-existence of two conformations of SP-B rings, open and closed (Olmeda et al., 
2015), which could be important for allowing a proper ability of the protein to promote 
lipid transfer among surfactant membranes. According to the model, 5 or 6 dimers are 
associated to form a ring-shaped structure of 10 nm of diameter, which is anchored to the 
membrane surface. The modeled hexamer of dimers in its closed conformation locates 
parallel to the membrane surface in a conical shape where the inner pore diameter ranges 
from 4.75 nm, close to the membrane, to 1.75 nm, projected towards the aqueous 
environment. Although permeability of whole surfactant membranes to fluorescent 
dextrans appears to differ from these pore sizes of SP-B, describing an inner pore diameter 
> 4.5 nm and ˂ 6 nm, we should also consider the possible effects of the ellipsoidal shape 
of dextran molecules. The opening of dimers would induce pivoting of the whole 
structure, promoting the exposure of the hydrophobic cavity of the SP-B ring to the acyl 
chains of the membrane. This structural transition of SP-B ring towards an open 
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conformation might be promoted through exposure of SP-B to the interface or the 
establishment of SP-B/SP-B interactions between membranes, which ultimately would 
catalyze the rapid flow of lipid to the interface or between surfactant membranes (Olmeda 
et al., 2015; Hobi et al., 2016). The present work has demonstrated that selective blockage 
of SP-B by antibodies prevents achieving low surface tension and stability of compressed 
films. Therefore, α-SP-B antibody interaction with SP-B ring would hinder the proper 
conformational change of the protein, blocking not only the interfacial adsorption of 
surface active lipid species to the interface but also disturbing film stability during 
breathing cycles, impeding the formation of a network of interconnected surfactant 
membranes through SP-B/SP-B interactions upon compression of the interface.  
SP-B is the main responsible of promoting surface activity and stability. However, it 
has been suggested that a cooperative action of SP-B and SP-C could enhance lipid 
insertion into the interface (Oosterlaken-Dijksterhuis et al., 1991b, 1991a; Wang, Hall 
and Notter, 1996; Schurch et al., 2010). In the present chapter, it has been described that 
permeability of pulmonary surfactant membranes to polar molecules is blocked at similar 
levels by either α-SP-B or α-SP-C antibodies, presumably by interaction with protein 
complexes formed by SP-B and SP-C. These results are consistent with a recent research 
that reported that not only α-SP-B antibodies but also α-SP-C antibodies are able to 
abolish the adsorption of secreted lamellar bodies into the air-liquid interface (Hobi et al., 
2016).  
Although interfacial activities of SP-B and SP-C partly overlap and both proteins seem 
to promote the rapid adsorption of phospholipids to the air-liquid interface and ensure the 
film stability during compression/expansion cycles, different mechanisms have been 
proposed for each protein. SP-B would be crucial for film stability during compression 
and re-extension (Schurch et al., 2010), promoting the formation of multilayered 
membrane reservoirs through connecting neighboring membranes by the apposition of 
SP-B rings (as it is addressed in Chapter 4 and by (Bernardino de la Serna et al., 2013)). 
On the other hand, SP-C is not essential to achieve low minimum tension during 
compression (Schurch et al., 2010), although it allows the attachment of membrane 
patches to compressed films (von Nahmen et al., 1997; Kramer et al., 2000), which would 
facilitate the reinsertion of the prepackaged lipid units associated with SP-B. The 
existence of different mechanisms of action suggests that SP-B and SP-C could play 
complementary roles that could be modulated by the formation of heterocomplexes in the 
surface active film and its associated membranes. We have found that SP-B and SP-C 
even show opposite membrane-activities, fusion and fission respectively, but our results 
also point to the existence of SP-B/SP-C interactions, and show that establishment of such 
interactions stabilizes surfactant membranes by counteracting its activities. Here, we 
propose that SP-B/SP-C complexes could be initially present in surfactant membranes 
Surfactant protein complexes: Permeability and interfacial dynamics 
147 
 
(Figure 5.9). Then, probably as a result of its exposition to air, a conformational change 
would be triggered and SP-B/SP-C interactions might be dissociated. Disassembly of this 
heterocomplex, which has been previously also proposed (Cabre et al., 2018), would 
allow each protein to perform its specific activities in the surroundings of the interfacial 
film. Future studies could clarify the mechanisms underlying the conformational change 
triggered into SP-B/SP-C structures. 
 
Figure 5.9. Hypothetical model of combined SP-B and SP-C activities on the biophysical function 
of pulmonary surfactant and membrane permeability. SP-B and SP-C could be forming protein 
complexes in newly secreted surfactant membranes. The synergetic actions of SP-B and SP-C confer 
simultaneous permeability to ions, oxygen and polar molecules on surfactant. Upon touching the air-
liquid interface, phospholipids are instantaneously adsorbed into the interface due to the cooperative 
action of SP-B and SP-C. Then, conformational changes would lead to disassembly of SP-B and SP-
C, allowing that each protein display its specific activities. SP-B/SP-B interactions could promote 
membrane connections, generating a dynamic network of membranes interconnected among them and 
to the interfacial monolayer. The close apposition of SP-B oligomers would constitute the machinery 
for lipid transfer between connected membranes and between membranes and the monolayer. On the 
other hand, SP-C could diffuse to regions particularly enriched in less surface-active lipids, such as 
cholesterol or unsaturated phospholipids, where it could promote membrane fragmentation and 
conversion into small vesicles targeted for recycling (Roldan et al., 2016). 
 
Finally, results from the present chapter point out that the oligomeric ring-shaped SP-
B structure could be simultaneously responsible for both lipid transfer and membrane 
permeability through the protein pore. Self-interactions of SP-B oligomers would 
promote the formation of an interconnected membrane network ensuring a rapid and 
efficient transfer of lipids between membranes, all the way up to the interface. In this line, 
angle X-ray diffraction experiments have suggested that SP-B accelerates lipid adsorption 
by inducing the formation of a rate-limiting negatively curved structure (Chavarha et al., 
2012, 2015), in a process favored by the presence of PG (Chavarha et al., 2013). On the 
other hand, SP-B has been suggested to induce permeability through the formation of 
toroidal pores (Parra et al., 2013).  All these findings are consistent with the creation of a 
SP-B-induced toroidal pore with two types of curvature: negative (concave) curvature in 
the plane of the bilayer and positive curvature perpendicular to the membrane surface, in 
line with the structure of the pore induced by the peptide amylin, characterized by NMR 
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(Smith, Brender and Ramamoorthy, 2009) (Figure 5.10 B). Due to the superficial 
location of the SP-B ring in the bilayer, the protein would induce the formation of toroidal 
pores that would favor the orientation of lipids to be transferred through the hydrophobic 
pore constituted by two connected SP-B rings (Figure 5.10 A). Through the SP-B pore, 
the acyl chain of a phospholipid would be shielded in the hydrophobic cavity formed by 
each SP-B dimer, allowing its polar head group to be oriented towards the center of the 
pore, in contact with the aqueous environment (Olmeda et al., 2015). In this way, SP-B 
would drive the lipid transfer between interconnected membranes and bilayers-interface. 
On the other hand, the presence of these SP-B-induced toroidal pores in bilayers would 
also serve as a passage for polar molecules to cross between surfactant membranes, 
through the hydrophilic tunnel generated by lipid polar heads.  
 
Figure 5.10. Model for lipid transfer induced by SP-B between bilayers and from bilayer to 
monolayer. A) SP-B induces the formation of toroidal pores, in which the headgroups of 
phospholipids line their surface. These structures together with the apposition of two SP-B rings would 
ensure a lipid flow between interconnected bilayers and bilayer-interface. B) Schematic representation 
of the structure of a toroidal pore in a bilayer, constituted by areas with positive curvature, 
perpendicular to the plane of the bilayer (green lines) and negatively-curved regions, in the plane of 
the bilayer (red lines). Adapted from (Smith, Brender and Ramamoorthy, 2009). 
 
Regarding the physiological meaning of the polar permeability of surfactant 
membranes, the presence of SP-B pores in the continuous membrane network would 
make it accessible to small hydrophilic molecules (those able to pass through a pore with 
a rp ˂ 70 KDa), as small peptides involved in innate lung defense, such as defensins or 
cathelicidins. Furthermore, this permeable membrane system would be relevant for 
sustaining a proper equilibrium of ions in the alveolar subphase (Parra et al., 2013) and 
ensuring a rapid diffusion of oxygen from air space through the membrane network 
(Olmeda et al., 2010). Lastly, the highly permeable character of surfactant membranes 
could be considered as an advantageous feature which could have an impact in the 
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administration of hydrophilic drugs directly through the airways. Small hydrophilic active 
molecules could take advantage of the protein pores to pass through surfactant 
membranes in the respiratory surface and reach their targets, such as the respiratory 
epithelium or the bloodstream. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
Chapter 3   
 
STRUCTURAL CHARACTERIZATION 
OF SP-B OLIGOMERS 
 
Results from the structural study of SP-B oligomers by atomic force microscopy were 
partially included in the article: 
Olmeda, B., García-Álvarez B., Gómez MJ., Martínez-Calle M, Cruz A, Pérez-Gil J. 
(2015). “A model for the structure and mechanism of action of pulmonary surfactant 
protein B”. FASEB Journal, 29(10):4236-47. 
 
 
  
 
 
 
 
  
Fluorescence spectroscopy study of SP-B oligomers 
153 
 
6. STRUCTURAL CHARACTERIZATION OF SP-B OLIGOMERS 
6.1. INTRODUCTION 
SP-B is an essential protein for the function of pulmonary surfactant, so that its genetic 
deficiency leads to lethal respiratory failure at birth (Nogee et al., 1993; Melton et al., 
2003). SP-B belongs to the family of saposin-like proteins (SAPLIPs). These proteins are 
a diverse family of lipid-interacting proteins, defined by a mainly helical secondary 
structure and the presence of 3 intramolecular disulfide bonds that provide stability to the 
protein structure (Munford, Sheppard and O’Hara, 1995). Despite these common features 
shared by SP-B, this protein differs from the rest of them in two main features: the 
existence of an additional cysteine responsible for the formation of a covalent dimer and 
the permanent association to lipids, due to its high hydrophobicity. Recently, a 3D model 
of the SP-B structure was built based on the structure of a member of SAPLIPs, Saposin 
B, considering the sequence homology between these two proteins and the dimeric state 
of Saposin B (Olmeda et al., 2015). The model generated for the 3D structure of SP-B 
predicts an oligomeric organization formed by the association of five or six covalent SP-
B dimers. Consistently, native SP-B complexes were purified from CHAPS-solubilized 
pulmonary surfactant membranes and visualized by negative-staining transmission 
electron microscopy, revealing the presence of ring-shaped particles of 10 nm of 
diameter. The 3D volume obtained from the averaged particles was successfully fitted to 
the structural model of SP-B, confirming the existence of native SP-B oligomers 
composed by 5 or 6 covalent dimers. Until now, transmission electron microscopy 
analysis was performed at low resolution, which prevents establishing a fully 
characterized structure of the SP-B oligomer. 
In this chapter, we attempted to get deeper insight into the structural characterization 
of SP-B oligomers. To get this aim, two specific objectives were covered. Firstly, we 
studied the oligomeric organization of SP-B in interfacial monolayers and membranes 
with different lipid composition by atomic force microscopy (AFM) and negative-
staining transmission electron microscopy (TEM). Moreover, two different SP-B protein 
sources were characterized: SP-B complexes purified from CHAPS-solubilized 
pulmonary surfactant and SP-B isolated from minced lungs using organic solvents. 
 Secondly, several strategies were applied to obtain native SP-B oligomers with a high 
sample quality, which would allow the determination of high-resolution SP-B structure 
by, for instance, electron microscopy or X-ray crystallography. The original protocol 
established for the purification of native SP-B complexes from detergent-solubilized 
surfactant gave rise to a heterogeneous suspension with SP-B/detergent complexes of 
diverse molecular sizes. Here, we attempted to enhance the quality of the sample by the 
incorporation of additional steps of purification to SP-B oligomers, such as size exclusion 
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chromatography and GraFix (Gradient Fixation) method. GraFix is a purification process 
consisting of a density gradient ultracentrifugation in the presence of a gradient of a 
crosslinking agent, which stabilizes the structure of macromolecules. This method was 
specifically developed to improve the sample quality for structural determination by 
negative-staining EM and cryo-EM (Kastner et al., 2008).  
Finally, and as an alternative to the use of detergents, we attempted different strategies 
to isolate and stabilize the SP-B oligomers using amphipols (amphipatic polymers) and 
POPC or POPC:POPG nanodiscs assembled by MSP1D1, as scaffold protein, or SMA 
copolymers. 
 
6.2. RESULTS 
6.2.1. STRUCTURAL STUDY OF SP-B OLIGOMERS BY ATOMIC FORCE AND 
TRANSMISSION ELECTRON MICROSCOPY 
The structure and distribution of SP-B complexes were studied as assembled in 
POPC:POPG bilayers and POPC:DPPG monolayers. Besides, a structural analysis of SP-
B complexes purified in detergent and organized at an air-liquid interface was performed 
in the absence of lipids. 
6.2.1.1 Structure of SP-B in POPC:POPG bilayers 
Suspensions of small unilamellar vesicles (SUVs) containing lipid-protein complexes 
were directly applied onto mica supports to visualize them by atomic force microscopy 
(AFM). The samples consisted of 50 µg/ml POPC:POPG (7:3, w:w) supplemented with 
SP-B isolated in organic solvent or SP-B complexes purified from CHAPS-solubilized 
pulmonary surfactant, at a protein to lipid ratio of 10% by weight. 
Images taken from POPC:POPG bilayers containing SP-B isolated in organic solvent 
show the presence of circular particles with a central pore (Figure 6.1 A). Diameters of 
over 60 particles were measured, resulting on an average diameter of 15.4 (± 2.7) nm. 
Similar particles in shape and size were visualized in bilayers containing SP-B purified 
in detergent, with an average diameter of 14.8 (± 2.6) nm (Figure 6.1 B). These ring-
shaped particles resemble in size and shape the native SP-B rings purified in detergent 
and visualized previously in the absence of lipid by TEM (Olmeda et al., 2015). As 
controls, two different protein-free suspensions of POPC:POPG SUVs were prepared by 
(1) resuspension of a dried lipid film in Tris buffer, as a control for proteoliposomes with 
SP-B isolated in organic solvent, or (2) resuspension of the lipid film in buffer 
supplemented with similar amount of CHAPS to that present in proteoliposomes 
containing SP-B purified in detergent. Note that the detergent in both samples, the control 
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and the one containing SP-B purified in CHAPS, was previously removed from vesicle 
suspensions by adsorption to nonpolar polystyrene adsorbent beads, so that only detergent 
traces are expected in the preparations. AFM images from POPC:POPG bilayers 
reconstituted in buffer alone show that lipids were adsorbed forming a flat bilayer surface 
over the mica (Figure 6.1 C). In contrast, bilayers of POPC:POPG reconstituted in buffer 
with detergent show a humped distribution, suggesting that the reconstitution method in 
the presence of detergent could have interfered in the adsorption dynamics of the resulting 
vesicles to the mica support, maybe due to detergent traces (Figure 6.1 D). In contrast, 
bilayers containing SP-B purified in detergent seem to have a lower average height profile 
than control vesicles reconstituted in the presence of detergent, suggesting that SP-B 
could favor the adsorption of proteoliposomes onto the mica (Figure 6.1 B). 
 
Figure 6.1. Topographical comparison of lipid bilayers containing SP-B isolated in organic 
solvent (SP-Bo.s.) or SP-B complexes purified in detergent (SP-Bdet). AFM images of POPC:POPG 
(7:3, by weight) SUVs supplemented with 10% (protein/lipid, w/w) of SP-Bo.s (A) or SP-Bdet (B). 
Lower panels depict illustrative AFM images of control lipid samples in the absence of protein, which 
were reconstituted in aqueous buffer alone (C) or supplemented with CHAPS at similar concentration 
than vesicles with SP-Bdet (D). Scale bars, 50 nm. 
 
POPC:POPG vesicles supplemented with SP-B purified in detergent were also 
visualized under TEM. Images show large membrane layers with an apparent roughness 
(Figure 6.2). The surface of these bilayers seemed to be formed by heterogeneous 
particles in size and shape that appeared to be closely associated between them, and even 
form larger fiber-like structures (some examples are labeled with black lines in magnified 
views of images in Figure 6.2). Regarding the size of the particles, it was mainly 
distributed between 7 and 10 nm of diameter, although smaller particles were also 
observed at the surface of the vesicles. It is also worth to notice the presence of areas of 
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interaction between bilayers (see for instance in Figure 6.2 A two independent bilayers 
partly connected through contact sites). A detailed look shows defined structures at these 
membrane contact sites (labeled with a black arrow in the magnified view), which could 
correspond to SP-B as a result of its membrane fusion activity, a widely reported function 
(Poulain, Nir and Hawgood, 1996; Chang, Nir and Poulain, 1998; Ryan et al., 2005). 
Figure 6.2 B could illustrate a final stage of the fusion of two vesicles, when a rift 
between the fused vesicles was still apparent (pointed with white arrowheads). 
 
Figure 6.2. TEM images of SP-B complexes purified in detergent (SP-Bdet) reconstituted into 
POPC:POPG (7:3, w:w) SUVs, at 10% protein/lipid, by weight. Black lines indicate some 
examples of particle association in fiber-like structures over the surface of proteoliposomes (magnified 
views of images A and B). In the upper magnified view of image A, the black arrow points to the 
contact site between two proteoliposomes, whereas white arrowheads in image B indicate the diffuse 
boundary between two vesicles that likely underwent a recent fusion process. 
 
6.2.1.2 Structure of SP-B in POPC:DPPG monolayers 
The morphology of POPC:DPPG monolayers containing SP-B isolated in organic 
solvent or SP-B complexes purified from detergent-solubilized pulmonary surfactant was 
structurally compared by AFM. Two different strategies were used to generate the films: 
1) direct application at the interface of organic solvent mixtures containing lipids and SP-
B isolated in solvent and 2) deposition at the interface of vesicle suspensions containing 
SP-B purified in detergent. Since the generation of a interfacial monolayer from vesicles 
requires destabilization of the continuous bilayer and the lipid insertion into the air-liquid 
interface, the binary lipid system POPC:DPPG (7:3, w:w), composed by unsaturated and 
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saturated phospholipids, was selected to enhance lipid adsorption. Unsaturated 
phospholipids provide the bilayer with the fluidity and dynamic properties required for 
the structural transformation that allows lipid insertion into the interface, whereas 
saturated phospholipids are essential to reduce dramatically the surface tension, imposing 
an extremely ordered monolayer (Lopez-Rodriguez and Perez-Gil, 2014). Organic 
solvent mixtures of POPC:DPPG, with or without SP-B, were spread onto an air liquid 
interface to form a single molecule thick film. π-A isotherms for POPC:DPPG (7:3) films 
compressed at 65 cm2/min revealed that this binary system underwent a quick LE-LC 
transition between 13 and 19 mN/m, where the compression work required to achieve 
lipid packing was scarce (Figure 6.3 A). In order to analyze by AFM the topography of 
lipid films containing or not SP-B isolated in organic solvent, monolayers were 
compressed to a surface pressure of 15 mN/m and then transferred onto mica supports. 
AFM images of these POPC:DPPG (7:3) films depict the coexistence of liquid-
condensed/liquid-expanded phases or domains, where DPPG condensed domains show a 
variety of shapes and sizes at the micrometer range (left image, Figure 6.3 B). In the case 
of POPC:DPPG:SP-Bo.s. (20% protein/lipid, by weight) films, coexistence of LC/LE 
phases was also found, but the condensed domains were substantially smaller than in the 
absence of the protein (right image, Figure 6.3 B). 
 
Figure 6.3. Surface pressure measurements and AFM images of solvent-spread interfacial films. 
Organic solvent mixtures of POPC:DPPG (7:3, by weight) containing or not SP-B isolated in organic 
solvent (20% SP-Bo.s., protein/lipid, by weight) were spread onto the surface of an aqueous buffer 
trough and the interfacial films were transferred onto mica supports at a constant surface pressure of 
15 mN/m. A) π-area isotherm. B)  Height micrographs of an area covering 25 µm of length. 
 
Then, monolayers of POPC:DPPG containing native SP-B complexes purified in 
detergent were formed from POPC:DPPG SUVs in the absence or presence of 10% or 
20% (protein/lipid, w/w) of SP-B purified in detergent. Protein-free liposomes were 
prepared with the equivalent amount of detergent in the buffer to that of the sample 
containing the protein, and then, detergent was removed from all samples by adsorption 
to non-polar beads. Vesicle suspensions were deposited onto the surface of the buffered 
subphase in the Langmuir trough. As it can be observed in the right part of the π- % area 
isotherms of figure 6.4 A, the presence of SP-Bdet at high concentration (20%) enhanced 
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the spreading of the proteolipid material along the air-liquid interface, reaching a surface 
pressure of 2.5 mN/m after 10 minutes of sample application, in comparison to 0.05 and 
0.2 mN/m achieved by vesicles with 0% and 10% of SP-Bdet, respectively, Once formed, 
films were subjected to compression up to a maximal surface pressure of 15 mN/m in 
order to be transferred to mica supports for AFM analysis. Upon compression, films 
containing 20% SP-Bdet achieved 15 mN/m of surface pressure with only 30% of surface 
area reduction. Films in the absence or presence of 10% of the protein needed higher 
compression rates to achieve  an increase in lateral pressure, reaching maximal pressures 
of only 6.2 and 10 mN/m, respectively. In the particular case of the protein-free lipid film, 
a sudden loss of material from the interface occurred after compressing up to 6.2 mN/m. 
This indicates that vesicle-spread monolayers of POPC:DPPG were not able to form 
effective monolayers, while SP-Bdet at concentrations ≥ 20% improved the spreading of 
the vesicles to the interface and promoted the stability of phospholipid monolayers 
subjected to compression forces. Observed under AFM, POPC:DPPG films at surface 
pressures between 5 and 6 mN/m showed condensed domains highly variable in size 
(Figure 6.4 B). In the case of films with 10% and 20% of SP-Bdet, transferred at higher 
surface pressures, the micrographs showed a distribution of domains similar to that of the 
monolayer constituted only by lipids at the lower pressures observed.  
 
Figure 6.4. Surface pressure measurements and AFM images of vesicle-spread interfacial films. 
POPC:DPPG (7:3) SUVs containing 0, 10 or 20% (protein/lipid, by weight) of SP-B complexes 
purified in detergent (SP-Bdet) were applied onto the buffer surface and transferred onto mica supports. 
Sample transferring onto mica supports was performed at surface pressures of 5-6, 11 and 15 mN/m 
for samples containing 0, 10 and 20% of SP-Bdet, respectively. A) π-% area isotherms. B) Height 
micrographs of an area covering 25 µm of length. C) Percentage of condensed area of different 
monolayers was analyzed in height images for both types of films: solvent-spread film, in figure 6.3 
and vesicle-spread film, in this figure. Statistical analysis by paired student’s t test was performed (* 
P<0.05). 
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The effect of the protein on the condensation of POPC:DPPG monolayers was 
quantitatively analyzed. The percentage of condensed domains in solvent-spread 
monolayers compressed at 15 mN/m decreased significantly in the presence of SP-Bo.s. 
(Figure 6.4 C), as previously described in DPPC films (Nag et al., 1997; Cruz et al., 
2000). In the case of vesicle-spread monolayers containing SP-Bdet at surface pressure of 
15 mN/m, the percentage of condensed domains showed similar values than pure lipid 
films at surface pressure of 5-6 mN/m, although they are not comparable due to the 
difference in lateral pressures between both interfacial films. It has been previously 
reported that SP-B affects the LC and LE distribution in DPPC and DPPC:DPPG 
monolayers at microscopic and nanoscopic levels (Cruz et al., 2004). Thus, we quantified 
not only the area of microdomains but also that of nanodomains (domains with ˂ 100 nm 
in their larger axis) (Figure 6.5 B). SP-Bo.s. in solvent-spread POPC:DPPG films caused 
a marked decrease in the area taken by microdomains over the total condensed area, 
resulting in an increase in the area occupied by nanodomains. In the case of SP-Bdet in 
vesicle-spread lipid films, the protein could also promote the generation of nanodomains, 
although the potency of this effect cannot be inferred due to the control lipid monolayers 
were subjected to lower lateral pressures. Figure 6.5 A shows that the size of domains in 
pure lipid solvent-spread films was larger than in films containing SP-B. SP-Bdet 
containing lipid films exhibited large condensed areas in combination with numerous 
smaller microdomains around 200 nm of length. In contrast, SP-Bo.s lipid films showed 
few microdomains and numerous nanodomains. Despite these different sizes of 
condensed domains in pure lipid films or SP-B containing films, in all monolayers the 
height of condensed domains was around 1 nm over the liquid-expanded phase 
background (Figure 6.5 C), regardless of the size of domains, in either micro- or 
nanometer range. 
Interestingly, phase images of POPC:DPPG films containing 20% SP-Bdet show some 
dark areas within the condensed domains, suggesting that these areas have a different 
chemical composition (Figure 6.6 A). In their corresponding topographic images, it can 
be observed that these areas show a lower height than the lipid condensed domains 
(examples of these low, dark areas are tagged with red arrowheads in phase images). As 
the frequency of appearance is linked to the protein concentration in the film, we propose 
that these dark areas could be enriched in SP-B. Thus, the number of dark areas in films 
with 10% SP-Bdet is reduced compared with those in films containing 20% SP-Bdet, 
(compare Figure 6.6 B to A) whereas they do not appear in pure POPC:DPPG films (data 
not shown). It is noteworthy to point that these possible protein clusters were not seen in 
POPC:DPPG films containing 20% SP-Bo.s. Following with the structural 
characterization of the condensed domains in films of POPC:DPPG + 20% SP-Bdet, a 
magnified view of a large domain of this sample shows an extremely rough surface 
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(height image in lower panel, Figure 6.6 A). Besides the aforementioned low height areas 
inside the condensed domains, the surface showed a high density of pores (blue arrows 
point some of these pores in Figure 6.6 A). The average inner diameter of these pores 
was 8.96 (± 1.33) nm, which resembles the pore size of SP-B rings in POPC:POPG 
bilayers, 8.93 (± 1.15) nm of average inner diameter (see Figure 6.1 B). Therefore, AFM 
image analysis of POPC:DPPG films containing 20% SP-Bdet suggested the presence of 
SP-B rings distributed inside the condensed lipid domains, as well as protein clusters, 
which would be formed as a consequence of the high SP-B concentration. 
 
Figure 6.5. Langmuir-Blodgett films of pure POPC:DPPG or POPC:DPPG containing 20% 
(protein/lipid, by weight) of SP-B isolated in organic solvent (SP-Bo.s.) or SP-B complexes 
purified in detergent (SP-Bdet). A) Height images of different monolayers. Squares tag regions with 
nanodomains (˂ 100 nm in their larger axis). B-C) Several parameters were quantitatively analyzed 
in AFM topographic images: % area occupied by micro or nanodomains and height of the condensed 
domains. Data from pure POPC:DPPG and POPC:DPPG containing 20% SP-B were compared by 
paired student’s t test (** P<0.01 and *** P<0.001). 
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Figure 6.6. AFM image analysis of vesicle-spread interfacial films formed by POPC:DPPG (7:3, 
w:w) supplemented with SP-B complexes purified in detergent (SP-Bdet).  Monolayers containing 
20% (A) or 10% (B) (protein/lipid; w/w) of SP-Bdet were transferred at constant surface pressures of 
15 or 11 mN/m, respectively. From each pair of micrographs, height (left) and phase (right) images 
are shown. Besides, lower and larger panel in A) is a magnified height image of a large condensed 
domain in a monolayer containing 20% SP-B purified in detergent. Red arrowheads in phase images 
indicate possible protein clusters, whereas blue arrows in the height magnified image point to SP-B 
rings. 
 
6.2.1.3 Structure of SP-B in interfacial films 
SP-B complexes purified from CHAPS-solubilized PS at different concentrations of 
protein (1 and 2 mg/ml of SP-Bdet) in the absence of lipids were applied and spread onto 
the buffered surface of the balance trough. To achieve samples of SP-Bdet at 1 or 2 mg/ml 
of protein, purified suspensions of SP-Bdet were concentrated 10 or 20 times, respectively, 
in centrifuge tubes supplied with a porous membrane of 10,000 Da of cut off. Interfacial 
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films of SP-Bdet were transferred to a mica support at a surface pressure of 11 mN/m (the 
maximal surface pressure achieved for the film) and analyzed by AFM. SP-Bdet at a 
concentration of 2 mg/ml generated films with a variety of protein-detergent structures 
(Figure 6.7): diffused extended structures (A), ring-shaped particles (B) and also 
condensed platforms with a height of 0.5 nm over the background, which showed a 
surface replenished of pores of irregular sizes (C).  In the case of SP-Bdet films at lower 
protein concentration, AFM images showed that the protein was arranged mostly in 
diffused extended structures and ring-shaped particles (Figure 6.7 D). These ring-shaped 
particles found in films at both SP-B concentrations showed an average diameter of 16.7 
(± 4.2), which is consistent with the SP-B rings purified in detergent and visualized by 
TEM (Olmeda et al., 2015). In order to discard that the structures seen in the SP-Bdet 
interfacial films could be artifacts due to the presence of detergent present in the sample, 
Langmuir-Blodgett films of CHAPS alone were formed. After application of CHAPS at 
a concentration of 195 mM equivalent to that present in the SP-B 2 mg/ml sample, the 
material was spread onto the surface of the subphase in the trough and the film was 
transferred at the maximal surface pressure achieved, 8 mN/m. AFM analysis revealed 
that CHAPS formed micelles with diameters around 15-30 nm and heights over 1.5 nm, 
but no other structures could be identified. This fact confirms that the structures observed 
in films of SP-B purified in detergent are constituted by the protein or protein/detergent 
assemblies. Upon film compression, the protein could be disposed as thread-like or ring-
shaped structures in areas with low SP-B concentration (Figure 6.7 A, B, D), whereas 
more complex structures could be formed as protein concentration increased, as the 
described large platforms of condensed domains with irregular pores (Figure 6.7 C). 
 
Figure 6.7. 
Langmuir-Blodgett 
films of SP-B 
purified in 
detergent. Films 
were formed by 
deposition onto the 
interface of SP-B 
purified in detergent 
at (A-C) 1 mg/ml and 
(D) 2 mg/ml of 
protein, and 
transferred at 11 
mN/m. E) Films of 
CHAPS at a final 
concentration of 195 
mM. Arrows point to 
ring-shaped 
structures. 
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6.2.2. PURIFICATION OF NATIVE SP-B COMPLEXES FOR HIGH 
RESOLUTION STRUCTURAL CHARACTERIZATION 
Traditionally, hydrophobic surfactant proteins SP-B and SP-C have been purified from 
organic solvent extraction of pulmonary surfactant or minced lungs. Then, both proteins 
can be further obtained from the organic extract by two sequential size exclusion 
chromatographies using organic solvents as eluent. These surfactant proteins can be 
reconstituted into membranes, preserving most of their original functional properties in 
the pulmonary surfactant system. 
Recently, a new method for native SP-B purification allowed to determine the 
supramolecular organization of this protein in pulmonary surfactant membranes (Olmeda 
et al., 2015). Solubilization of pulmonary surfactant by zwitterionic detergent CHAPS 
(molar ratio detergent:phospholipid 6:1) and a subsequent ion exchange chromatography 
(IEC) yield native SP-B complexes with a high oligomerization state (Figure 6.8). These 
purified SP-B structures were analyzed by transmission electron microscopy, showing 
the presence of ring-shaped complexes of 10 nm of diameter, whose structure is consistent 
with a 3D structural model of SP-B based on the structure of Saposin B. According to this 
model, each SP-B ring might be formed by the association of 5 or 6 SP-B covalent dimers, 
although the low resolution of the images together with the heterogeneous nature of the 
sample did not allow the determination of the structure of the oligomer, including the 
accurate stoichiometry of the complexes.  
 
Figure 6.8. Purification of SP-B complexes from CHAPS-solubilized pulmonary surfactant. PS 
solubilized with CHAPS (detergent:phospholipid molar ratio of 6:1) was loaded onto a Hitrap SP column 
for ion exchange chromatography (IEC). Phosphate buffers with increasing NaCl concentrations were used. 
Negatively-charged proteins, such as SP-A, were eluted with 25 mM NaCl. Elution of positively charged 
proteins required a dramatic increase of ionic strength of buffers, 500 mM NaCl, or even 1M NaCl to ensure 
the elution of proteins highly attached to the resin. SP-B complexes purified in detergent (SP-Bdet) were 
mostly eluted with 1M NaCl-supplemented buffer. A) Elution profile of the IEC. B) Comparative Blue 
Native (BN)-PAGE analysis of SP-B complexes purified in detergent (SP-Bdet) and SP-B isolated in organic 
solvent (SP-Bo.s.). SP-B purified in detergent shows a high oligomerization state, with no clear bands, 
although the major proportion of the protein seems to be assembled into structures with electrophoretic 
mobilities corresponding to sizes between 140 and 440 KDa. 
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Therefore, during this Thesis a number of biochemical methodologies were used with 
the aim to improve the quality of the samples containing SP-B complexes to a point that 
could allow obtaining a high-resolution structure of the protein. 
 
6.2.2.1. Size exclusion chromatography of SP-B complexes purified from detergent-
solubilized pulmonary surfactant 
The first experimental approach consisted on subjecting SP-B complexes purified in 
detergent to a size exclusion chromatography (SEC) in a fast performance liquid 
chromatography (FPLC) system. Three different fractions of the previous ion exchange 
chromatography of CHAPS-solubilized PS were loaded onto the SEC column Superdex 
200 10/300GL: a) IEC fraction directly eluted with 1 M NaCl, b) fraction eluted with 0.5 
M NaCl (second peak in IEC profile, Figure 6.8 A), c) fraction eluted in a second step 
with 1 M NaCl (third peak in IEC profile, Figure 6.8 A), which contained the SP-B rings 
of 10 nm of diameter observed by TEM. SEC profiles for all the samples contained 2 
peaks in common, one eluted at around 9 ml of volume (P1) and a second one that eluted 
at the end of the chromatography (P3) (Figure 6.9 A). The latest peak might be composed 
by non-assembled protein units, such as SP-B dimers. Besides, IEC fractions eluted with 
0.5 M NaCl or directly with 1 M NaCl showed an additional peak between 200 KDa and 
12.4 KDa markers (P2). The electrophoretic analysis in the presence of SDS determined 
that all peaks from each SEC profile contained SP-B, mainly covalent SP-B dimers with 
a typical electrophoretic mobility of around 20-25 KDa (Figure 6.9 B). In contrast, 
neither SP-A nor SP-C were detected in any of these samples obtained from detergent-
solubilized PS. 
 
Figure 6.9. Size exclusion chromatography of SP-B complexes purified from detergent-solubilized 
pulmonary surfactant. A) SEC profiles of Superdex 200 10/300GL column for fractions obtained from 
IEC of CHAPS-solubilized PS (1) eluted directly with 1 M NaCl (gray dashed line), (2) eluted with 0.5 M 
NaCl (light blue dotted line), (3) eluted in a second step with 1 M NaCl (dark blue line). Elution volumes 
of a set of proteins of known molecular weight for SEC column calibration are indicated over x-axis.  B) 
Peaks obtained from SEC were analyzed by SDS PAGE in a 16% polyacrylamide gel, followed by α-SP-
B western blot. 
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Fractions obtained from SEC of SP-B complexes purified in the presence of CHAPS 
and 1M NaCl were also analyzed by non-denaturing electrophoresis (BN-PAGE) and 
transmission electron microscopy in order to get a deeper structural characterization of 
SP-B complexes purified in detergent (Figure 6.10). BN-PAGE analysis of the original 
suspension containing SP-B complexes purified in detergent indicates that the sample is 
composed by supramolecular SP-B assemblies, highly diverse in size (Figure 6.10 B). In 
the case of the fractions obtained from SEC, the non-denaturing electrophoresis showed 
that SP-B complexes of the different fractions underwent a gradual decrease in size as 
SEC progressed (Figure 6.10 B). BN-PAGE analysis of fraction 1 barely detected SP-B 
complexes higher than 669 KDa, despite the high absorbance at 280 nm seen for this 
fraction in the SEC profile. Thus, it is likely that a major part of SP-B was forming part 
of aggregates which scarcely penetrated into the acrylamide gel. On the other hand, 
fraction 2 was enriched in SP-B complexes with approximate molecular weights varying 
from 500 to 200 KDa, whereas fraction 3 contained SP-B complexes with lower 
molecular weights from around 440 to over 100 KDa. In contrast, bands lower than 66 
KDa were detected in fraction 4, similar to those obtained from covalent SP-B dimers 
isolated in organic solvent (Figure 6.10 B). Thus, fraction 4 seemed to contain SP-B 
dimers, which is in agreement with its late elution in SEC. It is noticeable the discrepancy 
between the molecular weights of SP-B complexes estimated by BN-PAGE analysis and 
the estimated molecular weights according to the elution volumes of a set of calibration 
proteins in the SEC column. This fact could be the consequence of the intrinsic properties 
of the SEC column (Superdex 200 10/300 GL has a fractionation range for globular 
proteins of 10,000-600,000 Da) and/ or the presence of self-aggregation process between 
SP-B complexes after sample collection from SEC. 
Finally, the selected fractions from SEC were further analyzed by negative-staining 
TEM (Figure 6.10 C). On the contrary to the expected size separation provided by the 
chromatography, all fractions showed significant sample heterogeneity. In the case of 
micrographs from fractions 1-3, ring-shaped particles of 10 nm of diameter were 
observed, which resembled, in size and shape, those previously described in preparations 
of SP-B complexes purified from CHAPS-solubilized PS (Olmeda et al., 2015). Fraction 
1 also contained large aggregates of protein/detergent micelles, as suggested before in 
BN-PAGE analysis of this fraction.  In contrast, images from fraction 4 seemed to contain 
small particles, diverse in morphology, which are partly masked by background noise. To 
sum up, size exclusion chromatography of SP-B complexes purified from CHAPS-
solubilized PS allowed to obtain samples enriched in ring-shaped structures but without 
accomplishing the requirements of sample purity and quality for unraveling the structure 
of native SP-B complexes at high resolution. 
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Figure 6.10. Structural characterization of different samples obtained from SEC of SP-B 
complexes purified in detergent in the presence of 1 M NaCl. A) SEC profile of Superdex 200 
10/300GL column. Elution volumes of a set of proteins of known molecular weight for SEC column 
calibration are indicated over x-axis. B) Blue native-PAGE of the original sample containing SP-B 
complexes (SP-Bdet) and the obtained fractions from SEC. In addition, a sample containing SP-B 
isolated in organic solvent (SP-Bo.s.) was included in the electrophoretic analysis. BN-PAGE was 
performed on a 5-20% polyacrylamide gel followed by α-SP-B western blot. C) Representative 
micrographs of selected fractions from SEC taken by negative-staining transmission electron 
microscopy. White circles indicate ring-shaped structures of 10 nm of diameter. Scale bars, 100nm. 
 
Prior to further structural characterization of SP-B complexes purified in detergent, it 
was necessary to establish the optimal storage and handling conditions to prevent the 
alteration of the structure of protein assemblies. So, SP-B complexes were challenged to 
freezing-thawing cycles or sample concentration processes, and the resulting protein 
stability was analyzed by SEC profiles. After 1 freezing-thawing cycle, new eluted peaks 
appeared at around 18 and 23 ml. In addition to those, upon a second freezing-thawing 
cycle, intermediate peaks emerged in detriment of the main peak containing SP-B 
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aggregates. Thus, consecutive freezing-thawing cycles of SP-B purified in detergent leads 
to a progressive disassembly of high molecular weight SP-B particles into SP-B entities 
of lower molecular weight (Figure 6.11 A). On the other hand, upon 20 times sample 
concentration in centrifuge tubes supplied with a porous membrane of 10,000 Da of cut 
off, SEC profile of SP-B purified in detergent did not result substantially altered (Figure 
6.11 B). However, lower molecular weight SP-B entities were lost, as their size was below 
the cut off of the membrane in tubes. 
 
Figure 6.11. Stability of SP-B purified from CHAPS-solubilized PS upon successive freezing-thawing 
cycles (A) or 20x sample concentration (B). SEC profiles in Superdex 200 10/300GL column are shown 
where the elution volumes of a set of proteins of known molecular weight are indicated over x-axis. 
 
6.2.2.2. Stabilization of SP-B complexes by GraFix method 
This method consists on a purification process by density gradient ultracentrifugation 
in the presence of a crosslinker gradient, which stabilizes the structure of individual 
macromolecules and prevents them from aggregation. In order to purify homogeneous 
samples of SP-B complexes in detergent that could allow its structural characterization at 
high resolution, SP-B purified from CHAPS-solubilized PS was subjected to a glycerol 
density gradient ultracentrifugation with an additional gradient of glutaraldehyde, as 
crosslinker agent. The effect of the crosslinker over the stabilization of SP-B complexes 
was evaluated by comparison with a glycerol density gradient ultracentrifugation in the 
absence of glutaraldehyde. In order to set up this method for purification of SP-B 
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complexes, a number of experiments with different gradients of glycerol and 
glutaraldehyde were performed, although only the results of the best experimental 
conditions achieved are shown here. The profile of a 15-45% glycerol gradient 
ultracentrifugation in the absence of glutaraldehyde (black symbols, Figure 6.12 A) 
together with the SDS-PAGE analysis under non-reducing conditions (Figure 6.12 B) 
showed that a fraction of SP-B purified in detergent was pelleted during centrifugation, 
while the remaining SP-B was distributed along the tube with a major presence at the top 
of the tube, in 15-26% glycerol solution. SP-B was detected in major bands of 20 KDa, 
corresponding to SP-B dimers. In the case of samples with a high SP-B concentration also 
SP-B monomers can be slightly detected in the western blot. 
 
Figure 6.12. Stabilization of SP-B complexes purified from CHAPS-solubilized PS by GraFix 
method. SP-B purified in detergent was subjected to glycerol-density gradient ultracentrifugation in 
the presence or absence of an additional glutaraldehyde gradient. After ultracentrifugation, samples 
were collected from bottom to top of the centrifuge tube and absorbance at 280 nm was measured. A) 
Profile of density gradient ultracentrifugation with (blue) or without (black) glutaraldehyde. In the 
lower panels, α-SP-B western blots are shown, corresponding to SDS-PAGE analysis under non-
reducing conditions of fractions obtained from gradient ultracentrifugation in the absence (B) or 
presence (C) of the glutaraldehyde gradient. P corresponds to samples obtained from solubilization of 
the pellet in buffer. 
 
On the other hand, the glutaraldehyde/glycerol gradient ultracentrifugation revealed 
that the presence of the crosslinker agent partly prevented the protein from pelleting 
during ultracentrifugation (blue symbols, Figure 6.12 A). SP-B was distributed along ¾ 
of the tube, with a major presence in 15-19% glycerol solution (Figure 6.12 C), where 
the protein was detected in bands around 20 KDa (SP-B dimer) and higher bands at 25 
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KDa and 37 KDa, which would correspond to trimers or tetramers of SP-B. These SP-B 
supradimeric assemblies were detected in solutions with 0-0.06% crosslinker agent, 
although SP-B tetramers are restricted to 0.006-0.02% glutaraldehyde solutions. As 
previously seen in gradient ultracentrifugation in the absence of crosslinker, SP-B 
monomer bands were also observed in samples with high SP-B concentrations. Therefore, 
the glutaraldehyde gradient did not achieve an efficient stabilization of SP-B complexes, 
formed by decamers or dodecamers of SP-B. 
 
6.2.2.3. Purification of SP-B complexes by amphipols 
As an alternative to detergents, SP-B complexes purified from CHAPS-solubilized PS 
were stabilized by amphipatic polymers, shortly named as amphipols. Sample 
suspensions were prepared by addition of amphipols to SP-B complexes purified in 
CHAPS and subsequent detergent removal. In order to achieve the purification of 
decamers or dodecamers of SP-B, different suspensions with a wide range of amphipol 
A8-35/SP-B ratios (from 0.25:1 to 8:1, w/w) were prepared and then analyzed by non-
denaturing electrophoresis (Figure 6.13 A). For amphipol to protein ratios below 1:1, SP-
B was detected as a smear with molecular weights from about 100 KDa up to higher than 
669 KDa, so it is very likely that a huge proportion of SP-B would be forming aggregates. 
In contrast, for amphipol to protein ratios above 1:1, the smear above 140 KDa 
disappeared, and diffused bands below 66 KDa became more apparent as ratio increases. 
In the case of amphipol/SP-B ratio 1:1, most of SP-B was detected over 66 KDa and up 
to   ̴200 KDa. Previously, ring-shaped SP-B structures had been visualized by TEM in 
SP-B complexes purified in detergent with similar molecular weights range estimated by 
BN-PAGE (Figure 6.10). Therefore, further characterization of SP-B solubilized in 
amphipols was performed using the amphipol/SP-B ratio, 1:1. SP-B complexes 
solubilized in amphipols were analyzed by negative-staining TEM. Micrographs showed 
the presence of particles with high heterogeneity in size and shape (Figure 6.13 B). Four 
types of structures seemed to be predominant: 1) spherical particles of around 4-5 nm 
(arrowheads), which might fit with self-assembled polymers of A8-35 (Gohon et al., 
2011), 2) fibril structures (arrow) which seemed to be constituted by small round particles, 
3 and 4) two types of ring-shaped structures with approximate diameters of 10 nm or 14 
nm (white and yellow circles, respectively), which might be constituted by SP-B and 
amphipols. Since membrane protein/amphipol complexes might slightly increase in size 
compared with the protein solubilized in detergent (Popot, 2010), it is possible that 
particles of 14 nm would be composed of SP-B rings stabilized by amphipols, whereas 
SP-B complexes solubilized in a remainder fraction of CHAPS would constitute the 10 
nm-particles. 
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Figure 6.13. Purification of SP-B complexes in amphipol A8-35. A) α-SP-B western blot after BN-
PAGE analysis of SP-B complexes solubilized with amphipols at different mass ratios A8-35/ SP-B 
(right membrane) and the original suspension of SP-B complexes purified in detergent (left 
membrane). Samples were analyzed by α-SP-B western blot of BN-PAGE in 4-20% polyacrylamide 
gel. B) Representative TEM image of a negatively stained sample of SP-B purified in amphipols (mass 
ratio A8-35/SP-B, 1:1). Ring-shaped particles with diameters of around 10 nm or 14 nm are labeled 
within white and yellow circles, respectively. Arrowheads point to particles of around 4-5 nm of 
diameter, whereas arrow marks a fiber-like structure. Scale bar, 100 nm. 
 
In order to achieve more homogeneous samples, SP-B complexes solubilized in 
amphipols at a mass ratio A8-35/SP-B of 1:1 were subjected to a size exclusion 
chromatography (SEC) in a Superdex 200 10/300 column (Figure 6.14 A). The 
chromatogram showed a main peak with a left-shoulder, which might be composed of 
aggregates. At the end of the SEC profile, some peaks could be observed, that might 
correspond to SP-B structures of low molecular weight associated or not with amphipols. 
The main peak of the SEC profile seems to be formed by two peaks overlapped with a 
high absorbance at 280 nm (P1 and P2). BN-PAGE of P1 and P2 confirmed that these 
fractions contained SP-B complexes solubilized in amphipols at different oligomerization 
states (Figure 6.14 B). P1 contained mainly SP-B complexes with approximate molecular 
weights between 200 KDa and 669 KDa, whereas P2 is composed of a wide range of SP-
B assemblies, from lower than 66 KDa to about 500 KDa, although SP-B seemed to be 
enriched in regions between 140 to 440 KDa and below 66 KDa.  
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Figure 6.14. Characterization of SP-B complexes purified in amphipols (mass ratio A8-35/ SP-
B, 1:1). A) SEC profile in Superdex 200 10/300GL column, indicating fractions P1 and P2 collected 
for subsequent analysis. B) α-SP-B western blot after BN-PAGE of P1 and P2 fractions from SEC. C) 
Velocity sedimentation-analytical ultracentrifugation experiments for P1 and P2 fractions from SEC 
of SP-B solubilized in amphipols (left panels) and for SP-B complexes purified in detergent (right 
panel). Tables show the calculated sedimentation coefficient (s), the corrected sedimentation 
coefficient for water as solvent and temperature of 20 °C and the percentage of protein present on each 
peak, over the total protein in the sample. 
 
Finally, to further characterize the complexes present in the SP-B/amphipol sample, 
velocity sedimentation experiments in an analytical ultracentrifuge were performed from 
SEC fractions P1 and P2 containing SP-B solubilized in amphipols, as well as from the 
original suspension of SP-B complexes purified in detergent (Figure 6.14 C). Velocity 
sedimentation profile of the latter showed that it is a highly heterogeneous suspension, in 
which SP-B is distributed between 6 main different populations with different 
sedimentation coefficient, where the most abundant population (24.1%) had a 
sedimentation coefficient, s20,w, of 3.281 S (right panel, figure 6.14 C). For samples 
obtained from SEC of SP-B solubilized in amphipols, velocity sedimentation-AUC 
showed a moderate heterogeneity of samples (left panels, figure 6.14 C). P1 sample was 
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composed by a main peak with a s20,w value of 2.168 S, which represents 52.3% of total 
sample, and four additional minority populations, with a maximal s20,w value of 10.68 S. 
On the other hand, the number of populations in the P2 sample was reduced to two 
populations, where the most abundant, with a 72.5%, showed a s20,w value of 1.676 S. As 
it can be observed, results from velocity sedimentation experiments showed a high 
heterogeneity of the samples, so that they are not suitable for equilibrium sedimentation-
analytical ultracentrifugation experiments, which could provide accurate information 
about the exact mass of each protein species. To sum up, it has been demonstrated that 
amphipols are able to solubilize SP-B previously purified in detergent, although they fail 
in stabilizing an oligomeric SP-B structure of a defined molecular size. 
 
6.2.2.4. Purification of SP-B into MSP1D1 nanodiscs 
In this case, the SP-B source was not purified from CHAPS-solubilized PS, but SP-B 
isolated in organic solvent and later reconstituted into POPC vesicles. SP-B isolation into 
His6tag-MSP1D1 nanodiscs was attempted following a similar strategy to that previously 
developed for SP-C solubilization in nanodiscs (Roldán et al., 2014). Suspensions of 
nanodiscs with different molar ratios of phospholipid to MSP1D1 (40:1; 50:1 and 60;1), 
but at a fixed MSP1D1:SP-B molar ratio of 4:1, were prepared by addition of cholate-
solubilized MSP1D1 to POPC vesicles containing SP-B and solubilized by CHAPS. After 
detergent removal, different particle suspensions were subjected to a size exclusion 
chromatography in Superdex 200 10/300GL column for further compositional analysis. 
SEC profiles for all ratios assayed showed two different populations, which eluted at 12.4 
ml and around 15.5 ml, both containing MSP1D1, as shown by the presence of 25 KDa 
bands in silver-staining SDS-PAGE (Figure 6.15 A-B). Faint bands above 25 KDa would 
correspond to MSP1D1 assemblies that were not entirely denatured and reduced before 
the electrophoretic analysis, or to traces of contaminant proteins from the recombinant 
expression of the MSP1D1. Considering the elution volumes for both peaks, the first peak 
would correspond to MSP1D1 self-assembled to form nanodiscs, whereas the second 
peak would contain free units of MSP1D1. Regarding SP-B, 15-20 KDa bands 
corresponding to the surfactant protein were only detected in the nanodisc suspension 
with the lowest molar ratio phospholipid: MSP1D1, 40:1, although SP-B could not be 
confined into MSP1D1 nanodiscs, as shown by its presence in the second peak. On the 
contrary, SP-B might have remained associated to lipids (or even to detergent traces, 
coming from the process of SP-B solubilization into nanodiscs), which eluted 
simultaneously with free MSP1D1 (Figure 6.15 B). This interpretation of the results is 
in agreement with those from SP-C solubilization into POPC nanodiscs (Roldán et al., 
2014), where SP-C-free POPC nanodiscs formed by the self-assembly of His6tag-
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MSP1D1 eluted at 12.5 ml in Superdex 200 10/300GL column at similar experimental 
conditions (Roldán López et al., 2017). Thus, in the present work, MSP1D1, at least under 
the assayed ratios and lipid conditions, does not seem able to incorporate SP-B into 
assembled nanodiscs. 
 
Figure 6.15. Purification of SP-B complexes into MSP1D1 nanodiscs. A) SEC profiles of SP-B 
nanodiscs obtained at different molar ratios of phospholipid to MSP1D1, 40:1, 50:1 and 60:1. B) 
Selected fractions 1-4 collected from each chromatography were analyzed by silver-staining of SDS-
PAGE under-reducing conditions in a 12% polyacrylamide gel. 25 KDa bands correspond to His6tag-
MSP1D1 monomers, whereas 15-20 KDa bands to SP-B.  
 
6.2.2.5. Purification of SP-B into SMA lipid particles 
In this work, POPC:POPG vesicles containing SP-B 10% (by weight) were solubilized 
with styrene maleic anhydride (SMA) copolymers. The size of the resulting lipid 
nanoparticles can be determined by both the ratio of the mixture of styrene and maleic 
anhydride polymers and the number of assembled copolymers, which one can easily 
modulate by the lipid to copolymer ratio (Craig et al., 2016). So, a high lipid/SMA ratio 
favors the formation of large particles, although the homogeneity of the suspension could 
be compromised by a scarce membrane solubilization. In our case, the SMA copolymer 
used was styrene/maleic anhydride at molar ratio 3:1 and lipid nanoparticles were 
performed at a lipid/copolymer weight ratio of 1:1.5, based on previous literature 
referring to the solubilization of KCNE1 protein channel isolated into POPC:POPG 
SMALPs of 14 nm of diameter (Zhang et al., 2017), and the successful confinement of 
SP-C into POPC lipid nanoparticles using this same ratio (Roldan, Cruz, et al., 2017). 
Once SP-B/SMALPs were generated, the particle suspension was subjected to a size 
exclusion chromatography in a Superdex 200 10/300GL column to purify particles from 
free-copolymer. The chromatogram showed that the suspension contains particles of a 
wide range of sizes, resulting in the presence of a broad peak of absorbance (Figure 6.16 
A). It is convenient to mention that SMA copolymer adsorbs at UV wavelengths (Oluwole 
et al., 2017), so that the secondary peak eluted at the end of the chromatogram could be 
formed by free SMA and/ or SP-B. In parallel, SMALPs were generated from 
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POPC:POPG liposomes in the absence of protein. This control sample showed a SEC 
profile with the main peak narrower than in the case of SP-B/SMALPs (Figure 6.16 A). 
Selected fractions obtained from SEC of SP-B/SMALPs suspension were analyzed by 
non-denaturing electrophoresis, showing that SP-B was present in a band of about 100 
KDa (blue arrowhead) and as smeared bands with molecular weights between 200 and 
669 KDa (Figure 6.16 B). P1 sample seemed to be particularly aggregated, as a wide 
amount of protein was not able to penetrate through the gel.  
 
Figure 6.16. Solubilization and purification of SP-B into SMA lipid particles (SMALPs). A) SEC 
of suspensions composed by SMA lipid particles without protein (orange dashed line) or containing 
SP-B (dark red line) in Superdex 200 10/300GL column. B) SEC fractions of SP-B/SMALPs were 
analyzed by α-SP-B western blot of BN PAGE in a 4-20% polyacrylamide gel. Blue tag points a 100 
Kda band of SP-B present in all analyzed fractions of SP-B/SMALPs. C) Negative-staining TEM 
images of SEC fractions from SP-B/SMALPs (upper panels) and from control SMALPs without 
protein (lower panel). Yellow circles in SP-B/SMALPs images identify low contrast ring-shaped 
particles with an average diameter of 10.1 (± 0.6) nm, whereas red circles in control SMALPs point 
to high contrast particles with average diameter of 14 (± 1.2) nm. Arrowheads indicate round particles 
with high diffraction contrast. Scale bars, 100 nm. 
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To keep on characterizing SP-B/SMALPs, the selected SEC samples were analyzed 
by negative-staining TEM. In general, all samples showed high structural heterogeneity 
(Figure 6.16 C), as SEC profiles and BN-PAGE analysis suggested before (Figure 6.16 
A-B). Representative images from P1 and P2 samples showed large aggregates and round 
particles of high diffraction contrast (arrowheads), which became smaller in P3. Particles 
and aggregates with high diffraction contrast by negative-staining TEM were also seen in 
POPC:POPG SMALPS in the absence of protein, suggesting that these entities are 
constituted by the copolymer, which is in accordance with previous published works 
(Craig et al., 2016; Zhang et al., 2017). On the other hand, images taken from SP-
B/SMALPs samples (P1-P3) did not clearly show nanodiscs of defined size containing 
protein complexes inside. Nevertheless, all SP-B/SMALPs samples showed some ring-
shaped particles with lower contrast with an average diameter of 10.1 (± 0.6) nm (white 
circles) that are not present in POPC:POPG SMALPs. These ring-shaped particles are 
consistent with native SP-B complexes purified in detergent (Olmeda et al., 2015). 
Therefore, it is likely that at least part of SP-B would not have been participating in the 
structure of SMA lipid nanoparticles, but presumably would remain associated only with 
phospholipids. Further optimization of experimental conditions for SP-B purification into 
SMALPs could lead to enhance sample quality in order to characterize a high-resolution 
SP-B structure. 
 
6.3. DISCUSSION 
The first evidence of the oligomeric structure of SP-B in pulmonary surfactant was the 
purification of native SP-B complexes from PS membranes by detergent solubilization 
(Olmeda et al., 2015). In such preparations, the presence of ring-shaped particles of 10 
nm of diameter were revealed by TEM (Olmeda et al., 2015). These SP-B complexes 
could be formed by the association of 5 or 6 covalent dimers, as a theoretical 3D structural 
model of SP-B predicts. The existence of native SP-B oligomers has been supported by 
our results, which show that SP-B dimers isolated in organic solvent are reassembled in 
membranes forming a ring-shaped structure, consistent in size and shape with native SP-
B complexes purified in detergent. Besides, AFM and TEM analysis of bilayers and 
monolayers containing SP-B complexes showed a preferential orientation of the protein, 
where the ring-shaped particle was located parallel over the polar lipid surface. This 
orientation is in agreement with that predicted by the model of SP-B oligomer, in which 
protein-membrane interaction is hold by the interaction between polar sides of helices 1 
and 5 with the phospholipid headgroup, as well as with FRET experiments which assign 
a superficial topology to the protein, at the headgroup region of lipids (Cabré et al., 2012; 
Olmeda et al., 2015). Moreover, in the case of interfacial films formed by SP-B 
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complexes purified in detergent in the absence of lipids, SP-B rings were also located 
parallel to the air-liquid interface. The preferential orientation of the structure in 
membranes and interfacial films could be linked to the function of the protein in the 
pulmonary system, interconnecting membranes (Bernardino de la Serna et al., 2013) and 
ensuring both fast adsorption of surfactant and a high stability during respiratory 
dynamics (Schurch et al., 2010). In fact, fusion of lipid membranes promoted by SP-B 
was observed by TEM in the form of scars between bilayers. Besides the orientation of 
the structure with respect to the membrane, the information obtained by TEM images also 
suggests the existence of tight lateral contacts between SP-B particles, as the appearance 
of fiber-like protein structures could reflect. However, experimental artifacts cannot be 
discarded as the cause of the generation of the observed fibers due to the high protein 
concentration of the preparation (10% protein to lipid, by weight), which could induce a 
non-physiological protein aggregation. 
SP-B promotes film stability under mechanical stress and enhances monolayer 
compressibility to achieve optimal lipid packing (Krol et al., 2000; Diemel et al., 2002; 
Cruz et al., 2004). In this work, we have analyzed the effect of SP-B on POPC:DPPG 
films generated by two application methods: 1) placing the surfactant mixture in organic 
solvent on the air-liquid surface of the through and 2) by deposition of vesicles onto the 
surface. In contrast to solvent-spread monolayers, the generation of a monolayer film 
from a vesicle suspension was less efficient, as it was also previously described by (Cruz 
et al., 2000). The formation of a vesicle-spread monolayer might be probably limited by 
the opening of bilayers and the transfer of lipid packages to the interface. Our results 
showed that the presence of SP-B complexes purified in detergent in those vesicles 
enhanced the transfer of lipids from vesicles to the air-liquid interface and their spreading, 
allowing the efficient formation of a monolayer film, which, in contrast to vesicles lacking 
SP-B, was stable at least at the low compression pressures achieved (π = 15 mN/m). 
SP-B oligomers were only visualized in monolayers generated from vesicle 
suspensions containing SP-B purified in detergent, not in solvent-spread films with SP-
B. Although a functional characterization of these monolayers would be necessary to 
determine how the different organization of the protein influences its function in the 
interfacial film, we hypothesize that the presence of SP-B complexes would imply an 
enhancement of the film stability upon compression-expansion cycles. Results in Chapter 
2 strongly suggested that native SP-B complexes in surfactant membranes were essential 
for the optimal surface function of surfactant films. Moreover, a comparative study 
between solvent- and vesicle-spread films reported higher stabilization effects of SP-B 
on compressed monolayers generated from vesicle spreading (Cruz et al., 2000). We 
propose that this enhancement in stability upon film compression would be a consequence 
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of the assembly of SP-B into the oligomeric structure upon reconstitution into lipid 
vesicles. 
SP-B altered the structural organization of condensed domains of POPC/DPPG films 
at the micro- and the nanoscale. SP-B in solvent-spread films caused a marked decrease 
of both size and total amount of microdomains, whereas the number of nanodomains 
increased. Similar effects were previously reported for SP-B in solvent-spread films of 
DPPC and DPPC:DPPG (Cruz et al., 2004). In the case of vesicle-spread films, SP-B 
complexes purified in detergent could have a similar effect on the structure of condensed 
domains of POPC:DPPG films. However, a detailed AFM image analysis of condensed 
domains in vesicle-spread monolayers suggested the presence of SP-B inside the 
condensed domains, mostly in ring-shaped structures, but also the existence of some areas 
enriched in protein, which would be formed by SP-B clusters. Therefore, SP-B complexes 
present in vesicles maintain its native structure once surfactant material spreads forming 
a monolayer. The presence of SP-B clusters above 10% of protein (by weight) could 
suggest that the concentration of SP-B in monolayers exceeds the solubility limit of the 
protein in lipid films. A number of previous publications reported that the distribution of 
fluorescently-labeled SP-B is confined to the liquid-expanded phase in solvent-spread 
DPPC films (Nag et al., 1997; Cruz et al., 2000). Analysis at higher resolution of 
monolayers using AFM showed that SP-B in solvent-spread films forms protein clusters 
at the boundaries of liquid-expanded/liquid-condensed phases in DPPC and DPPC:DPPG 
films (Cruz et al., 2004). Moreover, AFM images of compressed films of DPPG 
containing SP-B in organic solvent showed the presence of ring-shaped protein structures 
in the liquid-expanded phase, not associated to condensed domains (Olmeda et al., 2015). 
Regarding the lipid system used in our study, POPC:DPPG (7:3, w:w), it is predictable 
that SP-B establishes preferential interactions with the anionic phospholipid DPPG in the 
monolayer, as it was previously described in membranes (Baatz, Elledge and Whitsett, 
1990; Perez-Gil, Casals and Marsh, 1995; Cabré et al., 2012). However, at a low surface 
pressure of π=15 mN/m, a fraction of DPPG would be forming condensed domains and 
the remaining would be located at the liquid-expanded phase together with POPC. Thus, 
the preferential partitioning of SP-B in DPPG condensed domains could be at least partly 
explained by mere attractive electrostatic interactions between the cationic protein and 
the negatively charged phospholipid.  
In the second part of the present chapter, we addressed the improvement of the 
purification of SP-B complexes as a prior step to determine the high-resolution structure 
of the SP-B oligomer by electron microscopy or X-ray crystallography. High-resolution 
structural techniques require a high homogeneity of the sample and a proper stability of 
the protein (Carpenter et al., 2008; Thompson et al., 2016). Size exclusion 
chromatography of SP-B purified in detergent allowed the obtaining of samples 
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containing ring-shaped SP-B complexes of 10 nm of diameter, free of aggregates and low 
molecular weight SP-B species, such as dimers. However, non-denaturing electrophoretic 
analysis and negative-staining TEM images showed that these suspensions enriched in 
SP-B complexes still had a heterogeneous composition, making them unsuitable for high-
resolution structural characterization. Alternatively, we attempted to increase the quality 
of the sample of SP-B complexes purified in detergent by a method called GraFix 
(Kastner et al., 2008), which consists on a glycerol gradient ultracentrifugation in the 
presence of a glutaraldehyde gradient, as crosslinking agent. Glutaraldehyde partly 
stabilizes SP-B complexes preventing the unspecific aggregation produced during the 
ultracentrifugation in the absence of the crosslinker. However, the GraFix methodology 
was not able to stabilize SP-B complexes of the expected molecular weights (87 or 104.4 
KDa, depending on whether the complex is formed by the association of 5 or 6 covalent 
SP-B dimers) (Olmeda et al., 2015). Glutaraldehyde is a bifunctional crosslinking reagent 
that reacts with amine groups to form Schiff’s bases. The efficiency of the crosslinking 
reaction strongly depends on the proximity of the amine-reactive groups of the protein. 
For glutaraldehyde crosslinking, amine groups should be at a distance of about 4.8 Å 
(Wine et al., 2007). As previously argued in the crosslinking experiments between 
surfactant hydrophobic proteins in Chapter 1, the 3D model of SP-B based on Saposin B 
structure predicts that the minimal interdimer distances between amino groups of lysines 
or lysine with amino terminal segment of SP-B are 10.8 and 9.7 Å, respectively, which 
exceeds significantly the distance between reactive amine groups subjected to 
glutaraldehyde crosslinking. Thus, crosslinking reaction by glutaraldehyde is not suitable 
to stabilize the association of 5 or 6 SP-B dimers of the native SP-B complex described 
in PS membranes.  
On the other hand, as an alternative to the use of the zwitterionic detergent CHAPS, 
an extensive study of SP-B complexes stabilized by amphipols was performed 
(Kleinschmidt and Popot, 2014). The non-denaturing electrophoretic analysis showed the 
presence of SP-B complexes of high molecular weight. Besides, the negative-staining 
TEM images confirmed the existence of ring-shaped particles of 10 nm of diameter, 
consistent in size and shape with SP-B structures purified in detergent (Olmeda et al., 
2015). Nevertheless, the analytical ultracentrifugation of SP-B/amphipols samples 
determined that the major proportion of the suspension was formed by entities of low 
molecular weight in a highly heterogeneous sample, suggesting that amphipols were not 
able to stabilize efficiently SP-B complexes of high molecular weight. Some works 
pointed that stability and homogeneity of a membrane protein can be further improved by 
forming ternary complexes consisting of membrane protein, detergent and amphipols 
(Champeil et al., 2000; Zoonens et al., 2007). Thus, this possibility could be investigated 
for stabilization of SP-B complexes in the future. 
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Finally, SP-B complexes were attempted to be confined within membrane nanodiscs 
prepared by using two different strategies: the membrane scaffold protein MSP1D1 or the 
copolymer styrene-maleic acid (SMA). In the case of MSP1D1, nanodiscs of POPC were 
formed, but SP-B could not be incorporated into them.  The assembly of two molecules 
of MSP1D1 in the presence of detergent-solubilized membranes generates nanodiscs of  ̴ 
9.7 nm of diameter (Denisov et al., 2004). Despite the nanodisc size is on the edge to 
confine ring-shaped SP-B particles of 10 nm of diameter, we previously demonstrated the 
presence of native SP-B and SP-C complexes into MSP1D1 nanodiscs obtained from 
detergent solubilized-pulmonary surfactant (Chapter 1). That means that the confinement 
of SP-B into nanodiscs could be favored by the presence of native surfactant membranes. 
It is very likely that the anionic phospholipids present in PS, such as PG or PS, accomplish 
a relevant role by establishing interactions with the cationic charges of the SP-B, favoring 
the incorporation of SP-B into MSP nanodiscs. On the other hand, SMA lipid 
nanoparticles were generated from POPC:POPG vesicles containing SP-B. The main 
advantage of SMALPs over MSP nanodiscs is the possibility to build particles of a desired 
size by setting the ratio of lipid to SMA copolymer. After subjecting them to a size 
exclusion chromatography, the electrophoretic analysis showed that SP-B complexes 
eluted together with SMA lipid nanoparticles. However, TEM micrographs showed that 
SP-B/SMALPs suspensions were formed by a wide variety of particles and aggregates, 
which makes difficult to identify SP-B-containing lipid nanoparticles. This heterogeneity 
could be due to an inappropriate balance between SMA and proteoliposomes, which 
could be overcome in the future by optimizing the lipid-to-SMA ratio, combined with the 
use of SMA containing different ratios of styrene/maleic anhydride, which also have 
influence in the size of the obtained nanoparticles. 
Throughout this chapter, the existence of native SP-B oligomers has been determined 
in lipid membranes containing SP-B from two different sources, SP-B dimers isolated in 
organic solvent and native SP-B complexes purified from CHAPS-solubilized pulmonary 
surfactant. Monolayers generated from vesicles supplemented with SP-B complexes 
purified in detergent showed SP-B rings and protein clusters in condensed domains. 
Moreover, SP-B rings showed a preferential orientation parallel to the plane of the lipid 
monolayer or bilayer, and in the absence of lipids, SP-B rings purified in detergent locates 
parallel to the interface. As mentioned before, this preferential orientation might be 
intrinsically related to the action of SP-B in the surface behavior of pulmonary surfactant, 
where SP-B catalyzes the adsorption of lipids and stabilizes the active film by the 
generation of a surfactant reservoir, mediating tight contacts between membranes. In 
addition, several membrane protein purification strategies were carried out in order to 
obtain a high quality sample of SP-B oligomers which could allow the determination of 
SP-B structure at high resolution. In the light of the obtained results, we can conclude that 
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solubilization of SP-B complexes in the zwitterionic detergent CHAPS or in amphipols 
did not yield a sufficient pure and stable sample. Conversely, nanodisc and lipid 
nanoparticle technologies could be potentially useful to purify an adequate sample of SP-
B complexes attached to the surface of negatively charged membranes. However, further 
studies are required to optimize the yield of SP-B oligomer isolation into lipid discs. For 
instance, the use of other variants of membrane scaffolding protein MSP and mixtures of 
copolymers, as well as an appropriate lipid composition, could have a strong impact in 
the generation of these nanodiscs. 
 
  
  
 
 
  
  
 
 
  
  
 
 
 
 
 
 
 
 
Chapter 4   
 
FLUORESCENCE SPECTROSCOPY APPLIED TO 
THE STUDY OF THE SUPRAMOLECULAR 
ORGANIZATION OF SP-B 
The experiments included in this chapter was performed during a short-term stay in the 
Centre for Molecular Chemistry and Physics (Lisbon University, Portugal) assisted and 
supervised by Dr. Luís Miguel Santos Loura, Pr. Mário Nuno Berberán Santos and Pr. 
Manuel Prieto. This stay was funded by an EMBO short-term fellowship (7343).  
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7. FLUORESCENCE SPECTROSCOPY APPLIED TO THE STUDY OF THE 
SUPRAMOLECULAR ORGANIZATION OF SP-B 
7.1. INTRODUCTION 
Förster resonance energy transfer (FRET) has been widely used to study protein-
protein and protein-lipid interactions, providing relevant information at molecular level 
given its spatial resolution in the nanometer range. 
FRET between identical fluorophores, called homo-FRET, has been revealed as a 
powerful tool to determine the oligomerization of free and membrane-bound proteins 
(Lillo et al., 2002; Otto et al., 2003; Bader et al., 2011; Chan, Kaminski and Kaminski 
Schierle, 2011; Melo et al., 2014). When energy homotransfer is efficient between the 
fluorophores of a labeled oligomeric protein, the oligomer stoichiometry of the protein 
can be determined by analyzing the effect of energy transfer on the fluorescence 
anisotropy of the system. Upon excitation with a polarized light, if a population of 
fluorophores undergoes homo-FRET, the fluorescence anisotropy will decrease because 
the fluorophores directly excited by the polarized light can then transfer energy to other 
fluorophores whose dipole orientations are little (or not at all) correlated with the 
orientation of the electric field vector of the excitation light. The probability that the 
fluorophore directly excited by the polarized light will emit a photon decreases with the 
number of the fluorophores involved in energy homotransfer processes in the cluster. As 
previously shown by (Runnels and Scarlata, 1995), when the distances between 
fluorophores within an oligomer are below 0.8𝑅0, the anisotropy is inversely proportional 
to the number of fluorophores if depolarizing rotation is absent.  
The first aim of this chapter was to attempt the determination of the SP-B oligomer 
stoichiometry in synthetic negatively charged membranes and in pulmonary surfactant-
derived membranes using homo-FRET methodologies. With this purpose, the extent of 
homo-FRET among BODIPY-labeled SP-B molecules involved in the protein complex 
was measured by steady-state and time-resolved fluorescence anisotropy. 
Besides the analysis of oligomerization of the native SP-B complex, we investigated 
the structure of SP-B/membrane aggregates. SP-B interacts peripherally with 
phospholipid membranes, with its amphipathic helical regions oriented parallel to the 
membrane surface and establishing electrostatic interactions between its positively 
charged residues and anionic phospholipids (G Vandenbussche et al., 1992; Morrow et 
al., 1993; Perez-Gil, Casals and Marsh, 1995; Cruz et al., 1998; Cabré et al., 2012). SP-
B has been reported to promote perturbations in membranes leading to aggregation and 
fusion between vesicles, lipid mixing, and rapid leakage of their content (Oosterlaken-
Dijksterhuis et al., 1992; Poulain et al., 1992; Ryan et al., 2005).  Furthermore, it has 
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been proposed that SP-B initiates transfer of lipids between membranes or to the interface 
through lipid packing disturbance, where the amino-terminal segment of the protein plays 
a crucial role (Serrano et al., 2006).  
Hetero-FRET is particularly useful to study the structural effects of proteins on the 
organization of the bilayers, due to its large sensitivity to distances in the 1-10 nm scale 
(Loura, de Almeida and Prieto, 2001; Loura et al., 2006; Coutinho et al., 2008). In the 
present work, time-resolved FRET experiments combined with a careful analysis based 
on a meaningful model provided quantitative topological information regarding the 
interaction of SP-B with POPC:POPG model membranes.  
 
7.2. RESULTS 
7.2.1. STUDY OF THE STOICHIOMETRY OF THE SP-B OLIGOMER BY HOMO-
FRET 
The main goal of the present work is to use homo-FRET measurements to determine 
the stoichiometry of fluorescently-labeled SP-B in membranes. The presence of 
homoaggregates of BODIPY/SP-B dimers in surfactant and model lipid membranes has 
been suggested by steady-state and time-resolved quenching experiments (Cabre et al., 
2018). Besides this, the photophysical properties of BODIPY probes make them a useful 
tool for homotransfer processes (Karolin et al., 1994), so that BODIPY/SP-B was chosen 
to evaluate the oligomerization state of the protein by homo-FRET fluorescence 
anisotropy. 
The purification process of SP-B involves the use of organic solvents due to its highly 
hydrophobic character. Under these conditions, its structural conformation is a covalent 
dimer of 18 KDa stabilized by an intermolecular disulfide bond between Cys 48 residues 
(Johansson, Curstedt and Jornvall, 1991). In the present work, SP-B purified in organic 
solvent was covalently derivatized with BODIPY-FL preferentially at its N-terminal 
segment. In order to determine the stoichiometry of the SP-B complex in membranes, 
different mixtures of labeled and unlabeled protein were used to generate SP-B oligomers 
with different fractional labeling (𝑓) in large unilamellar vesicles (LUVs) made of 
POPC:POPG (7:3, molar ratio). The extent of homo-FRET in the different oligomer 
species was evaluated by steady-state and time-resolved anisotropy measurements.  
Figure 7.1 illustrates the overlap of excitation and emission spectra of BODIPY-
FL/SP-B. The homo-FRET Föster radius of BODIPY-FL, 𝑅0, is 5.7 nm (Johnson, Kang 
and Haugland, 1991). Furthermore, the excitation spectrum of BODIPY-FL/SP-B shows 
a strong S0→S1 transition located at 508 nm and a weak S0→S2 transition, with a 
maximum intensity at 358 nm. Due to intrinsic characteristics of the equipment, time-
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resolved experiments were performed by exciting the sample at a wavelength within the 
second singlet (S2), whereas steady-state anisotropy was measured at two different 
excitation wavelengths that correspond to both excitation singlets, S1 and S2. 
 
Figure 7.1. Relative excitation and emission spectra of BODIPY-FL/SP-B. Spectra were obtained 
from POPC:POPG (7:3, mol:mol) LUVs (0.3 mM phospholipid concentration) containing BODIPY-
FL/SP-B (0.6% protein/lipid molar ratio). Excitation and emission intensity spectra were obtained at 
𝜆𝑒𝑥𝑐𝑖𝑡𝑎𝑡𝑖𝑜𝑛 of 335 nm (solid line) and 𝜆𝑒𝑚𝑖𝑠𝑠𝑖𝑜𝑛 of 530 nm (dashed line).  
 
Firstly, steady-state fluorescence anisotropy of vesicle suspensions containing 
BODIPY/SP-B was measured at different fractional labeling (Figure 7.2 and table 7.1). 
In the case of extreme dilution of BODIPY/SP-B (𝑓 = 0.10), in which the amount of 
labeled protein was ten times lower than that of full-labeled protein, the anisotropy values 
were 0.176 ± 0.003 at 𝜆𝑒𝑥𝑐 of 470 nm and 0.085 ±  0.010 at 335 nm. These anisotropy 
values are compatible with the expected anisotropy for a dimer of BODIPY/SP-B, 
𝑟𝑑𝑖𝑚𝑒𝑟 = 𝑟0/2 , because the fundamental anisotropy (𝑟0) of BODIPY-FL shows values of 
0.37 and 0.175 at 𝜆𝑒𝑥𝑐 of 470 nm and 335 nm, respectively (Karolin et al., 1994). 
According to the 3D model of the SP-B oligomer based on Saposin B structure, 6 dimers 
could be forming the SP-B complex (Olmeda et al., 2015). Thus, considering the 
existence of homo-FRET among dimers of the hexameric complex, the anisotropy limit 
values for the full-labeled SP-B oligomer (𝑓 = 1) would be 0.031 and 0.015 at 
𝜆𝑒𝑥𝑐𝑖𝑡𝑎𝑡𝑖𝑜𝑛 of 470 nm and 335 nm, where 𝑟ℎ𝑒𝑥𝑎𝑚𝑒𝑟 𝑜𝑓 𝑑𝑖𝑚𝑒𝑟𝑠 = 𝑟0/12. Conversely, the 
full-labeled SP-B oligomer (𝑓 = 1) showed a slightly decrease in anisotropy compared 
to the highly diluted BODIPY/SP-B sample, but this reduction was not large enough to 
support a supradimeric organization of BODIPY/SP-B. In the same line, the steady-state 
measurements of samples with intermediate fractional labeling showed anisotropy values 
only compatible with dimers of BODIPY/SP-B.  
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Figure 7.2. Extent of homo-FRET in 
BODIPY/SP-B oligomers. Steady-state 
anisotropy measurements at 𝜆𝑒𝑥𝑐𝑖𝑡𝑎𝑡𝑖𝑜𝑛 of 
335 nm (black circles) and 470 nm (white 
circles) of BODIPY/SP-B at different 
fractional labelling reconstituted into 
POPC:POPG (7:3, mol/mol) LUVs. 
 
To gain a detailed description of the depolarizing motions of BODIPY/SP-B that 
occurred in the fluorescence timescale, time-resolved fluorescence anisotropy decays of 
vesicle suspensions containing BODIPY/SP-B at different fractional labeling were 
measured, providing information about the amplitude of motion and its rotational 
correlation time. Anisotropy decays of BODIPY/SP-B were described by two correlation 
times, independently of the fractional labeling of the sample. In all cases, the anisotropy 
decays were interpreted as the product of two independent depolarizing processes, since 
the second rotational times 𝜙2 were about 20-fold longer than the shorter ones 𝜙1 (Table 
7.1). The fast correlation time reflects the restricted movements resulting from local 
motions of the covalently bound probe and/or mobility of the protein segment to which 
the probe is linked. In homo-FRET experiments with fluorescently-labeled proteins, this 
fast depolarization component is typically due to FRET. On the contrary, the slow 
correlation time would be related to the overall rotation of the protein in the lipid 
environment or the whole vesicle in solution (Lipari and Szabo, 1980). 
 
Table 7.1. Time-resolved fluorescence parameters (amplitudes, 𝜷𝒊; rotational correlation times, 
𝝓𝒊; residual anisotropy, 𝒓∞) of 0.3 mM POPC:POPG (7:3, mol/mol) LUVs containing 
BODIPY/SP-B (at different fractional labeling, 𝒇, with fixed 0.67% protein/lipid molar ratio). 
Parameters were obtained from fitting equation 3.4.5 (in 3.4 section of Materials and methods) to the 
anisotropy decays measured at 𝜆𝑒𝑥𝑐𝑖𝑡𝑎𝑡𝑖𝑜𝑛 of 335 nm. The table also shows the experimental steady-
state anisotropy, 〈𝑟〉𝜆=335 𝑛𝑚  and 〈𝑟〉𝜆=470 𝑛𝑚, and the one calculated using the parameters obtained 
from the time-resolved analysis, 〈𝑟〉𝑐𝑎𝑙𝑐 (equation 3.4.6, in 3.4 section of Materials and methods). 
 
The anisotropy decay of a dimer that undergoes energy transfer process with additional 
rotational diffusion can be defined by: 
𝑟 =
𝑟0
2
∙ (1 + 𝑒−2𝑘𝑡) · 𝑒−𝑡 𝜏𝑟⁄  
(Eq. 7.1) 
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being 𝑘, the rate of energy transfer and 𝜏𝑟, the slow rotational correlation time of the 
system. This equation can be rewritten as a sum of two exponential decays, where the 
first term defines the depolarizing component due to FRET and the second term describes 
depolarization caused by rotational diffusion of the fluorophore: 
𝑟 =
𝑟𝑜
2
⋅ (𝑒
−(2𝑘+
1
𝜏𝑟
)𝑡
+ 𝑒
−
𝑡
𝜏𝑟) 
(Eq. 7.2) 
Comparing this theoretical formalism of the anisotropy decay with the empirical 
equation,  〈𝑟〉𝑡 =  𝛽1𝑒
−𝑡 𝜙1⁄ + 𝛽2𝑒
−𝑡 𝜙2⁄ , the first correlation time, 𝜙1, is attributed to 
1/2𝑘, as 1 𝜏𝑟⁄  can be neglected, and the slow rotational correlation time is described by 
the second correlation time, 𝜙2. 
The recovered values for 𝜙2 defined the local slow motions of the dimer in the bilayer, 
as the contribution of rotation of the whole vesicle can be neglected. The theoretical 
prediction from the Perrin equation (Perrin, 1926) for the overall rotation of a vesicle of 
100 nm of diameter was 130 µs, in aqueous solution at 23 ºC, suggesting that 𝜙2 in the 
range of ns described the slow motion of BODIPY/SP-B in the context of the whole 
rotation of the protein bound to the vesicle. 
At infinite times, when  𝜙1 ≪  𝜙2, the residual anisotropy (𝑟∞) could approximate to 
𝑟 = 𝛽2 in the empirical formalism fitting to anisotropy decays. The 𝑟∞ values for all 
BODIPY/SP-B samples were 0.06-0.07 (Table 7.1), which is close to the anisotropy at 
long times predicted for a dimer by the equation, 𝑟 = 𝑟0 2 = 0.088⁄ . Following with the 
analysis, time-zero anisotropy values, 𝑟(0) = 0.10 − 0.11, (Table 7.1) were below the 
fundamental anisotropy for BODIPY-FL at 𝜆𝑒𝑥𝑐𝑖𝑡𝑎𝑡𝑖𝑜𝑛of 335 nm (𝑟0 = 0.175), indicating 
the existence of ultrafast motions of the fluorophore which could not be registered within 
the time resolution of the instrumental setup. Moreover, the steady-state anisotropy 
calculated from the obtained time-resolved parameters by analysis of anisotropy decays 
(〈𝑟〉𝑐𝑎𝑙𝑐) showed a deviation compared to experimental steady-state at 𝜆𝑒𝑥𝑐𝑖𝑡𝑎𝑡𝑖𝑜𝑛of 335 
nm (〈𝑟〉𝜆=335 𝑛𝑚) for each sample (Table 7.1). This could be also attributed to the 
substantial loss of initial information in the anisotropy decays due to very fast 
depolarization processes. 
The distances between molecules of BODIPY-labeled protein involved in 
depolarization caused by homo-FRET can be calculated from obtained first correlation 
times, 𝜙1, and using the equation that relates the rate of energy transfer, 𝑘𝑇, with the 
donor-acceptor distances, assuming lifetime (𝜏𝐷) of BODIPY/SP-B= 4.085 ns (Cabre et 
al., 2018). 
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𝑘𝑇 =
1
𝜏𝐷
(
𝑅0
𝑟
)
6
 
(Eq. 7.3) 
In the case of the infinitely diluted BODIPY/SP-B sample (𝑓 = 0.10), the estimated 
distance between probes of the covalent SP-B dimer was 48.4 Å (table 7.2). Donor-
acceptor distances were maintained about this value for all samples, suggesting once more 
that the energy transfer only occurs between covalent BODIPY/SP-B dimer, regardless 
of the fractional labeling of the sample. 
 
Table 7.2. Distances between BODIPY-linked and N-terminal regions of SP-B dimer calculated 
from the parameters obtained from time-resolved anisotropy analysis. 0.3 mM POPC:POPG (7:3, 
mol/mol) LUVs containing BODIPY/SP-B (at different fractional labeling, 𝑓, with fixed 0.67% molar 
ratio of protein to lipid). 
 
A previous fluorescence spectroscopy study showed the interaction between SP-C and 
homoaggregates of SP-B (Cabre et al., 2018). In that work, quenching studies of wild-
type SP-B by SP-C in surfactant lipid membranes showed that SP-C up to a SP-C/SP-B 
molar ratio of 0.125% led to an increase in tryptophan fluorescence intensity over the 
intensity observed for SP-B in the absence of SP-C, suggesting that low SP-C densities 
would cause the dissociation of interconnected SP-B hexamers. In the present work, as 
we could not detect efficient FRET extent corresponding to the SP-B hexamer by 
anisotropy measurements, we hypothesized that SP-B oligomers could be participating in 
a higher molecular structure through apposition of SP-B complexes, leading to 
fluorescence quenching events that hampered the extent of FRET along all probes 
contained in a full-labeled BODIPY/SP-B hexamer. Thus, fluorescence anisotropy was 
evaluated in vesicle suspensions made by surfactant lipids, containing BODIPY/SP-B 
with different fractional labeling and SP-C (at protein-to-lipid molar ratios of 0.7% and 
0.088%, respectively) (table 7.3). Steady-state anisotropy measurements at both 
excitation wavelengths (335 and 470 nm) showed similar values for the extremely diluted 
BODIPY/SP-B (𝑓 = 0.10) in the absence and in the presence of SP-C (compare tables 
7.1 and 7.3). In the case of full-labeled BODIPY/SP-B (𝑓 = 1), the observed steady-state 
anisotropy values were scarcely lower than those observed for the diluted labeled protein 
in the presence of SP-C (table 7.3), suggesting the sole presence of BODIPY/SP-B 
dimers. These observations were corroborated by the analysis of anisotropy decays of 
each sample, where the residual anisotropy (𝑟∞) values obtained were 0.08 and 0.06 for 
diluted and full-labeled BODIPY/SP-B samples, respectively, which resemble well the 
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long times anisotropy expected for a dimer, as mentioned above. Therefore, SP-C did not 
contribute to enhance the extent of homo-FRET among BODIPY/SP-B molecules. 
 
Table 7.3. Time-resolved fluorescence parameters (amplitudes, 𝜷𝒊; rotational correlation times, 
𝝓𝒊; residual anisotropy, 𝒓∞) of 0.357 mM of surfactant lipid fraction (LF) LUVs containing SP-
C (0.088% protein/lipid molar ratio) and BODIPY/SP-B (at different fractional labeling, 𝒇, with 
fixed protein/lipid molar ratio of 0.67%). Parameters were obtained from fitting equation 3.4.5 (in 
3.4 section of Materials and methods) to the anisotropy decays measured at 𝜆𝑒𝑥𝑐𝑖𝑡𝑎𝑡𝑖𝑜𝑛 of 335 nm. The 
table also shows the experimental steady-state anisotropy, 〈𝑟〉𝜆=335 𝑛𝑚  and 〈𝑟〉𝜆=470 𝑛𝑚, and the one 
calculated using the parameters obtained from the time-resolved analysis, 〈𝑟〉𝑐𝑎𝑙𝑐 (equation 3.4.6, in 
3.4 section of Materials and methods). 
 
Finally, to evaluate a potential effect of the probe on the structure of SP-B oligomer, 
POPC:POPG (7:3) vesicles containing BODIPY/SP-B or SP-B (0.67% molar 
protein/lipid) were visualized by atomic force microscopy. Micrographs of both samples 
showed the presence of ring-shaped particles with similar averaged diameters (14.5 ± 2.7 
nm, for BODIPY/SP-B, and 15.3 ± 3.9 nm for SP-B) (Figure 7.3). These particles are 
consistent in size and shape with the SP-B oligomers previously described by 
transmission electron and atomic force microscopies (Olmeda et al., 2015).  
 
 
 
Figure 7.3. AFM micrographs of 
oligomers of BODIPY/SP-B and 
SP-B in bilayers. BODIPY/SP-B 
(A) or SP-B (B) (0.67% protein/lipid 
molar ratio) were reconstituted into 
small unilamellar vesicles of 
POPC:POPG (7:3, molar) at 65 µM 
final lipid concentration. Both 
samples showed ring-shaped 
particles. The averaged diameter of 
these rings were 14.5 (± 2.7) nm, for 
BODIPY/SP-B and 15.3 (± 3.9) nm 
for SP-B. Depth of images is 3 nm. 
Magnified images are shown on the 
right. 
 
7.2.2. MULTILAMELLAR STRUCTURES INDUCED BY SP-B: A FRET STUDY 
The structure of aggregates formed by SP-B in negatively-charged membranes made 
of POPC:POPG, 7:3 molar ratio, were analyzed using FRET methodologies. FRET 
experiments were performed between donor and acceptor membrane probes, 
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BODIPY(500/510)-PC and ORB, respectively, or between SP-B labeled with BODIPY-
FL as donor, and ORB as acceptor. 
7.2.2.1. R0 calculations 
All energy transfer experiments performed involved the use of BODIPY derivative 
probes and octadecyl rhodamine B (ORB). Emission spectra of BODIPY-FL/SP-B and 
BODIPY(500/510)-PC (donors) overlap with the absorption spectrum of ORB (acceptor), 
which makes these probes suitable as a FRET pair (Figure 7.4). 
 
Figure 7.4. Corrected normalized fluorescence emission spectra of BODIPY-FL/SP-B and 
BODIPY(500-510)-PC (both with excitation at 335 nm) and ORB absorption spectrum. Spectra 
were obtained from samples of POPC:POPG (7:3, mol:mol) LUVs (0.5 mM phospholipid 
concentration) supplemented with BODIPY-FL/SP-B, BODIPY(500-510)-PC or ORB. Probe/lipid 
molar ratios were 1:1000 for BODIPY derivatives and 1:400 for ORB. 
 
Förster radius (R0), or the critical distance at which the transfer efficiency is 50% for 
an isolated donor-acceptor pair, was calculated for both FRET pairs, BODIPY-PC/ORB 
and BODIPY-SP-B/ORB, using the relationship (Lakowicz, 2006): 
𝑅0 = 0.2108 ∙ [𝜅
2 ∙ 𝛷𝐷 ∙ 𝑛
−4 ∙ ∫ 𝐼𝐷(𝜆)
∞ 
0
∙ 𝜀𝐴(𝜆) ∙ 𝜆
4 ∙ 𝑑𝜆]1/6               (Eq. 7.4) 
where 𝜅2 is the orientation factor (assumed in this study as 2/3, the dynamical isotropic 
value, whose validity for fluid bilayers is extensively discussed in (Van Der Meer, Coker 
III and Chen, 1994; Loura, Fedorov and Prieto, 1996)), 𝛷𝐷 is the donor quantum yield in 
the absence of acceptor, 𝑛 is the refractive index, 𝜆 is the wavelength, 𝐼𝐷(𝜆) is the 
normalized donor emission spectrum and 𝜀𝐴(𝜆) is the molar absorption spectrum of the 
acceptor. 
The quantum yield of the donor, 𝛷𝐷, was estimated for BODIPY-FL/SP-B 
reconstituted into LUVs to be 0.78, assuming proportionality between the quantum yield 
and the area under the intensity decay. For BODIPY(500-510)-PC, the published value 
of quantum yield of the probe in ethanol was used (𝛷𝐷= 0.90)  (Haugland, 2002). From 
these values and the measured spectra, 𝑅0 of 5.5 and 5.7 nm were calculated for BODIPY-
PC/ORB and BODIPY-SP-B/ORB FRET pairs, respectively. 
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From the analysis of time resolved donor decays in the absence (𝑖𝐷(𝑡)) and in the 
presence of acceptors (𝑖𝐷𝐴(𝑡)), FRET efficiency, 𝐸𝑡, can be calculated by 
𝐸𝑡 = 1 − ∫ 𝑖𝐷𝐴(𝑡)𝑑𝑡
∞
0
∫ 𝑖𝐷(𝑡)𝑑𝑡
∞
0
⁄  
(Eq. 7.5) 
 
7.2.2.2. FRET modelling 
Time-resolved FRET experiments can also offer quantitative topological information 
regarding the interaction of the protein SP-B with POPC:POPG model membranes. To 
get this aim, two different experimental configurations were considered: 1) FRET 
between membrane probes (Figure 7.5 A-B) and 2) FRET between BODIPY/SP-B and 
an acceptor membrane probe (Figure 7.5 C-E). For each FRET pair, different formalisms  
were developed based on (Coutinho et al., 2008), describing different donor/acceptor 
distributions. 
 
Figure 7.5. Schematic diagrams of the FRET models used for the study of bilayer stacking 
induced by SP-B. FRET between two membrane probes (A and B) or between SP-B labeled with 
BODIPY and acceptor membrane probe (C–E). A and C depict topological models for SP-B 
interaction with only one bilayer, whereas B, D and E illustrates arrangements for SP-B-mediated 
aggregation of bilayers. These models only considered the interaction between two bilayers, since the 
contribution of a third bilayer to the FRET would result negligible given the Förster radii of the FRET 
pairs. h1, h2 and h3 indicate the donor-acceptor distances for each FRET situation. 
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Figure 7.5 A illustrates a FRET scenario between membrane probes in the absence of 
vesicle aggregation. Each donor fluorophore transfers energy to acceptor molecules 
located in the same leaflet at transverse distance h1, or located in the opposite leaflet of 
the bilayer at distance h2. So, the donor decay in the presence of uniformly distributed 
acceptor is defined by: 
𝑖𝐷𝐴(𝑡) = 𝑖𝐷(𝑡)𝜌(𝑡, ℎ1)𝜌(𝑡, ℎ2)                                 (Eq. 7.6) 
where 
𝑖𝐷 = ∑ 𝐴𝑖  exp (−𝑡 𝜏𝑖)⁄𝑖                                        (Eq. 7.7) 
is the donor decay in the absence of acceptor, given by a sum of exponentials. The FRET 
contributions were calculated from (Davenport et al., 1985): 
𝜌(𝑡, ℎ) = exp (−𝑡𝑘𝐶ℎ𝐹(𝑡, ℎ))                               (Eq. 7.8) 
where 
𝐶 = Γ(2/3)𝑛𝜋𝑅0
2                                           (Eq. 7.9) 
and 
𝐹(𝑡, ℎ) = ∫
1 − 𝑒𝑥𝑝[(−𝑡/𝜏)(𝑅0/ℎ)
6𝛼6]
𝛼3
𝑑𝛼
∞
0
 
(Eq. 7.10) 
𝑘 = 2/𝑅0
2 , 𝑛 is the surface density of acceptors, 𝜏 is the average donor lifetime in the 
absence of acceptor (Loura et al., 2006), and Γ is the complete gamma function. 
If ℎ1 ≪ 𝑅0 , where donor and acceptor probes show identical transverse location, the 
corresponding FRET contribution is simplified 
𝜌(𝑡, ℎ1) ≅ 𝜌(𝑡) = exp [−𝐶(𝑡/𝜏)
1/3]                          (Eq. 7.11) 
Figure 7.5 B illustrates the situation of SP-B-induced bilayer aggregation. Here, a new 
acceptor plane becomes available for each donor at distance h3. Thus, an additional term 
is inserted in the donor decay law, 
𝑖𝐷𝐴(𝑡) = 𝑖𝐷(𝑡)𝜌(𝑡, ℎ1)𝜌(𝑡, ℎ2)𝜌(𝑡, ℎ3)                       (Eq. 7.12) 
Figure 7.5 C depicts the FRET situation between donors bound to SP-B protein and 
acceptor membrane probe without vesicle aggregation. Each donor fluorophore can only 
sense acceptors that share the same transverse location 
𝑖𝐷𝐴(𝑡) = 𝑖𝐷(𝑡)𝜌(𝑡, ℎ1)                                      (Eq. 7.13) 
Figure 7.5 D-E refers to FRET from BODIPY/SP-B to two planes of acceptor of 
different bilayers. Both cartoons depict the situation of vesicle aggregation induced by 
the protein, although they differ on the mechanism by which the protein mediates contacts 
between bilayers, through a single SP-B oligomer (D) or through the vertical apposition 
of two SP-B oligomers (E). In the case depicted in Figure 7.5 E, the donor decay is given 
by 
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𝑖𝐷𝐴(𝑡) = 𝑖𝐷(𝑡)𝜌(𝑡, ℎ1)𝜌(𝑡, ℎ2)                                (Eq. 7.14) 
If the membrane aggregation is induced by only one single SP-B oligomer (Figure 7.5 
D), then ℎ1 ≈ ℎ2 (similar distance from donors to both acceptor planes). 
 
7.2.2.3. Partitioning of ORB into POPC:POPG membranes 
Time-resolved experiments presented in this chapter were performed between 
BODIPY derivatives as FRET donor molecules, and ORB as the FRET acceptor 
membrane probe. ORB is a cationic amphiphilic fluorescent probe which is able to bind 
and insert into a lipid bilayer, with the acyl chain of 18 carbons protruding into the bilayer 
and the fluorophore located at the level of the polar heads of phospholipids. In the aqueous 
phase, ORB can be found as fluorescent monomers or forming non-fluorescent 
aggregates, with a critical aggregation concentration of 14 nM (Kenichi and Yoshinori, 
1994; Buranda et al., 2010). The aim of the present study is to analyze the organization 
of SP-B into membrane aggregates by FRET detection between the membrane probes 
BODIPY-PC (donor) and ORB (acceptor) or between the SP-B labeled with BODIPY 
and ORB inserted into the membrane, so that an uncharacterized partial incorporation of 
ORB in the membranes could hinder the interpretation of the FRET analysis. Thus, it was 
necessary to determine the optimal liposome concentration that ensures the complete 
incorporation of ORB into membranes. Suspensions of POPC:POPG (7:3, mol/mol) 
LUVs at different phospholipid concentration with a fixed concentration of ORB (0.75 
µM) were prepared and their fluorescence intensity was measured (at excitation 
wavelength of 505 nm). In order to favor the partitioning of ORB into liposomes, the 
probe was dried together with the lipid mixture and then reconstituted into vesicles. The 
plot of fluorescence intensity depicts how ORB soluble in water scarcely showed 
fluorescence, whereas its fluorescence intensity raises as phospholipid concentration 
increases, until reaching a plateau up to 0.2 mM of POPC:POPG liposomes (Figure 7.6). 
 
Figure 7.6. Partitioning of the 
acceptor probe, ORB, into 
membranes. Integrated 
fluorescence intensity over the 
emission spectrum, at an 
excitation wavelength of 505 
nm, in the absence or presence 
of POPC:POPG LUVs at 
different phospholipid 
concentrations, from 0.05 to 1 
mM. 
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The partition coefficient, 𝐾𝑝, of ORB into POPC:POPG vesicles was calculated from 
the intensity measurements by using the following equation (Santos, Prieto and Castanho, 
1998): 
𝐼 − 𝐼𝑤 =
(𝐼𝐿 − 𝐼𝑊)𝐾𝑝 𝛾𝐿 [𝐿]
1 + 𝐾𝑝 𝛾𝐿 [𝐿]
 
(Eq. 7.15) 
where 𝐼𝐿 and 𝐼𝑊 are the limit fluorescence  intensity with all the probe in lipid phase or 
in water, respectively, 𝛾𝐿 is the molar volume of lipid phase, and [𝐿] is the lipid 
concentration. By plotting the values 𝐼 − 𝐼𝑤 measured at 505 nm versus [𝐿] of the 
different suspensions of ORB-labeled vesicles and fitting to a hyperbolic regression, a 
value of 𝐾𝑝 = 9.9 (±5.2)·10
3 was obtained, considering 𝛾𝑃𝑂𝑃𝐶= 0.754 M
-1 (Koenig and 
Gawrisch, 2005) and 𝛾𝑃𝑂𝑃𝐺= 0.723 M
-1 (Marsh, 2013). 
 
The membrane-bound solute mole fraction of ORB, 𝑥𝐿, for a defined lipid 
concentration is described by:  
  
𝑥𝐿 =
𝐾𝑝,𝑥[𝐿]
[𝑊] + 𝐾𝑝,𝑥[𝐿]
 
(Eq. 7.16) 
where [𝑊] is the molar concentration of water, approximately 55.5 M at 25ºC (Santos, 
Prieto and Castanho, 2003), and 𝐾𝑝,𝑥 is the mole-fraction partition constant, which is 
related with 𝐾𝑝 by the following equation: 
𝐾𝑝 = 𝐾𝑝,𝑥(𝛾𝑊 𝛾𝐿)⁄                                      (Eq. 7.17) 
Using equations 7.16 and 7.17, the molar fraction of ORB inserted into 0.5 mM 
POPC:POPG (7:3, molar) LUVs was estimated to be 𝑥𝐿= 0.79 (with a range of uncertainty 
of 0.64-0.85). Since a high proportion of the probe partitionates into POPC:POPG 
membranes at a phospholipid concentration of 0.5 mM, the following experiments were 
performed with POPC:POPG LUVs at this phospholipid concentration. 
The aim of the present work was to characterize the structure of aggregates formed by 
SP-B and negatively-charged membranes using FRET methodologies. To do this, two 
different FRET experiments were designed: 1) between BODIPY/SP-B as donor and 
membrane probe as acceptor; and 2) between membrane probes, BODIPY-PC and ORB. 
Moreover, two different methodologies of sample preparation were compared: A) SP-B 
or BODIPY/SP-B reconstituted together with labeled lipids to form vesicles; and B) SP-
B or BODIPY/SP-B was added to preformed labeled vesicles. Combination of the sample 
Fluorescence spectroscopy study of SP-B oligomers 
197 
 
preparation methods for sample preparation with the designed FRET experiments gave 
rise to four different experiments, whose results are explained below. 
 
7.2.2.4. SP-B reconstituted into liposomes: FRET between BODIPY/SP-B and the lipid 
probe 
To study the effect of SP-B on the organization of membrane aggregates, time-
resolved FRET experiments were performed using BODIPY/SP-B, as donor, and the 
membrane probe ORB, as acceptor, which showed a 𝑅0 value of 5.5 nm. For this FRET 
experiment, increasing concentrations of BODIPY/SP-B were reconstituted into 
POPC:POPG (7:3, molar ratio) LUVs labeled with or without ORB. Time-resolved donor 
intensity decays were measured in the presence or in the absence of the acceptor for each 
BODIPY/SP-B concentration. Figure 7.7 A depicts how, as BODIPY/SP-B 
concentration increases, FRET efficiency between probes diminishes, which shows that 
the distance between BODIPY/SP-B and the membrane probe ORB become longer. To 
discard that this decrease in FRET could be related to a progressive loss of the donor in 
the vesicle suspensions, ratios of donor absorption (εD) to acceptor absorption (εA) were 
analyzed for each sample (Figure 7.7 B). εD/εA ratios were increased proportionally to 
the BODIPY/SP-B concentration in vesicle suspension, except for the vesicles 
supplemented with the highest protein concentration (4.17 µM BODIPY/SP-B). For this 
sample, it is likely that a minor fraction of BODIPY/SP-B was not successfully 
reconstituted into the lipid vesicles due to the high protein/lipid molar ratio, 0.8 % (10% 
protein to lipid by mass). Thus, in general, the progressive FRET decrease observed with 
increasing concentrations of BODIPY/SP-B was not caused primarily by a loss of donor, 
except for 4.17 µM BODIPY/SP-B. We also considered the possibility that BODIPY/SP-
B contained in MLVs could have promoted the formation of large membrane aggregates 
that would hinder the generation of LUVs of 100 nm by extrusion, yielding a substantial 
loss, not only of donor molecules, but of total material during the process, which would 
be larger, the higher protein concentrations. To test this hypothesis, donor and acceptor 
were quantified from absorption spectra of the original MLVs and the generated LUVs 
samples. Figure 7.7 C depicts the percentage of recovery for donor and acceptor probes 
upon extrusion of the vesicle suspensions, showing that the loss of material caused by the 
extrusion process affects similarly to both probes, BODIPY/SP-B and ORB. Absorptions 
of donor and acceptor molecules decreased between 10 and 20% in LUVs, independently 
of the [BODIPY/SP-B] contained in the original suspensions. Thus, the marked reduction 
in FRET efficiency between BODIPY/SP-B and ORB as increasing concentrations of 
labeled protein could not be explained by a loss of constituents during the vesicle 
preparation. An alternative explanation for the progressive longer distances between ORB 
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membrane probe and BODIPY bound to SP-B at increasing protein concentrations, 
represented by a decrease in FRET efficiency, could be the potential appearance of 
repulsive interactions forces between the cationic membrane probe ORB and the cationic 
charges of the SP-B, whose net charge is + 7 (Hawgood, Derrick and Poulain, 1998), that 
would imply the physical separation of donor and acceptor molecules. 
 
Figure 7.7. Membrane aggregation induced by BODIPY/SP-B, reconstituted into liposomes. 
Increasing amounts of BODIPY/SP-B (0; 0.25; 0.5; 0.67; 1.67; 4.17 µM BODIPY/SP-B, final 
concentration) were reconstituted in 0.5 mM POPC:POPG (7:3, molar ratio) LUVs labeled with ORB 
(probe/phospholipid molar ratio, 1:400). A) FRET efficiency between BODIPY/SP-B and ORB. B) 
Absorption donor to acceptor ratios for the different samples. C) Recovery (in percentage, %) of 
BODIPY/SP-B and ORB, calculated from absorption spectra of the samples before and after the 
extrusion of the vesicles. D) Turbidity of LUVs induced by BODIPY/SP-B. The extent of light 
scattering was determined by absorbance at 630 nm.  
 
In addition to time-resolved FRET experiments, the ability of SP-B to induce 
membrane aggregation was also evaluated by absorption measurements of the different 
vesicle suspensions at a wavelength of 360 nm, showing no increase in turbidity as protein 
concentration increases (Figure 7.7 D). All together, the lack of increase in FRET 
efficiency and in turbidity as BODIPY/SP-B concentration increased, suggested the 
inability of the labeled protein to promote membrane aggregation, in contrast to the 
extensive published evidences describing membrane association and fusion induced by 
native SP-B (Cruz et al., 1997; Chang, Nir and Poulain, 1998; Ryan et al., 2005; Cabre 
et al., 2009). 
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7.2.2.5. SP-B reconstituted into liposomes: FRET between lipid probes 
To continue with the FRET-based study of membrane aggregation induced by SP-B, 
different amounts of wild-type SP-B were reconstituted in POPC:POPG (7:3) LUVs, 
labeled with BODIPY-PC (donor) and ORB (acceptor), at 0.5 mM phospholipid 
concentration. This FRET pair showed a 𝑅0=5.7 nm. Analysis of time-resolved FRET 
experiments showed that all samples displayed similar FRET efficiencies independently 
of the SP-B concentration (Figure 7.8 A). In the same line, there was no increase in 
turbidity associated to the increase of protein concentration in vesicle suspensions 
(Figure 7.8 B). Therefore, these results suggested that wild-type SP-B was not able to 
promote vesicle aggregation, as it has also previously been shown for BODIPY/SP-B. 
 
Figure 7.8. Membrane aggregation induced by non-labeled SP-B, reconstituted into liposomes. 
Increasing amounts of SP-B (0; 0.22; 0.42; 0.83; 1.67; 3.3 and 5 µM SP-B, final concentration) were 
reconstituted in 0.5 mM POPC:POPG (7:3, molar ratio) LUVs, labeled with BODIPY-PC and ORB 
(probe/phospholipid molar ratios, 1:1000 and 1:400, respectively). A) FRET efficiency between 
BODIPY-PC and ORB. B) Turbidity of LUVs induced by SP-B. The extent of light scattering was 
determined by absorbance at 630 nm.  
 
7.2.2.6. SP-B added to preformed vesicles: FRET between lipid probes 
In the light of these results, we attempted another experimental approach consisting on 
the addition of 5 µl of SP-B solubilized in methanol (at different protein concentrations) 
to preformed POPC:POPG LUVs labeled with BODIPY-PC and ORB. Absorption 
measurements of the samples at a wavelength of 630 nm showed higher turbidity of the 
vesicle suspensions as the protein concentration increases (Figure 7.9 A). Therefore, 
addition of SP-B in methanolic solution induced vesicle aggregation. 
 Time-resolved FRET experiments were performed using the FRET pair BODIPY-
PC/ORB, with a large 𝑅0 (5.7 nm). Once SP-B in methanolic solution was added to the 
labeled POPC:POPG LUVs, fluorescence donor decays in the absence or in the presence 
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of acceptor were measured. Time-resolved experiments showed that FRET efficiency 
increased upon SP-B addition (Figure 7.9 B), confirming that SP-B was able to induce 
membrane aggregation. Absorption spectra of the different samples showed similar 
maximal absorption values for ORB, except for samples with 0.44 and 2.5 µM of SP-B, 
where ORB absorption at 562 nm were slightly higher (data not shown).  The analysis of 
absorption ratios of donor to acceptor molecules (εD/εA) in the vesicle suspensions 
showed the existence of slight differences of the probes concentrations between samples 
(Figure 7.9 C). Particularly, D/A absorption ratios were diminished for samples 
containing 0.44 and 2.5 µM of SP-B. Thus, the acceptor concentration in these samples 
was above the expected value, which likely caused an overestimation of FRET efficiency 
values for 0.44 and 2.5 µM of SP-B, as one can appreciate in Figure 7.9 B. Moreover, it 
is also possible that the highest protein concentration (5 µM of SP-B) could have been 
produced a repulsion effect on ORB, leading to a non-uniform distribution of membrane 
probes and a subsequent decrease in FRET efficiency at this protein concentration, as it 
was proposed before for BODIPY/SP-B reconstituted into liposomes labeled with ORB 
(Figure 7.7 A). 
 
Figure 7.9. Membrane aggregation induced by addition of SP-B in methanolic solution to 
preformed liposomes. A fixed volume of 5 µl of a methanolic solution containing different SP-B 
amounts were added to 0.5 mM POPC:POPG (7:3, molar ratio) LUVs, labeled with BODIPY-PC and 
ORB (phospholipid/probe molar ratios, 1:1000 and 1:400, respectively). Increasing final SP-B 
concentrations in the vesicle suspensions were: 0; 0.4; 1; 2.5; 5 µM SP-B. A) Turbidity of LUVs 
induced by SP-B. The extent of light scattering was determined by absorbance at 630 nm. B) FRET 
efficiency between BODIPY-PC (donor) and ORB (acceptor). C) Donor to acceptor absorption ratios 
for the different samples. 
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Additionally, time-resolved donor fluorescence decay curves were analyzed using the 
formalisms described in section 7.2.2.2 FRET theoretical background, (eq. 7.6 and 7.12, 
and figures 7.5 A-B) (Table 7.4). For FRET between membrane probes, the model 
predicts that donors and acceptors in the same leaflet of the bilayer locate at the same 
plane, at a fixed distance h1 ≈ 0 nm. The fluorophore of ORB locates at the lipid interface, 
whereas BODIPY-PC has a main population where the fluorophore loops to the interface 
and another one, with the fluorophore embedded within the bilayer (Kaiser and London, 
1998). Considering the coexistence of these two populations, the repeat distance 
recovered from this model geometry would probably correspond to the major one. 
Following, the distance between donor and acceptor fluorophores in opposite leaflets of 
the bilayer, h2 , was determined by fitting fluorescence decays in the absence of SP-B 
with diverse h2 values to the equation 7.6. The best fit was achieved with h2 = 3.9 nm for 
POPC:POPG (7:4, mol:mol) bilayers. In this same line, a previous work determined by 
time-resolved FRET methodology that the thickness of POPC:POPS (4:1, molar ratio) 
was 3.7 nm (Coutinho et al., 2008). Fixing h1 ≈ 0 nm and h2 ≈ 3.9 nm, a third plane of 
acceptors was attempted at variable distance h3 . The implementation of a third plane of 
acceptors for samples with [SP-B] ≤ 1 µm did not led to an improvement in the fitness 
compared to the two acceptor planes model. However, for higher SP-B concentrations (≥ 
2.5 µM), the incorporation of a third plane of acceptors resulted in a refinement of the 
goodness of the fit (X2) and a decrease of h3 up to 8.1 nm for the highest protein 
concentration (5 µM SP-B). In addition, the acceptor surface density for the different 
protein concentrations settled around a constant value, except for suspension with 2.5 µM 
SP-B. The imbalance for this sample might be due to an excessive acceptor concentration 
in the lipid mixture, as previously observed (Figure 7.9 C).  
 
Table 7.4. Comparison of the fitting parameters recovered for single bilayer and aggregated 
bilayers models applied to FRET experiments between membrane probes BODIPY-PC and 
ORB, in the presence of increasing concentrations of SP-B. Parameters obtained from pairwise 
global analysis of the time-resolved decays of BODIPY-PC (donor) in the absence and in the presence 
of ORB (acceptor). n is the number of acceptors/nm2. The time-resolved FRET data were analyzed 
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assuming BODIPY-PC looping, so h1 ≈ 0; and h2 = 3.9 nm was recovered from fitting the data obtained 
from the protein free sample to the single bilayer model. 
 
7.2.2.7. SP-B added to preformed vesicles: FRET between BODIPY/SP-B and lipid 
probe 
The ability of BODIPY/SP-B to induce vesicle aggregation was confirmed by 
absorption measurements at 630 nm (Figure 7.10 A). Upon addition of increasing 
concentrations of BODIPY/SP-B in methanolic solution (at final protein concentrations 
from 0 to 4.40 µM), the turbidity of the vesicle suspension increased, describing a 
sigmoidal curve. At the highest protein concentration assessed, both SP-B and BODIPY-
SP-B induced vesicle aggregation to a similar extent (Figures 7.9 A and 7.10 A).  
 
Figure 7.10. Membrane aggregation induced by addition of BODIPY/SP-B in methanolic 
solution. A fixed volume of 5 µl of a methanolic solution containing different BODIPY/SP-B amounts 
were added to 0.5 mM POPC:POPG (7:3, molar ratio) LUVs labeled with ORB (probe/phospholipid 
molar ratio, 1:400). Increasing final SP-B concentrations in the vesicle suspensions were: 0; 0.44; 
0.88; 2.20 and 4.40 µM BODIPY/SP-B. A) Turbidity of LUVs induced by SP-B. The extent of light 
scattering was determined by absorbance at 630 nm. B) FRET efficiency between BODIPY/SP-B 
(donor) and ORB (acceptor).  
 
Time-resolved FRET experiments were performed using BODIPY/SP-B and ORB as 
the FRET pair, with a value of 𝑅0= 5.5 nm. Addition of increasing BODIPY/SP-B 
concentrations led to a progressive increase in FRET efficiency (Figure 7.10 B). For 
protein concentrations between 0.44 and 2.5 µM of BODIPY/SP-B the efficiency 
underwent an apparently linear increase and then remained constant for higher protein 
concentrations. Therefore, FRET efficiencies suggested the existence of multibilayer 
structures induced by [BODIPY/SP-B] ≥ 2.5 µM. From previous FRET experiments in 
BODIPY/SP-B reconstituted into liposomes labeled with ORB, we proposed that there 
was a segregation process between the protein and the lipid probe due to the existence of 
repulsive electrostatic forces (Figure 7.7 A). The apparent stabilization of FRET 
efficiency values for BODIPY/SP-B concentrations higher than 2.5 µM could have been 
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as a consequence of the combined effect of an increased vesicle aggregation and the 
repulsion process between the protein and ORB. 
For an extensive study of the organization of the membranes in the presence of 
BODIPY/SP-B, the experimental fluorescence donor decays in the presence and absence 
of acceptor were analyzed using the formalisms described in the section 7.2.2.2 (eq. 7.13-
14 and figure 7.5 C-E). The distance (h1 = 2.5 nm) between the protein donor to one 
acceptor plane was fixed from the best fit to the donor decay of vesicle suspension with 
the lowest protein concentration (0.44 µM BODIPY/SP-B). This single acceptor plane 
showed a well-fitting model for [BODIPY/SP-B] ≤ 0.88 µM (Table 7.5). On the contrary, 
in the case of higher protein concentration, it did not fit to such a single bilayer model. 
Comparing the two FRET models under consideration, X2 values underwent a significant 
improvement (> 24%) in samples with [BODIPY/SP-B] ≥ 2.2 µM when an additional 
second plane was inserted, at a distance (h2) of around 5-5.5 nm. Figure 7.11 shows 
decays of donor emission in the absence and in the presence of acceptor for samples with 
[BODIPY/SP-B] = 4.4 µM, and depicts how the experimental data fit better to the 
aggregated bilayer model, as is evident from residual weights and autocorrelation plots.  
 
Table 7.5. Comparison of the fitting parameters recovered for single bilayer and aggregated 
bilayers models applied to FRET experiments between BODIPY/SP-B and ORB. Parameters 
obtained from pairwise global analysis of the time-resolved decays of BODIPY/SP-B (donor) in the 
absence and in the presence of ORB (acceptor). n is the number of acceptors/ nm2. The distance h1 = 
2.5 nm was recovered from fitting the data obtained from the sample with the lowest [BODIPY/SP-
B] (0.44 µM) to the single bilayer model. 
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Figure 7.11. Time-resolved fluorescence intensity decays of BODIPY/SP-B. Upper panels: 
BODIPY/SP-B fluorescence decay in the absence (donor only, blue) and presence of ORB (donor + 
acceptor, red) in 0.5 mM POPC:POPG (7:3, mol/mol) LUVs, upon addition of 4.4 µM BODIPY/SP-
B. The fittings of donor fluorescence decays to single bilayer (left) and to aggregated bilayers model 
(right) are compared. Weighted residual plots (middle panels) and autocorrelation plots (lower panels) 
for the fits of donor and donor + acceptor decays to the single bilayer (left) and aggregated bilayers 
models (right). 
 
Additionally, these time-resolved donor decays were analyzed using a linear 
combination of the formalisms for one-acceptor plane and two-acceptor planes, with fixed 
distances h1 = 2.5 nm and h2 = 5 nm (Table 7.6). The fraction of donor molecules that 
transfer energy to one acceptor plane or to two acceptor planes was calculated for each 
protein concentration. So, for the lowest BODIPY/SP-B concentration, all donors 
transferred energy to only one acceptor plane at a distance h1 = 2.5 nm. Conversely, for 
[BODIPY/SP-B] ≥ 2.5 µM, the whole fraction of donors sensed the two acceptor planes. 
Thus, all BODIPY/SP-B molecules are involved in vesicle aggregation at these high 
protein concentrations. An intermediate situation was reported for samples with 
[BODIPY/SP-B] = 0.88 µM, where the best fit to this linear combination model indicated 
that 70% of donors transferred energy only to a single acceptor plane, against 30% of 
donors that did it to two acceptor planes. 
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Table 7.6. Linear combination of the single bilayer and the aggregated bilayers models applied 
to FRET experiments between BODIPY/SP-B and ORB. Parameters obtained from pairwise global 
analysis of the time-resolved decays of BODIPY/SP-B (donor) in the absence and in the presence of 
ORB (acceptor). For each protein concentration, the fraction of donors transferring energy to two 
planes of acceptors, f2planes, was calculated for the fixed distances h1 = 2.5 nm and h2 = 5 nm. n is the 
number of acceptors/nm2.  
 
7.3. DISCUSSION 
7.3.1. STOICHIOMETRY OF THE SP-B OLIGOMER BY HOMO-FRET 
In the first section of the results presented in this chapter, a homo-FRET study was 
approached to determine the degree of oligomerization of the SP-B complex in synthetic 
lipid membranes, as well as in pulmonary surfactant-derived membranes. Previously, it 
had been described that SP-B adopts a supradimeric structure in membranes. A 3D model 
of SP-B based on the structure of Saposin B predicted that five or six covalent SP-B 
dimers could self-assemble by specific interactions involving N-terminal and C-terminal 
helical segments into a ring-shaped structure (described in chapter 3 and in (Olmeda et 
al., 2015)). To confirm experimentally the stoichiometry of SP-B oligomers, SP-B 
derivatized with a BODIPY probe on its amino terminal segment was used to evaluate 
the extent of energy transfer within the SP-B oligomer. 
The relatively large homo-FRET Förster radius of BODIPY-FL probe, 𝑅0 = 5.7 nm, 
makes in principle this fluorophore suitable for efficient donor-donor energy migration in 
macromolecular complexes. As a theoretical 3D model for SP-B oligomer already exists 
(Olmeda et al., 2015), distances between amino groups of amino-terminal regions of each 
SP-B molecule in the protein complex were measured, which allowed a first assumption 
of the convenience of a fluorophore for homo-FRET along the SP-B complex. Figure 
7.12 illustrates the SP-B oligomer formed by the association of six covalent dimers, where 
the distance between NH2-terminal groups of both monomers forming the covalent SP-B 
dimer is 5.31 nm, whereas the amino-amino interdimer distances lower to 1.87 and 2.51 
nm. Therefore, the Förster radius of BODIPY is large enough to allow energy transfer 
between the subunits as an efficient process. 
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Figure 7.12. Three-dimensional model of SP-B oligomer based on the structure of Saposin B 
(Olmeda et al., 2015). A) The SP-B complex shown is formed by the association of six covalent 
dimers, each of them represented in a different color. The amino group of amino-terminal region of 
each monomer is tagged in red. B) Detail of three adjacent covalent dimers inside the tridimensional 
model of SP-B oligomer. Covalent dimers are represented in different range of colors: purple, blue 
and green, with their respective monomers colored in dark and light tones. Distance between amino-
groups of amino-terminal segments of the same covalent dimer is tagged with a dotted line, whereas 
distances between adjacent covalent dimers are represented with long dashed lines. Distance values 
are reported in angstroms. 
 
The extent of homo-FRET among BODIPY/SP-B molecules in POPC:POPG model 
membranes was analyzed by fluorescence anisotropy. Both steady-state and time-
resolved anisotropy measurements suggested the presence of BODIPY/SP-B dimers, but 
no higher degrees of oligomerization. Similar results were also obtained for BODIPY/SP-
B in surfactant lipid membranes with little amounts of SP-C. Despite potential SP-B/SP-
C interactions described in a previous work (Cabre et al., 2018), and also suggested by 
results obtained in chapters 1 and 2 of this Thesis, the presence of SP-C did not induce an 
increase in the energy transfer neither between BODIPY/SP-B molecules involved in a 
large complex, nor among the fluorophores within the dimer. Nevertheless, AFM 
micrographs of BODIPY/SP-B in POPC:POPG membranes showed that labeled protein 
is assembled into ring-shaped particles with a diameter of 14.5 (± 2.7) nm, similar to the 
particles size observed in in POPC:POPG bilayers containing wild-type SP-B, and 
consistent with SP-B oligomers previously described (Olmeda et al., 2015). It is 
important to remark that the labeling efficiency of the protein with BODIPY was high 
(91%), although we could not determine whether the ring-shaped complexes seen by 
AFM correspond to fully-labeled SP-B complexes, only wild type SP-B or a mixture of 
both proteins. 
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The dimer detected by homo-FRET anisotropy measurements (for infinite dilution of 
BODIPY/SP-B (𝑓 = 0.10)) showed a distance between fluorophores of 4.84 nm. This 
distance was maintained around this value for samples with higher fractional labeling, 
where slight deviations observed in the length would be due to residual interdimer homo-
FRET. Since the amino terminal groups of the monomers forming the covalent SP-B 
dimer are located at 5.31 nm (Figure 7.12), it is reasonable to suggest that the dimer 
structure of BODIPY/SP-B detected by homo-FRET is, indeed, the covalent SP-B dimer. 
At this point, it is convenient to indicate that the oligomer model was built up using the 
human SP-B sequence lacking the first four amino acid residues (FPIP). It is known that 
prolines in the N-terminal segment of SP-B (residues 1-9) are involved in the spatial 
orientation of this segment with respect to -helix 1 (Serrano et al., 2006). Thus, the lack 
of FPIP in the SP-B model could vary noticeably the location of the N-terminal region 
compared to the full-sequence of SP-B, which could explain the slight difference (+ 0.47 
nm) in the intradimer N-terminal distance measured in the SP-B oligomer model, 
compared to the distance recovered by homo-FRET.  
The stoichiometry of a number of protein complexes associated to lipid membranes 
has been previously analyzed successfully by homo-FRET time-resolved spectroscopic 
studies (Yeow and Clayton, 2007; Hofman et al., 2010; Melo et al., 2014). However, this 
is not the case for BODIPY/SP-B oligomers, as our results indicated that energy transfer 
only occurred between fluorophores of the same covalent dimer, not between those of 
adjacent dimers. The extent of energy migration between a population of fluorophores 
located at distances ˂ 𝑅0 can be affected by self-quenching processes; fluorophores in 
close contact can form a non-fluorescent complex, or upon contact, the excited 
fluorophore returns to the ground state without emission of a photon (collisional 
quenching), leading to a strong decrease in the fluorescence lifetime of the donor. A 
previous work reported solely a slight decrease of lifetime for 2 µM of full-labeled 
BODIPY/SP-B in POPC vesicles (comparable protein and lipid concentrations to the 
conditions used in this work) (Cabre et al., 2018), thus there was no evidence of the 
presence of collisional quenching that would hinder the extent of homo-FRET among 
BODIPY/SP-B subunits in the oligomer structure. Moreover, in the case that quenching 
events between fluorophores of adjacent dimers would be taking place in full-labeled 
BODIPY/SP-B oligomer, the energy migration between intradimer fluorophores would 
be also hampered because BODIPYs from adjacent dimers alternate along the structure 
(see Figure 7.12). Therefore, the inability to detect the high degree of oligomerization of 
BODIPY/SP-B complex by homo-FRET, which was presumably observed by atomic 
force microscopy, was not due neither to quenching processes, nor to unfavorable 
orientation of BODIPYs from adjacent dimers, as samples underwent ultrafast initial 
depolarization, which contributes to randomize orientations. It therefore remains an open 
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question the interpretation of the anomalous FRET behavior in SP-B oligomers that seem 
to assemble similarly to non-fluorescent SP-B forms. The final answer to the actual 
stoichiometry of SP-B complexes, as well as the particular disposition of N-terminal 
groups, will come from alternate experimental approaches different from fluorescence 
spectroscopy, such as X-ray crystallographic analysis. 
 
7.3.2. MULTILAMELLAR STRUCTURES INDUCED BY SP-B: A FRET STUDY 
FRET reports an interbilayer distance of 7.5 nm  
FRET measurements are a sensitive tool to obtain quantitative information of the  
topological changes in membrane arrangements induced by proteins, as previously 
reported (Loura et al., 2006; Coutinho et al., 2008). In this work, we studied the 
interaction of native or fluorescently labeled SP-B with POPC:POPG model bilayers 
using time-resolved FRET methodology. 
SP-B is a hydrophobic protein widely known for promoting membrane perturbations 
leading to vesicle aggregation, lipid exchange and membrane fusion (Oosterlaken-
Dijksterhuis et al., 1992; Poulain et al., 1992; Cruz et al., 1997; Ryan et al., 2005). In the 
present work, and as it was reported in these previous studies, the addition of SP-B and 
BODIPY/SP-B in methanolic solution to vesicle suspensions confirmed, by turbidity 
measurements, the ability of both proteins to induce vesicle aggregation.  
As a first approach in FRET data analysis, fluorescence intensity decays of the donor 
were described as a sum of exponential functions, and the recovered fitting parameters 
were used to calculate the experimental FRET efficiencies between BODIPY/SP-B or 
BODIPY-PC, as donor molecules, and ORB, as acceptor membrane probe. Upon addition 
of SP-B or SP-B labeled with BODIPY-FL in methanolic solution, FRET efficiencies 
reached maximal values for protein concentrations ≥ 2.2 µM of BODIPY/SP-B and ≥ 2.5 
µM SP-B, suggesting that a high protein concentration induces vesicle aggregation. 
Although both proteins led to a rise in FRET efficiency, the relative increase in efficiency 
was higher for BODIPY/SP-B (compare Figure 7.9 B and 7.10 B). This was an expected 
result as donor-acceptor distances between protein-bound donor and the membrane probe, 
ORB, are shorter than distances between the FRET pair constituted by membrane probes, 
BODIPY-PC/ORB, resulting in a higher efficiency of energy transfer. 
However, despite FRET efficiency is a useful parameter to inform about the relative 
proximity between probes, it cannot resolve changes in membrane lipid organization. For 
this, more sophisticated models to fit FRET experimental data are required (Loura et al., 
2006; Coutinho et al., 2008). In this work, the analysis of the fluorescence decays was 
performed using FRET formalisms corresponding to single bilayer or aggregated bilayers 
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models. In the case of experiments with BODIPY-SP-B/ORB FRET pair, it was 
determined that [BODIPY/SP-B] ≥ 2.2 µM induced the formation of membrane 
aggregated structures, where the bilayers connected by SP-B were located at a distance 
of approximately 7.5 nm (h1+h2) (see table 7.5, figure 7.13 A). Using a linear 
combination of the formalisms describing the models for single bilayer and aggregated 
bilayers, we determined that none of BODIPY/SP-B molecules were connecting vesicles 
at 0.44 µM of labeled protein. When the protein concentration was increased up to 0.88 
µM, a minor fraction of BODIPY/SP-B (about 30% of total protein) was involved in the 
connection between two bilayers. This proportion increased up to 100% of BODIPY/SP-
B connecting bilayers, for protein concentration ≥ 2.2 µM (table 7.6). On the other hand, 
the analysis of time-resolved FRET experiments between membrane probes suggested 
that membrane aggregation induced by SP-B took place from [SP-B] ≥ 2.5 µM. 
Recovered distances h3 underwent a reduction inversely proportional to [SP-B]. For 
instance, the sample with 2.5 µM of SP-B showed a good fitting to the aggregated bilayers 
model with an interbilayer distance (h3) of 9.1 nm, whereas for 5 µM of SP-B the 
recovered distance was 8.1 nm (see table 7.4, figure 7.13 B). Although this distance is 
consistent with the  ̴ 7.5 nm interbilayer distance from the protein-bound donor/membrane 
acceptor FRET system, it is reasonable to suggest that the range of protein concentrations 
assayed do not allow to confirm whether this distance h3 would be stabilized to around 
8.1 nm for higher SP-B concentrations. Besides, in the case of experiments using 
BODIPY/SP-B and ORB as FRET pair, the interbilayer distance (h1+h2) is expected to 
be determined more accurately because the recovered distances refer to the attachment 
point between the two bilayers. Beyond these considerations, it is clear that both FRET 
experimental configurations resolved successfully the study of membrane aggregation 
induced by SP-B. 
 
Figure 7.13. Schematic representation of the distances determined by FRET pairs BODIPYSP-
B/ORB (A) and BODIPY-PC/ORB (B) in membrane-membrane interaction induced by SP-B. 
 
SP-B shows an oligomeric organization in surfactant membranes, as well as in lipid 
model monolayers and bilayers (Olmeda et al., 2015 and see chapters 1 and 3). 
Transmission electron and atomic force micrographs revealed that SP-B is assembled as 
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ring-shaped structures of 10 nm of diameter, which stand parallel to the surface of lipid 
layers. According to the 3D model structure based on Saposin B structure, the SP-B 
oligomer, formed by the association of six dimers, is projected around 3.7 nm over the 
lipid layer. Considering this height value, the apposition of two SP-B rings, one on top of 
each other, would connect two membranes with an interbilayer distance of 7.4 nm, which 
is in close agreement with the distance predicted by our time-resolved FRET experiments. 
Therefore, this work confirms that SP-B/SP-B interaction mediates contacts between 
membranes, as suggested by quartz crystal microbalance with dissipation (QCM-D) 
experiments (Cabre et al., 2009). SP-B participates in vesicle aggregation processes (Cruz 
et al., 1997) by allowing membrane interactions that deform vesicles which evolve to the 
formation of multilamellar structures (Cabre et al., 2009), with two SP-B oligomers 
connecting adjacent membranes. This membrane perturbation process would be governed 
by the combined action of SP-B/SP-B interactions and lipid-protein interactions. Due to 
the large interplanar distances induced by the protein (7.5 nm), the present time-resolved 
FRET study could not detect possible stacking of membranes beyond two connected 
bilayers. 
The previous oligomerization study of BODIPY/SP-B by homo-FRET did not prove 
higher oligomerization degree of the protein than the covalent dimer. If we assume that 
labeling of SP-B with BODIPY at its N-terminal region would have hindered the 
assembly of SP-B dimers into the ring-shaped oligomer, one could speculate that two 
covalent dimers of BODIPY/SP-B might mediate the connection between two bilayers, 
reporting interbilayer distance similar to those obtained by SP-B, which are consistent 
with the height of two juxtaposed modelled SP-B oligomers. However, it is unlikely that 
a sole covalent SP-B dimer could adopt a similar configuration in a phospholipid bilayer 
than covalent dimers inside the SP-B oligomer do, in which the interaction of the protein 
with the membrane surface is mediated by N-terminal and C-terminal amphipathic helical 
segments of two non-covalent SP-B dimers. 
 
Influence of sample preparation methods: addition of SP-B onto preformed vesicles 
versus SP-B reconstituted in vesicles  
Effective vesicle aggregation induced by SP-B was detected after addition of SP-B in 
methanolic solution onto preformed vesicles (Figures 7.9 and 7.10). Previous work 
reported lipid mixing activity of SP-B applied to preformed PC or DPPC vesicles by the 
same method (Poulain et al., 1992; Poulain, Nir and Hawgood, 1996). Upon injection of 
the protein in small volumes of methanol, SP-B would be able to interact with the bilayers, 
adopting a tertiary structure similar to that formed by SP-B reconstituted from a dried 
proteolipid film, showing analogous promoting effects of adsorption of phospholipid 
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vesicles into the air-liquid interface (Cruz et al., 1997). Nevertheless, neither turbidity nor 
FRET efficiency measurements of samples containing SP-B reconstituted into liposomes 
evidenced the presence of vesicle aggregation (Figures 7.7 and 7.8). This is in line with 
a previous work that showed that addition of SP-B onto preformed vesicles causes an 
instantaneous and extensive aggregation of vesicles in contrast to SP-B reconstituted 
together with liposomes (Cruz et al., 1997). The method of proteoliposome preparation 
might influence the SP-B orientation in the vesicle. Thus, SP-B reconstituted together 
with lipids would be located in both leaflets of the bilayer, while the injection of SP-B to 
preformed liposomes would favor the preferential location of the protein in external 
leaflets of the vesicle, increasing the number of protein molecules available to mediate 
contact between vesicles. We propose that, due to this different disposition of the protein 
reconstituted into the vesicles, the effective protein concentration of these samples could 
be lower than in the case of the protein added in methanol, and not enough to generate 
detectable levels of membrane aggregation, as is illustrated in Figure 7.14. Our results 
are in line with previous evidences that suggests SP-B injected onto preformed vesicles 
causes an instantaneous and extensive aggregation of vesicles, in contrast to SP-B 
reconstituted together with liposomes (Cruz et al., 1997). However, electron microscopy 
analysis showed that SP-B reconstituted in vesicles is also able to promote aggregation 
of lipid vesicles and the formation of multilayered surfactant assemblies (Parra et al., 
2011; Bernardino de la Serna et al., 2013). Considering these evidences, it is likely that 
longer incubation time of sample containing SP-B reconstituted in vesicles would lead to 
a greater extent of vesicle aggregation that could be detected by turbidity and FRET 
measurements. 
The distinct preparation methods of SP-B vesicles appear to lead to different SP-
B/membrane structures, whose activities differs very slightly. In the context of the 
pulmonary surfactant, it has been proposed that the process that follows SP-B added in 
methanol to interact with phospholipid membranes could be more representative to the 
interaction of SP-B with lipids in the surfactant cycle in vivo (Cruz et al., 1997). During 
the proteolytic processing of pro-SP-B, the mature segment of the protein would be 
covered by N-terminal and C-terminal propeptides until the cleavage of mature protein, 
instant in which SP-B interacts with lipids and participates in lamellar body biogenesis 
by promoting membrane remodeling.  The processing of proSP-B to generate the mature 
form of the protein could be somehow analogous to the exposure of hydrophobic regions 
of SP-B in organic solvents to lipid vesicles. 
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Figure 7.14. Schematic representation of the effect of the two methods of sample preparation 
assessed on vesicle aggregation induced by SP-B. 
 
7.3.3. CONCLUDING REMARKS 
 In this chapter, FRET methodologies were applied to determine structural and 
functional features of SP-B oligomers. Despite homo-FRET experiments did not allow to 
determine the stoichiometry of the SP-B oligomer in lipid membranes, time-resolved 
FRET measurements revealed that SP-B in methanolic solution is able to self-assemble 
into native oligomers attached to the membrane surface and induce membrane stacking 
through protein-protein interactions.  
SP-B has been suggested as essential for ensuring an efficient flow of lipid molecules 
between different surfactant structures and with the associated-interfacial film. The close 
apposition of membrane layers to interfacial monolayers induced by SP-B was reported 
by AFM and QCM-D analysis (Krol et al., 2000; Diemel et al., 2002; Cabre et al., 2009). 
Our time-resolved FRET approach resolved, at nanoscale, the structure of multibilayer 
organization induced by SP-B, and supports for the first time with experimental data, the 
apposition of two SP-B ring-shaped oligomers that had been previously suggested as an 
important feature for the optimal function of surfactant (Olmeda et al., 2015).  
The present study provides quantitative topological information about the structure of 
protein-membrane aggregates induced by SP-B. These structures would not only be 
essential for lipid adsorption to the interface, but also would be required for allowing the 
proper biogenesis of lamellar bodies, their unraveling to form diverse extracellular forms 
and the generation of the multibilayer reservoir of surfactant membranes necessary to 
stabilize the respiratory surface during breathing dynamics (reviewed in (Perez-Gil, 
2008)).  
 
 
  
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Chapter 5   
 
ROLE OF SP-B ON THE EXOCYTOSIS OF 
LAMELLAR BODIES IN ALVEOLAR TYPE II CELLS 
The experiments included in this chapter was performed during a short-term stay in the 
Institute of General Physiology (Ulm University, Germany) assisted and supervised by 
Pr. Manfred Frick and Pr. Paul Dietl. This stay was partially funded by a fellowship from 
Spanish Ministry of Economy and Competitiveness (EEBB-I-2015-10363). The results 
of this study were published in the article: 
Martínez-Calle, M., Olmeda, B., Dietl, P., Frick, M., Pérez-Gil, J. (2018). “Pulmonary 
surfactant protein SP-B promotes exocytosis of lamellar bodies in alveolar type II cells”. 
FASEB Journal, 32 (8): 4600-4611. 
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8. ROLE OF SP-B ON THE EXOCYTOSIS OF LAMELLAR BODIES IN 
ALVEOLAR TYPE II CELLS 
8.1. INTRODUCTION 
Pulmonary surfactant is synthesized and secreted by alveolar type II (ATII) cells. Prior 
to secretion, surfactant lipids and hydrophobic proteins are assembled into highly packed 
membranous structures, called lamellar bodies (LBs). LBs are acidic secretory organelles 
which range in size from 1.0 to 2.0 μM (Weaver, Na and Stahlman, 2002). The continuous 
availability of surfactant at the air-liquid interface is controlled by highly-regulated 
exocytosis of LBs. Alveolar mechanical stretching during inspiration is the main 
physiological stimulus for LB exocytosis. Large inflation of the lungs lead to an increase 
of the cytoplasmic calcium concentration, which triggers surfactant secretion (Nicholas, 
Power and Barr, 1982; Wirtz and Dobbs, 1990; Frick et al., 2004).  
Several agonists and molecular mechanisms are involved in the regulation of 
surfactant release (reviewed in (Rooney, 2001)). Among others, the purinergic-induced 
signaling pathway in ATII cells has been widely characterized. Purinergic agonists, such 
as ATP or UTP, activate P2Y2 receptors, expressed in these cells. Their activation results 
in formation of inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG), and 
subsequent Ca2+ release from intracellular stores and PKC activation, respectively, which 
ultimately trigger LB fusion with the plasma membrane and surfactant secretion. ATP is 
a very potent stimulus for surfactant secretion in vitro, but it also seems to be relevant in 
alveolar mechanotransduction (Patel et al., 2005). 
Ca2+ plays a central role as a second messenger in the regulation of surfactant 
exocytosis, both in lungs and in isolated alveolar type II cells (Nicholas, Power and Barr, 
1982; Wirtz and Dobbs, 1990; Haller et al., 1998; Ashino et al., 2000; Frick et al., 2001, 
2004). The transient elevation of cytoplasmic calcium concentration, [Ca2+]c,  with an 
amplitude over 320 nM Ca2+ activates the fusion machinery, composed of several 
cytoskeletal elements, which prompts the fusion of LBs with plasma membrane and the 
final surfactant release ((Haller et al., 1999); fusion machinery reviewed in (Olmeda, 
Martinez-Calle and Perez-Gil, 2017)).  
In this chapter, a wide study of the effect of SP-B on the secretion of lamellar bodies 
by rat primary ATII cell cultures was performed. This study was primarily carried out 
using a fluorescent-based method developed by Haller and co-workers (Haller et al., 
1998), which enables real-time monitoring of surfactant release in stimulated primary 
ATII cell cultures by the fluorescence signal of styril dye FM1-43 in combination with 
Fura-2 measurements. This method has the unique advantage of detecting single 
exocytotic events, as phospholipid staining by FM1-43 results in bright fluorescence 
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when the dye in the extracellular medium gains access to surfactant through the fusion 
pore. In parallel, Fura-2 measurements report changes in [Ca2+]c occurring in single 
stimulated cells.  
 
8.2. RESULTS 
8.2.1. EFFECT OF EXTRACELLULAR SP-B ON LAMELLAR BODY 
EXOCYTOSIS BY ATII CELLS 
The possible role of surfactant protein SP-B on regulation of pulmonary surfactant 
exocytosis in alveolar type II cells has been tested by treating primary ATII cell cultures 
with phospholipid vesicles containing SP-B. Figure 8.1 A shows that POPC:POPG (7:3, 
w:w) vesicles containing SP-B (final protein concentration 13 µM) promoted lamellar 
bodies exocytosis in 65% of ATII cells, a 7.8-fold increase compared to cells maintained 
in control buffer. In comparison, ATP, a well-known surfactant secretagogue, induced 
LB fusion in 25% of ATII cells. Thus, SP-B induced a 3.4-fold higher LB exocytosis 
response than ATP. The combined treatment of cells with ATP and SP-B-containing 
vesicles did not result in an enhancement of LB exocytosis as a result of a cooperative 
action. Several control experimental conditions were also assayed to discard that 
surfactant secretion by ATII cells could have been affected by the mere exposure to 
liposomes. The results showed that cells treated with vesicles without protein did not 
exhibit a higher percentage of fusion than cells in control buffer, whereas cells treated 
simultaneously with ATP and vesicles without protein showed levels of surfactant 
secretion similar to those obtained by ATP alone. In the light of these results, we can 
conclude that SP-B could be a potent inducer of surfactant exocytosis by alveolar type II 
cells. 
It has been well-established that surfactant secretion is highly regulated by cytoplasmic 
calcium concentration, [Ca2+]c, in ATII cells. Changes in cytoplasmic calcium 
concentration over time were registered by the ratiometric fluorescence intensity of Fura-
2. Stimulation with ATP induced a Ca2+ signal consisting of a peak followed by a plateau 
(Figure 8.1 B, upper panel). Previous work determined that such ATP-induced peak 
phase is generated from the release of Ca2+ from intracellular stores and it is related to an 
early exocytotic activity, whereas a late Ca2+ entry from the extracellular medium elicits 
a Ca2+ plateau phase and late fusion events (Frick et al., 2001; Dietl, Haller and Frick, 
2012). Fura-2 ratio measurements revealed that, as in the case of ATP, SP-B stimulated 
Ca2+ signaling in ATII cells (Figure 8.1 B, lower panel). Similar to ATP, SP-B also 
triggered an intracellular Ca2+ peak, and a subsequent sustained increase in [Ca2+]c over 
time. Figure 1C illustrates, after 1 minute of cell treatment with SP-B vesicles, how 
ratiometric Fura-2 fluorescence increases and, almost simultaneously, the fusion of LBs 
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with the plasma membrane occurs. This event is shown by the subsequent burst of bright 
FM1-43 fluorescence as this probe enters into the surfactant lipid-filled LB compartment 
through the open fusion pore. 
 
Figure 8.1. SP-B promotes lamellar body exocytosis in ATII cells.  A) Stimulation of lamellar body 
fusion with plasma membrane in ATII cells by treatment with 100 µM ATP and/or vesicles containing 
SP-B at a final protein concentration of 13 µM. Control conditions tested included vesicles without 
protein and cell bath solution, named as control buffer. ANOVA was performed, where each 
experimental condition was compared to control buffer using Dunn’s multiple comparison test. 
Additionally, SP-B vesicles, ATP + SP-B vesicles and ATP were analyzed by paired student’s t test 
(* P < 0.05 and *** P < 0.001). B) Representative plot of time course of Fura-2 ratio in response to 
100 µM ATP or vesicles containing SP-B at a final protein concentration of 13 µM. C) Typical images 
from an ATII cell culture, 1 minute after stimulation with SP-B vesicles (13 µM final protein 
concentration). Left image shows ratiometric Fura-2 fluorescence in the cytoplasm; dark spots (no 
fluorescence) in the cytoplasm represents lamellar bodies. The image in the center shows a lamellar 
body fusion event seen as a local increase of FM1-43 fluorescence at the site of the fusion pore in the 
plasma membrane of the ATII cell. An overlay of these images is shown (right). White arrows point 
to the site of LB fusion. In the left image note that once LB fuses with plasma membrane, it is no 
longer detected in the cytoplasm (absence of a dark spot). 
 
In order to characterize the efficiency of SP-B to stimulate LB exocytosis, we next 
analyzed this issue upon treatment with different SP-B concentrations (Figure 8.2). LB 
exocytosis underwent a linear growth in response to increasing concentrations of SP-B, 
until reaching a plateau when cells were treated with SP-B concentrations above 13 µM.  
 
 
 
 
 
 
SP-B-induced LB exocytosis in ATII cells 
220 
 
 
 
 
 
 
Figure 8.2. Characterization of the activity of SP-B as inducer 
of lamellar body exocytosis and evaluation of its effect on 
ATII cell viability. Concentration-response curve, where 
increasing SP-B concentrations (from 6.6 to 19.5 µM SP-B) 
versus exocytotic response were plotted. Lipid concentration in 
all vesicle samples was kept constant. ANOVA with all pairwise 
multiple comparison procedures (Holm-Sidak method) was 
performed (* P<0.05). 
 
Besides, we tested the viability of the cells challenged with SP-B vesicles. As shown 
in Figure 8.3, vesicles containing SP-B at a final protein concentration of 13 µM did not 
compromise cell viability through permeabilization of the plasma membrane, revealed by 
the inability of propidium iodide, a DNA-binding fluorescent probe, to enter the cells, 
which is a typical consequence of cell damage. This SP-B concentration was therefore 
effective at stimulation of surfactant secretion but non-toxic for ATII primary cell 
cultures. Hence, we established this SP-B final concentration as our reference 
concentration for the following experiments. In most of them, unless otherwise stated, all 
vesicles used were made by POPC:POPG (7:3, w:w). 
 
 
 
 
 
 
Figure 8.3. Effect of the extracellular 
SP-B on ATII cell viability. 
Cytotoxicity analysis by permeability to 
propidium iodide (PI). Cell uptake of PI 
was assessed after 15 min incubation 
with 100 µM ATP or vesicles containing 
SP-B (13 µM). As a control of cell 
damage, cell culture buffer was replaced 
by distilled water prior to propidium 
iodide incubation. Percentage of cells 
showing viability (lack of PI permeation) 
was plotted for each treatment. Data 
were analyzed by ANOVA, followed by 
Dunn’s multiple comparison test (*** 
P<0.001). Overlay images of PI (red)-
associated nuclear fluorescence and 
bright field are shown; scale bar, 50 µM.  
 
 
8.2.2. EFFECT OF DIFFERENT SURFACTANT LIPID-PROTEIN MIXTURES ON 
LAMELLAR BODY EXOCYTOSIS IN ATII CELLS 
The dynamics of surfactant films formed at the air-water interface of the alveoli is 
supported by the activities of proteins SP-B and SP-C. A likely cooperative action of both 
proteins at the respiratory surface has been suggested (Schurch et al., 2010), and even the 
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existence of SP-B/SP-C complexes in surfactant membranes has been recently proposed 
(Cabre et al., 2018). Both proteins are also involved together in the permeability of 
surfactant membranes, as previously described in chapter 2 of this Thesis. Therefore, we 
next investigated whether SP-C, together with SP-B, might also be involved in the 
regulation of surfactant secretion by alveolar type II cells. To test this, samples containing 
different mixtures of the surfactant components were analyzed. Vesicles containing SP-
C alone were not able to trigger lamellar bodies exocytosis in ATII cells (Figure 8.4 A). 
However, vesicles containing both purified hydrophobic proteins, SP-B and SP-C, 
stimulated LB exocytosis at similar levels than vesicles containing SP-B alone (Figure 
8.4 B). This exocytotic activity was also achieved when ATII cells were treated with 
vesicles formed by the organic fraction of the pulmonary surfactant, which contains the 
native lipids and the original proportion of hydrophobic proteins (Figure 8.4 C). 
Therefore, SP-B was able to promote lamellar body exocytosis independently of the 
presence of SP-C, showing the latter no effect on this feature. 
 
Figure 8.4. Effect of different surfactant protein mixtures on the exocytosis of LBs in primary 
ATII cell cultures. A) Cell treatment with vesicles containing SP-C. B) Cell treatment with vesicles 
containing a combination of purified SP-B and SP-C compared to treatment with vesicles containing 
SP-B alone. C) Treatment with vesicles formed by the organic extract of pulmonary surfactant (O.E.), 
containing all surfactant lipids and the physiological proportion of the hydrophobic proteins SP-B and 
SP-C. Vesicles tested in all these experiments are composed of SP-C and/or SP-B, with each protein 
at a final concentration of 13 µM. Control treatments included addition of 100 µM ATP, control 
vesicles without any protein or cell bath solution (control buffer). For panel A, data were analyzed 
using one-way ANOVA, followed by Dunn’s multiple comparison test. Data from panels B and C 
were analyzed by paired student’s t test (*** P<0.001). 
SP-B-induced LB exocytosis in ATII cells 
222 
 
Apart from the classical method to purify SP-B dimers in organic solvent, native SP-
B complexes from pulmonary surfactant can be obtained by its solubilization with 
detergent (Olmeda et al., 2015). Structural characterization of these SP-B particles 
revealed a supramolecular organization of five or six SP-B dimers that adopt a ring-
shaped protein structure, functionally competent to promote formation and proper 
dynamics of interfacial phospholipid films. Figure 8.5 shows that both, vesicles 
containing native SP-B complexes originally solubilized in detergent or SP-B obtained in 
organic solvent, were able to promote LB exocytosis at similar efficiency levels.  
 
 
 
Figure 8.5. SP-B oligomers stimulates LB 
exocytosis in ATII cells. A) Cells were treated 
with vesicles containing detergent-solubilized SP-
B complexes (SP-Bdet) in comparison to those 
treated with vesicles containing SP-B purified in 
organic solvent. Control treatments included 
addition of 100 µM ATP, control vesicles without 
any protein or cell bath solution (control buffer). 
Data were analyzed by paired student’s t test (*** 
P<0.001).  
 
Due to the cationic nature of SP-B, the protein establishes electrostatic interactions 
with anionic phospholipids in bilayers (Perez-Gil, Casals and Marsh, 1995; Cabré et al., 
2012). Therefore, we analyzed a likely influence of the anionic phospholipids on the 
ability of SP-B to induce LB exocytosis in ATII cells (Figure 8.6). With this aim, ATII 
cell cultures were treated with SP-B reconstituted in POPC or POPC:POPG (7:3, w:w) 
vesicles. The results showed that SP-B incorporated in negatively-charged vesicles 
promoted slightly higher levels of LB secretion than SP-B in zwitterionic vesicles, 
suggesting that the anionic phospholipid POPG would enhance the activity of SP-B as 
inducer of LB exocytosis. 
 
 
 
 
 
Figure 8.6. Influence of anionic phospholipid on 
stimulation of LB exocytosis by SP-B. ATII cell 
cultures were treated with POPC or POPC:POPG (7:3) 
vesicles, containing SP-B. Control treatments 
included addition of 100 µM ATP, cell bath solution 
(control buffer), or control vesicles made of POPC or 
POPC: POPG (7:3, w:w) in the absence of protein. 
Data were analyzed by paired student’s t test (* P<0.05 
and *** P<0.001). 
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8.2.3. BLOCKAGE OF SP-B-INDUCED LAMELLAR BODY EXOCYTOSIS BY 
ANTIBODIES 
In this work, we have shown that extracellular pulmonary surfactant, specifically 
through an effect promoted by SP-B, would play a role in the regulation of its own 
secretion. To confirm this outcome, we performed a set of experiments to test whether 
SP-B-mediated LB exocytosis could be blocked when vesicles containing different 
surfactant components were pre-incubated with antibodies against surfactant proteins SP-
B or SP-C (Figure 8.7). As expected, blockage of SP-B vesicles with α-SP-B antibody 
arrested the induction of LB secretion by ATII cells in a dose-dependent manner (Figure 
8.7 A). To discard a non-specific effect of the antibody, SP-B vesicles were treated with 
α-SP-C antibody, which showed no alteration in the SP-B ability to stimulate LB 
exocytosis (Figure 8.7 B). Vesicles made up by organic extract from pulmonary 
surfactant showed a reduced ability to stimulate LB secretion when they were pre-
exposed to α-SP-B antibody as well as, surprisingly, upon pre-exposure to α-SP-C 
antibody (Figure 8.7 C). Interestingly, when the cells were treated with vesicles 
containing a mixture of purified proteins SP-B and SP-C, pre-treatment with α-SP-B 
antibody led to a blockage of LB exocytosis, but no effect was observed when the vesicles 
were pre-treated with α-SP-C antibody (Figure 8.7 D). Thus, the blocking effect of the 
α-SP-C antibody towards SP-B-promoted secretion stimulatory function when both 
proteins are co-purified, but not when they are separated and later combined. These results 
strongly suggest a disruption of SP-B/SP-C interactions during the purification process, 
as previously described in chapter 2 regarding the effect of both proteins in surfactant 
permeability, which could be caused by a possible loss of unknown factors or by alteration 
of the proteins conformation once SP-B/SP-C complexes are dissociated. 
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Figure 8.7. Blockage by antibodies of SP-B-stimulation of LB exocytosis in ATII cells. ATII cell 
cultures were treated with vesicles containing SP-B (A, B), vesicles made up of organic extract from 
pulmonary surfactant (C) or vesicles containing a combination of isolated SP-B and SP-C (D). The 
vesicles were pre-incubated with either α-SP-B or α-SP-C antibodies (150 µg/ml of antibody 
concentration, unless otherwise stated). Control treatments included addition of 100 µM ATP, control 
vesicles without any protein or cell bath solution (control buffer). Data were analyzed by paired 
student’s t test (*** P<0.001). 
 
8.2.4. UNRAVELING THE SIGNALING PATHWAY BY WHICH SP-B INDUCES 
LAMELLAR BODY EXOCYTOSIS IN ATII CELLS 
In order to get deeper insight into the effect of SP-B on LB secretion, besides 
evaluating LB fusion with plasma membrane the exocytotic response was studied 
focusing on the percentage of cells responding to the stimulus, by analysis of Ca2+ 
signaling through Fura-2 measurements. Figure 8.8 A shows that both ATP and SP-B-
containing vesicles induced Ca2+ signal in the majority of cells (about 90% of cells). 
However, regarding the fusion activity, SP-B vesicles induced lamellar body fusion in 
65% of cells, while ATP, despite promoting a robust Ca2+ response, only caused LB 
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fusion in 25% of cells (Figure 8.8 B). Therefore, SP-B seems to stimulate surfactant 
secretion in a more efficient and potent way than ATP. 
 
Figure 8.8. Effect of ATP or SP-B on the proportion of ATII cells showing LB fusion with plasma 
membrane. (A) Effect of ATP or SP-B on the percentage of cells showing LB fusion-associated 
calcium signal. (B) Effect of ATP or SP-B on the proportion of cells with fusion activity. ATII cells 
were stimulated with 100 µM ATP or vesicles containing SP-B at a final concentration of 13 µM. 
Values are means ± SEM. Data were analyzed by paired student’s t test (*** P<0.001). 
 
With the aim of unraveling the signaling pathway by which SP-B promotes lamellar 
body fusion and subsequent surfactant release from ATII cells, SP-B-stimulated LB 
exocytosis was assessed in the presence of different antagonists, chemical agents and 
ionic conditions. A significant decrease in the levels of SP-B-induced LB exocytosis was 
found when cell cultures were treated with suramin, an agonist of P2Y2 purinergic 
receptors, or when extracellular ATP was depleted by addition of apyrase (Figure 8.9 A). 
These results suggest that SP-B-induced LB exocytosis is mediated by ATP through 
activation of the P2Y2 purinergic receptors. Attempts to detect a SP-B-promoted direct 
increase in ATP concentration at the extracellular medium revealed a trend of SP-B to 
induce higher extracellular concentration of ATP (Figure 8.9 B), which resulted non-
significant as a consequence of high inter-experimental variability. The recent finding 
that ATP is also stored and secreted within LBs (Fois et al., 2018), together with the 
variability of the number of exocytotic events per cell, may be behind that high variability 
in total extracellular ATP levels as detected at prolonged times. We still speculate that 
the source of a primary local rise in ATP concentration could be the release of intracellular 
ATP towards the extracellular medium, which could be triggered by SP-B. Connexin and 
pannexin channels have been proposed as ATP release pathways in a broad range of cell 
types. To test whether this type of channels could be involved in SP-B-induced ATP 
release by ATII cells, inhibitors of pannexin/connexin channels were used. Treatment of 
cells with flufenamic acid (FFA) or carbenoxolone (CBX) caused a marked reduction of 
SP-B-induced LB secretion (Figure 8.9 A). In the light of these results, we propose that 
extracellular SP-B, via a yet unknown mechanism, results in opening of hemichannels 
and ATP release towards the hypophase in primary ATII cells. This released ATP then 
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triggers a local autocrine or paracrine activation of P2Y2 receptors, inducing purinergic-
signaling mediated LB exocytosis. 
 
Figure 8.9. SP-B induces LB exocytosis via activation of P2Y2 purinergic pathway through ATP 
release by ATII cells. (A) Evaluation of SP-B-stimulated LB exocytosis in the presence of several 
inhibitors of purinergic pathway, suramin and apyrase, and pannexin/connexin hemichannels, 
flufenamic acid (FFA) and carbenoxolone (CBX) (under conditions detailed in Materials and 
Methods). Vesicles containing SP-B at a final concentration of 13 µM were used for ATII cell 
stimulation of exocytosis, whereas ATP 100 µM was used as a control for stimulation. Values are 
means ± SEM. Data were analyzed by paired student’s t test (*** P<0.001). (B) Time-course of ATP 
release (fold increase) in ATII cell cultures non-treated (white squares) or treated (black circles) with 
SP-B vesicles. Results have been averaged from 7 independent experiments. Extracellular ATP was 
quantified by the luciferase assay. Data show mean +- SD. T-test analysis were performed between 
non- and SP-B-treated cells at 5 and 10 min, showing non-significant differences. 
 
To further substantiate our hypothesis that SP-B induces LB exocytosis through an 
ATP release mechanism and the subsequent activation of purinergic P2Y2 receptors, the 
impact of SP-B on intracellular Ca2+ signals was evaluated. Regulated surfactant secretion 
is linked to a rise in intracellular Ca2+ concentration that is essential to recruit the 
exocytotic machinery. Stimulation with ATP results in a Ca2+ signal consisting of an early 
peak, sustained by intracellular Ca2+ release, and a delayed plateau phase, as a result from 
Ca2+ entry (Frick et al., 2001; Dietl, Haller and Frick, 2012). In line with our hypothesis, 
that SP-B triggers LB fusion via release of ATP through channels, inhibitors flufenamic 
acid (FFA) or carbenoxolone (CBX) significantly reduced the percentage of cells 
showing a Ca2+ peak upon SP-B treatment (Figure 8.10 A). Also, presence of 
extracellular suramin or apyrase, as well as depletion of intracellular Ca2+ stores using the 
endoplasmic Ca2+-ATPase inhibitor thapsigargin, abolished the SP-B induced Ca2+ peak. 
Inhibition of Ca2+ peaks was in accordance with a reduction in SP-B-induced LB 
exocytosis (Figure 8.10 A and 8.10 B). Surprisingly, removal of extracellular Ca2+ alone 
(which does not affect the ATP-induced initial Ca2+ peak resulting from release of Ca2+ 
from intracellular stores) also decreased significantly the frequency of SP-B induced-Ca2+ 
peaks and LB exocytosis (Figure 8.10 A and 8.10 B). This could indicate that 
extracellular Ca2+ might be required upstream of the SP-B-mediated activation of the 
purinergic pathway. For instance, Ca2+ might somehow mediate SP-B binding to 
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particular sites of the ATII plasma membrane or modulate ATP release through channels. 
Nevertheless, further research will be needed to clarify the role of extracellular Ca2+ in 
SP-B-stimulated surfactant secretion by ATII cells. 
 
Figure 8.10. Relevance of Ca2+ in SP-B-induced LB exocytosis in ATII cells. Evaluation of SP-B-
induced Ca2+ signal (A) and SP-B-induced LB exocytosis (B) in the presence of several inhibitors of 
purinergic pathway, suramin and apyrase, pannexin/connexin hemichannels inhibitors, carbenoxolone 
(CBX) and flufenamic acid (FFA), and thapsigargin (Thap), inhibitor of the sarco/endoplasmic 
reticulum Ca2+ ATPase, as well as some saline conditions, depleted Ca2+ from cell bath solution 
(procedure detailed in Materials and Methods). ATII cells were stimulated with vesicles containing 
SP-B at a final concentration of 13 µM or 100 µM ATP for control of stimulation. Values are mean ± 
SEM. Data were analyzed by paired student’s t test (*** P<0.001). 
 
To discard a potential cytotoxic effect of these treatments, we assessed the percentage 
of cells whose plasma membrane was damaged and allowed permeabilization of the probe 
FM1-43 and the subsequent staining of internal membranes (Table 8.1 and Figure 8.11). 
In all the conditions tested, the percentage of viable cells was always higher than 96.7 %. 
 
Table 8.1. Cell viability during SP-B- or ATP-stimulated LB fusion experiments. Fraction of 
viable (non-damaged) ATII cells in the presence of apyrase (50 U/ml), 800 µM suramin, 200 nM 
thapsigargin, 100 µM flufenamic acid, 10 µM carbenoxolone or Ca2+-free extracellular solution. 
Cytotoxicity of the different treatments was evaluated from the proportion of ATII cells that uptake 
FM1-43 into their internal membranes. Data are shown as % cell viability (SD). 
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Figure 8.13. Cytotoxicity of different exocytosis stimulators and inhibitors on ATII cell cultures. 
Representative images from SP-B or ATP-stimulated LB fusion experiments in the presence of 50 
U/ml apyrase, 800 µM suramin, 200 nM thapsigargin, 100 µM flufenamic acid (FFA), 10 µM 
carbenoxolone (CBX) or Ca2+ free-extracellular solution. Cells whose plasma membrane integrity is 
damaged (white arrows) show a strong FM1-43 labeling of the internal membranes, specially the pool 
of lamellar bodies in the cytoplasm. Additionally, FM1-43 signal stains vesicles and secreted LBs in 
solution, as well as LBs in late stages of secretion that remain attached to the cell. Scale bars show 
25µm. 
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In order to identify the putative ATP release channel regulated by extracellular SP-B, 
a co-immunoprecipitation assay with an anti-SP-B antibody was performed on a 
preparation of plasma membrane from rat primary ATII cell cultures pre-incubated with 
SP-B vesicles.  The assay consisted of several steps, from light to harsh treatments, to 
elute SP-B and SP-B-bound protein complexes. The electrophoretic analysis of the 
different eluted samples showed the presence of multiple bands for most of the elution 
treatments (Figure 8.11). Several silver-stained bands were subjected to protein 
identification by mass spectrometry, revealing that the bands of around 20 KDa from 
SDS-eluted samples contained porcine SP-B (red arrowhead). However, none of the 
remaining analyzed bands (black arrowheads) was successfully identified as plasma 
membrane proteins from ATII cells. Specifically, bands 2 and 3 were identified as bovine 
serum albumin, protein present in some of the buffers used during co-
immunoprecipitation, whereas band 5 contained keratin, a common protein contaminant. 
Analysis of bands 1 and 4 did not provide conclusive results. 
 
Figure 8.11. Co-immunoprecipitation assay of SP-B vesicles with plasma membrane of ATII 
cells. SDS/PAGE was performed on gradient gels of 4-20% acrylamide. For immunoprecipitation, α-
SP-B antibody was used. Protein elution was performed under several conditions. MW: molecular 
weight; E1: 0.2 M glycine eluted fraction; E2.1 and E2.2: two consecutive SDS eluted fractions; E3.1 
and E3.2: β-mercaptoethanol eluted fractions. After SDS/PAGE, labeled bands were analyzed by mass 
spectrometry analysis, indicating the presence of porcine SP-B (red arrowhead), bovine serum albumin 
(bands 2 and 3) and keratin (band 5). No protein was successfully identified from bands 1 and 4. 
 
 
8.3. DISCUSSION 
Surfactant secretion is highly regulated in alveolar type II cells by a concerted action 
of several physicochemical agents, such as mechanical stimulation or CO2, and several 
agonists are known to activate surfactant secretion pathways. Here we demonstrate that 
surfactant protein SP-B is a potent factor stimulating the secretion of lamellar bodies by 
alveolar type II cells. SP-B stimulation prompts a rise in cytoplasmic calcium 
concentration, which is sufficient to trigger fusion of LBs with the plasma membrane and 
surfactant release. The increase of [Ca2+]c would be related to intracellular Ca
2+ release, 
and is followed by a plateau phase of the Ca2+ signal, sustained by Ca2+ entry from the 
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extracellular space. In the light of the present results, we propose the following model of 
the mechanisms behind SP-B-induced surfactant secretion (Figure 8.12). Initially, 
extracellular SP-B leads to a local ATP release from ATII cells through channels via a 
yet unknown mechanism that likely involves Ca2+-dependent binding of SP-B to ATII 
cells. ATP then activates purinergic P2Y2 receptors in an autocrine/paracrine fashion, 
which results in hydrolysis of phosphatidylinositol (3,4,5)-trisphosphate (PIP3) into IP3 
by phospholipase C (PLC). IP3 activates receptors (IP3R) on intracellular Ca
2+ stores and 
leads to release of Ca2+ into the cytoplasm, prompting LB exocytosis. In addition to 
activation of the purinergic pathway, ATP could mediate the entry of Ca2+ from the 
extracellular medium (probably via P2X4 receptors (Miklavc, Thompson and Frick, 
2013)), which triggers a late exocytotic activity. Previous work had already shown similar 
autocrine ATP-stimulated surfactant secretion in response to mechanical stretching (Patel 
et al., 2005).  
 
Figure 8.12. Pulmonary surfactant protein SP-B as a key element for pulmonary surfactant to 
regulate its own secretion by ATII cells. Secreted SP-B stimulates surfactant secretion via 
hemichannel-mediated ATP release. ATP released into the extracellular fluid triggers the activation 
of P2Y2 purinergic receptors, which leads to the generation of IP3 and concomitant Ca2+ release from 
intracellular Ca2+ stores via IP3 receptors. Rise in [Ca2+]c triggers lamellar body fusion with plasma 
membrane and surfactant release. 
 
Although we propose that SP-B-induced ATP release is mediated by opening of 
channels in alveolar type II cells, further experiments will be required to identify the 
specific channel involved, as well as the extent and the location of the specific sites at 
which ATP release is primarily triggered by the action of SP-B at the plasma membrane 
of ATII cell. Several studies have reported a connection between Pannexin-1-dependent 
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ATP release and activation of purinergic P2Y2 receptors in a variety of cell types (Séror 
et al., 2011; Lu et al., 2012; Velasquez and Eugenin, 2014). Moreover, pannexin-1 
hemichannels are expressed in A549 cells, an ATII cell-derived line, where they may 
elicit hypotonicity-induced ATP release (Seminario-Vidal et al., 2011). Pannexin-1 might 
therefore be a good candidate to mediate ATP release in SP-B-stimulated ATII cells, 
something that should be confirmed by further studies. Another feature that still remains 
unclear is the mechanism by which SP-B might activate the opening of channels and ATP 
release. This process could be driven directly by SP-B or through an intermediate 
molecular machinery, which could involve a plasma membrane protein receptor in ATII 
cells. At this point, the co-immunoprecipitation assay of SP-B with plasma membrane of 
ATII cells did not shed light about the identity of a putative receptor of SP-B. A future 
extension of this work should pursue the identification of molecular events linking the 
activation of channels with SP-B action at the plasma membrane of ATII cells. 
Regarding the blocking assays with antibodies, the results suggest, once again, that 
SP-B is associated with SP-C in surfactant membranes, although SP-C would not be 
directly involved in stimulation of surfactant secretion. This is consistent with a previous 
study that revealed the existence of SP-B/SP-C complexes in secreted LBs, which would 
form a “gating” machinery allowing the unravelling of surfactant membranes of the LB 
and their rapid spreading once at the air-liquid interface (Hobi et al., 2016). Regarding 
the implication of anionic phospholipids in SP-B-induced LB secretion, our results 
suggest that POPG could modulate the structural disposition of the SP-B oligomer to 
achieve an optimal activity. This effect of POPG over the structural conformation of the 
SP-B oligomer was also stated in Chapter 2, where the presence of the anionic 
phospholipid was found to be important for achieving the native pulmonary surfactant 
permeability to polar molecules.  
Despite surfactant secretion is primarily stimulated by mechanical stretching of the 
epithelial alveoli during breathing, our results show for the first time that SP-B may act 
as a positive regulatory key element of pulmonary surfactant exocytosis via purinergic 
signaling pathway. The participation of other surfactant proteins in the regulation of 
surfactant exocytosis has been previously described. Hydrophilic surfactant protein SP-
A inhibits surfactant secretion through the specific receptor SPAR via activation of 
phosphatidylinositol 3-Kinase (PI3K) in ATII cells (Dobbs et al., 1987; Rice et al., 1987; 
Strayer, Yang and Jerng, 1993; White and Strayer, 2000). Several lines of evidence 
support the existence of possible interactions between SP-A and SP-B. Both proteins are 
required for the formation of tubular myelin, another type of highly ordered array of 
surfactant membranes, which suggests a likely specific interaction between them (Perez-
Gil, 2008). Other experimental results have also suggested SP-A/SP-B relationships via  
direct protein-protein interactions (Taneva and Keough, 2000) or mediated by lipids 
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(Sarker, Jackman and Booth, 2011). Besides this, the results obtained in Chapter 1 also 
pointed the possibility of the existence of SP-A/SP-B complexes in native surfactant 
membranes. In the light of the present results, we propose that pulmonary surfactant might 
regulate its own secretion through the coordinated action of SP-B-inducing and SP-A-
inhibiting activities. Combined effects of SP-B and SP-A on surfactant secretion might 
be elicited by the interaction of extracellular forms of both proteins.  
To conclude, the present work showed evidences of the relevance of SP-B in the 
alveolar homeostasis. SP-B would not be only essential for the optimal surface active 
function of surfactant at the interface, but also our current in vitro results suggests that 
SP-B acts as a potent stimulating agent of purinergic-mediated surfactant secretion by 
ATII cells, ensuring that a proper density of newly secreted surfactant complexes are 
assembled at the respiratory interface. 
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9. GENERAL DISCUSSION 
In this work, three main features of pulmonary surfactant have been extensively 
analyzed: membrane aggregation as a basis to rearrange surfactant structures, membrane 
permeability through the generation of pores generation which allow the flow of both 
polar solutes and lipids, and stimulation of surfactant secretion by alveolar type II cells. 
In all of these three activities, the action of protein SP-B has been found to be essential. 
Throughout this Thesis, the existence of a supramolecular organization of SP-B in 
pulmonary surfactant has been repeatedly proven. Besides native SP-B complexes 
purified from detergent-solubilized surfactant membranes, SP-B dimers from both the 
whole organic extract of pulmonary surfactant or the protein isolated in organic solvent 
are able to self-assemble yielding a ring-shaped structure of the SP-B oligomer that 
locates over the polar head groups of bilayers and monolayers. Besides these structures, 
a more complex organization of the oligomers, in the form of fibers or protein clusters, 
could be also inferred from our results, though their structure and functional implication 
has to be still further investigated.  
It was previously known that the ability of SP-B to induce tight connections between 
membranes yields the generation of multilayered structures associated to the interface 
(Taneva and Keough, 1994b; Krol et al., 2000; Diemel et al., 2002; Cruz et al., 2004; 
Cabre et al., 2009; Bernardino de la Serna et al., 2013) that appear to be crucial for 
sustaining the surface active film against the mechanical stress induced by continuous 
compression-expansion cycles (Schurch et al., 2010). Time-resolved FRET experiments 
performed in this Thesis provide quantitative information of the topology of membrane 
aggregates induced by SP-B, confirming that the connection between two neighboring 
bilayers is mediated by the vertical apposition of two SP-B ring-shaped oligomers. These 
structures would be relevant for the role of SP-B not only on the biophysical function of 
pulmonary surfactant at the alveolar interface, but also on the biogenesis of lamellar 
bodies and the structural rearrangements that undergo surfactant once secreted into the 
alveolar subphase (Perez-Gil, 2008). 
Regarding the permeability properties of surfactant, the selective blockage of SP-B 
with antibodies allowed to determine that SP-B ring-shaped structures are responsible for 
the formation of pores in surfactant membranes, which allow the flow of polar molecules, 
as well as the lipid transfer through interconnected membranes of the surfactant reservoir, 
and between those membranes and the interfacial monolayer. As mentioned above, SP-B 
mediates the connection between membranes through the interaction of two SP-B 
oligomers, which would constitute a lipid transfer machinery, shielding the acyl chains 
of phospholipids in hydrophobic cavities provided by SP-B dimers and exposing the polar 
head groups towards the aqueous solvent, as previously proposed by (Olmeda et al., 
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2015). Thus, SP-B rings are essential to ensure optimal interfacial adsorption and stability 
of the surface active film during respiratory cycles, so that permeability of surfactant 
membranes appears to be a consequence of the architecture of the SP-B machinery 
specialized in lipid transfer between interconnected bilayers and between bilayers and 
monolayer. Furthermore, the existence of such pores would, as a consequence, provide 
surfactant membranes with the ability to facilitate diffusion of ions, gases, such as 
oxygen, poorly soluble in water, or small peptides involved in innate defense, ensuring a 
proper ion balance in the alveolar subphase (Parra et al., 2013) and a rapid oxygen 
diffusion from air space (Olmeda et al., 2010).  
In addition to study the role of SP-B on membrane permeability and on the surface 
behavior of pulmonary surfactant, the stimulating effect of SP-B on surfactant secretion 
by alveolar type II cells was also revealed for the first time. Extracellular membrane-
associated SP-B promotes lamellar body fusion with plasma membrane and subsequent 
surfactant secretion via P2Y2 purinergic pathway in primary ATII cell cultures. We 
propose that stimulation of LB exocytosis could be triggered by SP-B rings that are not 
participating in connections between surfactant membranes. These free SP-B oligomers 
might be available to interact with ATII cells triggering the activation of purinergic P2Y2 
receptors via channel-mediated ATP release, leading finally to lamellar body fusion with 
plasma membrane and surfactant secretion. The final stage of surfactant secretion 
stimulation would be reached once the hypophase is fullly replenished with a sufficiently 
dense network of surfactant membranes, in which most of the secreted SP-B rings would 
be participating in connections between membranes or between those and the interfacial 
monolayer. In this way, extracellular SP-B complexes may act as a feedback mechanism 
to ensure availability of enough surfactant to convert the alveolar interface into a so-called 
“membrane interface” (Olmeda et al., 2015), optimized to facilitate rapid transfer of 
lipids, as well as transit of polar molecules, ions and gases. Future work should confirm 
whether the proposed SP-B regulatory mechanism also regulates pulmonary surfactant 
pools and alveolar homeostasis in vivo. 
A considerable outcome of this work is the importance of the preservation of native 
interactions in the whole surfactant system. Despite the crucial role of SP-B in the 
investigated activities of surfactant, interactions of this protein with the many other 
components of the system have been found to be significant. It has been widely described 
that SP-B establishes preferential electrostatic interactions with anionic phospholipids 
through its cationic amino acids (Baatz, Elledge and Whitsett, 1990; Perez-Gil, Casals 
and Marsh, 1995; Cabré et al., 2012). Our results are in agreement with these published 
data, as PG, the most abundant anionic phospholipid in PS, becomes relevant to ensure 
the proper function of SP-B in pulmonary surfactant with respect two key features: 
membrane permeability and stimulation of surfactant secretion by alveolar type II cells. 
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However, in contrast to a previous work that considered that anionic phospholipids could 
be necessary for the oligomerization of SP-B (Olmeda et al., 2015), here  we have 
demonstrated that PG is not essential for SP-B dimers isolated in organic solvent to 
oligomerize in a phospholipid environment, displaying a structure similar to those 
complexes formed in the presence of PG or the native SP-B complexes purified in 
detergent. We speculate that PG is still crucial at surfactant layers to promote a solid 
anchor of SP-B rings at the surface of membranes and monolayers. Only with that solid 
attachment, SP-B rings could play their key role to I) facilitate efficient flow of surface 
active species and II) stabilize multilayered structures along breathing mechanics. 
Besides lipids, SP-B oligomers also demonstrated to be associated with other 
surfactant proteins. Recently, a time-resolved fluorescence spectroscopy study has 
demonstrated a direct interaction between SP-B oligomers and SP-C (Cabre et al., 2018). 
Here, our results suggest the integration of both proteins into native complexes of 
surfactant solubilized by detergents. Furthermore, it has been certainly proven that the 
original activities of SP-B and SP-C when kept together from the organic extract of 
surfactant, are not preserved after their physical separation during their purification 
process, highlighting the importance of potential native protein-protein interactions. 
Additionally, as in the case of PG, the presence of SP-C has been found to be relevant for 
maintaining the proper native surfactant permeability through SP-B-generated pores. As 
previously discussed, interaction of SP-B and SP-C would be crucial for the spatial and 
temporal modulation of their cooperative and counteracting activities, necessary for the 
optimal function of the system.  
On the other hand, the physical interaction of SP-B with the collectin SP-A has been 
also deduced from 2D BN/SDS-PAGE of surfactant membranes solubilized by CHAPS. 
Further investigations would be necessary to determine whether SP-A and SP-B establish 
direct protein/protein interaction or whether it could be mediated by other molecules, such 
as lipids. Some important physiological implications can be attributed to such 
interactions, because the cooperation of both proteins in several aspects of surfactant 
structure or function has been previously described (Hawgood et al., 1987; Palaniyar et 
al., 1999). Moreover, as a consequence of our results, a new coordinated role of SP-B and 
SP-A could be ascribed to both proteins at the tight regulation of surfactant secretion by 
type II cells.  
As a concluding remark, the present Thesis confirms that SP-B is a central cornerstone 
in the pulmonary surfactant system at a higher level than envisioned before, with SP-B 
participating at every stage of the surfactant cycle. Firstly, SP-B is required to achieve the 
optimal surface activity of pulmonary surfactant at the interface, where the connection 
between membranes established by SP-B rings results essential. Secondly, SP-B is 
General discussion 
240 
 
involved in the proper assembly of surfactant membranes inside the lamellar bodies 
(Stahlman et al., 2000). And lastly, extracellular SP-B stimulates the surfactant 
exocytosis via purinergic pathway, ensuring a proper density of secreted surfactant at the 
alveolar interface.  
In the light of these evidences, it is no surprising that lack of SP-B is incompatible 
with life. The production of human SP-B is therefore a priority if future therapeutic 
strategies in respiratory medicine have to go through restoration of a proper SP-B-based 
surfactant network in the lungs of patients. 
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10. CONCLUSIONS 
1. The native oligomeric structure of SP-B is able to be re-assembled from SP-B 
dimers dissolved in organic solvent once it is reconstituted with lipids in aqueous 
environments. The preferential orientation of these SP-B ring-shaped complexes, 
parallel to the plane of lipid bilayers or monolayers, is related to its function. 
 
2. The presence of anionic phospholipid PG modulates the oligomeric structure of 
SP-B, being necessary for an optimal function of the protein. 
 
3. SP-B participates in native heterocomplexes together with proteins SP-A or SP-
C. Direct interactions SP-A/SP-B and SP-B/SP-C could not be proven in the 
present work. 
 
4. Permeability of surfactant membranes to polar molecules is the consequence of 
the synergistic action of both SP-B and SP-C in bilayers. SP-B is able to induce 
the formation of pores of a defined size in membranes, whereas SP-C participates 
in the architecture of these pores by constricting the pore size. 
 
5. The native SP-B oligomer is responsible of lipid transfer between surfactant 
membranes and the interface, ensuring the optimal surface function of pulmonary 
surfactant. 
 
6. SP-B ring-shaped structures could be simultaneously responsible for both lipid 
transfer and membrane permeability through SP-B pores. 
 
7. SP-B sustains multilamellar structures in surfactant by connecting membranes 
through the vertical apposition of two SP-B rings. These SP-B/SP-B interactions 
would be at the core of the role of SP-B on the biophysical function of pulmonary 
surfactant at the alveolar interface, but also might be involved in the generation of 
lipid packing during lamellar body biogenesis. 
 
8. Extracellular membrane-associated SP-B induces lamellar body exocytosis by 
activation of P2Y2 purinergic signaling pathways in alveolar type II cells. SP-B 
prompts Ca2+-dependent surfactant secretion via ATP release from ATII cells. 
Thus, SP-B is not only relevant for the biophysical function of pulmonary 
surfactant, but also a central element in the surfactant homeostasis at the alveolar 
spaces by regulating its secretion. 
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